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ABSTRACT	  
The	   genome	   of	   humans	   and	   other	   eukaryotes	   contain	   multiple	   non-­‐coding	  
elements	   including	   microRNA,	   which	   are	   now	   recognised	   as	   important	   negative	  
regulators	   of	   gene	   expression.	   Indeed,	  microRNA	  are	   likely	   to	   be	   critical	   regulators	   of	  
the	  biological	  processes	  underlying	  memory	  and	  its	  dysfunction	  in	  Alzheimer’s	  disease.	  
Long-­‐term	   potentiation	   (LTP)	   is	   the	   preeminent	   model	   of	   memory	   widely	   used	   to	  
understand	   its	   underlying	   molecular	   and	   cellular	   processes.	   LTP	   induced	   at	  
hippocampal	   perforant	   path	   synapses	   of	   awake	   freely	   moving	   animals	   shows	  
remarkable	  persistence,	  which	  is	  underpinned	  by	  dynamic	  regulation	  of	  gene	  networks.	  
Our	  recent	  bioinformatic	  analysis	  predicted	  microRNA	  to	  be	   important	  contributors	   in	  
regulating	  LTP-­‐related	  gene	  expression.	  Further,	  our	  microarray	  analysis	  demonstrated	  
concurrent	  with	  rapid	  up-­‐regulation	  of	  mRNA	  expression	  post-­‐LTP	  induction	  was	  rapid	  
down-­‐regulation	  of	  microRNA	  expression.	  Therefore,	  it	  was	  hypothesised	  that	  a	  release	  
of	  microRNA-­‐mediated	  inhibition	  on	  gene	  expression	  may	  contribute	  to	  LTP	  persistence.	  
To	  explore	  the	  significance	  of	  microRNA	  regulation	  following	  LTP,	  the	  expression	  
of	   two	   mature	   microRNA	   (miR-­‐34a-­‐5p	   and	   miR-­‐132-­‐3p),	   down-­‐regulated	   in	   the	  
microarray	   analysis,	  were	   assessed	   with	   RT-­‐qPCR	   in	   our	   in	   vivo	  LTP	   model	   in	   awake	  
male	  Sprague-­‐Dawley	  rats.	  These	  microRNA,	  previously	   linked	  to	  multiple	  LTP-­‐related	  
processes,	  including	  neurotransmission,	  transcription,	  and	  dendritic	  spine	  morphology,	  
were	   confirmed	   to	   be	   down-­‐regulated	   20	   min	   post-­‐LTP	   induction	   in	   a	   N-­‐methyl-­‐D-­‐
aspartic	   acid	   receptor-­‐dependent	  manner.	  While	   levels	   of	   both	  microRNA	   returned	   to	  
baseline	   by	   24	   h,	  miR-­‐34a-­‐5p	   remained	   down-­‐regulation	   at	   5	   h.	   Further,	   no	   temporal	  
regulation	   of	   pri-­‐miR-­‐34a	   was	   found,	   while	   pri-­‐miR-­‐132/212	   showed	   a	   dramatic	   up-­‐
regulation	  at	  20	  min,	  attenuated	  by	  5	  h,	  and	  down-­‐regulated	  at	  24	  h.	  Therefore,	  multiple	  
regulatory	  mechanisms	  appear	  to	  underlie	  the	  expression	  of	  these	  microRNA	  following	  
LTP	  induction.	  
To	  fully	  understand	  the	  potential	  contribution	  of	  miR-­‐34a-­‐5p	  and	  miR-­‐132-­‐3p	  to	  
the	  persistence	  of	  LTP,	  a	  number	  of	  bioinformatic	   tools	  were	  utilised	   to	   identify	  novel	  
targets	   of	   these	   microRNA.	   A	   Weighted	   Gene	   Co-­‐Expression	   Network	   Analysis	  
demonstrated	  these	  microRNA	  did	  not	  target	  clusters	  of	  genes	  temporally	  co-­‐expressed	  
post-­‐LTP.	   Next,	   evaluation	   of	   nine	   microRNA	   targeting	   algorithms	   showed	   no	   one	  
algorithm,	  or	  their	  intersection,	  predicted	  sufficiently	  previously	  validated	  targets.	  Their	  
union,	   however,	   covered	   the	   majority	   of	   this	   microRNA-­‐target	   interactome,	   and	   was	  
filtered	  for	  genes	  annotated	  as	  involved	  in	  LTP-­‐related	  processes.	  This	  identified	  several	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novel	   targets	   of	   miR-­‐34a-­‐5p	   and	   miR-­‐132-­‐3p.	   Of	   interest	   were	   predicted	   interactions	  
between	   miR-­‐132-­‐3p	   and	   the	   α-­‐amino-­‐3-­‐hydroxyl-­‐5-­‐methyl-­‐4-­‐isoxazole-­‐propionate	  
receptor	   subunit	   gene	   Gria2,	   and	   the	   important	   signalling	   molecule	   gene	   Mapk1.	  
Luciferase	   assays	   demonstrated	  miR-­‐132-­‐3p	   does	   interact	  with	  Mapk1,	   but	   not	  Gria2.	  
Further	  investigation	  of	  Mapk1	  using	  RT-­‐qPCR	  and	  Western	  blots	  found	  that	  the	  mRNA	  
and	   associated	   p42-­‐MAPK	   protein	   were	   up-­‐regulated	   5	   and	   24	   h	   following	   LTP	  
induction.	   These	   results	   support	   the	   hypothesis	   that	   miR-­‐132-­‐3p	   is	   involved	   in	  
regulating	  Mapk1	  post-­‐LTP	  induction.	  
In	   summary,	   this	  work	  demonstrated	   that	  microRNA	  are	  dynamically	   regulated	  
following	   LTP	   induction	   and	   that	   they	   can	   target	   genes	   involved	   in	   the	   processes	  
underlying	   its	   persistence.	   Further,	   with	   careful	   consideration,	   microRNA	   targeting	  
algorithms	   have	   the	   potential	   to	   identify	   microRNA	   targets	   for	   further	   investigation.	  
Thus,	   microRNA	   are	   likely	   to	   play	   an	   important	   role	   in	   regulating	   gene	   expression	  
underlying	  LTP	  persistence	  and	  memory.	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1.1 The	  Complexity	  of	  the	  Genome	  
The	  ability	  of	  humans	  to	  think	  broadly,	  empathise,	  and	  to	  use	  language	  and	  tools	  
sets	   us	   apart	   from	   other	   creatures.	   While	   other	   animals	   have	   shown	   some	   of	   these	  
abilities,	  none	  show	  them	  to	  such	  a	  great	  extent	  as	  humans.	  Some	  believe	  humans	  have	  
been	   created	   in	   the	   image	   of	   a	   higher	   being,	   and	   that	   our	   intelligence	   is	   a	   gift.	  
Scientifically,	  evolution,	  through	  the	  accumulation	  of	  small	  changes	  to	  our	  genome	  over	  
millions	   of	   years,	   or	   a	   small	   number	   of	   discrete	   critical	   events,	   combined	   with	  
sociocultural	  influences,	  is	  likely	  to	  be	  responsible	  for	  our	  phenotype	  or	  our	  observable	  
characteristics.	  While	  changes	  in	  human	  society	  and	  culture	  can	  be	  determined	  through	  
the	  investigation	  of	  the	  development	  of	  tools,	  communication,	  and	  rituals,	  changes	  in	  our	  
genetic	  makeup	  can	  be	  traced	  through	  our	  genome	  using	  comparative	  genomics.	  	  
Previous	  analyses	  comparing	  our	  genotype,	  our	  underlying	  genetic	  make-­‐up,	  with	  
our	   closest	  biological	   ancestors,	   the	   great	   apes,	   have	   shown	  very	   little	  difference.	   It	   is	  
estimated	  that	  96%	  of	  our	  genome	  sequence	  is	  homologous,	  with	  these	  changes	  single	  
nucleotide	   substitutions	   and	   sequence	   deletion	   (Chimpanzee	   Sequencing	   and	  Analysis	  
Consortium,	  2005;	  Varki	  &	  Altheide,	  2005).	  These	  changes	  result	  in	  alterations	  in	  amino	  
acid	  sequences	  affecting	  less	  than	  1%	  of	  the	  total	  orthologous	  proteins.	  Proteins,	  which	  
are	  responsible	  for	  the	  expression	  of	  the	  phenotype,	  are	  translated	  from	  RNA	  transcripts	  
which	  are	  transcribed	  from	  genes,	  segments	  of	  the	  DNA	  that	  encode	  functional	  products.	  
As	   such,	   it	   appears	   that	   the	   differences	   in	   the	   phenotype	   between	   humans	   and	  
chimpanzees	   is	   not	   the	   result	   of	   changes	   to	   the	   protein	   coding	   genes,	   but	   may	   be	  
attributed	   to	   changes	   to	   other	   parts	   of	   the	   genome.	   Therefore,	   understanding	   the	  
function	  of	  all	  aspects	  of	  the	  human	  genome,	  not	   just	  those	   involved	  directly	   in	  coding	  
for	  protein,	  is	  crucial.	  	  
The	   Encyclopaedia	   of	   DNA	   Elements	   (ENCODE)	   project	   searched	   the	   human	  
genome	   for	   additional	   functional	   elements	   beyond	   that	   of	   protein	   coding	   genes	  
(Bernstein	   et	   al.,	   2012).	   This	   work	   has	   resulted	   in	   the	   genome	   being	   more	   fully	  
understood,	  with	  80%	  of	  the	  human	  genome	  annotated	  to	  at	  least	  one	  biochemical	  RNA-­‐	  
and/or	  chromatin-­‐associated	  event,	  and	  95%	  of	  the	  genome	  lying	  within	  8	  kb	  of	  a	  DNA-­‐
protein	   interaction.	   Beyond	   protein-­‐coding	   genes,	   the	   genome	   encodes	   regulatory	  
elements	  such	  as	  non-­‐coding	  RNA	  (ncRNA),	  and	   includes	  regulatory	  sites	  such	  as	  DNA	  
methylation	   sites,	   histone	  modification	   sites,	   and	   chromosome	   interaction	   sites.	  These	  
additional	   elements	   are	   highly	   important	   as	   they	   are	   able	   to	   affect	   gene	   expression	  
without	   altering	   the	   DNA	   sequence,	   and	   are	   referred	   to	   as	   epigenetic	   regulators.	   For	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example,	  ncRNA	  are	  transcribed	  and	  contribute	  to	  the	  regulation	  of	  gene	  expression	  at	  a	  
post-­‐transcriptional	  level	  (Mattick	  &	  Makunin,	  2006).	  Methylation	  of	  a	  gene’s	  promoter	  
sequences	   can	   repress	   its	   expression,	   with	   differences	   in	   methylation	   predicted	   to	  
explain	  12	  to	  18%	  of	  the	  variance	  in	  gene	  expression	  between	  humans	  and	  chimpanzees	  
(Pai	  et	  al.,	  2011).	  These	  mechanisms	  are	  able	   to	   change	   the	  expression	  of	   these	  genes	  
without	   affecting	   the	   sequence	   of	   the	   gene	   itself.	   Therefore,	   the	   differences	   in	   the	  
genomes	  are	  not	  likely	  to	  be	  solely	  changes	  to	  the	  protein-­‐coding	  genes,	  but	  also	  to	  the	  
regulatory	  mechanisms	  acting	  on	  them,	  leading	  to	  changes	  in	  how	  the	  genotype	  leads	  to	  
our	  phenotype.	  
This	  means	  that	  in	  order	  to	  fully	  understand	  the	  differences	  between	  our	  species	  
or	  any	  biological	  process,	  moving	  from	  a	  single	  gene	  approach	  to	  a	  more	  holistic	  view	  of	  
gene	  expression	   is	   required	   to	   take	   into	  account	   these	  additional	   regulatory	  elements.	  
Work	  in	  the	  past	  has	  focused	  on	  single	  genes	  and	  their	  involvement	  in	  a	  process.	  While	  
this	   approach	   can	   highlight	   a	   specific	   role,	   it	   does	   not	   take	   into	   account	   the	   genes	  
contribution	   to	   a	   wider	   functional	   network	   underlying	   a	   biological	   process.	   With	  
powerful	  computational	  tools	  coming	  online,	  the	  ability	  to	  look	  at	  gene	  as	  they	  function	  
within	  networks	  as	  a	  whole	  and	  understand	  how	  they	  are	  involved	  in	  a	  biology	  together	  
is	  now	  possible.	  It	  is	  through	  understanding	  these	  interactions	  between	  multiple	  genetic	  
elements	  collectively	  that	  mechanisms	  underlying	  a	  particular	  biology	  or	  disease	  will	  be	  
unveiled.	  	  
	  For	  example,	  the	  genetics	  underlying	  Alzheimer’s	  disease,	  the	  most	  common	  form	  
of	  dementia,	  are	  poorly	  characterised.	  In	  the	  familial	  variant	  of	  the	  disease,	  mutations	  in	  
at	   least	   three	  genes	  have	  been	   identified	  as	  being	  causative.	  However,	   these	  genes	  are	  
specific	   to	   this	   form	   of	   the	   disease	   and	   account	   for	   less	   than	   5%	   of	   all	   cases	   of	  
Alzheimer’s	   (Ballard	   et	   al.,	   2011).	   In	   the	   sporadic	   form	   of	   the	   disease,	   while	  
environmental	  factors	  likely	  contribute,	  it	  is	  estimated	  that	  there	  is	  an	  attributable	  risk	  
of	   70%	   from	   genetic	   components	   (Ballard	   et	   al.,	   2011),	   though	   the	   nature	   of	   these	  
genetic	  components	  is	  unknown.	  Therefore,	   it	   is	  highly	  likely	  this	  sporadic	  Alzheimer’s	  
disease	  has	  a	  complex	  genetic	  origin	  and	  involves	  multiple	  genetic	  elements	  in	  contrast	  
to	  the	  relatively	  simple	  mono-­‐genetic	  origin	  of	  the	  familial	  form.	  	  
Identifying	   the	   gene	   networks	   underlying	   the	   pathology	   of	   Alzheimer’s	   disease	  
requires	   multiple	   tools.	   Genome	   and	   transcriptome	   array	   and	   sequencing,	   and	  
proteomic	  mass	  spectrometry	  can	  be	  used	  to	  help	  identify	  differentially	  expressed	  genes	  
in	   diseased	   brains	   compared	   to	   healthy	   brains.	   With	   the	   combined	   additional	   use	   of	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tools	   such	   as	   chromatin	   immunoprecipitation,	   methylation	   and	   histone	   modification	  
screens,	  and	  computational	  bioinformatic	  tools,	  the	  genetic	  mechanisms	  underlying	  the	  
disease	   and	   how	   this	   leads	   to	   the	   loss	   of	   neurons	   and	   synapses	   in	   the	   brain	   will	   be	  
exposed.	   As	   this	   cell	   death	   could	   result	   from	   abnormal	   cellular	   activity,	   revealing	   this	  
molecular	  pathology	  will	  not	  only	  describe	  how	  these	  cellular	  changes	  occur,	  but	  allow	  
greater	  insight	  into	  how	  multiple	  signalling	  pathways	  are	  altered	  within	  the	  cells	  prior	  
to	  death	   (Crews	  &	  Masliah,	  2010;	  Serrano-­‐Pozo	  et	  al.,	  2011).	  As	   these	  alterations	  may	  
lead	  to	  dysregulation	  of	  memory-­‐related	  gene	  networks	  in	  dementia	  and	  affect	  memory	  
formation	   and	   persistence,	   investigating	   the	   networks	   of	   memory-­‐related	   processes	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1.2 Long-­‐Term	  Potentiation	  	  
Long-­‐term	  potentiation	   (LTP)	   is	   an	  experimental	  phenomenon	   first	   reported	   in	  
1973,	   and	   remains	   the	   leading	   model	   for	   the	   cellular	   and	   molecular	   mechanisms	  
underlying	   memory	   (Bliss	   &	   Gardner-­‐Medwin,	   1973;	   Bliss	   &	   Lomo,	   1973;	   Bliss	   &	  
Collingridge,	   1993).	   Occurring	   at	   synapses,	   the	   structural	   unit	   that	   allow	   neurons	   to	  
communicate	  with	  each	  other,	  LTP	   is	  essentially	  a	  persistent	  enhancement	  of	  synaptic	  
transmission.	  It	  involves	  an	  amplification	  of	  the	  excitatory	  postsynaptic	  response	  (EPSP)	  
after	  a	  bout	  of	  high	  frequency	  stimulation	  (HFS)	  delivered	  to	  presynaptic	  neurons.	  This	  
increase	   in	   the	   EPSP	   persists	   for	   long	   periods	   of	   time.	   Indeed,	   LTP	   has	   been	  
demonstrated	   to	   persist	   at	   synapses	   of	   the	   hippocampus,	   a	   memory	   related	   brain	  
structure,	   in	  rodents	  360	  days	  after	  induction,	  a	  significant	  portion	  of	  their	   life	  (Figure	  
1.1)	  (Abraham	  et	  al.,	  2002).	  This	  persistence	  of	  LTP	  is	  key	  as	  a	  memory	  mechanism,	  as	  
memory	  is	  known	  to	  be	  able	  to	  last	  decades	  in	  humans.	  Strengthening	  this	  link	  between	  
memory	  and	  LTP	  are	  the	  other	  shared	  properties,	   including	  their	   localisation	  to	  active	  
synapses,	   associativity	   properties,	   and	   similar	   gene	   transcription	   and	   translation	  
processes	  (Abraham	  &	  Williams,	  2003,	  2008).	  	  
This	   characteristic	   increase	   in	   the	   EPSP	   following	   LTP	   induction	   has	   been	  
demonstrated	   to	  occur	   following	  stimulation	  of	   the	  visual	   cortex	   in	  humans	   (Teyler	  et	  
al.,	   2005).	  Using	   a	   checkerboard	   image,	  which	   can	   act	   as	   a	   visual	   tetanic	   stimulator,	   a	  
potentiated	  response	  was	  found	  in	  the	  N1b	  component	  of	  the	  visual	  evoked	  potential	  in	  
the	   contralateral	   hemisphere	   to	   the	   stimulated	   eye.	   The	   selectivity	   to	   a	   specific	  
component	   suggested	   it	   was	   not	   mediated	   by	   an	   increase	   in	   global	   brain	   activity.	  
However,	   the	   authors	  noted	   that	   this	   potentiation	   in	   the	  visual	   cortex	  was	  unlikely	   to	  
Figure	  1.1:	  Hippocampal	  LTP	  persists	  for	  at	  least	  360	  days	   in	  vivo	  following	  high	  frequency	  stimulation	  
(4*5T:	  four	  sets	  of	  five	  400	  Hz	  trains	  delivered	  10	  min	  apart).	  The	  fEPSP	  at	  the	  end	  of	  the	  experiment	  was	  
10%	  above	  baseline.	  From	  Abraham	  et	  al.	  (2002).	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underlie	   the	   formation	  of	  a	  memory,	  but	  rather	   increase	  contrast	  sensitivity.	  A	  similar	  
phenomenon	  with	   the	  N1	  component	  of	   the	  auditory	  evoked	  potential	   in	   the	  auditory	  
cortices	  of	  human	  patients	  were	  found	  with	  the	  tetanic	  presentation	  of	  a	  tone	  (Clapp	  et	  
al.,	  2005).	  This	  demonstrates	  that	  LTP	  can	  be	  induced	  through	  environmental	  stimulus,	  
just	  as	  memories	  are.	  
Additionally,	   inhibitory	  avoidance	   training	   in	   the	  hippocampus	  has	  been	  shown	  
to	   induce	   LTP	   (Whitlock	   et	   al.,	   2006).	   In	   this	   study,	   rats	  were	   exposed	   once	   to	   a	   foot	  
shock	  when	   they	  entered	  a	  dark	   chamber,	   forming	  a	   strong	  avoidance	  memory	   to	   the	  
dark	  chamber.	  Measurements	  of	  the	  EPSP	  using	  multi-­‐electrode	  arrays	  implanted	  in	  the	  
hippocampus	  showed	  an	  increase	  following	  exposure	  to	  the	  shock,	  consistent	  with	  that	  
observed	   following	   LTP.	   This	   was	   the	   first	   study	   showing	   LTP-­‐like	   changes	   directly	  
associated	  with	  memory	  formation	  in	  the	  hippocampus,	  and	  demonstrated	  an	  important	  
clear	  link	  between	  LTP	  and	  memory.	  	  
More	   recently,	   it	   has	   been	   shown	   using	   optogenetics	   that	   LTP	   can	   reactivate	   a	  
memory	   following	   its	   inactivation	   in	   the	   fear-­‐related	   brain	   structure,	   the	   amygdala	  
(Nabavi	  et	  al.,	  2014).	  As	  above,	  mice	  injected	  with	  an	  adeno-­‐associated	  virus	  expressing	  
channelrhodopsin,	   were	   exposed	   to	   the	   fear	   conditioning	   paradigm,	   and	   neural	  
pathways	   in	   the	   amygdala	   were	   activated.	   Along	   this	   pathway,	   this	   activation	   caused	  
these	   channelrhodopsin	  proteins	   to	  be	   expressed	   in	   the	  membrane	  of	   the	   cells.	   These	  
channelrhodopsins	  are	  activated	  by	  blue	  light,	  and	  as	  they	  are	  excitatory,	  allow	  an	  influx	  
of	  cations	  and	  generate	  a	  membrane	  potential.	  When	   the	  blue	   light	  was	  administrated	  
with	  a	  long-­‐term	  depression	  (LTD)	  stimulation	  paradigm,	  where	  a	  decrease	  in	  the	  EPSP	  
occurs,	  the	  fear	  memory	  was	  occluded.	  However,	  administration	  of	  LTP	  reactivated	  the	  
memory.	  While	   LTP	   stimulation	  was	  unable	   to	   elicit	   a	   fear	   response	   in	  naive	   animals,	  
this	   study	   suggested	   the	   LTP	   is	   involved	   in	   forming	   neuronal	   traces	   underlying	   a	  
memory.	  
	  
1.2.1 The	  Hippocampus	  
LTP	   can	   be	   induced	   in	   multiple	   regions	   in	   the	   brain	   in	   both	   cortical	   and	  
subcortical	  structures	  (Abraham	  et	  al.,	  2002;	  Cooke	  &	  Bear,	  2014;	  Dityatev	  &	  Bolshakov,	  
2005;	  Zhao	  et	  al.,	  2005),	  but	  the	  most	  common	  region	  to	  study	  LTP	  is	  the	  hippocampus.	  
Located	  deep	  in	  the	  brain	  in	  the	  medial	  temporal	  lobe,	  the	  hippocampus	  has	  been	  shown	  
to	  be	  vital	  for	  the	  formation	  of	  memories,	  classically	  shown	  through	  Henry	  Molaison,	  or	  
patient	  H.M.	   (Corkin,	  2002).	   In	  order	   to	   reduce	   the	   severity	  of	  his	  epilepsy,	   a	  bilateral	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removal	  of	  his	  medial	  temporal	  lobes,	  which	  contain	  the	  hippocampus,	  was	  undertaken.	  
Post-­‐surgery,	  it	  was	  found	  that	  his	  anterograde	  episodic	  memory,	  or	  ability	  to	  form	  new	  
memories,	   had	   been	   ablated	   and	   his	   retrograde	   episodic	   memory	   was	   temporally	  
degraded.	   A	  majority	   of	   his	  memories	   laid	   down	   two	   years,	   but	   some	  up	   to	   11	   years,	  
prior	  to	  the	  surgery	  were	  unable	   to	  be	  recalled.	  However,	  his	  procedural	  memory	  was	  
unaffected	  as	  he	  retained	  motor	  skills.	  While	  this	  memory	  loss	  could	  be	  due	  to	  the	  loss	  of	  
any	   structure	   within	   the	   medial	   temporal	   lobe,	   lesion	   studies	   in	   the	   hippocampus	   of	  
rodents	   have	   shown	   similar	   deficits	   as	  Molaison,	   including	   poor	   inhibitory	   avoidance	  
task	   performance,	   and	   retrograde	   and	   anterograde	   memory	   loss	   (Sara,	   1981).	   These	  
studies	   supported	   the	   hypothesis	   that	   the	   hippocampus	   was	   important	   for	   memory	  
formation.	  	  
Anatomically,	   the	   hippocampus	   is	   well	   defined	   with	   a	   particularly	   organised	  
structure	  compared	   to	  other	   regions	  of	   the	  brain,	  making	   it	   ideal	   for	  experimentation.	  
Axon	   fibres	   from	   the	   entorhinal	   cortex	   which	   form	   the	   perforant	   path	   are	   the	  major	  
source	   of	   input	   into	   the	   hippocampus.	   The	  majority	   of	   these	   fibres	   synapse	   onto	   the	  
granule	  cells	   in	  the	  dentate	  gyrus	  (DG).	  These	  granule	  cells	  project	  via	  the	  Mossy	  fibre	  
tract,	   to	   the	   pyramidal	   cells	   in	   CA3,	  which	   in	   turn	   send	   their	   axons	   to	   CA1	   along	   the	  
Schaffer	   collateral	   tract	   (Figure	   1.2).	   The	   axons	   from	   the	   CA1	   pyramidal	   cells	   then	  
output	   back	   into	   the	   entorhinal	   cortex	   through	   the	   subiculum	   and	   into	   the	   cerebrum	  
through	   the	   fornix.	   Additionally,	  minor	   groups	   of	   fibres	   connect	   the	   different	   regions	  
together	  (Deng	  et	  al.,	  2010).	  For	  example,	  some	  perforant	  path	  fibres	  synapse	  onto	  CA3,	  
Figure	  1.2:	  The	  hippocampus	  and	  the	  tri-­‐synaptic	  loop.	  Perforant	  path	  fibres	  from	  the	  entorhinal	  cortex	  
(EC)	   form	  synapses	  onto	  the	  granule	  cells	  of	   the	  dentate	  gyrus	  (DG).	  Mossy	  fibres	   from	  these	  cells	  then	  
synapse	   onto	   the	   pyramidal	   cells	   of	   CA3.	   The	   Schaffer	   collaterals	   then	   synapse	   onto	   CA1.	   Axons	   from	  
these	  cells	  then	  move	  out	  into	  the	  entorhinal	  cortex	  via	  the	  subiculum.	  Connections	  between	  each	  of	  the	  
regions	  and	  within	  regions	  also	  exist,	  but	  are	  not	  shown	  on	  this	  diagram.	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while	   some	   Schaffer	   collaterals	   synapse	   back	   onto	   CA3	   itself,	   and	   CA1	   receives	   input	  
from	   the	   entorhinal	   cortex.	   This	   circuitry	   is	   preserved	   when	   experimental	   slices	   are	  
prepared	   from	   the	  hippocampus,	   thus	  making	   the	  hippocampus	  an	   ideal	   experimental	  
model	   for	   in	  vitro	  work	  on	  LTP.	  For	   in	  vivo	  work,	  as	   the	  hippocampus	  of	   the	  rodent	   is	  
easily	   accessible,	   sitting	   more	   superficially	   than	   in	   humans	   under	   the	   cerebrum,	  
stimulating	   and	   recording	   electrodes	   can	   be	   inserted	   without	   interrupting	   multiple	  
regions	   of	   the	   brain.	   Together,	   disruption	   of	   these	   areas	   does	   not	   lead	   to	   detrimental	  
effects	  on	  the	  rats	  lives,	  with	  continued	  eating,	  drinking,	  and	  grooming.	  
	  
1.2.2 Mechanisms	  Underlying	  Long-­‐Term	  Potentiation	  
LTP	   is	   an	   enhancement	   of	   synaptic	   transmission.	   When	   one	   action	   potential	  
propagates	   down	   the	   axon,	   it	   causes	   release	   of	   the	   excitatory	   neurotransmitter	  
glutamate	   from	   axon	   terminals	   into	   the	   synaptic	   cleft.	   This	   glutamate	   binds	   to	   the	   α-­‐
amino-­‐3-­‐hydroxyl-­‐5-­‐methyl-­‐4-­‐isoxazole-­‐propionate	  receptors	  (AMPAR)	  or	  N-­‐methyl-­‐D-­‐
aspartic	  acid	  receptor/channel	  complex	   (NMDAR)	  present	  on	   the	  postsynaptic	  density	  
(PSD)	  of	  an	  adjacent	  dendritic	   spine.	  Binding	  of	  glutamate	   to	  AMPAR	  allows	  a	   sodium	  
influx	   through	   the	   associated	   ion	   channel,	   creating	   a	   positive	   charge	   across	   the	  
membrane	  or	  an	  EPSP.	  With	  the	  administration	  of	  LTP-­‐inducing	  HFS,	  increased	  amounts	  
of	   glutamate	   are	   released	   across	   the	   synaptic	   cleft.	   This	   depolarising	   event,	   combined	  
with	   the	   binding	   of	   glutamate	   to	   the	   NMDAR,	   will	   expel	   magnesium	   ions	   from	   the	  
NMDAR	  channels,	  allowing	  the	  crucial	   influx	  of	  calcium	  into	  the	  postsynaptic	  dendritic	  
spine.	  
LTP	  is	  generally	  induced	  electrically,	  using	  different	  stimulation	  patterns	  such	  as	  
delta-­‐	  or	  theta-­‐burst	  paradigms,	  which	  mimic	  physiologically	  induced	  activity	  (Abraham	  
et	  al.,	  2002;	  Bowden	  et	  al.,	  2012).	  However,	  LTP	  can	  be	  induced	  chemically	  by	  activating	  
metabotropic	   glutamate	   receptors	   (Bortolotto	   et	   al.,	   1994),	   or	   by	   the	   application	   of	  
brain-­‐derived	   neurotropic	   factor	   (BDNF)(Messaoudi	   et	   al.,	   2007;	   Ying	   et	   al.,	   2002).	  
Further,	   it	   has	   been	   found	   that	   the	   resultant	   LTP	   can	   have	   distinct	   mechanisms	  
underlying	   its	   induction,	   dependent	   on	   whether	   the	   NMDAR	   is	   activated	   or	   not	  
(Abraham	  et	  al.,	  2002;	  Collingridge	  et	  al.,	  1983).	  During	  NMDAR-­‐independent	  LTP,	  other	  
calcium	   permeable	   channels	   such	   as	   voltage	   gated	   calcium	   channels	   (VGCC)	   may	  
compensate	  for	  the	  functionality	  of	  the	  NMDAR	  (Harris	  &	  Cotman,	  1986;	  Johnston	  et	  al.,	  
1992;	  Moosmang	  et	  al.,	  2005).	  For	  this	  study,	  the	  form	  of	  LTP	  described	  and	  undertaken	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is	  electrically-­‐induced	  NMDAR-­‐dependent	  LTP	  that	  occurs	  at	  perforant	  path	  synapses	  in	  
the	  dentate	  gyrus.	  
In	  this	  NMDAR-­‐dependent	  form	  of	  LTP,	  the	  influx	  of	  calcium	  has	  been	  shown	  to	  
be	   crucial	   for	   the	   persistence	   of	   LTP	   (Raymond,	   2007;	   Raymond	   &	   Redman,	   2002;	  
Regehr	   &	   Tank,	   1990).	   In	   addition	   to	   this	   influx	   of	   calcium	   through	   the	   NMDAR,	  
increased	  calcium	  released	  from	  other	  sources	  appears	  to	  contribute	  to	  the	  persistence	  
properties	   of	   LTP.	   While	   calcium	   through	   NMDAR	   can	   induce	   early	   LTP,	   additional	  
calcium	  release	  from	  the	  endoplasmic	  reticulum	  through	  ryanodine	  and	  inositol	  (1,4,5)-­‐
trisphosphate	   receptors,	   and	   through	   L-­‐type	   VGCC,	   appears	   to	   be	   important	   for	  
activating	   multiple	   signalling	   pathways	   involved	   in	   LTP	   persistence	   (Raymond	   &	  
Redman,	   2002).	   The	   signals	   generated	   by	   the	   release	   of	   calcium	   mediated	   by	   these	  
receptors	   and	   channels	   appear	   to	   lead	   to	   differing	   effects.	   Effects	   through	   NMDAR-­‐
mediated	  calcium	  influx	  only	  appears	  to	  be	  restricted	  to	  the	  dendritic	  spine,	   leading	  to	  
short	  term	  changes,	  while	  the	  additional	  involvement	  of	  L-­‐type	  VGCC	  appears	  to	  activate	  
longer-­‐term	  changes	  at	  the	  soma.	  Indeed,	  these	  effects	  mediated	  by	  the	  differing	  sources	  
of	  calcium	  have	  been	  linked	  to	  the	  temporally	  and	  mechanistically	  distinct	  phases	  of	  LTP	  
(Raymond,	   2007).	   Defined	   based	   on	   their	   time	   constants	   of	   decay,	   LTP1,	   LTP2,	   and	  
LTP3,	   are	   the	   weakest	   to	   strongest,	   shortest	   to	   longest	   phases	   of	   LTP	   respectively	  
(Abraham	  &	  Otani,	  1991).	  
LTP1	   lasts	   for	   a	   few	   hours	   in	   vivo,	   and	   involves	   the	   post-­‐translational	  
modification	   of	   synaptic	   proteins.	   These	   modifications	   include	   increased	  
phosphorylation	   of	   AMPAR	   containing	   the	   subunit	   GluA1	   by	   protein	   kinase	   A	   (PKA)	  
resulting	  in	  increased	  open	  time	  of	  the	  channels,	  allowing	  increased	  exchange	  of	  cations	  
and	   the	   generation	   of	   a	   membrane	   potential	   (Banke	   et	   al.,	   2000).	   Further,	   increased	  
trafficking	   of	   AMPAR	   into	   the	   synapse	   is	   mediated	   by	   the	   calcium	   activated	   kinase,	  
calcium/calmodulin-­‐dependent	  protein	  kinase	  II	  (CaMKII),	  and	  is	  dependent	  on	  subunit	  
composition	   (Hayashi	   et	   al.,	   2000;	   Williams	   et	   al.,	   2007).	   Indeed,	   GluA1-­‐containing	  
AMPAR	   are	   trafficked	   from	   an	   extrasynaptic	   pool	   to	   accumulate	   at	   the	   PSD	   following	  
induction	  and	  are	  crucial	   for	   the	  persistence	  of	  LTP,	   though	   this	  can	  be	  supplemented	  
through	   other	   subunits	   (Granger	   et	   al.,	   2013).	   Combined	  with	   an	   enhanced	   release	   of	  
neurotransmitter,	   these	   are	   likely	   to	   underlie	   the	   rapid	   strengthening	   of	   the	   synapse,	  
though	   this	   effect	   is	   only	   transient.	   For	  LTP	   to	  persist,	   activation	  of	   its	   later	  phases	   is	  
needed.	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LTP2	  can	  persist	  for	  approximately	  two	  days	  in	  vivo	  and	  involves	  the	  synthesis	  of	  
new	  proteins	   at	   synapses	   (Abraham	  &	  Otani,	   1991;	  Abraham	  &	  Williams,	  2003,	   2008;	  
Frey	  et	  al.,	  1989;	  Kang	  &	  Schuman,	  1996;	  Krug	  et	  al.,	  1984;	  Raymond,	  2007).	  Application	  
of	  the	  antibiotic	  anisomycin,	  which	  inhibits	  the	  80S	  ribosome	  and	  therefore	  new	  protein	  
synthesis,	  was	   found	   to	  prevent	  LTP	  persistence	  when	  applied	   to	   the	  dentate	  gyrus	   in	  
vivo	  prior	  to	  the	  stimulation	  (Otani	  et	  al.,	  1989).	  In	  fact,	  this	  protein	  synthesis	  appears	  to	  
be	   required	   immediately,	   as	   application	   of	   anisomycin	   at	   tetanisation	   resulted	   in	   a	  
short-­‐lasting	  potentiation.	  However,	  a	  15	  min	  delayed	  administration	  did	  not,	  suggesting	  
crucial	  LTP	  proteins	  are	  synthesised	  in	  this	  short	  initial	  window	  that	  are	  required	  for	  its	  
maintenance	   later.	   This	   synthesis	   of	   new	   protein	   appears	   to	   not	   require	   new	   mRNA	  
transcription	  to	  occur,	  as	  when	  dendrites	  in	  CA1	  are	  separated	  from	  their	  cell	  bodies	  in	  
slices,	  LTP	  can	  be	  induced	  and	  persist	  for	  a	  short	  time	  before	  decaying	  (Frey	  et	  al.,	  1989;	  
Kang	  &	  Schuman,	  1996).	  	  
Interestingly,	  BDNF	   in	   the	  presence	  of	   anisomycin	   is	   sufficient	   to	  maintain	  LTP	  
persistence	   in	   hippocampal	   slices	   (Pang	   et	   al.,	   2004).	   This	   could	   be	   through	   a	  
compensatory	   mechanism	   mediated	   by	   BDNF	   that	   involves	   a	   brain-­‐specific	   protein	  
kinase	   C	   (PKC)	   isoform,	   protein	   kinase	  M-­‐zeta	   (PKMζ).	   PKMζ,	   shown	   to	   be	   increased	  
following	  LTP	   induction,	   is	   unique	   as	   it	   is	   synthesised	  without	   a	   inhibitory	   regulatory	  
site	  that	  binds	  to	  the	  active	  enzymatic	  site,	  as	  seen	  for	  PKC.	  Therefore,	  this	  allows	  PKMζ	  
to	   be	   constitutively	   active	   once	   synthesised	   (Hernandez	   et	   al.,	   2003;	   Sacktor	   et	   al.,	  
1993).	   In	  hippocampal	  slices,	   increased	  expression	  of	  PKMζ	  protein	   in	   the	  presence	  of	  
anisomycin	   and	   BDNF	   was	   detected,	   with	   inhibition	   of	   PKMζ	   using	   PKMζ	   inhibitory	  
peptide	  (ZIP)	  leading	  to	  LTP	  degradation	  (Mei	  et	  al.,	  2011).	  Its	  increased	  expression	  in	  
the	   absence	   of	   protein	   synthesis	   suggests	   that	   it	   could	   be	   possible	   that	   there	   was	  
decreased	  degradation	  of	  PKMζ,	  resulting	  in	  its	  accumulation.	  
PKMζ	   has	   been	   shown	   to	   be	   important	   in	   promoting	   increased	   movement	   of	  
GluA1-­‐containing	  AMPAR	  from	  extrasynaptic	  sites	  into	  the	  synapse,	  crucial	  in	  increasing	  
the	  excitability	  of	   the	  synapse	   (Selcher	  et	  al.,	  2012;	  Yao	  et	  al.,	  2008).	   It	   is	   through	   this	  
mechanism	   that	   BDNF	   is	   thought	   to	   act	   to	   increase	   AMPAR	   trafficking	   and	   possibly	  
contribute	  to	  the	  maintenance	  of	  LTP.	  Inhibition	  of	  PKMζ	  with	  ZIP	  has	  shown	  that	  LTP	  
persistence	  is	  ablated	  at	  any	  time	  point	  it	  is	  administered,	  suggesting	  continued	  PKMζ	  is	  
crucial	  for	  maintenance	  (Ling	  et	  al.,	  2002;	  Serrano	  et	  al.,	  2005).	  However,	  recent	  findings	  
using	  transgenic	  Pkmζ	  knockout	  mice,	  which	  include	  those	  that	  are	  inducible,	  showed	  no	  
impairment	   in	   LTP	   persistence,	   suggesting	   the	   inhibitor	   ZIP	   may	   not	   be	   specific	   for	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PKMζ	  (Volk	  et	  al.,	  2013).	  Whether	  ZIP	  targeted	  another	  PKC	  isoform	  such	  as	  PKCι/λ	  that	  
may	  be	  involved	  in	  LTP,	  or	  PKMζ	  is	  involved	  in	  LTP	  persistence	  but	  another	  PKC	  isoform	  
compensated	  in	  the	  knockout	  animal,	  it	  is	  likely	  there	  is	  some	  crucial	  involvement	  of	  this	  
family	  of	  molecules	  in	  LTP	  maintenance.	  Indeed,	  this	  supports	  the	  crucial	  need	  for	  new	  
protein	  synthesis	  of	  genes	  such	  as	  PKMζ	  for	  the	  persistence	  of	  LTP.	  
LTP3	   requires	   the	   activation	   of	   new	   transcription	   in	   addition	   to	   the	   new	  
translation,	  and	  can	  last	  days	  to	  weeks	  in	  vivo	  (Abraham	  &	  Otani,	  1991;	  Frey	  et	  al.,	  1996;	  
Nguyen	   &	   Kandel,	   1996;	   Raymond,	   2007).	   The	   application	   of	   the	   transcriptional	  
inhibitor	   actinomycin	   D	   to	   CA1	   and	   dentate	   gyrus	   synapses	   in	   vitro	   and	   in	   vivo	  
respectively	  blocked	  the	  maintenance	  of	  LTP	  3-­‐4	  h	  after	  induction,	  compared	  to	  at	  least	  
8	   h	   normally	   (Frey	   et	   al.,	   1996;	   Frey	   et	   al.,	   1989;	   Otani	   et	   al.,	   1989).	   This	   result	   is	  
consistent	  with	  the	  above	  studies	  with	  the	  separation	  of	  dendrites	  from	  their	  cell	  bodies	  
as	  it	  demonstrated	  that	  transcription	  of	  new	  mRNA	  transcripts	  is	  not	  necessary	  for	  the	  
initial	   stages	  of	  LTP	  up	   to	  3-­‐4	  h,	  but	   is	   required	   for	   the	   continued	  persistence	  of	  LTP.	  
These	  studies	  underscore	  the	  importance	  of	  new	  transcription	  in	  the	  persistence	  of	  LTP.	  
Indeed,	  multiple	  transcription	  factors	  have	  been	  shown	  to	  be	  activated	  following	  
LTP	   induction,	   suggesting	   that	   there	  are	   significant	   changes	   in	  gene	  expression.	  These	  
transcription	  factors	  include	  cAMP	  response	  element	  binding	  protein	  (Creb)	  and	  nuclear	  
factor	   kappa-­‐light-­‐chain-­‐enhancer	   of	   activated	   B	   cells	   (Nf-­‐κb).	   Nf-­‐κb,	   a	   transcription	  
factor	   made	   of	   two	   subunits,	   has	   also	   been	   shown	   to	   be	   important	   for	   LTP,	   with	  
knockout	   of	   the	   p50	   subunit	   impairing	   LTP	   by	   4	   h,	   suggesting	   it	   promotes	   the	  
transcription	  of	   genes	   crucial	   for	   its	   long-­‐term	  persistence	   (Oikawa	   et	   al.,	   2012).	  Creb	  
knockout	  mice	   show	   impaired	   LTP	  persistence	   (Bourtchuladze	   et	   al.,	   1994),	   though	   it	  
may	   not	   be	   crucial	   for	   LTP	   persistence	   (Balschun	   et	   al.,	   2003).	   Importantly	   though,	  
activation	   of	   Creb	   occurs	   through	   its	   phosphorylation	   and	   does	   not	   require	   new	  
translation	  and	  can	  rapidly	  regulate	  the	  expression	  of	   its	  target	  post-­‐LTP.	  One	  of	  these	  
targets	   is	   another	   transcription	   factor,	   early	   growth	   response	   protein	   1	   (Egr1).	  When	  
Egr1	  was	  disrupted	  in	  mice,	  early	  LTP	  was	  unaffected	  yet	  LTP	  and	  memory	  were	  ablated	  
from	   24	   h	   in	   addition	   to	   long-­‐term	   memory	   (Jones	   et	   al.,	   2001).	   Further,	   LTP	   was	  
facilitated	  when	  Egr1	  was	  overexpressed	  (Penke	  et	  al.,	  2014).	  Therefore,	   these	  studies	  
suggest	  that	  Egr1	  is	  important	  for	  the	  persistence	  of	  LTP.	  	  
Egr1	  is	  a	  member	  of	  a	  group	  of	  genes	  that	  are	  rapidly	  transcribed	  independent	  of	  
protein	  synthesis	  following	  the	  induction	  of	  LTP	  called	  immediate-­‐early	  genes	  (IEG).	  IEG	  
genes	   include	   EGR1,	  whose	  mRNA	   transcript	   has	   been	   shown	   to	   be	   rapidly	   regulated	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following	   LTP	   induction	   (Cole	   et	   al.,	   1989).	   Its	   transcription	   is	   protein	   synthesis-­‐
independent	   as	  CREB	   is	   constitutively	   expressed	   and	   activated	  by	  phosphorylation	  by	  
the	  mitogen	  activated	  protein	  kinase	  (MAPK)	  pathway,	  and	  CaMKII	  and	  CaMKIV	  (Bozon	  
et	   al.,	   2003;	   Sun	   et	   al.,	   1994),	   thus	   not	   requiring	   new	   synthesis	   to	   regulate	   the	  
transcription	  of	  target	  genes.	  	  
Additionally,	   another	   IEG	   and	   target	   of	   Creb	   is	   activity	   regulated	   cytoskeleton	  
associated	  protein	   (Arc)	   (Kawashima	   et	   al.,	   2009).	  Arc	   is	   dramatically	   and	   rapidly	  up-­‐
regulated	   post-­‐LTP	   both	   at	   the	  mRNA	   and	   protein	   levels	   and	   is	   localised	   to	   activated	  
synapses	  (Rodríguez	  et	  al.,	  2005;	  Steward	  et	  al.,	  1998).	  Indeed,	  this	  rapid	  transcription	  
of	  Arc	  has	   been	   shown	   to	   occur	   as	   a	   result	   of	   an	   RNA	   polymerase	   II	   being	   poised	   to	  
transcribe	  the	  gene	  (Saha	  et	  al.,	  2011).	  With	  activity	  though,	  the	  polymerase	  is	  released	  
from	   its	   stalled	   state	   and	   begins	   to	   produce	  mRNA	   transcripts.	   This	   suggests	   that	   the	  
rapid	   up-­‐regulation	   of	  Arc	   post-­‐LTP	   is	   crucial	   for	   its	   persistence.	   Further	   knockdown	  
and	   knockout	   experiments	   of	   the	   Arc	   mRNA	   and	   gene	   respectively	   have	   shown	  
inhibition	  of	  LTP	  persistence	  (Guzowski	  et	  al.,	  2000;	  Plath	  et	  al.,	  2006).	  The	  function	  of	  
ARC	   appears	   to	   be	   as	   a	   homeostatic	   regulator,	   enhancing	   endocytosis	   of	   the	   AMPAR	  
receptors	  to	  maintain	  the	  relative	  strengths	  of	  the	  synapses	  in	  the	  dendrite	  (Chowdhury	  
et	   al.,	   2006;	  Rial	  Verde	  et	   al.,	   2006;	   Shepherd	  &	  Bear,	   2011).	  The	  mechanisms	  of	  how	  
ARC	  promotes	  AMPAR	  endocytosis	  is	  not	  yet	  clear,	  but	  the	  rapid	  regulation	  of	  Arc	  post-­‐
LTP	  makes	  it	  a	  suitable	  candidate	  for	  marking	  recently	  active	  synapses	  and	  potentially	  
recruit	   proteins	   that	   mediate	   this	   process.	   ARC	   has	   also	   been	   shown	   in	   vivo	   to	   be	  
important	   for	   the	   stabilisation	   of	   F-­‐actin	   at	   synapse	   sites,	   affecting	   spine	   remodelling,	  
and	  the	  anchoring	  and	  trafficking	  of	  AMPAR	  to	  the	  synapse	  (Kim	  &	  Lisman,	  1999;	  Liu	  et	  
al.,	  2012;	  Messaoudi	  et	  al.,	  2007).	  With	  transcription	  factors	  activated	  post-­‐LTP,	  and	  the	  
importance	  of	  new	  gene	  transcription	  and	  translation	   in	  the	  persistence	  of	  LTP,	  which	  
genes	  are	  expressed	  is	  an	  important	  area	  of	  research.	  
	  
1.2.3 Gene	  Networks	  Regulated	  Following	  LTP	  
To	   fully	   understand	   the	   impact	   and	   role	   of	   new	   gene	   expression	   following	   the	  
induction	  of	  LTP,	  identifying	  the	  genes	  that	  are	  regulated	  and	  the	  relationships	  between	  
them	  is	  important.	  Investigating	  these	  will	  allow	  an	  understanding	  of	  the	  processes	  that	  
are	  occurring	   to	  maintain	   the	   increased	  excitability	  at	   synapses.	  The	   focus	   in	  profiling	  
LTP-­‐related	   genes	   to	   date	   has	   been	   on	   the	   expression	   of	   mRNA	   transcripts	   using	  
microarrays.	  While	   the	  expression	  of	   the	  mRNA	   transcript	  may	  not	  be	   reflective	  of	   its	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protein	  (Dhingra	  et	  al.,	  2005;	  Rogers	  et	  al.,	  2008),	  profiling	  the	  protein	  expression	  will	  
require	   additional	   steps	   to	   consider	   their	   functionality,	   with	  many	   proteins	   requiring	  
post-­‐translational	  modifications	   such	   as	  phosphorylation	  or	   ubiquitination	   in	   order	   to	  
function.	   Therefore,	   while	   not	   necessarily	   correlated,	  mRNA	   can	   give	   an	   indication	   of	  
genes	   that	   are	   potentially	   involved,	   which	   can	   then	   be	   investigated	   in	   more	   depth,	  
including	  the	  expression	  of	  the	  resulting	  protein	  
Four	  groups,	   including	  our	  own,	  have	  undertaken	  microarray	  screens	  to	   look	  at	  
gene	  expression	  following	  LTP	  induction	  in	  vitro	  (Lee	  et	  al.,	  2005;	  Park	  et	  al.,	  2006)	  and	  
in	  vivo	  (Havik	  et	  al.,	  2007;	  Ryan	  et	  al.,	  2011;	  Ryan	  et	  al.,	  2012;	  Wibrand	  et	  al.,	  2006).	  In	  
these	   studies,	   it	   was	   demonstrated	   that	   a	   large	   number	   of	   genes	   were	   regulated	  
following	  LTP	   induction.	  A	  number	  of	  processes	   found	   to	  be	  enriched	   in	   these	  studies	  
included	   signal	   transduction,	   transcription	   and	   translation,	   protein	   trafficking,	   and	  
synaptic	  reorganisation	  and	  growth,	  consistent	  with	  the	  changes	  already	  observed	  at	  the	  
synapse	   post-­‐LTP.	   Some	   regulated	   genes	   were	   also	   linked	   to	   the	   immune	   response,	  
though	  whether	  this	   is	   linked	  to	  LTP	  or	   just	  neuronal	  stimulation	  is	  unknown,	  as	  their	  
expression	  was	  NMDAR-­‐independent	  (Havik	  et	  al.,	  2007).	  
Work	   was	   undertaken	   in	   our	   own	   lab	   using	   Affymetrix	   mRNA	   microarrays	   to	  
temporally	  profile	  which	  genes	  were	  differentially	  expressed	  post-­‐LTP.	  Using	  our	  in	  vivo	  
awake	  rat	  model	  of	  LTP,	  gene	  expression	  was	  profiled	  20	  min,	  5	  h	  and	  24	  h	   following	  
HFS.	  It	  was	  found	  that	  in	  general,	  a	  majority	  of	  the	  transcripts	  were	  rapidly	  up-­‐regulated	  
at	   20	   min	   (Ryan	   et	   al.,	   2011;	   Ryan	   et	   al.,	   2012).	   At	   5	   h	   post-­‐LTP,	   an	   increase	   in	  
transcription	  persisted,	  though	  the	  cohort	  of	  genes	  regulated	  was	  different	  from	  that	  at	  
20	  min.	  By	  24	  h	  though,	  the	  majority	  of	  regulated	  transcripts	  were	  down-­‐regulated.	  Not	  
only	   was	   this	   cohort	   of	   genes	   different	   compared	   to	   the	   previous	   time	   points,	   the	  
number	   of	   genes	   regulated	   was	   higher,	   with	   691	   genes	   differentially	   expressed,	  
compared	   to	   the	   226	   and	  190	   genes	   regulated	  20	  min	   and	  5	   h	   post-­‐LTP	   respectively.	  
Further,	   there	  was	  very	   little	   crossover	   in	   the	  genes	   represented	   in	  each	  dataset.	  This	  
suggested	  that	  post-­‐LTP,	  there	  were	  temporally	  specific	  gene	  expression	  profiles.	  	  
To	   understand	   the	   function	   of	   these	   differentially	   expressed	   genes,	   the	  
bioinformatic	   software	   Ingenuity	   Pathway	   Analysis	   (IPA)	   was	   used.	   While	   an	  
assessment	   of	   those	   transcripts	   most	   differentially	   expressed	   may	   identify	   these	  
processes,	   this	  would	   disregarded	   those	   genes	   undergoing	  minor	   regulation	   that	  may	  
cumulatively	  have	  significant	  effects	  through	  common	  biological	  processes.	  IPA	  allows	  a	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Figure	   1.3:	   IPA	   pathway	   analysis	   of	   LTP-­‐regulated	   genes	   at	   5	   h.	   These	   networks	   predicted	   epigenetic	  
regulation	   by	   HDAC1	   (A)	   and	  miR-­‐24-­‐3p	   (B).	   Red,	   up-­‐regulated	   genes;	   white,	   genes	   not	   regulated,	   but	  
interacts	  with	  other	  genes,	  as	  identified	  by	  IPA.	  A	  solid	  line	  denotes	  a	  direct	  functional	  interaction	  of	  the	  
products	  of	   the	  two	  genes	  while	  a	  dotted	   line	  denotes	  an	   indirect	   interaction.	  An	  arrow	  indicates	   that	  a	  
gene	  product	  ‘‘acts	  on’’	  a	  target.	  Adapted	  from	  Ryan	  et	  al.	  (2012).	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manually	   curated	   database	   of	   relationships	   between	   genes,	   biological	   pathways,	   and	  
canonical	   pathways,	   to	   generate	   gene	   networks	   based	   on	   genes	   that	   are	   differentially	  
expressed.	   However,	   genes	   not	   differentially	   expressed	   that	   could	   be	   involved	   in	   the	  
network	   are	   included.	   For	   example,	   Creb	   was	   found	   to	   not	   be	   regulated	   at	   the	  
transcriptional	  level	  following	  LTP	  induction,	  but	  the	  protein	  was	  predicted	  to	  be	  active	  
post-­‐LTP	   and	   play	   an	   important	   role	   in	   the	   transcription	   response,	   consistent	   with	  
previous	  studies	  (Figure	  1.3A)	  (Alberini,	  2009).	  The	  involvement	  of	  CREB	  in	  regulating	  
part	   of	   these	   gene	   networks	   could	   not	   have	   been	   identified	   from	   just	   looking	   at	  
differentially	  expressed	  genes.	  However,	   its	   role	  can	  be	  highlighted	  from	  bioinformatic	  
analysis	   showing	   genes	   differentially	   expressed	   are	   under	   its	   transcriptional	   control.	  
Therefore,	   these	   networks	   demonstrate	   how	   these	   genes	   are	   regulated,	   how	   they	  
interact,	  and	  the	  processes	  they	  are	  involved	  in,	  elucidating	  potential	  causal	  LTP-­‐related	  
interactions.	  	  
The	  gene	  networks	  created	  for	  the	  three	  time	  points	  post-­‐LTP	  showed	  that	  there	  
was	   a	   high	   level	   of	   complexity	   underlying	   the	   regulation	   of	   gene	   expression.	   In	  many	  
cases,	   each	   gene	   has	   been	   shown	   to	   interact	   with	  multiple	   other	   genes,	   and	   in	   some	  
cases,	  a	  gene	   is	   regulated	  by	  a	  number	  of	  other	  genes	   (Figure	  1.3).	  The	  networks	  also	  
demonstrated	   that	   there	   is	   a	   coordinated	   gene	   response	   to	   LTP,	   with	  multiple	   genes	  
along	  crucial	  pathways	   found	  within	  networks.	  For	  example,	   the	  network	  presented	  in	  
Figure	  1.3A	  was	  biologically	  enriched	   for	  calcium	  signalling	  and	  negative	  regulation	  of	  
gene	  expression.	  Other	  biological	  functions	  such	  as	  transcription,	  protein	  trafficking	  and	  
immune	  response	  were	  also	  found	  in	  other	  networks,	  consistent	  with	  previous	  studies.	  
This	   study	   showed	   that	   these	   changes	   in	   gene	   expression	   across	   time	   are	   likely	   to	  
contribute	  to	  the	  molecular	  and	  structural	  changes	  occurring	  at	  the	  synapse	  leading	  to	  
its	  potentiation.	  	  
Predictions	  as	  to	  how	  these	  complex	  networks	  are	  regulated	  were	  found	  within	  
them.	   While	   transcription	   factors	   targeting	   several	   other	   genes	   were	   identified	   as	  
regulatory	  hubs,	   other	   elements	   such	   as	  histone	  deacetylases	   and	  microRNA	   (miRNA)	  
were	  predicted	   to	  act	  as	   regulatory	  hubs.	  These	  epigenetic	   regulators	  were	  present	   in	  
multiple	   networks.	   For	   example,	  within	   one	   network	   of	   LTP-­‐related	   genes	   at	   5	   h,	   the	  
histone	  deacetylase	  Hdac1,	  was	  predicted	  to	  regulate	  a	  number	  of	  genes	  (Figure	  1.3A).	  
HDAC1	   functions	   by	   removing	   acetyl	   groups	   on	   lysine	   amino	   acids	   on	   the	   histones,	  
causing	   tighter	  winding	   of	   the	   DNA	   around	   it	   and	   preventing	   stretches	   of	   DNA	   being	  
available	  for	  transcription.	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Within	   other	   networks	   at	   5	   h	   were	   two	   miRNA,	   miR-­‐24-­‐3p	   (Figure	   1.3B)	   and	  
miR-­‐34a-­‐3p.	   MiRNA	   are	   short	   RNA	   that	   function	   generally	   as	   inhibitory	   regulatory	  
molecules	   for	   RNA	   stability	   and	   translation.	   As	   the	   microarrays	   did	   not	   profile	   the	  
expression	   of	   miRNA,	   their	   involvement	   was	   predictive	   only,	   with	   the	   expression	   of	  
these	   two	   miRNA	   predicted	   be	   down-­‐regulated	   based	   on	   the	   up-­‐regulation	   of	   their	  
target	   genes.	   These	   predictions	   were	   later	   confirmed	   by	   reverse	   transcription	  
quantitative	  polymerase	  chain	  reaction	  (RT-­‐qPCR)	  (Ryan	  et	  al.,	  2012).	  Therefore,	  miRNA	  
appear	  to	  be	  regulated	  post-­‐LTP,	  and	  are	  predicted	  to	  play	  a	  role	  in	  regulating	  the	  gene	  
networks	  underlying	  the	  persistence	  of	  LTP.	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1.3 MicroRNA	  
DNA	  encoding	  ncRNA	  make	  up	  the	  large	  majority	  of	  the	  human	  genome	  and	  are	  
more	  numerous	  than	  protein	  coding	  regions	  (Bernstein	  et	  al.,	  2012).	  Multiple	  different	  
types	  of	  ncRNA	  exist	  spanning	  a	  range	  of	  sizes,	  and	  function	  (Brosnan	  &	  Voinnet,	  2009).	  
For	  example,	   short	  ncRNA	  (<40	  nucleotides)	   include	  miRNA	  and	  piwi-­‐interacting	  RNA	  
(piRNA).	   However,	   while	   miRNA	   regulate	   gene	   expression	   at	   the	   level	   of	   translation	  
(Fabian	  et	  al.,	  2010),	  piRNA	  have	  been	  shown	  to	  regulate	  gene	  expression	  at	  the	  level	  of	  
transcription	  by	  affecting	  the	  methylation	  surrounding	  promoter	  sites	  for	  transcription	  
factors	  in	  germ	  lines	  and	  neurons	  (Rajasethupathy	  et	  al.,	  2012;	  Watanabe	  et	  al.,	  2011).	  In	  
contrast,	   there	   are	   long	   ncRNA	  of	   at	   least	   300	   nucleotides	   long	   and	   include	   antisense	  
RNAs,	  ribosomal	  RNAs,	  and	  circular	  RNA	  transcripts,	  the	  latter	  shown	  to	  act	  as	  sponges,	  
or	  bind	  and	  inhibit	  large	  numbers	  of	  miRNA	  transcripts	  (Hansen	  et	  al.,	  2013;	  Memczak	  
et	  al.,	  2013).	  Interestingly,	  a	  number	  of	  these	  ncRNA	  have	  been	  shown	  to	  be	  involved	  in	  
memory	   formation	   and	   synaptic	   plasticity	   (Mercer	   et	   al.,	   2008;	   Smalheiser,	   2014),	  
supportive	   of	   the	   potential	   role	  miRNA	  may	   play	   in	   LTP	   as	   hypothesised	   by	   the	   gene	  
networks	  above.	  	  
MiRNA	   are	   functional	   ncRNA	   molecules	   ranging	   from	   15	   to	   34	   nucleotides	   in	  
length,	  and	  of	  an	  average	  length	  of	  22	  nucleotides.	  Numbered	  in	  the	  order	  of	  discovery	  
and	   homology	   (miR-­‐34a	   has	   a	   very	   similar	   sequence	   to	  miR-­‐34c),	   over	   2,500	   unique	  
mature	   human	  miRNA	   are	   identified	   in	   miRBase	   (version	   21)	   (Griffiths-­‐Jones,	   2004).	  
MiRNA	   are	   generally	   negative	   regulators	   of	   protein	   synthesis,	   acting	   by	   inhibiting	  
translation	   or	   promoting	   degradation	   of	  mRNA	   transcripts,	   though	   in	   rare	   cases,	   they	  
are	   able	   to	   activate	   transcription	   (Fabian	   et	   al.,	   2010;	   Vasudevan	   et	   al.,	   2007).	   Their	  
regulatory	   potential	   is	   large	   as	   through	   their	   short	   sequence,	   a	   single	   miRNA	   can	  
regulate	  a	  group	  of	  mRNA	  as	   shown	  above	   in	   the	  LTP-­‐related	  networks.	   In	   fact,	   it	  has	  
been	   predicted	   that	   miRNA	   could	   each	   target	   approximately	   200	   genes	   (Krek	   et	   al.,	  
2005).	  Together,	  miRNA	  have	  been	  predicted	   to	   regulate	   the	   activity	   of	   between	  30%	  
(Bentwich,	  2005;	  Lewis	  et	  al.,	  2005)	  and	  60%	  (Friedman	  et	  al.,	  2009)	  of	  all	  human	  genes,	  
although	   this	   number	   could	  be	   as	   low	  at	   10%	  as	   seen	   in	  C.	   elegans	   (Lall	   et	   al.,	   2006).	  
However,	  with	  miRNA	  present	  in	  all	  body	  tissues,	  even	  the	  most	  conservative	  prediction	  
of	  direct	  interactions	  could	  still	  mean	  significant	  effects	  could	  be	  mediated	  by	  miRNA.	  
Indeed,	  miRNA	  have	  been	  shown	  to	  be	  vital	  for	  cellular	  survival:	  it	  was	  observed	  
that	  20	  weeks	  after	  a	  knock-­‐out	  of	  Dicer,	  an	  important	  miRNA	  processing	  protein,	  there	  
was	   increased	  neurodegeneration	  correlated	  with	  decreased	  expression	  of	  mature	  and	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active	   miRNA	   (Konopka	   et	   al.,	   2010).	   Furthermore,	   the	   importance	   of	   some	   miRNA	  
sequences	   can	   be	   seen	   with	   the	   same	   mature	   miRNA	   sequences	   being	   derived	   from	  
primary	   transcripts	   transcribed	   from	   disparate	   areas	   of	   the	   genome	   (noted	   with	   an	  
additional	   dash-­‐number	   suffix;	   for	   example	   miR-­‐24-­‐1	   and	   miR-­‐24-­‐2),	   showing	  
convergence	   onto	   physiologically	   and	   evolutionary	   important	   inhibitory	   sequences.	  
Therefore,	   this	   underscores	   the	   important	   role	   miRNA	   appear	   to	   play	   within	   the	  
genomic	  landscape.	  
	  
1.3.1 The	  Biogenesis	  of	  microRNA	  
The	  biogenesis	  of	  miRNA	  is	  a	  three-­‐step	  process	  involving	  transcription	  and	  two	  
cleavage	  events	  (Figure	  1.4)	  (Kim,	  2005;	  Krol	  et	  al.,	  2010b).	  Within	  the	  genome,	  miRNA	  
can	  originate	  from	  two	  places:	  between	  or	  within	  genes.	  Those	  miRNA	  that	  lie	  between	  
genes	   are	   generally	   under	   the	   expression	   of	   their	   own	   promoter,	   which	   include	  
plasticity-­‐related	  response	  elements	  such	  as	  Creb	  or	  Nf-­‐κb	  (Li	  et	  al.,	  2012;	  Remenyi	  et	  al.,	  
2010;	  Vo	  et	  al.,	  2005).	  Indeed,	  just	  like	  any	  RNA,	  the	  transcription	  of	  the	  pri-­‐miRNA	  can	  
be	   regulated	   by	   transcription	   factors	   or	   other	   epigenetic	   mechanisms	   such	   as	  
methylation	  and	  histone	  modifications	   (Lujambio	  et	   al.,	   2008;	   Scott	   et	   al.,	   2006).	  With	  
the	  recruitment	  of	  RNA	  polymerase	  II,	  a	  single	  stranded	  primary	  miRNA	  transcript	  (pri-­‐
miRNA)	  is	  produced,	  which	  can	  be	  several	  thousand	  nucleotides	  long	  (Lee	  et	  al.,	  2004).	  
Within	  the	  pri-­‐miRNA	  transcript,	  hairpin	  secondary	  structures	  which	  contain	  the	  mature	  
miRNA	  form	  from	  the	  single	  stranded	  RNA.	  These	  hairpin	  structures	  can	  form	  multiple	  
Figure	  1.4:	  Biogenesis	  and	  function	  of	  microRNA.	  Primary	  miRNA	   (pri-­‐miRNA)	  are	  transcribed,	  cleaved	  
into	   precursor	   miRNA	   (pre-­‐miRNA)	   and	   mature	   miRNA	   duplexes.	   This	   duplex	   is	   broken	   down	   and	  
integrated	  into	  the	  miRNA-­‐containing	  RNA-­‐induced	  silencing	  complex	  (miRISC)	  which	  can	  bind	  to	  mRNA	  
transcripts	   and	   cause	   mRNA	   degradation	   or	   translational	   inhibition,	   depending	   on	   the	   strength	   of	   the	  
complementation	  between	  the	  mRNA	  and	  miRNA.	  From	  Ryan	  et	  al.	  (2015).	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times	  within	  one	  pri-­‐miRNA,	  giving	  rise	  to	  a	  number	  of	  different	  mature	  miRNA	  such	  as	  
the	  pri-­‐miR-­‐132/212	  transcript,	  which	  contains	  the	  hairpins	   for	  both	   the	  mature	  miR-­‐
132	  and	  miR-­‐212	   transcripts.	  These	  pri-­‐miRNA	   rarely	   leave	   the	  nucleus	  due	   to	  highly	  
efficient	  processing	  of	  the	  transcript	  by	  the	  RNase	  III	  enzyme	  Drosha,	  responsible	  for	  the	  
first	  cleavage	  event	  of	  miRNA	  biogenesis.	  However,	  there	  is	  evidence	  that	  pri-­‐miRNA	  can	  
be	  found	  outside	  the	  nucleus	  and	  in	  dendrites	  in	  neurons	  (Lugli	  et	  al.,	  2012).	  	  
The	   first	   cleavage	   event	   by	   Drosha	   converts	   the	   pri-­‐miRNA	   into	   the	   precursor	  
miRNA	   transcript	   (pre-­‐miRNA).	   The	   pre-­‐miRNA	   transcripts	   are	   comprised	   of	   hairpin	  
structures	   and	   are	   an	   average	   length	   of	   70	   nucleotides.	   DiGeorge	   syndrome	  
chromosomal	   region	   8	   (DGCR8)	   protein	   binds	   to	   Drosha	   to	   form	   the	  microprocessor	  
complex	  (Gregory	  et	  al.,	  2004;	  Lee	  et	  al.,	  2003).	  DGCR8	  contains	  an	  RNA-­‐binding	  domain	  
that	  interacts	  with	  the	  pri-­‐miRNA	  (Yeom	  et	  al.,	  2006),	  positioning	  Drosha	  for	  cleavage	  of	  
the	  primary	   transcript	   11	  nucleotides	   from	   the	   junction	  between	   the	  double	   stranded	  
RNA	   hairpin	   structure	   and	   the	   single	   stranded	   RNA	   portion,	   forming	   one	   end	   of	   the	  
mature	  miRNA	  in	  the	  process	  (Figure	  1.5)	  (Han	  et	  al.,	  2006;	  Zeng	  et	  al.,	  2005).	  In	  most	  
cases,	  but	  not	  all,	  a	  two	  or	  three	  nucleotide	  overhang	  will	  be	  present	  on	  the	  3’	  end	  of	  the	  
new	  pre-­‐miRNA.	  	  
Figure	   1.5:	  Summary	   of	   how	   the	  mature	  microRNA	   are	   liberated	   from	   the	   primary	  miRNA	   transcript	  
(pri-­‐miRNA).	   The	   microprocessor	   complex	   cleaves	   the	   pri-­‐miRNA	   11	   nucleotides	   from	   the	   junction	  
between	  single	  and	  double	  stranded	  RNA.	  The	  resulting	  precursor	  transcript	  (pre-­‐miRNA)	  is	  then	  cleaved	  
by	   the	  Dicer	   complex	  approximately	  22	   nucleotides	   from	  where	  Drosha	   cleaved,	   resulting	   in	   a	  mature	  
miRNA	  duplex.	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Both	   Drosha	   and	   DGCR8	   can	   be	   post-­‐translationally	   modified	   to	   affect	   their	  
stability,	  localisation,	  and	  efficiency	  through	  changes	  in	  phosphorylation	  and	  acetylation	  
(Ha	  &	  Kim,	  2014).	  Furthermore,	  it	  has	  been	  shown	  that	  several	  proteins	  are	  able	  to	  act	  
as	  scaffolds	  to	  recruit	  other	  factors	  to	  promote	  the	  processing	  of	  particular	  pri-­‐miRNA.	  
For	   example,	   heterogeneous	   nuclear	   ribonucleo-­‐protein	   A1	   (HNRNPA1)	   can	   promote	  
the	   splicing	   of	   miR-­‐18a-­‐5p	   over	   miR-­‐17-­‐5p	   and	   miR-­‐19a-­‐3p	   with	   whom	   it	   shares	   a	  
primary	  transcript	  (Guil	  &	  Caceres,	  2007).	  
However,	   not	   all	   miRNA	   are	   cleaved	   by	   Drosha.	   First	   shown	   in	   fruit	   fly	   and	  
nematode	  before	  humans,	  miRNA	  can	  originate	  from	  within	  the	  introns	  of	  a	  host	  gene,	  
and	   are	   called	  mirtrons.	   There	   are	   predicted	   to	   be	   up	   to	   240	  mirtrons	   in	   the	   human	  
(Ladewig	   et	   al.,	   2012;	   Okamura	   et	   al.,	   2007;	   Ruby	   et	   al.,	   2007;	   Sibley	   et	   al.,	   2012).	  
Mirtrons	   are	   spliced	   out	   during	   normal	  mRNA	   transcript	   processing	   and	   become	   the	  
equivalent	  of	  a	  pre-­‐miRNA.	  As	  they	  are	  located	  in	  introns,	  their	  expression	  is	  reliant	  on	  
the	  expression	  of	  their	  host	  gene.	  The	  pre-­‐miRNA	  transcripts	  are	  then	  transported	  into	  
the	   cytoplasm	   through	   the	  nuclear	  pores,	  mediated	  by	  an	   interaction	  with	   the	  protein	  
exportin	  5	  (Okamura	  et	  al.,	  2007;	  Yi	  et	  al.,	  2003).	  
In	   the	   cytoplasm,	   pre-­‐miRNA	   can	   be	   processed	   immediately	   into	   the	   mature	  
miRNA	  by	  the	  RNase	  III	  enzyme	  Dicer.	  In	  neurons,	  it	  has	  been	  observed	  that	  pre-­‐miRNA	  
transcripts	  can	  be	  transported	  down	  dendrites	  to	  be	  processed	  at	  synapses,	  where	  Dicer	  
has	  been	  found	  to	  be	   localised	  at	   the	  PSD	  (Lugli	  et	  al.,	  2005;	  Lugli	  et	  al.,	  2008).	   Just	  as	  
with	  Drosha,	  Dicer	   associates	  with	   other	   proteins	   in	   order	   to	   process	   the	   pre-­‐miRNA,	  
including	   TAR	   RNA-­‐binding	   protein	   (TRBP),	   which	   binds	   to	   the	   pre-­‐miRNA,	   and	   can	  
stabilise	   Dicer	   (Chendrimada	   et	   al.,	   2005).	   While	   the	   underlying	   mechanisms	   are	  
unknown,	  TRBP	  has	  been	  able	  to	  affect	  the	  efficiency	  of	  pre-­‐miRNA	  processing	  and	  the	  
length	  of	  the	  mature	  miRNA	  (Fukunaga	  et	  al.,	  2012;	  Lee	  &	  Doudna,	  2012).	  	  
Dicer	  is	  responsible	  for	  cleaving	  the	  hairpin	  loop	  of	  the	  pre-­‐miRNA	  to	  leave	  just	  
the	  double	  stranded	  stem	  (Feng	  et	  al.,	  2012).	  Binding	  to	  the	  nucleotide	  overhang	  on	  the	  
3’	   end	   of	   the	   pre-­‐miRNA,	   Dicer	   has	   been	   shown	   to	   cleave	   22	   nucleotides	   from	   the	  
Drosha-­‐cleaved	  end	  to	  produce	  the	  duplex	  (Figure	  1.5)	  (Park	  et	  al.,	  2011).	  However,	  as	  
pre-­‐miRNA	   can	   vary	   in	   length,	   an	   interaction	   with	   the	   hairpin	   loop	   may	   allow	   for	  
cleavage	   to	   occur	   at	   variable	   distances	   along	   the	   stem	   (Feng	   et	   al.,	   2012;	   Lau	   et	   al.,	  
2012).	  Further,	  it	  appears	  that	  the	  Argonaute	  (AGO)	  proteins	  may	  have	  an	  influence	  on	  
the	  biogenesis	  of	  miRNA,	  with	  studies	  showing	  that	  AGO2	  has	  the	  ability	  to	  cleave	  pre-­‐
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miRNA	  (Diederichs	  &	  Haber,	  2007)	  and	  deficiencies	  in	  AGO2	  expression	  can	  reduce	  the	  
conversion	  of	  pre-­‐miRNA	  to	  mature	  miRNA	  (O'Carroll	  et	  al.,	  2007).	  
As	   a	   result	   of	  processing	  by	  Dicer	   and	   its	   accessory	  proteins,	   the	  pre-­‐miRNA	   is	  
converted	  into	  a	  duplex	  containing	  two	  mature	  miRNA	  bound	  to	  Dicer,	  and	  in	  most	  cases	  
imperfectly	  bound	  to	  each	  other	  (Figure	  1.5).	  Both	  of	  these	  mature	  transcripts	  are	  able	  
to	  be	  active,	  and	  are	  named	  according	  to	  whether	  their	  3’	  or	  5’	  end	  of	  the	  transcript	  was	  
cleaved	   by	   Drosha	   (miR-­‐132-­‐3p/miR-­‐132-­‐5p).	   However,	   there	   is	   normally	   a	  
preferentially	  active	  transcript,	  based	  on	  the	  thermodynamic	  stability	  of	  the	  ends	  of	  the	  
duplex	   (Khvorova	   et	   al.,	   2003;	   Meijer	   et	   al.,	   2014).	   When	   loaded	   into	   the	   miRNA-­‐
containing	   RNA-­‐induced	   silencing	   complex	   (miRISC),	   the	   strand	   with	   the	   weaker	  
interaction	  at	  the	  5’	  end	  is	  more	  frequently	  loaded	  into	  the	  miRISC.	  This	  is	  because	  the	  
AGO	  protein,	  a	  key	  component	  of	  the	  miRISC,	  is	  more	  easily	  able	  to	  unwind	  the	  duplex.	  
When	  no	  bias	  exists,	  both	  strands	  are	  equally	  able	  to	  be	  biologically	  active	  (Yang	  et	  al.,	  
2013).	  When	   one	   is	   preferred,	   the	   guide	   strand	   is	   bound	   to	   the	  miRISC	   and	   becomes	  
active,	   while	   the	   passenger	   strand	   is	   generally	   degraded.	   Once	   the	   miRNA	   is	   loaded,	  
Dicer	  dissociates	  from	  the	  miRISC	  (MacRae	  et	  al.,	  2008;	  Pratt	  &	  MacRae,	  2009).	  
	  
1.3.2 MicroRNA	  Function	  
By	  binding	  to	  an	  AGO	  protein	  and	  its	   incorporating	   into	  the	  miRISC,	  the	  mature	  
miRNA	  increases	  its	  functionality	  against	  complementary	  mRNA	  targets	  compared	  to	  as	  
a	   lone	   transcript	   (Ameres	   et	   al.,	   2007).	  How	   the	  miRNA	   and	   in	   the	  miRISC	   locates	   its	  
targets	   is	   still	   broadly	   unknown.	   It	   was	   initially	   suggested	   targets	   were	   located	   and	  
identified	  while	  they	  were	  being	  translated,	  but	  this	  was	  shown	  not	  to	  be	  a	  prerequisite	  
for	  miRNA	  activity	  (Sen	  et	  al.,	  2005).	  Later	  work	  now	  suggests	  that	  the	  miRISC	  interacts	  
transiently	   with	   single	   stranded	   but	   not	   double	   stranded	   RNA	   molecules	   non-­‐
specifically,	  facilitating	  potential	  hybridisation	  between	  the	  miRNA	  and	  mRNA	  (Ameres	  
et	  al.,	  2007).	  If	  sufficient	  hybridisation	  does	  occurs,	  then	  the	  target	  can	  be	  regulated.	  This	  
regulation	   can	   take	   one	   of	   three	   forms,	   with	   one	   enhancement	   and	   two	   inhibitory	  
mechanisms.	   In	   very	   few	   cases,	   miRNA	   have	   been	   shown	   to	   lead	   to	   increased	  
transcription	   and	   therefore	   translation	   of	   their	   targets	   through	   the	   process	   of	   RNA	  
activation,	  and	  accordingly	  have	  been	  classified	  as	  being	  small-­‐activating	  RNA	  (Li	  et	  al.,	  
2006;	   Portnoy	   et	   al.,	   2011).	   For	   example,	   miR-­‐10a-­‐5p	   was	   shown	   to	   enhance	   the	  
translation	   of	   ribosomal	   proteins	   (Orom	   et	   al.,	   2008),	   while	   let-­‐7	   was	   found	   to	   up-­‐
regulate	  translation	  during	  cell	  cycle	  arrest,	  but	  repress	  translation	  in	  proliferating	  cells	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(Vasudevan	  et	  al.,	  2007).	  In	  most	  cases	  though,	  regulation	  of	  the	  expression	  of	  the	  target	  
mRNA	  is	  through	  mRNA	  degradation	  or	  translation	  inhibition.	  	  
AGO2	  is	  the	  catalytic	  component	  of	  the	  miRISC	  underlying	  the	  cleavage	  of	  target	  
mRNA	  (Liu	  et	  al.,	  2004).	  Responsible	  for	  causing	  hydrolysis	  and	  cleavage	  of	  mRNA,	  it	  is	  
the	   main	   effector	   protein	   involved	   in	   degrading	   the	   target	   following	   near-­‐perfect	  
complementation	  between	  the	  miRNA	  and	  the	  mRNA.	  Furthermore,	   it	  has	  been	  shown	  
that	   this	   cleavage	   mediated	   by	   AGO2	   could	   occur	   multiple	   times,	   with	   increased	  
efficiencies	  with	   large	   amounts	   of	   target	   transcript	   (Ameres	   et	   al.,	   2007;	  Hutvagner	  &	  
Zamore,	   2002).	   With	   partial	   complementation,	   translational	   inhibition	   or	   decreased	  
stability	  of	   the	  mRNA	   through	  deadenylation	  may	  occur	   (Lim	  et	   al.,	   2005)	   and	   can	  be	  
mediated	   through	  multiple	  mechanisms	   (Iwasaki	   et	   al.,	   2009).	   AGO1	  promotes	  mRNA	  
deadenylation,	   which	   eventually	   leads	   to	   degradation	   of	   the	   transcript,	   or	   it	   blocks	  
translation	  after	  5’	  cap	  recognition,	  an	  initial	  step	  of	  translation.	  AGO2	  on	  the	  other	  hand	  
binds	   to	   eukaryotic	   translation	   initiation	   factor	   4E	   (eIF4E)	   at	   the	   same	   site	   that	   it	  
interacts	   with	   eIF4G,	   thus	   preventing	   their	   involvement	   in	   recruiting	   ribosomes	   to	  
translate	  the	  mRNA	  transcript.	  
Of	   these	   two	   negative	   regulatory	   mechanisms,	   translational	   inhibition	   is	   more	  
prevalent	  than	  degradation	  of	  the	  mRNA	  transcript.	  It	  has	  been	  shown	  that	  knockdowns	  
in	   miRNA	   expression	   do	   result	   in	   changes	   in	   the	   expression	   of	   hundreds	   of	   proteins	  
directly	   and	   thousands	   of	   genes	   indirectly	   (Baek	   et	   al.,	   2008;	   Selbach	   et	   al.,	   2008).	  
However,	   there	   is	   little	   correlation	   between	   mRNA	   and	   protein	   expression.	   Initially,	  
prolonged	  inhibition	  by	  the	  miRNA	  eventually	  leads	  to	  degradation	  of	  the	  mRNA.	  This	  is	  
consistent	   with	   evidence	   that	   although	   miRNA-­‐mediated	   mRNA	   degradation	   is	   rare,	  
given	   enough	   time,	   degradation	   will	   occur	   (Baek	   et	   al.,	   2008;	   Eichhorn	   et	   al.,	   2014).	  
Further,	   it	  has	  been	  shown	  that	  effects	  at	  the	  protein	   level	  can	  be	  small,	   leading	  to	  the	  
hypothesis	   that	   at	   least	   in	  mammals	  miRNA	   play	   a	   secondary	   role	   in	   gene	   regulation	  
through	  fine-­‐tuning	  expression	  (Baek	  et	  al.,	  2008;	  Hornstein	  et	  al.,	  2005;	  Nielsen	  et	  al.,	  
2009;	  Selbach	  et	  al.,	  2008).	  However,	  the	  short	  nature	  of	  miRNA,	  which	  allows	  multiple	  
genes	   to	   be	   targets	   of	   a	   singular	  miRNA,	   and	   affect	   global	   expression	   of	   thousands	   of	  
genes,	  predicts	  an	  important	  and	  relevant	  physiological	  role	  for	  miRNA	  in	  the	  regulation	  
of	  a	  large	  number	  of	  genes	  in	  complex	  systems.	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1.3.3 Regulation	  of	  Mature	  microRNA	  Expression	  
Once	  processed	  through,	  the	  expression	  of	  the	  mature	  miRNA	  can	  be	  additionally	  
regulated	  through	  alteration	  of	  their	  stability.	  It	  has	  been	  suggested	  that	  miRNA	  remain	  
stable	  as	  long	  as	  they	  are	  associated	  with	  the	  AGO	  proteins,	  and	  are	  actively	  regulating	  
their	   targets.	   Indeed,	   alteration	   in	   the	   expression	   of	   AGO	   proteins	   can	   alter	   the	   total	  
levels	   of	  mature	  miRNA	   (Diederichs	  &	  Haber,	   2007;	  O'Carroll	   et	   al.,	   2007),	   suggesting	  
that	  while	  the	  miRNA	  are	  in	  the	  miRISC,	  they	  are	  protected	  from	  degradation.	  Further,	  
reduction	   in	   their	   targets	   decreased	   the	   expression	   of	   the	   targeting	   miRNA	   and	   vice	  
versa,	   suggesting	   some	  mechanism	   ensures	   efficient	   use	   of	   the	   miRISC	   (Chatterjee	   &	  
Großhans,	   2009).	   This	   mechanism	   would	   support	   the	   observation	   that	   miRNA	   are	  
rapidly	  turned	  over	  in	  retinal	  cells	  by	  light,	  with	  half-­‐lives	  of	  an	  hour	  or	  less	  (Krol	  et	  al.,	  
2010a).	   These	   findings	   were	   replicated	   in	   both	   hippocampal	   and	   neuronal	   cells,	   the	  
turnover	  shown	  to	  be	  mediated	  by	  neuronal	  activity.	  As	  activity	  regulates	  the	  expression	  
of	   a	   large	  number	  of	   genes,	   it	  was	   suggested	   that	   the	   rapid	   turnover	   is	   the	   result	  of	   a	  
large	  number	  of	  their	  targets	  being	  expressed.	  
How	   the	   stability	   of	   the	   mature	   miRNA	   is	   changed	   though	   is	   still	   mostly	  
unresolved.	  If	  bound	  to	  their	  targets,	  they	  could	  be	  similarly	  degraded,	  along	  with	  their	  
target,	  by	  AGO2.	  Another	  way	  may	  be	  through	  other	  miRNA	  binding	  to	  complementary	  
sequences.	  For	  example,	  miR-­‐107	  has	  been	  shown	  to	  reduce	  the	  stability	  of	  let-­‐7,	  though	  
whether	  this	  requires	  a	  miRISC	  to	  occur	  is	  unknown	  (Chen	  et	  al.,	  2011).	  Additionally,	  it	  
has	  been	  shown	  that	  a	  class	  of	  ncRNA	  called	  circular	  RNA	  (circRNA)	  are	  able	   to	  act	  as	  
“sponges”	   against	   miRNA,	   sequestering	   the	   miRNA	   and	   inhibiting	   their	   expression	  
(Hansen	  et	  al.,	  2013;	  Memczak	  et	  al.,	  2013).	  Interestingly,	  these	  circRNA,	  are	  resistant	  to	  
the	  effects	  of	  miRNA	  as	  they	  are	  not	  degraded	  when	  bound	  to	  their	  target	  miRNA.	  One	  
miRNA,	  miR-­‐7	  has	  been	  found	  to	  be	  a	  target	  of	  both	  ciRS-­‐7	  in	  the	  mouse	  hippocampus	  
(Hansen	   et	   al.,	   2013)	   and	  CDR1	   in	   the	   zebrafish	  midbrain	   (Memczak	   et	   al.,	   2013),	   the	  
latter	   inducing	   impaired	   midbrain	   development	   similar	   to	   a	   miR-­‐7	   knockdown.	   This	  
demonstrates	  circRNA	  have	  the	  potential	  to	  regulate	  miRNA	  expression.	  
Furthermore,	  while	  some	  proteins	  have	  been	  identified	  as	  being	  able	  to	  affect	  the	  
stability	  of	   the	  mature	  miRNA,	   these	  have	  not	  been	   shown	   to	   apply	   to	   all	  miRNA.	   For	  
example,	  it	  has	  been	  shown	  that	  5’-­‐3’	  exoribonuclease	  2	  (Xrn2)	  is	  able	  to	  degrade	  single	  
stranded	   miRNA,	   which	   may	   play	   a	   role	   in	   the	   removal	   of	   the	   passenger	   strand	  
(Chatterjee	  &	  Großhans,	  2009),	   though	  this	  also	  appears	  to	  be	  miRNA-­‐specific	   to	   let-­‐7.	  
Conversely,	   germline	  development	  2	   (Gld2),	  a	  poly(A)	  polymerase,	  has	  been	   shown	   to	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add	  adenine	  to	  the	  3’	  end	  of	  miR-­‐122-­‐5p	  in	   liver	  cells	  and	  has	  been	  shown	  to	  stabilise	  
that	  mature	  miRNA	  transcript,	  though	  as	  the	  stability	  of	  other	  miRNA	  were	  not	  affected	  
when	  Gld2	  was	   removed,	   this	   suggests	   that	   this	   is	   not	   a	   universal	   effect	   (Katoh	   et	   al.,	  
2009).	  However,	  a	  later	  study	  found	  that	  there	  was	  widespread	  addition	  of	  both	  adenine	  
and	   uridine	   nucleotides	   to	   miRNA	   across	   a	   number	   of	   species,	   including	   human	  
(Burroughs	  et	  al.,	  2010).	  Further,	  they	  showed	  that	  adenine	  addition	  modulated	  miRNA	  
effectiveness,	  with	   reduction	   in	   the	   repression	  mediated	  by	   the	  miRNA	  on	   the	   targets	  
and	   alteration	   to	   the	   loading	   of	   the	  miRNA	   into	   the	  miRISC.	  Whether	   this	  means	   that	  
miRNA	  that	  end	  naturally	  with	   these	  nucleotides	  have	  altered	  stability	  and	   function	   is	  
unknown.	  While	  the	  regulation	  of	  the	  mature	  miRNA	  is	  still	  an	  area	  where	  a	   lot	   is	  still	  
unknown,	   early	   indications	   suggest	   that	   there	   are	  multiple	  mechanisms	   regulating	   its	  
expression.	   	  
Long-­‐Term	  Potentiation	  and	  microRNA	   	   25	  
1.4 Involvement	  of	  microRNA	  in	  LTP-­‐Related	  Processes	  
With	  miRNA	  able	  to	  regulate	  large	  networks	  of	  genes,	  it	  is	  likely	  that	  miRNA	  are	  
involved	  in	  regulating	  the	  processes	  underling	  LTP	  via	  the	  genes	  involved	  in	  them.	  Our	  
recent	   review	   of	   the	   literature	   demonstrated	   that	  miRNA	   are	   likely	   to	   impinge	   on	   all	  
aspects	  of	  LTP	  maintenance	  (Ryan	  et	  al.,	  2015).	  These	  processes	  involved	  in	  maintaining	  
LTP	   at	   stimulated	   synapses	   include	   enhanced	   release	   of	   neurotransmitter,	   changes	   to	  
the	   postsynaptic	   responsiveness	   and	   spine	   size,	   and	   changes	   in	   gene	   expression	  
(Abraham	  &	  Williams,	  2008).	  
	  
1.4.1 MicroRNA	  and	  Neurotransmission	  
Two	   major	   mechanisms	   underlie	   LTP	   maintenance	   affecting	   synaptic	  
transmission:	   enhanced	   presynaptic	   release	   of	   neurotransmitter	   and	   enhanced	  
postsynaptic	  responsiveness	  (Abraham	  &	  Williams,	  2003).	  Increased	  quantal	  release	  of	  
neurotransmitter	  can	  activate	  more	  receptors,	  allowing	  for	  a	  more	  prolonged	  response,	  
while	   increased	   numbers	   or	   changes	   in	   the	   type	   of	   receptors	   can	   result	   in	   a	   larger	  
potential	  being	  generated.	  	  
Several	   genes	   involved	   in	   mediating	   the	   release	   of	   the	   presynaptic	   vesicles	  
containing	  neurotransmitter	  have	  been	  shown	  to	  be	  regulated	  by	  miRNA.	  For	  example,	  
the	   activity-­‐dependent	  miRNA,	  miR-­‐485-­‐5p	   has	   been	   shown	   to	   target	   synaptic	   vesicle	  
glycoprotein	  2A	  (Sv2a)	  in	  hippocampal	  neurons	  in	  vitro.	  Overexpression	  of	  miR-­‐485-­‐5p,	  
resulted	  in	  reduced	  vesicle	  release	  following	  depolarisation	  and	  reduced	  AMPA	  receptor	  
density	   (Cohen	  et	  al.,	  2011),	   suggesting	   that	  miR-­‐485-­‐5p	  acts	  as	  a	  part	  of	  homeostatic	  	  
mechanism	  engaged	  following	  synaptic	  plasticity.	  Further,	  miR-­‐34a-­‐5p	  targets	  synapsin	  
I	   (Syn1),	   synapsin	   II	   (Syn2),	   synaptotagmin	   I	   (Syt1)	  and	  syntaxin	  1a	   (Stx1a),	   inhibiting	  
their	  expression	   in	  vitro	  (Agostini	  et	  al.,	  2011).	  Both	  SYT1	  and	  STX1A	  are	  known	  to	  be	  
involved	   with	   LTP,	   mediating	   the	   release	   of	   the	   neurotransmitter	   from	   the	   vesicle	  
(Fujiwara	  et	   al.,	   2006;	  Lee	  et	   al.,	   2010).	  While	  no	   change	   in	   their	   expression	  post	  LTP	  
was	  detected	  on	  the	  microarrays	  (Ryan	  et	  al.,	  2011;	  Ryan	  et	  al.,	  2012),	  down-­‐regulation	  
of	   these	   genes	   was	   concomitant	   with	   the	   up-­‐regulation	   of	   miR-­‐34a-­‐5p	   in	   human	  
Alzheimer’s	  disease	  tissue	  (Agostini	  et	  al.,	  2011;	  Lynch	  et	  al.,	  1994).	  Additional	   targets	  
genes	  of	  miRNA	   include	  sarco/endoplasmic	  reticulum	  Ca2+	  ATPase	  (SERCA2),	  which	   is	  
involved	   in	  maintaining	   calcium	   levels	   in	   the	   endoplasmic	   reticulum.	   Interestingly,	   its	  
overexpression	   in	  a	  mouse	  model	  of	  schizophrenia	   lead	   to	   increased	  neurotransmitter	  
release	   and	   enhanced	   LTP.	   This	  was	   concurrent	  with	   its	   targeting	  miRNA,	  miR-­‐25-­‐3p	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and	   miR-­‐185-­‐5p,	   being	   down-­‐regulated	   (Earls	   et	   al.,	   2012).	   Replenishing	   the	   miRNA	  
returned	   the	   LTP	   back	   to	   normal	   levels,	   providing	   further	   evidence	   miRNA	   may	   be	  
involved	  in	  neurotransmitter	  release.	  
Postsynaptically,	   the	   expression	   and	   regulation	  of	   glutamate	   receptors	   can	   also	  
be	   mediated	   by	   miRNA.	   Increased	   expression	   of	   the	   AMPAR	   and	   NMDAR	   subunits	  
GluA1,	   GluN2A,	   and	   GluN2B	   has	   been	   observed	   following	  miR-­‐132-­‐3p	   overexpression	  
(Kawashima	  et	  al.,	  2010).	  However,	  in	  an	  LTP	  context,	  the	  rapid	  increased	  expression	  of	  
AMPAR	   at	   the	   synaptic	  membrane	   observed	   post-­‐LTP	   is	   due	   to	   changes	   in	   trafficking	  
and	  not	  synthesis	  (Williams	  et	  al.,	  2007),	  though	  increased	  synthesis	  has	  been	  shown	  to	  
occur	   at	   later	   time	  points	   (Kennard	   et	   al.,	   2009).	   Therefore,	   changes	   in	   its	   expression	  
may	  be	  mediated	  by	  miRNA	  through	  affecting	  chaperone	  molecules.	  For	  example,	  ARC,	  
which	  as	  mentioned	  above	   is	   involved	   in	  the	  trafficking	  on	  AMPAR	  out	  of	   the	  synapse,	  
appears	  to	  be	  basally	  inhibited	  by	  a	  group	  of	  synaptically	  located	  miRNA	  (Wibrand	  et	  al.,	  
2012).	   Additionally,	   CaMKIIγ,	  which	  mediates	   the	   rapid	   insertion	   of	   GluA1-­‐containing	  
AMPA	  receptors	  in	  the	  postsynaptic	  membrane	  in	  response	  to	  HFS,	  is	  inhibited	  directly	  
by	  miR-­‐219a-­‐5p	  (Hayashi	  et	  al.,	  2000;	  Kocerha	  et	  al.,	  2009).	  As	  for	  the	  NMDAR,	  transient	  
increases	  have	  been	  observed	  20	  min	  post-­‐LTP	  of	  the	  GluN2A	  and	  GluN2B	  that	  return	  to	  
baseline	  by	  4	  h,	  with	  GluN2B	  showing	  a	  later	  up-­‐regulation	  at	  48	  h	  post-­‐LTP	  (Williams	  et	  
al.,	   2003;	   Williams	   et	   al.,	   1998).	   These	   changes	   may	   be	   mediated	   by	   miR-­‐132-­‐3p,	   or	  
through	  chaperone	  molecules,	  such	  as	  PSD95,	  which	  can	  be	  regulated	  by	  miR-­‐125a-­‐5p	  
(Muddashetty	   et	   al.,	   2011).	   Therefore,	   through	   regulating	   the	   proteins	   mediating	   the	  
movement	  and	  insertion	  of	  glutamate	  receptors,	  miRNA	  can	  influence	  the	  generation	  of	  
the	  postsynaptic	  potential.	  
	  
1.4.2 MicroRNA	  and	  Dendritic	  Spine	  Morphology	  
While	   synapses	   are	   able	   to	   form	   directly	   onto	   the	   soma	   or	   dendrite	   tree	   of	   a	  
neuron,	   the	  majority	   of	   synapses	   form	   onto	   protrusions	   from	  dendrites	   called	   spines.	  
The	  morphology	  of	   these	  spines	  have	  been	  correlated	  with	  synaptic	  strength,	  with	   the	  
shape	  and	  size	  shown	  to	  change	   following	  LTP	  (Matsuzaki	  et	  al.,	  2004).	   Increasing	  the	  
size	  of	  the	  spine	  provides	  space	  for	  additional	  glutamate	  receptors	  to	  be	  present	  in	  the	  
membrane	   and	   the	   other	   proteins	   needed	   to	   maintain	   the	   potentiation	   (Lisman	   &	  
Raghavachari,	  2006).	  Changing	  the	  dendritic	  morphology	  requires	  a	  number	  of	  proteins	  
to	   change	   the	  underlying	  actin	   cytoskeleton,	  with	  a	  number	   shown	   to	  be	   regulated	  by	  
miRNA.	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For	   example,	   miR-­‐134-­‐5p	   appears	   to	   regulate	   a	   number	   of	   genes	   involved	   in	  
dendritic	  morphogenesis	  such	  as	  pumilio	  homolog	  2	  (Pum2)	  (Fiore	  et	  al.,	  2009).	  While	  
Pum2	   is	   a	   translational	   repressor,	   its	   expression	  was	  buffered	  by	  miR-­‐134-­‐5p	   as	   both	  
inhibition	   and	   overexpression	   of	   the	  miRNA	   and	   consequently	   the	   protein	   resulted	   in	  
poor	   dendritic	   growth.	   MiR-­‐134-­‐5p	   has	   also	   been	   shown	   to	   inhibit	   Limk1,	   which	   is	  
involved	  in	  actin	  polymerisation	  and	  causes	  structural	  abnormalities	  in	  dendritic	  spines	  
when	  knocked	  out	  (Meng	  et	  al.,	  2002;	  Schratt	  et	  al.,	  2006).	  MiR-­‐132-­‐3p	  has	  been	  found	  
to	  inhibit	  the	  translation	  of	  the	  protein	  Rho	  GTPase-­‐activating	  protein	  32	  (RICS)	  through	  
modulation	  of	   the	  Rho	  GTPase	  pathway,	  which	   is	   involved	   in	   cytoskeletal	   remodelling	  
(Impey	  et	  al.,	  2010;	  Wayman	  et	  al.,	  2008).	  In	  fact,	  miR-­‐132-­‐3p	  appears	  to	  have	  different	  
effects	   on	   spine	   morphology,	   with	   differing	   alterations	   of	   its	   expression	   leading	   to	  
mature	   mushroom	   spines	   or	   immature	   filopodia	   (Mellios	   et	   al.,	   2011;	   Tognini	   &	  
Pizzorusso,	   2012;	   Tognini	   et	   al.,	   2011),	   suggesting	   that	   like	   miR-­‐134-­‐5p,	   an	   optimal	  
range	   in	   expression	   of	   miR-­‐132-­‐3p	   is	   required	   for	   plasticity-­‐related	   dendritic	  
morphological	  changes.	  
	  
1.4.3 MicroRNA	  and	  Transcription	  
As	   shown	   above,	   new	   transcription	   is	   crucial	   for	   LTP	   to	   persist,	   but	   the	  
transcriptional	  response	  is	  dynamic.	  Changes	  in	  the	  abundance	  of	  the	  transcripts	  occur	  
across	   time,	  as	   seen	   in	   the	  specific	   regulation	  of	  genes	   following	   the	   induction	  of	  LTP,	  
(Ryan	  et	  al.,	  2011;	  Ryan	  et	  al.,	  2012).	  As	  described	  above,	  transcription	  factors	  involved	  
in	  the	  early	  gene	  response	  such	  as	  CREB	  are	  activated	  by	  phosphorylation	  while	  other	  
transcription	   factors,	   such	   as	   EGR1,	   are	   transcribed	   as	   a	   result	   of	   this	   early	   CREB	  
activation.	  MiR-­‐124-­‐3p	   has	   been	   shown	   to	   regulate	   CREB	   and	   its	   target	   transcription	  
factor	   EGR1	   in	   vitro	   and	   in	   vivo	   respectively	   (Rajasethupathy	   et	   al.,	   2009;	   Yang	   et	   al.,	  
2012).	  With	  these	  two	  miRNA	  mediating	  LTP-­‐induced	  transcription,	  the	  potential	  for	  the	  
brain-­‐specific	   miR-­‐124-­‐3p	   to	   play	   an	   important	   role	   in	   regulating	   the	   early	   gene	  
response	  of	  LTP	  is	  intriguing.	  
Other	   genes	   involved	   in	   regulating	   the	   transcriptional	   response	   targeted	   by	  
miRNA	  include	  the	  transcriptional	  repressors	  methyl	  CpG	  binding	  protein	  2	  (Mecp2)	  and	  
sirtuin	  1	   (Sirt1)	   (Li	  et	  al.,	  2011).	  Mecp2,	  which	  binds	   to	  selected	  methylation	  sites	  and	  
represses	  translation,	  and	  whose	  inhibition	  leads	  to	  a	  facilitation	  of	  LTP,	  has	  been	  shown	  
to	   be	   regulated	   by	   miR-­‐132-­‐3p	   and	   miR-­‐212-­‐3p	   (Im	   et	   al.,	   2010;	   Klein	   et	   al.,	   2007).	  
SIRT1,	  a	  deacetylase	  affecting	  histones,	  enzymes,	  and	  transcription	  factors	  that	  is	  crucial	  
Long-­‐Term	  Potentiation	  and	  microRNA	   	   28	  
for	  LTP	  maintenance,	  has	  been	  shown	  to	  be	  targeted	  by	  miR-­‐34c-­‐5p	  (Michan	  et	  al.,	  2010;	  
Zovoilis	   et	   al.,	   2011).	  Additionally,	   SIRT1	   regulates	  miR-­‐134-­‐5p	   expression,	  which	   can	  
regulate	   Creb	   (Gao	   et	   al.,	   2010).	   Furthermore,	   the	   activity-­‐dependent	   transcription	  
factor	   myocyte	   enhancer	   factor-­‐2	   (Mef2)	   is	   required	   for	   the	   depolarization-­‐induced	  
transcription	   of	   the	   miR-­‐379-­‐410	   cluster,	   which	   contains	   miR-­‐134-­‐5p	   (Fiore	   et	   al.,	  
2009).	  Mef2	  inhibition	  in	  rat	  hippocampal	  neurons	  decreased	  precursor	  miR-­‐134,	  which	  
may	   alter	   the	   expression	   of	  mature	  miR-­‐134-­‐5p	   and	   the	   subsequent	   regulation	   of	   its	  
targets	   like	   CREB.	   These	   complex	   networks	   of	   transcription	   factors	   and	   miRNA	  
demonstrate	   the	   wide	   potential	   of	   miRNA	   in	   regulating	   a	   large	   number	   of	   genes	  
indirectly.	  	  
	  
1.4.4 Potential	  for	  microRNA	  Involvement	  in	  Long-­‐Term	  Potentiation	  
These	   highlighted	   studies,	   summarised	   in	   Figure	   1.6	   with	   complementary	  
interactions	  (Ryan	  et	  al.,	  2015),	  show	  that	  miRNA	  regulate	  genes	  underlying	  processes	  
involved	   in	   LTP.	   Further,	   the	   presence	   of	   Drosha,	   DGCR8,	   and	   Dicer	   at	   the	   mouse	  
hippocampal	  PSD	  allows	  for	  specific	  expression	  of	  miRNA	  at	  activated	  synapses	  (Lugli	  et	  
al.,	   2012;	   Lugli	   et	   al.,	   2005;	   Lugli	   et	   al.,	   2008),	   and	   could	   contributing	   to	   the	   input	  
specificity	   of	   LTP.	   Pri-­‐miRNA	   have	   been	   found	   to	   be	   associated	   with	   RNA	   transport	  
granules,	   suggesting	   they	   are	   transported	   alongside	   mRNA.	   Once	   here,	   cleavage	   by	  
Drosha	   and	   Dicer	   could	   allow	   mature	   miRNA	   to	   be	   expressed	   specifically	   at	   active	  
synapses.	   Indeed,	   they	   could	   be	   activated	   following	   LTP	   induction,	   as	   calpain,	   a	  
proteolytic	  enzyme	  activated	  by	  calcium,	  appears	  to	  cleave	  Dicer	  and	  liberate	  or	  activate	  
it	   to	   generate	   new	   expression	   of	   mature	   miRNA	   at	   the	   synapse	   (Lugli	   et	   al.,	   2005).	  
Furthermore,	  miRNA	  have	  been	  shown	   to	  be	   localised	   to	  axons	  (Natera-­‐Naranjo	  et	  al.,	  
2010)	   and	   dendritic	   spines	   (Kye	   et	   al.,	   2007;	   Schratt	   et	   al.,	   2006;	   Siegel	   et	   al.,	   2009),	  
suggesting	  they	  may	  be	  able	  to	  regulate	  localised	  protein	  synthesis.	  	  
However,	  there	  is	  no	  direct	  evidence	  that	  altering	  miRNA	  expression	  affects	  LTP	  
maintenance.	   Indeed,	   while	   knockout	   of	   Dicer1	   enhanced	   induction,	   no	   effect	   on	   LTP	  
persistence	  was	   observed	   (Konopka	   et	   al.,	   2010).	   However,	   in	   this	   in	   vitro	   study,	   the	  
stability	  of	  LTP	  was	  assessed	  over	  a	  short	   recording	   time	  (50	  min),	  which	  may	  not	  be	  
long	   enough	   for	   an	   effect	   on	   the	   decay	   of	   LTP	   to	   manifest.	   Considering	   the	   initial	  
potentiation	   was	   affected	   suggests	   that	   there	   may	   have	   been	   changes	   in	   synaptic	  
excitability.	   Further,	   it	   was	   shown	   that	   the	   miRNA	   in	   this	   knockout	   mouse	   exhibited	  
prolonged	  half-­‐lives	  (Konopka	  et	  al.,	  2010),	  in	  contrast	  to	  the	  rapid	  turnover	  of	  miRNA	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in	   neuronal	   cells	   (Krol	   et	   al.,	   2010a),	   implying	   there	   were	   alterations	   in	   miRNA	  
processing.	   In	   contrast,	   knockdowns	   of	   miR-­‐132-­‐3p	   and	   miR-­‐134-­‐5p	   resulted	   in	  
decreased	   LTP	   (Gao	   et	   al.,	   2010;	   Scott	   et	   al.,	   2012),	   but	   as	   these	   knockdowns	   used	  
lentivirals	   administered	   five	   to	   six	   weeks	   in	   advance,	   whether	   the	   change	   in	   miRNA	  
expression	  affected	  the	  induction	  of	  LTP	  or	  the	  mechanisms	  underlying	  its	  consolidation	  
is	  unknown.	  	  
With	   miRNA	   seemingly	   involved	   in	   the	   regulation	   of	   a	   wide	   range	   of	   genes	  
involved	   in	  LTP-­‐related	  processes,	  combined	  with	  the	   localisation	  of	  proteins	   involved	  
in	   its	  biogenesis	  and	   its	   transcripts	   to	   the	  synapse,	  miRNA	  appear	   to	  play	  a	   role	   in	   its	  
persistence.	  Through	  fine-­‐tuning	  translation	  of	  proteins	  at	  activated	  synapses	  required	  
for	  LTP,	  to	  maintaining	  homeostasis	  by	  preventing	  excess	  translation,	  or	  translation	  of	  
LTP	  repressors,	  as	  well	  as	  regulating	  transcription,	  miRNA	  have	  the	  potential	  to	  play	  a	  
wide	  and	  important	  role	  in	  regulating	  the	  gene	  networks	  underlying	  LTP	  persistence.	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Figure	  1.6:	  Summary	  of	  the	  role	  microRNA	  play	  in	  LTP-­‐related	  processes.	  APT1,	  acyl-­‐protein	  thioesterase	  
1;	   ARC,	   activity-­‐related	   cytoskeleton-­‐associated	   protein;	   BDNF,	   brain-­‐derived	   neurotrophic	   factor;	  
CaMKIIγ,	  calcium/calmodulin-­‐dependent	  protein	  kinase	  II	  gamma;	  CREB,	  cAMP	  response	  element-­‐binding	  
protein;	  EGR1,	  early	  growth	  response	  1;	  GluA1,	  glutamate	  receptor,	  ionotropic,	  AMPA	  1;	  GluA2,	  glutamate	  
receptor,	   ionotropic,	   AMPA	   2;	   GluN2A,	   glutamate	   receptor,	   ionotropic,	   NMDA	   2A;	   GluN2B,	   glutamate	  
receptor,	   ionotropic,	   NMDA	   2B;	   LIMK1,	   LIM	   domain	   kinase	   1;	   MECP2,	   methyl	   CpG	   binding	   protein	   2;	  
MEF2,	  myocyte	  enhancer	   factor-­‐2;	  NRP2,	  neurophilin	  2;	  PTEN,	  phosphatase	  and	   tensin	  homolog;	  PUM2,	  
pumilio	  homolog	  2;	  SERCA,	  sarco/endoplasmic	  reticulum	  Ca2+	  ATPase;	  SIRT1,	  sirtuin	  1;	  STX1A,	  syntaxin	  
1a;	   SV2A,	   synaptic	   vesicle	   glycoprotein	   2A;	   SYN1,	   synapsin	   I;	   SYN2,	   synapsin	   II;	   SYT1,	   synaptotagmin	   I.	  
From	  Ryan	  et	  al.	  (2015).	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1.5 Aims	  and	  Hypothesis	  of	  the	  Current	  Study	  
Understanding	   the	   genetic	  mechanisms	  underlying	  LTP	   is	   crucial	   for	   advancing	  
our	   knowledge	   of	   how	  memories	   are	   formed.	   Studies	   from	  our	   laboratory	   and	   others	  
suggest	  that	  miRNA	  are	  involved	  in	  LTP-­‐related	  gene	  networks,	  and	  that	  miRNA	  regulate	  
genes	  involved	  in	  biological	  processes	  related	  to	  LTP.	  Therefore,	  the	  goal	  of	  this	  study	  is	  
to	  build	  upon	  pre-­‐existing	  work	  from	  both	  within	  and	  without	  our	   lab,	  and	  investigate	  
the	   role	   of	  miRNA	   in	   the	   regulation	   of	   gene	   expression	   underlying	   the	   persistence	   of	  
LTP.	  We	  hypothesise	  that	  there	  will	  be	  regulation	  of	  miRNA	  that	  target	  genes	  involved	  in	  
the	  regulation	  of	  LTP-­‐related	  processes.	  
In	  Chapter	  2,	  the	  expression	  of	  selected	  precursor	  and	  mature	  miRNA	  transcripts	  
were	   investigated,	   20	   min,	   5	   h	   and	   24	   h	   following	   LTP	   induction,	   using	   Reverse	  
Transcription-­‐quantitative	   PCR	   (RT-­‐qPCR).	   To	   predict	   how	   these	   miRNA	   may	   be	  
involved	   in	   the	   persistence	   of	   LTP,	   in	   Chapters	   3	   and	   4	   bioinformatic	   tools	   were	  
evaluated	   and	   used	   to	   identify	   potential	   targets	   of	   these	  miRNA.	   Lastly,	   in	   Chapter	   5,	  
luciferase	   assays	   were	   used	   to	   determine	   whether	   these	   predicted	   targets	   are	  
biologically	  valid	  and	  RT-­‐qPCR	  and	  Western	  blots	  were	  used	   to	   see	  how	   these	   targets	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2.1 Introduction	  
Following	  the	  induction	  of	  long-­‐term	  potentiation,	  the	  activation	  of	  complex	  gene	  
networks	   leads	   to	   molecular	   and	   cellular	   changes	   at	   the	   synapse	   that	   underlie	   its	  
persistence	   properties.	   Bioinformatic	   analysis	   predicted	   these	   networks	   may	   be	  
regulated	   by	   transcription	   factors,	   histone	   deacetylases	   and	   microRNA.	   Mounting	  
evidence	   supports	   the	   involvement	   of	   miRNA	   as	   key	   regulators	   of	   LTP	   (Ryan	   et	   al.,	  
2015),	   and	   that	   these	   non-­‐coding	   RNA	   are	   concurrently	   regulated	   with	   coding	  
counterparts.	  The	  aim	  of	  this	  chapter	  is	  to	  identify	  miRNA	  that	  are	  regulated	  following	  
LTP	  induction	  and	  characterise	  the	  mechanisms	  of	  their	  regulation.	  
	  
2.1.1 Previous	  Studies	  Investigating	  microRNA	  in	  Long-­‐Term	  Potentiation	  
Several	  studies	  to	  date	  have	  investigated	  the	  expression	  and	  role	  of	  miRNA	  in	  the	  
LTP	  model	  of	  memory.	  These	   studies	  have	  demonstrated	   that	  miRNA	  are	   regulated	   in	  
several	   models	   utilising	   both	   in	   vivo	   and	   in	   vitro	   preparations	   of	   chemically	   and	  
electrically	   induced	   forms	   of	   LTP.	   The	   first	   evidence	   that	   miRNA	   are	   regulated	   in	  
response	   to	   LTP	   came	   from	   a	   study	   where	   chemical	   LTP	   (cLTP)	   was	   induced	   using	  
calcium	   chloride	   in	   mouse	   hippocampal	   slices	   (Park	   &	   Tang,	   2009).	   Hybridisation	  
miRNA	  arrays	  were	  used	  to	  carry	  out	  a	  screen	  of	   the	  expression	  of	  237	  miRNA	  across	  
five	  time	  points	  following	  induction	  (0,	  15,	  30,	  60,	  and	  120	  min	  post-­‐cLTP;	  n=1	  per	  time	  
point).	   It	  was	   found	  that	  55	  miRNA	  were	  differentially	  expressed	  post-­‐LTP	  with	  a	   fold	  
change	   greater	   than	   two	   at	   one	   of	   the	   five	   time	   points,	   with	   a	   majority	   (46	   miRNA)	  
showing	   an	   increase	   in	   expression	   15	   min	   post-­‐LTP,	   suggesting	   rapid	   regulation.	  
However,	   validation	   using	   RT-­‐qPCR	   of	   these	   results	   was	   unsuccessful,	   though	   not	  
surprisingly	  as	  no	  biological	  replicates	  were	  carried	  out	  on	  the	  arrays,	  limiting	  the	  value	  
of	   this	   study.	   Nevertheless,	   this	   study	   proposed	   that	   these	   rapid	   increases	   in	   miRNA	  
expression	   were	   the	   result	   of	   increased	   maturation	   of	   miRNA	   by	   Dicer	   (Lugli	   et	   al.,	  
2005),	  acting	  to	  prevent	  excess	  translation	  of	  LTP-­‐related	  genes.	  	  
Another	  study	  induced	  cLTP	  in	  the	  dentate	  gyrus	  of	  rat	  hippocampal	  slices	  using	  
glycine,	  strychnine	  and	  picrotoxin.	  They	  found	  using	  an	  Agilent	  miRNA	  array	  that	  there	  
was	  differential	  expression	  of	  five	  miRNA	  showing	  at	  least	  a	  1.5	  fold	  change	  (n=2),	  later	  
confirming	  the	  up-­‐regulation	  of	  miR-­‐188-­‐5p	  1	  h	  post-­‐LTP	  using	  RT-­‐qPCR	  (n=3)	  (Lee	  et	  
al.,	   2012).	   MiR-­‐188-­‐5p	   was	   also	   shown	   to	   inhibit	   the	   expression	   of	   the	   protein	  
neuropilin	   2	   (NRP2),	   a	   negative	   regulator	   of	   spine	   density.	   This	   suggests	   the	   up-­‐
regulation	  of	  miR-­‐188-­‐5p	  down-­‐regulates	  NRP2,	  allowing	  the	  later	  growth	  of	  new	  spines	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preferential	  for	  LTP	  induction	  (Frey	  &	  Morris,	  1997,	  1998;	  Matsuzaki	  et	  al.,	  2004).	  How	  
NRP-­‐2	  mediates	  this	  effect	   is	  unknown.	  While	  this	  may	  be	  through	  its	   interaction	  with	  
vascular	  endothelial	  growth	  factor,	  implicated	  with	  hippocampal	  neurogenesis,	  it	  could	  
conversely	  or	  concurrently	  be	  through	  its	  interactions	  as	  a	  receptor	  for	  semaphorin	  3F,	  
an	  inhibitory	  axonal	  growth	  cone	  signalling	  molecule	  (Tran	  et	  al.,	  2009).	  Through	  either	  
of	   these	   mechanisms,	   NRP-­‐2	   appears	   to	   regulate	   spine	   morphology	   and	   synapse	  
structure.	   The	   differences	   between	   these	   two	   cLTP	   studies	   in	   the	   number	   of	   miRNA	  
found	  to	  be	  differentially	  expressed	  in	  their	  initial	  array	  screen	  and	  then	  validated	  using	  
RT-­‐qPCR	   is	   not	   surprising.	   Not	   only	   were	   there	   differences	   in	   the	   arrays	   used,	   and	  
species	  of	  the	  tissue,	  but	  a	  lack	  of	  biological	  replicates	  in	  the	  initial	  screens	  limited	  their	  
accuracy.	  Nevertheless,	   they	   demonstrate	   that	  miRNA	   can	   be	   regulated	   following	   LTP	  
induction.	  
With	  in	  vivo	  models	  of	  LTP,	  the	  majority	  of	  the	  work	  investigating	  the	  expression	  
of	  miRNA	  have	  been	  published	  from	  Clive	  Bramham’s	  group	  at	  the	  University	  of	  Bergen	  
(Pai	  et	  al.,	  2014;	  Wibrand	  et	  al.,	  2012;	  Wibrand	  et	  al.,	  2010).	  In	  these	  studies,	  a	  spaced	  
HFS	  protocol	  known	  to	  induce	  an	  NMDAR-­‐dependent	  form	  of	  LTP	  was	  used	  to	  stimulate	  
perforant	   path	   synapses	   in	   the	   dentate	   gyrus	   of	   adult	   anesthetised	   rats.	   Using	   this	  
model,	   and	  LC	   Sciences	  hybridisation	  microarrays,	   they	   found	   that	  21	  miRNA	   showed	  
differential	  expression	  2	  h	  post-­‐LTP	  of	  at	  least	  20%	  (n=2)	  (Wibrand	  et	  al.,	  2010).	  Using	  
RT-­‐qPCR,	   they	   validated	   that	   miR-­‐132-­‐3p	   and	   miR-­‐212-­‐3p	   were	   up-­‐regulated	   in	   the	  
stimulated	  hemisphere	  compared	   to	   the	  non-­‐stimulated	  contralateral	  hemisphere,	  and	  
miR-­‐219a-­‐5p	   was	   down-­‐regulated	   2	   h	   post-­‐LTP	   induction;	   however	   their	   expression	  
was	  not	  regulated	  10	  min	  post-­‐LTP.	  
While	   the	   primary	   and	   precursor	   transcripts	   for	   miR-­‐132-­‐3p	   and	   miR-­‐212-­‐3p	  
increased	   by	   at	   least	   50	   times	   2	   h	   following	   LTP	   induction,	   those	   for	   miR-­‐219a-­‐5p	  
showed	  no	  regulation.	  Smaller	  ten-­‐	  and	  five-­‐fold	  increases	  in	  the	  primary	  and	  precursor	  
transcripts	  of	  miR-­‐132-­‐3p	  were	  observed	  at	  10	  min	  post-­‐LTP.	  As	  noted	  previously,	  the	  
primary	   transcript	   for	   miR-­‐132-­‐3p	   and	   miR-­‐212-­‐3p	   is	   the	   same,	   though	   different	  
precursor	   transcripts	  precede	   these	  mature	   transcripts.	  These	   results	   suggest	   that	   the	  
increase	  in	  the	  mature	  transcripts	  at	  2	  h	  is	  likely	  the	  result	  of	  increased	  processing	  of	  the	  
primary	   and	   precursor	   transcripts,	   though	   the	   length	   of	   time	   these	   increases	   in	  
transcripts	  persist	  for	  post-­‐LTP	  is	  unknown.	  
To	   explore	   the	   relationship	   further	   between	   LTP	   and	   miRNA	   expression,	   the	  
dependence	   of	   its	   regulation	   on	   NMDAR	   activation	   was	   investigated.	   Following	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application	  of	   the	  NMDAR	  antagonist	  3-­‐(2-­‐Carboxypiperazin-­‐4-­‐yl)propyl-­‐1-­‐phosphonic	  
acid	   (CPP),	   enhanced	   up-­‐regulation	   of	   these	   mature	   miRNA	   were	   observed.	   This	  
included	  miR-­‐219a-­‐5p,	  which	  went	   from	  being	   down-­‐regulated	   to	   up-­‐regulated	   in	   the	  
presence	   of	   CPP	   2	   h	   post-­‐LTP.	   This	   suggests	   that	   activation	   of	   NMDAR	   acts	   to	   curtail	  
their	  expression	   following	  LTP	   in	   this	  model,	   and	   implicates	  other	  pathways	  activated	  
post-­‐LTP	   in	   mediating	   their	   expression.	   These	   alternate	   pathways	   include	   group	   1	  
metabotropic	   glutamate	   receptors	   (mGluR),	   previously	   shown	   to	   play	   a	   role	   in	   LTP	  
(Balschun	   et	   al.,	   1999;	   Le	  Duigou	  &	  Kullmann,	   2011;	  Manahan-­‐Vaughan,	   1997).	  When	  
these	   group	   1	   receptors	   were	   blocked	   by	   their	   antagonist	   1-­‐aminoindan-­‐1,5-­‐
dicarboxylic	  acid	  (AIDA),	  differential	  expression	  of	  these	  miRNA	  were	  blocked	  2	  h	  post-­‐
LTP	  with	  or	  without	  CPP.	  This	  suggests	  that	  mGluR-­‐mediated	  signalling	  plays	  a	  crucial	  
role	   in	   the	   regulation	   of	   miRNA	   post-­‐LTP	   and	   that	   these	   converging	   pathways	  
collectively	  regulate	  the	  expression	  of	  these	  miRNA	  following	  LTP	  induction.	  
However,	   in	   their	   most	   recent	   study,	   the	   idea	   that	   observing	   a	   change	   in	   the	  
expression	  of	  a	  miRNA	  only	  was	   reflective	  of	   changes	   in	   their	  activity	  was	  questioned	  
(Pai	   et	   al.,	   2014).	  Comparisons	  between	   those	  miRNA	   immunoprecipitated	  with	  AGO2	  
from	   the	   miRISC,	   and	   those	   total	   miRNA	   present	   within	   a	   sample	   lysate,	   showed	  
significant	   differences	   existed	   between	   the	   expression	   of	  miRNA	   between	   the	   groups.	  
Using	  locked	  nucleic	  acid	  PCR	  arrays,	  four	  and	  15	  miRNA	  were	  differentially	  expressed	  
30	  min	  post-­‐LTP	  in	  whole	  lysate	  and	  AGO2	  immunoprecipitate	  samples	  respectively.	  By	  
2	  h	  post-­‐LTP,	  17	  and	  ten	  miRNA	  were	  differentially	  expressed	  in	  whole	  lysate	  and	  AGO2	  
immunoprecipitate	   samples	   respectively.	   Further,	   the	   miRNA	   in	   these	   four	   groups	  
across	   the	   time	   points	   and	   samples	   were	   mutually	   exclusive.	   Investigating	   the	   ratios	  
between	   the	  miRNA	   expression	   in	   AGO2	   immunoprecipitate	   and	  whole	   lysate	   30	  min	  
post-­‐LTP	   indicated	   eight	   miRNA	   increased	   their	   association	   with	   AGO2,	   while	   five	  
miRNA	  dissociated	  from	  it	  in	  response	  to	  LTP	  induction.	  	  
These	   changes	   in	   the	   interactions	   between	   AGO2	   and	   the	   miRNA	   were	   also	  
NMDAR	  dependent	  as	  application	  of	  its	  antagonist	  2-­‐amino-­‐5-­‐phosphonopentanoic	  acid	  
(AP5),	  caused	  seven	  and	  three	  miRNA	  to	  have	  increased	  and	  decreased	  association	  with	  
AGO2	   respectively.	   Further,	   no	   changes	   in	   AGO2	   expression	   were	   observed.	   These	  
results	   suggest	   that	   the	   expression	   of	   a	   miRNA	   present	   in	   the	   sample	   does	   not	  
necessarily	  correlate	  with	  the	  activity	  of	  the	  miRNA.	  Additionally,	  they	  confirmed	  miR-­‐
132-­‐3p	  and	  miR-­‐212-­‐3p	  were	  up-­‐regulated	  in	  the	  dentate	  gyrus	  2	  h	  post-­‐LTP.	  This	  work	  
provided	  new	  insight	  into	  the	  regulation	  of	  miRNA	  following	  LTP	  induction.	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2.1.2 Screen	  of	  Differentially	  Expressed	  microRNA	  20	  min	  post-­‐LTP	  	  
While	   the	   previous	   studies	   have	   shown	   that	   investigating	   the	   expression	   of	  
miRNA	   in	   total	   lysate	   following	  LTP	   induction	   is	   not	   reflective	  of	   that	   associated	  with	  
AGO2,	  and	  thus	  active	  within	  the	  miRISC,	  other	  AGO	  proteins	  are	  known	  to	  interact	  with	  
miRNA,	   though	   to	   lower	   levels	   (Wang	   et	   al.,	   2010).	   Furthermore,	  we	   have	   previously	  
shown	  that	  there	  is	  regulation	  of	  two	  miRNA,	  miR-­‐24-­‐3p	  and	  miR-­‐34a-­‐5p,	  5	  h	  post-­‐LTP,	  
consistent	  with	   the	   predictions	   by	   the	   gene	   network	   analysis	   by	   IPA	   that	   they	   target	  
down-­‐regulated	   genes	   (Ryan	   et	   al.,	   2012).	   It	   has	   also	   been	   shown	   that	   the	   total	  
expression	  of	  miRNA	  is	  linked	  to	  the	  expression	  of	  their	  targets	  in	  other	  model	  systems,	  
suggesting	  that	  miRNA	  are	  not	  expressed	  or	  regulated	  unless	  they	  are	  biologically	  useful	  
(Chatterjee	   &	   Großhans,	   2009;	   Kai	   &	   Pasquinelli,	   2010).	   Therefore,	   profiling	   the	  
expression	  of	  miRNA	   is	   still	   a	  valuable	  exercise	   to	  understand	   their	   role	  and	  potential	  
regulation	  of	  mRNA	  targets	  in	  LTP.	  
As	  we	  have	  observed	  that	  there	  is	  a	  rapid	  general	  up-­‐regulation	  in	  the	  expression	  
of	  most	  mRNA	  transcripts	  20	  min	  post-­‐LTP,	  we	  proposed	  that	  this	  may	  occur	  as	  a	  result	  
of	   a	   concurrent	   general	   down-­‐regulation	   of	   miRNA	   releasing	   their	   inhibition	   of	   their	  
mRNA	  targets.	  While	  previous	  studies	  have	  shown	  little	  change	  in	  expression	  of	  miRNA	  
Figure	  2.1:	  Long-­‐term	  potentiation	   regulates	  microRNA	  20	  min	  post-­‐LTP.	   A	   summary	   (A)	   and	  detailed	  
(B)	  view	  of	  the	  65	  miRNA	  found	  to	  be	  differentially	  expressed	  using	  dual	  selection	  criteria	  (fold	  change	  ±	  
0.15,	  two-­‐tailed	  Students	  t-­‐test	  p<0.05)	  on	  the	  Affymetrix	  miRNA	  array.	  48	  miRNA	  were	  down-­‐regulated,	  
with	  17	  up-­‐regulated.	  Adapted	   from	   Joilin	   et	   al.	   (2014).	  Expression	  values:	  Average	   fold	   change	  ±	  SEM;	  
n=4.	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10	  min	  or	  30	  min	  post-­‐LTP,	  differences	  in	  their	  model	  and	  ours	  exist.	  For	  example,	  the	  
use	   of	   anaesthetic	   during	   induction	   may	   alter	   the	   regulation	   of	   miRNA	   post-­‐LTP	  
similarly	   to	   the	   gene	   response	   through	   alterations	   to	   channel	   conductance	   (Hara	   &	  
Harris,	  2002;	  Jeffery	  et	  al.,	  1990).	  Further,	  the	  anaesthetic	  urethane	  has	  been	  shown	  to	  
induce	  a	  hippocampal	   theta	   rhythm,	  which	  has	  been	  shown	   to	   facilitate	  LTP,	  and	  may	  
confound	   any	   miRNA	   regulation	   (Pagliardini	   et	   al.,	   2013;	   Sceniak	   &	   Maciver,	   2006;	  
Vertes,	   2005).	   While	   work	   from	   the	   Bramham	   group	   has	   shown	   that	   their	   LTP	   is	  
NMDAR-­‐	   and	   Arc-­‐dependent	   and	   show	   no	   impairment	   to	   its	   persistence,	   electrical	  
recordings	  have	  only	  been	  taken	  out	  to	  12	  h,	  in	  contrast	  to	  the	  360	  days	  demonstrated	  
previously	   in	   our	   awake	   freely	   moving	   LTP	   model	   (Abraham	   et	   al.,	   2002).	   As	   such,	  
differences	  in	  the	  expression	  of	  miRNA	  at	  20	  min	  could	  be	  possible.	  
Therefore,	   using	   this	   awake	  model	   known	   to	   have	   persistent	   LTP,	   dentate	   gyri	  
samples	   were	   isolated	   from	   awake	   adult	   rats	   20	   min	   following	   perforant	   path	  
stimulation	  with	  delta-­‐burst	  high	  frequency	  stimulation	  (DBS)	  in	  vivo.	  Comparing	  these	  
samples	   to	   within	   animal	   non-­‐stimulated	   contralateral	   hemispheres,	   Affymetrix	  
GeneChip	   miRNA	   arrays	   detected	   65	   differentially	   expressed	   mature	   miRNA	   (fold	  
change	   ±	   0.15,	   two-­‐tailed	   Students	   t-­‐test	   p<0.05),	   of	   which	   the	   majority	   were	   down-­‐
regulated	  (Figure	  2.1)	  (Joilin	  et	  al.,	  2014).	  Interestingly,	  only	  four	  miRNA	  (miR-­‐181c-­‐5p,	  
miR-­‐19b-­‐3p,	   miR-­‐218a-­‐5p,	   miR-­‐9a-­‐5p)	   showed	   more	   than	   a	   two-­‐fold	   change	   in	  
expression,	   the	  majority	  of	  miRNA	  showing	   less	  than	  a	  40%	  fold	  change,	  suggest	  most	  
early	   regulation	   of	   miRNA	   is	   subtle.	   This	   result	   was	   consistent	   with	   the	   general	   up-­‐
regulation	   of	  mRNA	   transcripts	   at	   20	  min,	   suggesting	   an	   anti-­‐correlative	   relationship	  
reflective	  of	  the	  function	  of	  miRNA	  (Ryan	  et	  al.,	  2011;	  Ryan	  et	  al.,	  2012).	  Furthermore,	  
considering	   the	   short	   time	   between	   LTP	   induction	   and	   tissues	   isolation,	   this	   study	  
demonstrates	   rapid	   changes	   in	   miRNA	   expression,	   suggesting	   a	   role	   for	   them	   in	  
regulating	  gene	  expression	  in	  the	  dentate	  gyrus	  basally	  and	  after	  activity.	  	  
	  
2.1.3 Current	  Study	  
The	  aim	  of	   this	  chapter	  was	  to	   identify	  a	  number	  of	  miRNA	  regulated	   following	  
LTP	  induction	  and	  profile	  their	  expression	  across	  time.	  Using	  the	  broad	  screen	  of	  mature	  
miRNA	   differentially	   expressed	   20	   min	   post-­‐LTP,	   validation	   of	   the	   expression	   of	   a	  
selected	   number	   of	  miRNA	   using	   RT-­‐qPCR	  was	   carried	   out.	   Validated	  mature	  miRNA	  
transcripts,	   along	   with	   their	   respective	   primary	   and	   precursor	   transcripts	   were	   then	  
profiled	  at	  20	  min,	  5	  h	  and	  24	  h	  post-­‐LTP	  to	  determine	  their	  regulation	  and	  biogenesis	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across	   time.	   Furthermore,	   their	   dependence	   on	   the	   activation	   of	   the	   NMDAR	   and	   by	  
extension	  their	  specificity	  to	  LTP	  and	  not	  just	  stimulation,	  was	  tested	  through	  the	  use	  of	  
the	  NMDAR	   antagonist	   CPP.	   Demonstrating	  which	  miRNA	   are	   regulated	   and	   how	   this	  
occurs	  will	  help	  to	  grow	  our	  understanding	  of	  how	  these	  transcripts	  are	  involved	  in	  the	  
gene	  networks	  underlying	  LTP.	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2.2 Materials	  and	  Methods	  
For	   all	   reactions,	   to	   minimise	   contamination,	   pipettes	   were	   washed	   with	   70%	  
ethanol	  and	  placed	  under	  UV	  lights	  to	  sterilise,	  bench	  tops	  were	  wiped	  down	  with	  70%	  
ethanol	  regularly,	  and	  RNase	  free	  tubes	  were	  used.	  
	  
2.2.1 LTP	  Induction	  
This	  procedure	  was	  carried	  out	  prior	   to	   this	  study	  by	  Barbara	  Logan	  (Abraham	  
Lab,	   Department	   of	   Psychology,	   University	   of	   Otago),	   using	   an	   established	   protocol	  
approved	  by	  the	  University	  of	  Otago	  Animal	  Ethics	  Committee,	  and	  known	  to	  produce	  a	  
very	  persistent	  form	  of	  LTP	  (Abraham	  et	  al.,	  2002).	  In	  brief,	  Sprague-­‐Dawley	  rats,	  aged	  
between	   four	   and	   five	   months,	   had	   stimulating	   and	   recording	   electrodes	   inserted	  
bilaterally	  within	   the	  hippocampus	   into	   the	  medial	   and	   lateral	  perforant	  pathway	  and	  
the	   dentate	   gyrus	   respectively.	   Baseline-­‐only	   stimulation	   to	   the	   contralateral	  
hemisphere	   was	   used	   as	   a	   within-­‐animal	   control.	   In	   some	   experiments	   (n=4),	   the	  
NMDAR	   antagonist	   CPP	   (Tocris)	   was	   applied	   (7.5	   mg/kg,	   i.p.)	   90	   min	   prior	   to	   the	  
administration	   of	   the	   same	   DBS	   stimulation	   paradigm.	   Once	   a	   consistent	   baseline	  
(variation	   ±5%)	  was	   established	   for	   30	  min,	   DBS	  was	   administered	  while	   the	   animal	  
was	  awake	  and	  freely	  moving,	  consisting	  of	  50	  trains	  of	  10	  pulses	  (400	  Hz,	  25	  ms,	  250	  µs	  
duration	   pulses)	   presented	   as	   bursts	   of	   5	   trains	   at	   1	  Hz	   (1	  min	   between	   bursts).	   The	  
minimal	   criteria	   accepted	   for	   LTP	   induction	   was	   a	   10%	   increase	   in	   the	   slope	   of	   the	  
evoked	   post-­‐synaptic	   potential	   (EPSP),	   and	   a	   50%	   increase	   in	   amplitude	   of	   the	  
population	  spike	  (PS)	  in	  mV,	  when	  compared	  to	  baseline.	  Each	  rat	  was	  anesthetised	  with	  
urethane,	  decapitated	  and	  the	  brain	  was	  removed	  20	  min	  (n=10;	  CPP:	  n=4),	  5	  h	  (n=10),	  
or	   24	   h	   (n=5)	   following	   the	   last	   stimulation	   pulse.	   The	   hippocampus	   was	   rapidly	  
dissected	   on	   ice	   to	   reduce	   RNA	   degradation.	   The	   dentate	   gyrus	   and	   hippocampal	   CA	  
regions	  were	  further	  sub-­‐dissected	  from	  each	  hemisphere	  and	  snap	  frozen	  in	  dry	  ice	  in	  
RNase	  free	  tubes.	  Tissue	  samples	  were	  stored	  at	  -­‐80°C	  prior	  to	  RNA	  isolation.	  
	  
2.2.2 RNA	  Isolation	  and	  Purification	  
Total	  RNA,	   including	  miRNA,	  was	   isolated	   from	  each	  dentate	  gyrus	  using	  Trizol	  
(Invitrogen)	   and	   further	   purified	   using	   resin	   purification	   columns	   (Norgen	   Biotek)	  
(Joilin	  et	  al.,	  2014).	  RNA	  extracted	  from	  a	  number	  of	  samples	  (20	  min:	  n=5;	  5	  h:	  n=	  10;	  
24	  h:	  n=5)	  was	  extracted	  prior	  to	  this	  study.	  Tissue	  was	  homogenised	  in	  300	  µL	  Trizol	  
using	  a	  plastic	  homogeniser.	  A	   further	  700	  µL	  of	  Trizol	  was	  added	  and	   the	   tissue	  was	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further	  disrupted	  and	   the	  DNA	  sheared	  using	  a	  23G	  needle	  and	  syringe.	  Following	  a	  5	  
min	   incubation	   at	   room	   temperature	   (approximately	   22°C),	   0.2	   mL	   chloroform	   was	  
added	  and	  left	  to	  incubate	  (3	  min),	  disrupting	  the	  organic	  and	  aqueous	  phases,	  followed	  
by	  centrifugation	  (4°C,	  15	  min,	  10,000	  g).	  The	  upper	  aqueous	  phase	  containing	  RNA	  was	  
pipetted	  into	  another	  RNase	  free	  tube.	  Prior	  to	  purification	  using	  Total	  RNA	  purification	  
column	   (Norgen	  Biotek),	   an	   equal	   volume	  of	  70%	  ethanol	  was	   added	  and	  vortexed.	  A	  
maximum	   of	   600	   µL	   of	   this	   mixture	   was	   transferred	   to	   purification	   column	   and	  
centrifuged	   (22°C,	   2	   min,	   14,000	   g)	   and	   repeated	   with	   the	   remaining	   mixture	   after	  
discarding	   the	   flow-­‐through.	  Wash	   solution	   (400	   µL)	   was	   applied	   to	   the	   column	   and	  
spun	   through	   (22°C,	   2	  min,	   14,000	   g)	   and	   the	   flow-­‐through	   discarded.	   Contaminating	  
DNA	   was	   degraded	   by	   applying	   80	   µL	   of	   DNase	   (10	   µL	   in	   70	   µL	   RDD	   buffer)	   to	   the	  
column	  membrane	  followed	  by	  centrifugation	  (22°C,	  2	  min,	  14,000	  g).	  The	  flow-­‐through	  
was	  reapplied	  on	  top	  of	  the	  membrane	  and	  incubated	  (22°C,	  15	  min).	  Two	  subsequent	  
wash	  steps	  were	  performed	  (400	  µL	  wash	  solution,	  22°C,	  2	  min,	  14,000	  g),	  followed	  by	  a	  
final	  dry	  spin.	  The	  column	  was	  then	  transferred	  to	  an	  elution	  tube.	  RNA	  was	  recovered	  
by	  addition	  of	  50	  µL	  of	  elution	  solution	  and	  two	  step	  centrifugation	  (22°C,	  1	  min,	  2,000	  
g;	  22°C,	  2	  min,	  14,000	  g).	  This	  was	  then	  transferred	  to	  an	  RNase	  free	  tube	  labelled	  as	  the	  
first	  elution.	  A	  second	  elution	  was	  performed	  to	  recover	  any	  residual	  RNA	  and	  was	  then	  
pooled	  with	  the	  first	  elution	  in	  the	  first	  set	  of	  rats.	  Purified	  RNA,	  including	  miRNA,	  was	  
stored	  in	  -­‐80°C	  until	  use.	  
	  
2.2.3 Quality	  Control	  and	  Quantification	  
Nanodrop.	   Using	   the	   Nanodrop	   ND-­‐1000	   Spectrophotometer	   and	   associated	  
software	   (ThermoFisher	   Scientific),	   following	   the	   onscreen	   prompts,	   1.5	   µL	   of	   RNase	  
free	  water	  was	   pipetted	   onto	   the	  measurement	   pedestal.	   This	  water	  was	  wiped	   from	  
both	  surfaces	  before	  1.5	  µL	  of	  elution	  buffer	  was	  pipetted	  onto	  the	  pedestal	  to	  do	  a	  blank	  
measurement	   before	   being	   cleaned.	   Setting	   the	   sample	   type	   to	   RNA	   and	   to	   start	  
recording,	  1.5	  µL	  of	  each	  sample	  was	  pipetted	  onto	  the	  pedestal,	  tested	  and	  cleaned.	  As	  
RNA	  has	  a	  maximum	  absorbance	  reading	  under	  260nm,	  a	  concentration	  in	  ng/µL	  can	  be	  
derived	  from	  the	  A260	  reading.	  In	  addition,	  the	  A260/A280	  ratio	  indicates	  the	  purity	  of	  
the	   RNA	   and	   the	   A260/A230	   ratio	   the	   presence	   of	   contamination	   in	   the	   forms	   of	  
proteins,	  chaotropic	  salts,	  or	  phenol,	  with	  ratios	  close	  to	  2.0	  for	  both	  indicating	  minimal	  
contamination.	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Bioanalyser.	   To	   further	   test	   the	   quality	   and	   concentration	   of	   the	   samples,	   the	  
Agilent	   2100	   Bioanalyser	   and	   associated	   software	   (Agilent)	  was	   used.	   Firstly,	   2	   µL	   of	  
sample	  RNA	  were	  denatured	  (70°C,	  2	  min)	  in	  0.6	  mL	  tubes	  to	  minimise	  evaporation	  and	  
were	   then	   put	   on	   ice.	   Using	   the	   RNA	   6000	   Nano	   kit	   (Agilent)	   following	   temperature	  
equilibration	  for	  30	  min,	  550	  µL	  of	  the	  kit’s	  gel	  matrix	  was	  pipetted	  onto	  a	  spin	  filter	  and	  
centrifuged	  (22°C,	  10	  min,	  1,500	  g).	  Next,	  65	  µL	  of	  the	  filtered	  gel	  and	  1	  µL	  of	  the	  kit’s	  
dye	  concentrate	  are	  pipetted	  into	  an	  RNase	  free	  tube	  and	  spun	  at	  (22°C,	  15	  min,	  13,000	  
g).	  Loading	  the	  RNA	  6000	  Nano	  chip	  (Agilent)	  into	  the	  chip	  priming	  station,	  9	  µL	  of	  the	  
gel/dye	  mix	  was	  pipetted	  into	  the	  well	   labelled	  with	  a	  G	  in	  a	  black	  circle.	  Ensuring	  the	  
plunger	  on	  the	  chip	  priming	  station	  was	  at	  1	  mL,	  the	  chip	  priming	  station	  was	  closed	  and	  
the	   plunger	  was	   pressed	   until	   it	  was	   held	   by	   the	   chip	   for	   30	   s,	   to	   ensure	   the	   gel/dye	  
mixture	  filled	  the	  capillaries	  of	  the	  chip.	  Into	  the	  other	  two	  wells	  marked	  ‘G’,	  9	  µL	  of	  the	  
gel/dye	  mix	  was	  pipetted,	  followed	  by	  5	  µL	  of	  the	  kit’s	  marker	  into	  the	  ladder	  well	  and	  
each	  sample	  well,	  and	  1	  µL	  of	  the	  prepared	  ladder	  in	  the	  ladder	  well.	  Into	  each	  sample	  
well,	  1	  µL	  of	  each	  sample	  was	  pipetted,	  with	  any	  unused	  wells	  pipetted	  with	  an	  equal	  
amount	  of	   the	  marker.	  Once	   loaded,	   the	   chip	  was	  mixed	  horizontally	   (IKA	  vortexer;	   1	  
min,	  2,400	  rpm)	  and	  then	  run	  in	  the	  Bioanalyser.	  In	  the	  associated	  software	  2100	  Expert	  
Software	   (Agilent),	   ‘Total	  RNA	  assay	   (Eukaryotic)’	  was	   selected	   and	   the	   chip	  was	   run.	  
Following	  the	  completion	  of	   the	  chip,	   the	  electrodes	  were	  decontaminated	  with	  RNase	  
free	  H2O.	  	  
The	  generated	  report	  gives	  a	  concentration,	  based	  on	  the	  amount	  of	  dye	  bound	  to	  
RNA	  fragments	  detected,	  and	  a	  RNA	  integrity	  number	  (RIN),	  which	   is	  calculated	  by	  an	  
algorithm	   based	   on	   the	   features	   of	   the	   electrophoresis	   trace	   such	   as	   signal	   area	   or	  
intensity,	  and	  indicates	  RNA	  quality	  of	  between	  1	  and	  10.	  While	  10	  indicates	  completely	  
intact	  RNA,	  a	  value	  above	  8	  is	  considered	  good	  enough	  to	  carry	  out	  microarray	  and	  RT-­‐
qPCR	  experiments.	  
	  
2.2.4 TaqMan	  microRNA	  RT-­‐qPCR	  
Primer	   Design.	  Pre-­‐designed	   primers	   for	   each	  miRNA	   of	   interest	   were	   ordered	  
from	  Applied	  Biosystems,	  based	  on	  the	  sequence	  in	  version	  17	  of	  miRBase,	  a	  repository	  
of	  all	  miRNA	  sequences	  (Griffiths-­‐Jones,	  2004;	  Griffiths-­‐Jones	  et	  al.,	  2006;	  Griffiths-­‐Jones	  
et	  al.,	  2008;	  Kozomara	  &	  Griffiths-­‐Jones,	  2011).	  
cDNA	   Synthesis.	  MicroRNA-­‐specific	   cDNA	   reactions	  were	   created	   from	   the	   total	  
RNA	  extracted	  from	  the	  dentate	  gyri	  using	  the	  TaqMan	  microRNA	  reverse	  transcription	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kit	   (Applied	  Biosystems).	   Following	   the	  manufacturer’s	   instructions	   for	   a	   15	  µL	   cDNA	  
reaction,	  a	  7	  µL	  master	  mix	  containing	  0.15	  µL	  100nM	  dNTPs	  (with	  DTTP),	  1	  µL	  50	  U/µL	  
MultiScribe	  RT,	  1.5	  µL	  RT	  buffer,	  0.19	  µL	  20	  U/µL	  RNase	   inhibitor,	  and	  4.16	  µL	  RNase	  
free	  H2O	  was	  made	  and	  placed	  on	  ice.	  Due	  to	  the	  small	  reagent	  volumes	  and	  allowing	  for	  
accurate	   pipetting	   of	   at	   least	   1	   µL,	   the	  master	  mix	  was	   scaled	   to	   a	  minimum	   of	   eight	  
reactions.	  7	  µL	  of	  this	  master	  mix	  was	  then	  added	  to	  10	  ng	  (5	  µL)	  of	  sample	  total	  RNA	  
(concentration	  determined	  by	  the	  Nanodrop),	  and	  3	  µL	  of	  the	  RT	  primer	  for	  the	  miRNA	  
of	  interest.	  Following	  an	  incubation	  on	  ice	  (5	  min),	  the	  cDNA	  reactions	  were	  incubated	  in	  
a	  thermal	  cycler	  (16°C,	  30	  min;	  42°C,	  30	  min;	  85°C,	  5	  min)	  before	  being	  cooled	  to	  4°C.	  
This	  cDNA	  was	  diluted	  to	  1:15	  and	  was	  stored	  in	  -­‐20°C	  freezers	  until	  used.	  
qPCR	  Amplification	  and	  Data	  Acquisition.	  On	  a	  96-­‐well	  plate	  (Applied	  Biosystems),	  
each	  well	  contained	  1.33	  µL	  of	  cDNA,	  1	  µL	  20x	  TaqMan	  miRNA	  specific	  primer,	  10	  µL	  2x	  
universal	  PCR	  master	  mix	   and	  7.66	  µL	  of	  RNase	   free	  H2O.	  Using	   an	  ABI	  7300	  and	   the	  
associated	  7300	  System	  SDS	  software	   (Applied	  Biosystems),	   the	  document	  was	   set	  up	  
using	  the	  assay	  ‘Standard	  Curve	  (Absolute	  Quantitation)’	  under	  the	  ‘Standard	  7300’	  run	  
mode.	  Selecting	  a	  detector	  with	  the	  reporter	  dye	  as	  ‘FAM’	  and	  no	  quencher,	  and	  setting	  
the	  sample	  volume	  as	  20	  µL,	  each	  plate	  underwent	  a	  pre-­‐incubation	  program	  at	  95°C	  for	  
10	  min.	  Following	  this,	  an	  amplification	  program	  involved	  40	  cycles	  with	  standard	  ramp	  
rate	  settings	  of	  95°C	  for	  15	  s,	  followed	  by	  data	  collection	  at	  60°C	  for	  60	  s.	  
Primer	   Standard	   Curves.	   To	   test	   the	   efficiency	   of	   each	   mature	   miRNA	   primer,	  
cDNA	  created	   from	  a	  combination	  of	  sample	  RNA	  was	  serially	  diluted	  with	  RNase	   free	  
H2O	   1:3	   to	   give	   5	   dilutions,	   with	   2	   on	   either	   side	   of	   the	   recommended	   1:15	   dilution	  
recommended	   by	   the	   protocol	   (0.400	   ng/µL,	   0.133	   ng/µL,	   0.044	   ng/µL,	   0.015	   ng/µL,	  
0.005	   ng/µL).	   Following	   qPCR	   amplification	   and	   data	   acquisition,	   the	   concentrations	  
were	  converted	  to	  log10	  values,	  the	  triplicates	  were	  averaged	  and	  graphed	  against	  each	  
other	  onto	  a	  scatter	  plot.	  A	  line	  of	  best	  fit,	  as	  determined	  by	  Excel	  2010	  (Microsoft),	  was	  
generated,	   giving	   an	  m	   value	   for	   the	   slope	   of	   best	   fit,	   and	   a	   R2	   value,	   quantifying	   the	  
percentage	   of	   the	   data	   explained	   by	   the	   line.	   The	   m	   value	   was	   inserted	   into	   the	  
formula,  𝐸𝐸 = 10 ×100,	   which	   gives	   us	   an	   efficiency	   value	   or	   E.	   A	   primer	   set	   was	  
determined	  to	  be	  efficient	  if	  E	  was	  between	  90%	  and	  105%	  and	  the	  R2	  value	  was	  equal	  
or	  greater	  to	  0.98.	  In	  certain	  cases,	  the	  highest	  or	  lowest	  value	  was	  removed	  as	  they	  may	  
affect	   the	   line	   of	   best	   fit,	   due	   to	   PCR	   inhibition	   and	   low	   concentrations	   of	   RNA	  
respectively.	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Sample	  Reactions.	  For	  each	  sample,	  10	  ng	  total	  RNA	  (30	  ng	  for	  miR-­‐214-­‐3p)	  was	  
converted	  into	  cDNA,	  and	  was	  diluted	  1:15	  to	  0.044	  ng/µL	  using	  RNase	  free	  H2O.	  Each	  
sample	   was	   present	   in	   triplicate	   with	   each	   primer	   on	   a	   96-­‐well	   plate	   (Applied	  
Biosystems).	  For	  each	  primer,	   two	  wells	  each	  were	  present	  on	  the	  plate	   for	  a	  negative	  
cDNA	   sample	   and	  RNase	   free	  H2O	   in	  place	  of	   the	   sample	   cDNA.	  Also	  present	  were	  Y1	  
RNA	   with	   mixed	   sample	   cDNA	   in	   triplicates,	   to	   control	   between	   differences	   between	  
plates	  and	  to	  act	  as	  positive	  controls	  for	  the	  plate,	  as	  seen	  in	  Figure	  2.2.	  
	  
2.2.5 TaqMan	  pri-­‐miRNA	  RT-­‐qPCR	  
Primer	  Design.	  Pre-­‐designed	  primers	  for	  each	  pri-­‐miRNA	  of	  interest	  were	  ordered	  
from	  Applied	  Biosystems,	  based	  on	  the	  sequence	  in	  version	  18	  of	  miRBase,	  a	  repository	  
of	  all	  miRNA	  sequences.	  Designed	  by	  the	  TaqMan	  assay	  design	  algorithm,	  the	  stem	  loop	  
sequences	  of	  the	  mature	  miRNA	  were	  mapped	  back	  to	  the	  genome,	  and	  flanking	  500	  bp	  
genomic	   regions	   were	   considered	   for	   designing	   primers.	   Primers	   meeting	   minimum	  
requirements	  were	  designed	  and	  tested,	  and	  made	  available	  for	  researchers	  to	  order	  to	  
use.	  
cDNA	  Synthesis.	  Universal	  cDNA	  libraries	  for	  the	  pri-­‐miRNA	  RT-­‐qPCR	  assays	  were	  
made	   from	   total	  RNA	  extracted	   from	   the	  dentate	   gyri	   using	   the	  High	  Capacity	  RNA	   to	  
Figure	  2.2:	  Layout	  of	  a	  96-­‐well	  plate	  for	  RT-­‐qPCR.	  Within	  each	  well	  was	  a	  mix	  of	  the	  sample	  cDNA	  and	  the	  
master	  mix	  created	  with	  RT-­‐qPCR	  reagents.	  Each	  sample	  was	  done	  in	  triplicate	  for	  each	  target	  primer	  set.	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cDNA	   kit	   (Appled	   Biosystems).	   Following	   the	  manufacturer’s	   instructions	   for	   a	   20	   µL	  
reaction	  500	  ng	  of	  sample	  total	  RNA	  (concentration	  determined	  by	  the	  Nanodrop)	  was	  
added	  to	  10	  µL	  2x	  RT	  buffer,	  1	  µL	  20x	  enzyme	  mix.	  RNase	  free	  H2O	  was	  then	  added	  to	  
make	  the	  final	  volume	  20	  µL.	  The	  mixture	  was	  mixed	  gently	  and	  incubated	  in	  a	  thermal	  
cycler	  (37°C,	  60	  min;	  95°C,	  5	  min)	  before	  being	  cooled	  to	  4°C.	  This	  cDNA	  was	  diluted	  1:2	  
and	  was	  stored	  in	  -­‐20°C	  freezers	  until	  used.	  
qPCR	  Amplification	  and	  Data	  Acquisition.	  On	  a	  96-­‐well	  plate	  (Applied	  Biosystems),	  
each	  well	  contained	  4	  µL	  of	  cDNA,	  1	  µL	  20x	  TaqMan	  pri-­‐miRNA	  specific	  primer,	  10	  µL	  2x	  
universal	   PCR	   master	   mix	   and	   5	   µL	   of	   RNase	   free	   H2O.	   The	   plate	   was	   then	   run	   as	  
described	  above	  in	  section	  2.2.4.	  
Primer	   Standard	   Curves.	   To	   test	   the	   efficiency	   of	   each	  pri-­‐miRNA	  primer,	   cDNA	  
created	  from	  a	  combination	  of	  sample	  RNA	  was	  serially	  diluted	  with	  RNase	  free	  H2O	  1:3	  
to	  give	  5	  dilutions	  (25	  ng/µL,	  8.3	  ng/µL,	  2.8	  ng/µL,	  0.9	  ng/µL,	  0.3	  ng/µL).	  The	  standard	  
curve	  was	  then	  carried	  out	  and	  the	  efficiencies	  determined	  as	  described	  above	  in	  section	  
2.2.4.	  
Sample	  Reactions.	  For	  each	  sample,	  500	  ng	   total	  RNA	  was	  converted	   into	  cDNA,	  
and	  was	  diluted	  1:2	  down	  to	  12.5	  ng/µL	  using	  RNase	  free	  H2O.	  Each	  sample	  was	  present	  
in	  triplicate	  with	  each	  primer	  on	  a	  96-­‐well	  plate	  (Applied	  Biosystems).	  For	  each	  primer,	  
two	  wells	  each	  were	  present	  on	   the	  plate	   for	  a	  negative	   cDNA	  sample	  and	  RNase	   free	  
H2O	   in	   place	   of	   the	   sample	   cDNA.	   Also	   present	  was	  Hprt	  with	  mixed	   sample	   cDNA	   in	  
triplicates,	  to	  control	  between	  differences	  between	  plates	  and	  to	  act	  as	  positive	  controls	  
for	  the	  plate,	  as	  seen	  in	  Figure	  2.2.	  
	  
2.2.6 SYBR	  Green	  pri-­‐miRNA	  and	  pre-­‐miRNA	  Primer	  Design	  
Primers	   for	   the	   primary	   and	   precursor	   transcripts	   of	   rno-­‐miR-­‐132	   were	  
developed	   by	   using	   freely	   available	   tools.	   The	   precursor	   sequence	  was	   obtained	   from	  
miRBase	   (version	   20)	   and	   mapped	   back	   to	   the	   genomic	   sequence	   using	   BLAST	   and	  
Ensembl.	  Flanking	  500	  bp	  regions	  of	  genomic	  regions	  were	  obtained.	  These	  sequences	  
were	  run	  in	  BLAST	  to	  ensure	  that	  the	  reference	  sequences	  was	  specific	  to	  the	  precursors	  
of	  the	  miRNA	  of	  interest	  in	  the	  rat.	  A	  note	  was	  made	  of	  any	  other	  genes	  that	  received	  a	  
100%	   score	   in	   query	   coverage	   as	   potential	   targets	   for	   non-­‐specific	   amplification.	  
Primers	   were	   then	   generated	   using	   Primer-­‐BLAST,	   with	   the	   parameter	   that	   it	   was	  
specific	  for	  the	  rat.	  Suitable	  primers	  were	  first	  designed	  for	  the	  hairpin	  structure,	  which	  
would	  profile	  the	  expression	  of	  the	  pre-­‐miRNA.	  An	  additional	  primer	  within	  the	  flanking	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regions	  to	  be	  used	  in	  conjunction	  with	  one	  primer	  from	  the	  pre-­‐miRNA	  primer	  was	  also	  
designed	  to	  profile	  the	  pri-­‐miRNA.	  Furthermore,	  an	  additional	  pair	  of	  primers	  within	  the	  
flanking	  regions	  were	  designed	  to	  profile	   the	  pri-­‐miRNA.	  Primers	  designed	  by	  Primer-­‐
BLAST	  were	  then	  selected	  on	  a	  number	  of	  criteria:	  there	  was	  specific	  amplification	  of	  the	  
gene	  of	  interest,	  the	  melting	  temperature	  (Tm)	  of	  each	  primer	  were	  within	  2.5°C	  of	  each	  
other,	   and	   the	   percentage	   of	   the	   primer	   made	   of	   guanine	   (G)	   or	   cytosine	   (C)	   was	  
between	  40%	  and	  60%.	  	  
These	   primers	   were	   then	   run	   through	   NetPrimer	   (Premier	   Biosoft;	  
http://www.premierbiosoft.com/netprimer/),	  where	  scores	  were	  generated	  about	  each	  
primer,	   where	   above	   80%	   was	   considered	   acceptable.	   This	   score	   considers	   primer	  
dimers	   (binding	  with	   itself),	   repeats	   (nucleotide	   sequences	   repeating),	   runs	   (the	   same	  
nucleotide	   in	   a	   row),	   palindromes	   (a	   sequence	   that	   is	   the	   same	   when	   inverted),	   and	  
hairpins	   (distal	   parts	   of	   the	   primer	   bind	   to	   each	   other),	   features	   of	   the	   primer	  which	  
may	  affect	  its	  efficiency	  in	  the	  RT-­‐qPCR	  reaction.	  Cross	  dimers,	  or	  binding	  between	  the	  
primers	   in	   a	   set,	   are	   not	   considered	   in	   this	   score	   but	   are	   shown.	   The	   primer	   set	  
containing	  highly	  scored	  primers	  that	  met	   the	  criteria	  were	  ordered	  at	  25	  nmole	   from	  
Integrated	  DNA	  Technologies.	  For	  each	  gene	  of	   interest,	   the	  two	  best	  primer	  sets	  from	  
Primer-­‐BLAST	   were	   ordered.	   Full	   sequences	   of	   the	   transcript	   and	   the	   primers	   are	  
included	  in	  Appendix	  A.	  
MiScript	   precursor	   miRNA	   primers	   targeting	   both	   the	   primary	   and	   precursor	  
transcripts	   of	   rno-­‐miR-­‐34a	   and	   rno-­‐miR-­‐132	   were	   also	   ordered	   from	   Qiagen.	   The	  
primers	  are	  designed	  to	  target	  the	  hairpin	  present	  in	  both	  pri-­‐	  and	  pre-­‐miRNA.	  
	  
2.2.7 SYBR	  Green	  pri-­‐miRNA	  and	  pre-­‐miRNA	  RT-­‐qPCR	  
qPCR	   Amplification	   and	  Data	   Acquisition.	   On	   a	   96-­‐well	   plate	   (Roche),	   each	  well	  
contained	  3	  µL	  of	  cDNA	  and	  7	  µL	  of	  a	  premade	  master	  mix,	  consisting	  of	  1	  µL	  of	  10	  µM	  
forward	   and	   reverse	   primer	   and	   5	   µL	   of	   SYBR	   Green	   Master	   Mix	   I	   (Roche).	   Using	   a	  
LightCycler	  480	  and	  its	  associated	  software	  (Roche),	  setting	  the	  sample	  volume	  to	  10	  µL,	  
each	   plate	   underwent	   a	   pre-­‐incubation	   program	   at	   95°C	   for	   5	  min.	   Following	   this,	   an	  
amplification	  program	  with	  a	  quantification	  analysis	  involved	  40	  cycles	  of	  95°C	  for	  30	  s,	  
60°C	   for	   30	   s,	   and	   then	   72°C	   for	   30	   s.	   Following	   this	   amplification,	   a	   melting	   curve	  
analysis	  was	   carried	   out	  with	   95°C	   for	   5	   s,	   65°C	   for	   1	  min,	   followed	   by	   a	   continuous	  
ramp	  at	  0.11°C/s	  up	  to	  97°C,	  before	  cooling	  to	  40°C	  and	  holding	  for	  30	  s.	  An	  excess	  of	  35	  
cycles	  is	  determined	  not	  to	  be	  amplified.	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Primer	  Standard	  Curves.	  To	  test	  the	  efficiency	  of	  each	  primer,	  cDNA	  created	  from	  
a	   combination	   of	   sample	   RNA	  was	   serially	   diluted	  with	   RNase	   free	  H2O	   1:3	   to	   give	   5	  
dilutions	  (25	  ng/µL,	  8.3	  ng/µL,	  2.8	  ng/µL,	  0.9	  ng/µL,	  0.3	  ng/µL).	  The	  standard	  curve	  was	  
then	  carried	  out	  and	  the	  efficiencies	  determined	  as	  described	  above	  in	  section	  2.2.4.	  
Additionally,	   it	   is	   also	   important	   to	   look	   at	   the	  melting	   curves	   of	   the	  primer	   to	  
identify	   if	   specific	   amplification	   is	  occurring.	  The	  LightCycler	  480	   software	   (Roche)	  or	  
Viia	   7	   software	   (Applied	   Biosystems)	   displayed	   the	   results	   from	   the	   melting	   curve	  
analysis	   step	   in	   the	   programming.	   The	   presence	   of	   a	   singular	   peak	   indicated	   a	   single	  
RNA	   product	   has	   been	   amplified,	   while	   a	   double	   peak	   indicated	   nonspecific	  
amplification	   of	   primer	   dimers.	   If	   the	   efficiency	   was	   not	   optimal	   and/or	   there	   were	  
multiple	  products	  amplified,	  then	  a	  change	  in	  temperature	  and/or	  the	  concentration	  of	  
the	  primers	  was	  made	  and	  the	  standard	  curve	  was	  repeated	  with	  these	  new	  parameters.	  
Sample	  Reactions.	  The	  same	  universal	  cDNA	  libraries	  created	  for	  the	  TaqMan	  pri-­‐
miRNA	  RT-­‐qPCR	  experiments	   for	   each	   sample	  were	  used	   for	  profiling	   the	  pre-­‐miRNA.	  
The	  preparation	  and	  layout	  of	  the	  plates	  is	  as	  described	  above	  in	  section	  2.2.5.	  
	  
2.2.8 RT-­‐qPCR	  Data	  Analysis	  
Within	   the	   software,	   Cq	   values	   for	   each	   sample	   were	   calculated	   based	   on	   an	  
automatically	  determined	  baseline.	  Averaged	  across	  the	  sample	  triplicates,	  each	  sample	  
was	  normalised	  per	   rat	   hemisphere.	  Normalisers	   for	  miRNA	  were	  previously	   selected	  
for	   their	  non-­‐variance.	  For	  mature	  miRNA	  transcripts,	   samples	  were	  normalised	   to	  Y1	  
RNA	  (Joilin	  et	  al.,	  2014;	  Wibrand	  et	  al.,	  2012;	  Wibrand	  et	  al.,	  2010).	  For	  pri-­‐miRNA	  and	  
pre-­‐miRNA	   transcripts,	   samples	  were	  normalised	   to	  Hprt	  as	   they	  are	  profiled	   just	   like	  
mRNA	   (Ryan	   et	   al.,	   2012).	   The	   2-­‐ΔΔCp	   method	   was	   used	   to	   give	   a	   fold	   change	   as	  
previously	  described	   (Joilin	  et	   al.,	   2014;	  Ryan	  et	   al.,	   2011;	  Ryan	  et	   al.,	   2012).	  The	   fold	  
change	  was	  calculated	  by	  subtracting	  the	  average	  Cq	  of	  the	  control	  hemisphere	  from	  the	  
stimulated	   hemisphere.	   Outliers	   were	   determined	   using	   the	   Grubb's	   test	   (GraphPad;	  
http://www.graphpad.com/quickcalcs/Grubbs1.cfm)	   where	   α	   =	   0.05.	   To	   determine	  
whether	  samples	  were	  differentially	  expressed,	  a	  one	  sample	  Student's	  t-­‐test	  using	  Excel	  
(Microsoft)	  was	  carried	  out	  where	  a	  significance	  criterion	  set	  at	  p<0.05	  was	  accepted.	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2.3 Regulation	   of	  miR-­‐34a-­‐5p	   and	  miR-­‐132-­‐3p	   Following	   Induction	  
of	  Long-­‐Term	  Potentiation	  
To	   investigate	   the	   regulation	   of	   miRNA	   following	   LTP,	   experiments	   using	   RT-­‐
qPCR	   were	   carried	   out	   to	   profile	   the	   expression	   of	   primary,	   precursor,	   and	   mature	  
miRNA	  transcripts	  across	  time.	  
	  
2.3.1 HFS	  Induced	  LTP	  and	  Related	  Gene	  Expression	  and	  Both	  were	  Blocked	  by	  CPP	  
LTP	   was	   induced	   using	   protocols	   known	   to	   induce	   long	   lasting	   plasticity	  
dependent	  on	  gene	  expression	  (Abraham	  et	  al.,	  2002).	  For	  each	  group	  of	  adult	  male	  rats,	  
DBS	  was	  administered	  while	  the	  animals	  were	  awake	  to	  perforant	  path	  synapses	  in	  the	  
dentate	  gyrus	  following	  a	  stable	  baseline	  for	  30	  min.	  All	  LTP	  experimental	  groups	  of	  rats	  
(20	   min,	   5	   h,	   and	   24	   h	   post-­‐LTP)	   met	   the	   minimal	   criteria	   for	   LTP	   induction	   (field	  
excitatory	   post-­‐synaptic	   potential	   (fEPSP):	   10%	   increase;	   population	   spike	   (PS):	   50%	  
Figure	  2.3:	  Induction	  of	  long-­‐term	  potentiation	  following	  administration	  of	  delta-­‐burst	  stimulation	  20	  min	  
(A),	  5	  h	  (B),	  and	  24	  h	  (C)	  post-­‐LTP.	  The	  average	  field	  evoked	  postsynaptic	  potential	  is	  plotted,	  with	  20	  min	  
shown	  with	  and	  without	  CPP.	  Traces:	  average	  waveforms	  after	  tetanus	  (n=10).	  Scale	  bar	  =	  x:	  5ms;	  y:	  5mV.	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increase)(Abraham	   et	   al.,	   2002),	   while	   the	   animals	   administered	   with	   the	   NMDAR	  
antagonist	  CPP	  prior	  to	  DBS	  demonstrated	  no	  increase	  in	  the	  fEPSP	  or	  PS,	  indicating	  an	  
occlusion	  of	  LTP	  induction	  (Figure	  2.3).	  Amplification	  in	  both	  fEPSP	  and	  PS	  persisted	  for	  
the	  20	  min	  prior	  to	  their	  sacrifice	  for	  all	  three	  groups.	  
	  Furthermore,	  dramatic	  up-­‐regulation	  of	   three	  key	  plasticity	  mRNA,	  Arc	   (Lyford	  
et	  al.,	  1995),	  FBJ	  murine	  osteosarcoma	  viral	  oncogene	  homolog	  (Fos)	  (Dragunow	  &	  Faull,	  
1989),	  and	  jun	  B	  proto-­‐oncogene	  (JunB)	  (Demmer	  et	  al.,	  1993)	  were	  observed	  in	  the	  20	  
min	   post-­‐LTP	   induction	   samples	   (Arc:	   16.87±5.05,	   p=0.02,	   n=10;	   Fos:	   5.13±1.02,	  
p=0.003,	   n=10;	   JunB:	   7.49±2.58,	   p=0.03,	   n=10;	   Figure	   2.4).	   This	   up-­‐regulation	   was	  
blocked	  with	  the	  application	  of	  the	  NMDAR	  antagonist	  CPP	  (Arc:	  4.69±3.87	  p=0.44,	  n=3;	  
Fos:	  2.73±1.55,	  p=0.38,	  n=3;	  JunB:	  2.29±1.18,	  p=0.35,	  n=4;	  Figure	  2.4).	  In	  addition,	  other	  
studies	   in	   our	   lab	   using	   the	   5	   h	   and	   24	   h	   samples	   used	   in	   this	   study	   have	   confirmed	  
regulation	   of	   plasticity-­‐related	   genes	   at	   these	   time	   points	   (Ryan	   et	   al.,	   2012).	   These	  
results	   suggest	   that	   the	   induction	   of	   LTP	   was	   sufficient	   to	   produce	   a	   gene	   response	  
consistent	  with	   previous	   studies	   (Abraham	  et	   al.,	   1991;	   Plath	   et	   al.,	   2006;	  Ryan	   et	   al.,	  
2011;	  Steward	  et	  al.,	  1998).	  	  
	  
2.3.2 Mature	  miR-­‐34a-­‐5p	  and	  miR-­‐132-­‐3p	  are	  Differentially	  Expressed	  post-­‐LTP	  
A	   subset	   of	   miRNA	   differentially	   expressed	   on	   the	   previously	   undertaken	  
Affymetrix	  miRNA	  array	  20	  min	  following	  LTP	  were	  identified	  for	  further	  investigation.	  
These	  miRNA	  were	  selected	  as	  a	  result	  of	  a	  literature	  search	  that	  demonstrated	  that	  they	  
were	   involved	   in	   regulation	   genes	   involved	   in	   LTP-­‐related	   processes	   (Table	   2.1).	   To	  
Figure	  2.4:	  Expression	  of	  key	  plasticity	  IEG	  20	  min	  post-­‐LTP	  induction.	  LTP	  regulates	  the	  expression	  of	  
activity	  regulated	  cytoskeletal	  protein	  (Arc),	  FBJ	  murine	  osteosarcoma	  viral	  oncogene	  homolog	  (Fos),	  and	  
jun	   B	   proto-­‐oncogene	   (JunB,	   before	   and	   after	   CPP.	   Expression	   values:	   average	   fold	   change	   ±	   SEM;	  
normalised	  to	  Hprt;	  one-­‐sample	  two-­‐tailed	  t-­‐test	  *	  p<0.05,	  **	  p<0.01;	  HFS:	  n=10;	  HFS	  +	  CPP:	  n=3-­‐4.	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validate	   the	  regulation	  of	   these	  miRNA,	  using	  the	   four	  20	  min	  LTP-­‐stimulated	  samples	  
used	  on	  the	  arrays,	  individual	  TaqMan	  RT-­‐qPCR	  assays	  were	  used.	  Technical	  replication	  
using	   TaqMan	   RT-­‐qPCR	   assays	   were	   chosen	   due	   to	   the	   increased	   sensitivity	   and	  
specificity	  afforded	  by	  their	  stem-­‐loop	  primers	  (Allanach	  et	  al.,	  2008;	  Chen	  et	  al.,	  2005;	  
Git	  et	  al.,	  2010).	  Further,	  an	  additional	  six	  20	  min	  LTP-­‐stimulated	  samples	  were	  used	  to	  
biologically	  replicate	  these	  results	  in	  a	  separate	  cohort.	  
This	  analysis	  confirmed	  the	  microarray	  and	  earlier	  RT-­‐qPCR	  work	  that	  miR-­‐34a-­‐
5p	   and	   miR-­‐132-­‐3p	   were	   down-­‐regulated	   20	   min	   post-­‐LTP	   (miR-­‐34a-­‐5p:	   0.44±0.07,	  
p<0.01,	   n=8;	   miR-­‐132-­‐3p:	   0.38±0.11	   p<0.01,	   n=8;	   Figure	   2.5)	   but	   not	   miR-­‐34c-­‐5p	  
Figure	   2.5:	   Long-­‐term	   potentiation	   differentially	   regulates	   mature	   miR-­‐34a-­‐5p	   and	   miR-­‐132-­‐3p.	   (A)	  
Down-­‐regulation	   of	   miR-­‐34a-­‐5p	   was	   observed	   at	   20	   min	   and	   5	   h	   (Ryan	   et	   al.,	   2012),	   but	   returned	   to	  
baseline	  by	  24	  h,	  and	  blocked	  at	  20	  min	  with	  CPP.	  (B)	  Down-­‐regulation	  of	  miR-­‐132-­‐3p	  was	  observed	  only	  
at	  20	  min,	  returning	  to	  baseline	  by	  5	  h,	  with	   its	   regulation	  was	  also	  blocked	  at	  20	  min	  by	  CPP.	  Adapted	  
from	  Joilin	  et	  al.	  (2014).	  Expression	  values:	  average	  fold	  change	  ±	  SEM;	  normalised	  to	  Y1	  RNA;	  one	  sample	  
two-­‐tailed	  t-­‐test	  *	  p<0.05;	  independent	  two-­‐tailed	  t-­‐test	  #	  p<0.05;	  n=3-­‐8.	  
Table	   2.1:	  MicroRNA	   differentially	   expressed	   at	   20	  min	   selected	   for	   RT-­‐qPCR	   validation	   involved	   in	  
LTP-­‐related	  processes.	  
miRNA	   Fold	  Change	  ±	  SEM	  (20	  min	  Affymetrix	  Array)	   n	  
Reference	  to	  LTP-­‐Related	  
Processes	  
miR-­‐34a-­‐5p	   0.78±0.02	   3	   Agostini	   et	   al.	   (2011),	   Ryan	  
et	  al.	  (2012)	  
miR-­‐34c-­‐5p	   0.76±0.02	   3	   Zovoilis	  et	  al.	  (2011)	  
miR-­‐132-­‐3p	   0.84±0.02	   4	   Wayman	  et	   al.	   (2008)	   Impey	  
et	  al.	  (2010)	  
miR-­‐181c-­‐5p	   0.52±0.05	   3	   Schonrock	  et	  al.	  (2010)	  
miR-­‐214-­‐5p	   0.61±0.03	   3	   Chen	  et	  al.	  (2010)	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(1.78±0.49	  p=0.15,	  n=9),	  miR-­‐181c-­‐5p	   (0.84±0.21	  p=0.45,	  n=10),	  or	  miR-­‐214-­‐3p	   (1.15	  
±0.33	  p=0.65,	  n=9).	  In	  parallel	  studies	  from	  our	  laboratory,	  down-­‐regulation	  of	  miR-­‐34a-­‐
5p	  had	  been	  previously	  shown	  5	  h	  post-­‐LTP	  (0.53±0.16,	  p<0.05,	  n=5;	  Figure	  2.5A)	  (Ryan	  
et	   al.,	   2012).	   Investigating	   the	   other	  miRNA	   that	   showed	  differential	   expression	   at	   20	  
min,	   miR-­‐132-­‐3p,	   showed	   no	   significant	   regulation	   (0.85±0.24,	   p=0.58,	   n=7;	   Figure	  
2.5B),	   suggesting	   the	  maximal	   reduction	   in	   its	   expression	   is	   near	  20	  min.	  At	   the	  most	  
distant	  time	  point	  at	  24	  h	  post-­‐LTP,	  neither	  miR-­‐34a-­‐5p	  (1.20±0.45,	  p=0.68,	  n=4;	  Figure	  
2.5A)	   nor	   miR-­‐132-­‐3p	   (0.86±0.38,	   p=0.74,	   n=4;	   Figure	   2.5B)	   showed	   differential	  
expression.	  	  
To	   determine	   whether	   the	   regulation	   of	   these	   miRNA	   was	   specific	   to	   LTP,	  
application	   of	   the	  NMDAR	   antagonist	   CPP	  was	   administered	   prior	   to	   the	   induction	   of	  
LTP.	  Concurrent	  with	  CPP	  occluding	  the	  NMDAR	  at	  the	  time	  of	  LTP	  induction,	  the	  down-­‐
regulation	  of	  miR-­‐34a-­‐5p	  and	  miR-­‐132-­‐3p	  20	  min	  post-­‐LTP	  was	  blocked	  (miR-­‐34a-­‐5p:	  
3.29±1.46,	  p=0.22,	  n=4;	  miR-­‐132-­‐3p:	  1.38±1.05	  p=0.75,	  n=3;	  Figure	  2.5).	  Indeed,	  CPP	  in	  
combination	  with	  tetanic	  stimulation	  led	  to	  increased	  but	  highly	  variable	  levels	  of	  miR-­‐
34a-­‐5p	  in	  the	  tetanised	  hemisphere,	  and	  was	  significantly	  different	  to	  the	  expression	  of	  
miR-­‐34a-­‐5p	  post-­‐LTP	  (p=0.02;	  Figure	  2.5A).	  These	  results	  show	  the	  mature	  transcripts	  
of	  miR-­‐34a-­‐5p	  and	  miR-­‐132-­‐2p	  have	  different	  expression	  profiles	  post-­‐LTP	  and	  suggest	  
that	  there	  are	  multiple	  NMDAR-­‐dependent	  mechanisms	  regulating	  their	  expression.	  	  
	  
2.3.3 Pri-­‐miR-­‐34a	   and	   pri-­‐miR-­‐132	   Show	   Differential	   Expression	   to	   Mature	  
microRNA	  
One	   possible	   mechanism	   underlying	   the	   down-­‐regulation	   of	   miR-­‐34a-­‐5p	   and	  
miR-­‐132-­‐3p	  post-­‐LTP	  is	  a	  rapid	  reduction	  in	  transcription	  of	  their	  primary	  transcripts	  in	  
the	  presence	  of	  continued	  high	  turnover	  as	  observed	  in	  Krol	  et	  al.	  (2010).	  To	  investigate	  
this,	   individual	   TaqMan	   pri-­‐miRNA	   assays,	   which	   target	   the	   single-­‐stranded	   region	  
adjacent	   to	   the	  stem	   loop	  containing	   the	  mature	   transcript,	  were	  used	   to	  measure	   the	  
expression	   of	   the	   primary	   transcripts	   (Figure	   2.6A).	  No	   significant	   change	   in	   pri-­‐miR-­‐
34a	  expression	  at	  20	  min	  (with	  and	  without	  CPP),	  5	  h,	  or	  24	  h	  post-­‐LTP	  was	  determined	  
(20	  min:	  1.02±0.25,	  p=0.93,	  n=5;	  5	  h:	  1.14±0.30,	  p=0.66,	  n=5;	  24	  h:	  0.71±0.55,	  p=0.63,	  
n=4;	   20	   min	   CPP:	   1.25±0.26,	   p=0.40,	   n=4;	   Figure	   2.6B).	   These	   results	   suggest	   that	   a	  
solely	  post-­‐transcriptional	  mechanism	   regulates	   the	   expression	  of	  mature	  miR-­‐34a-­‐5p	  
following	  LTP	  induction.	  	  
In	   contrast,	   the	   primary	   transcript	   of	   miR-­‐132-­‐3p,	   pri-­‐miR-­‐132/212,	   was	  
dramatically	   up-­‐regulated	   20	  min	   post-­‐LTP	   induction	   (6.92±1.97,	   p=0.04,	   n=5;	   Figure	  
microRNA	  Regulation	  post-­‐LTP	   	   51	  
2.6C).	  Pri-­‐miR-­‐132/212	  expression	  returned	  to	  baseline	  by	  5	  h	  (1.51±0.48,	  p=0.33,	  n=5;	  
Figure	  2.6C),	  but	  was	  significantly	  down-­‐regulated	  at	  24	  h	  post-­‐LTP	  (0.38±0.14,	  p=0.02,	  
n=4;	  Figure	  2.6C).	   In	  the	  presence	  of	  CPP,	  pri-­‐miR-­‐132/212	  had	  a	  reduced	  increase	  20	  
min	  after	  LTP	  induction	  (2.23±0.72,	  n=4;	  Figure	  2.6C),	  but	  was	  not	  significantly	  different	  
from	  baseline	  (p=0.18)	  or	   from	  the	  20	  min	  LTP-­‐stimulated	  group	  (p=0.08),	  suggesting	  
NMDAR	  activation	  might	  contribute	  to	  its	  regulation.	  	  
It	  should	  be	  noted	  that	  the	  pri-­‐miRNA	  of	  miR-­‐132-­‐3p	  also	  contains	  the	  hairpin	  for	  
the	  mature	  miR-­‐212-­‐3p.	   As	   its	   primary	   transcript	   is	   regulated,	   changes	   in	   the	  mature	  
miR-­‐212-­‐3p	   transcript	  may	   be	   possible.	   However,	   on	   the	   Affymetrix	  miRNA	   array,	   no	  
Figure	   2.6:	   Long-­‐term	   potentiation	   differentially	   regulates	   the	   primary	   transcripts	   of	   miR-­‐34a-­‐5p	   and	  
miR-­‐132-­‐3p.	  (A)	  Schematic	  diagram	  of	  the	  location	  of	  the	  primers	  for	  the	  primary	  transcript	  in	  relation	  to	  
the	  hairpin	  loop	  containing	  the	  mature	  miRNA	  sequence	  (B)	  No	  regulation	  of	  miR-­‐34a-­‐5p	  was	  observed	  at	  
any	   of	   the	   three	   time	   points	   post-­‐LTP	   (C)	   A	   dramatic	   up-­‐regulation	   of	   pri-­‐miR-­‐132/212	   at	   20	   min,	  
returning	  to	  baseline	  by	  5	  h,	  and	  down-­‐regulated	  by	  24	  h.	  The	  up-­‐regulation	  was	  attenuated	  by	  CPP	  at	  20	  
min.	  Adapted	  from	  Joilin	  et	  al.	  (2014).	  Expression	  values:	  average	  fold	  change	  ±	  SEM;	  normalised	  to	  Hprt;	  
one	  sample	  two-­‐tailed	  t-­‐test	  *	  p<0.05;	  n=4-­‐5.	  
Figure	   2.7:	   Long-­‐term	   potentiation	   does	   not	  
regulate	   the	   expression	   of	   miR-­‐212-­‐3p	   across	  
time	   at	   20	  min,	   5	   h,	   or	   24	   h.	   Expression	   values:	  
average	   fold	   change	   ±	   SEM;	   normalised	   to	   Y1	  
RNA;	  one	  sample	  two-­‐tailed	  t-­‐test	  *	  p<0.05.;	  n=2-­‐
5.	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differential	   expression	   was	   observed	   20	   min	   post-­‐LTP,	   confirmed	   with	   the	   more	  
sensitive	  RT-­‐qPCR,	  with	  or	  without	  CPP	  (20	  min:	  0.97±0.30,	  p=0.93,	  n=5;	  20	  min	  CPP:	  
0.92±0.23,	   p=0.79,	   n=2;	   Figure	   2.7).	   Furthermore,	   no	   differential	   expression	   was	  
observed	  at	  any	  later	  time	  point	  (5	  h:	  1.38±0.70,	  p=0.63,	  n=4;	  24	  h:	  1.61±0.77,	  p=0.47,	  
n=4;	  Figure	  2.7).	  These	   results	   suggest	   that	   the	  differential	   expression	  of	   the	  pri-­‐miR-­‐
132/212	  post-­‐LTP	   is	  selectively	  contributing	  to	   the	  regulation	  of	   the	  mature	  miR-­‐132-­‐
3p	  transcript,	  and	  that	  the	  down-­‐regulation	  of	  mature	  miR-­‐132-­‐3p	  at	  20	  min	  is	  likely	  to	  
be	  additionally	  regulated	  by	  post-­‐transcriptional	  mechanisms	  not	  related	  to	  the	  level	  of	  
its	  primary	  transcript.	  
	  
2.3.4 Expression	  of	  pre-­‐miR-­‐34a	  and	  pre-­‐miR-­‐132	  post-­‐LTP	  is	  Unknown	  	  
To	   further	   understanding	   the	   regulation	   of	   these	   miRNA	   along	   the	   biogenesis	  
pathway,	   the	   expression	   of	   the	   intermediate	   miRNA	   transcript,	   the	   pre-­‐miRNA	   were	  
investigated.	  Unlike	  the	  primary	  and	  mature	  transcripts,	  commercial	  primers	  that	  allow	  
specific	  measurement	  of	  the	  expression	  of	  pre-­‐miRNA	  are	  not	  available.	  The	  pre-­‐miRNA	  
consists	   of	   a	   single	   hairpin	   sequence,	   which	   is	   also	   present	   in	   the	   pri-­‐miRNA.	   This	  
presents	  a	  problem	  as	  profiling	  the	  pre-­‐miRNA	  with	  RT-­‐qPCR	  will	  likely	  also	  include	  the	  
pri-­‐miRNA.	  As	   such,	   a	   system	   that	   can	  measure	   the	   expression	  of	   the	  pre-­‐miRNA	   that	  
takes	  into	  account	  the	  amount	  of	  pri-­‐miRNA	  also	  present	  is	  needed.	  	  
One	  method	   has	   previously	   been	   used	   to	   successfully	   measure	   specifically	   the	  
expression	   of	   pre-­‐miRNA	   (Schmittgen	   et	   al.,	   2004).	   In	   this	   method,	   suitable	   primers	  
designed	   for	   the	   hairpin	   structure	   profile	   the	   expression	   of	   the	   pre-­‐miRNA.	   An	  
additional	  primer	  within	  the	  flanking	  regions	  of	  the	  hairpin	  on	  the	  respective	  pri-­‐miRNA	  
was	  designed	  to	  be	  used	  in	  conjunction	  with	  one	  primer	  from	  the	  pre-­‐miRNA	  primer	  to	  
profile	   the	   pri-­‐miRNA	   (Figure	   2.8A).	  With	   these	   two	   sets	   of	   primers,	   it	   is	   possible	   to	  
remove	  the	  contribution	  of	  the	  pri-­‐miRNA	  to	  the	  expression	  of	  the	  pre-­‐miRNA.	  	  
Unfortunately,	  using	  this	  approach	  was	  unsuccessful.	  A	  number	  of	  different	  sets	  
of	  primers	  were	  designed	  to	  profile	  pri-­‐miR-­‐132	  involving	  extensions	  from	  both	  hairpin	  
primers	   using	   SYBR	   Green	   RT-­‐qPCR.	   However,	   multiple	   products	   were	   persistently	  
produced	   despite	   variations	   in	   annealing	   temperatures	   and	   primer	   concentrations	  
(Figure	  2.8B).	   Primers	  designed	   to	  profile	   the	  pre-­‐miR-­‐132	  hairpin	   generated	   a	   single	  
product,	  but	   the	  primer	  efficiency	  was	  unable	   to	  be	  brought	   lower	   than	  170%	  (Figure	  
2.8C).	   Therefore,	   using	   these	   primers	   to	   profile	   the	   pre-­‐miRNA	   transcripts	   was	  
abandoned.	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  A	  variation	  of	  the	  above	  approach	  however	  was	  attempted.	  Firstly,	  primers	  were	  
designed	   to	  bind	   to	   the	   flanking	  regions	  of	   the	  hairpin	  on	   the	  pri-­‐miRNA,	   in	  a	  method	  
similar	   to	   that	  of	   the	  TaqMan	  pri-­‐miRNA	  primers	  (Figure	  2.9A)	  Additionally,	   to	  profile	  
the	   expression	   of	   the	   pre-­‐miRNA,	   primers	   designed	   by	   Qiagen	   to	   bind	   to	   sequences	  
within	   the	   hairpin	   structures	   of	   pre-­‐miR-­‐34a	   and	   pre-­‐miR-­‐132	   were	   ordered	   from	  
Qiagen	  to	  be	  used	  in	  SYBR	  Green	  RT-­‐qPCR.	  While	  the	  primer	  designed	  for	  pri-­‐miR-­‐34a	  
showed	  amplification,	   the	  Qiagen	  primers	   for	   the	  pre-­‐miR-­‐34a	  transcript	  showed	   little	  
or	   no	   amplification.	   However,	   both	   sets	   of	   primers	   for	   pre-­‐miR-­‐132	   showed	   single	  
Figure	  2.8:	  First	  attempt	  at	  primer	  design	  to	  determine	  pre-­‐miRNA	  expression	  based	  on	  Schmittgen	  et	  al.	  
(2004).	  (A)	  The	  pri-­‐miRNA	  set	  of	  primers	  should	  profile	  only	  the	  primary	  transcript,	  while	  the	  pre-­‐miRNA	  
set	   should	  detect	  both	  the	  primary	  and	  precursor	   transcripts,	  as	   the	  hairpin	   is	  present	   in	  both.	  (B)	  The	  
melting	   curve	   analysis	   of	   the	   pri-­‐miR-­‐132	   primers	   show	   multiple	   peaks,	   suggesting	   multiple	   product	  
amplification.	  Therefore,	  these	  primers	  were	  not	  suitable	  for	  RT-­‐qPCR.	  (C)	  The	  melting	  curve	  analysis	  for	  
the	   pre-­‐miR-­‐132	   primers	   showed	   one	   peak,	   suggesting	   single	   product	   amplification.	   However,	   the	  
standard	  curve	  analysis	  showed	  a	  high	  efficiency	  of	  170%,	  which	  is	  also	  unsuitable	  for	  RT-­‐qPCR.	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product	  amplification	  and	  acceptable	  efficiencies	  (pri-­‐miRNA:	  125%;	  pre-­‐miRNA:	  117%;	  
Figure	  2.9B-­‐C).	  	  
Using	  these	  primers	  to	  investigation	  the	  expression	  of	  the	  pre-­‐miR-­‐132	  following	  
LTP	   induction,	   it	   was	   found	   that	   there	   was	   differential	   expression	   of	   the	   transcripts	  
measured	   by	   the	   pre-­‐miR-­‐132	   primers.	   There	   was	   a	   non-­‐significant	   increase	   in	   its	  
expression	   at	   20	  min	  with	   or	  without	   CPP,	   no	   change	   at	   5	   h	   and	   a	   significant	   down-­‐
regulation	  at	  24	  h	  (20	  min:	  2.06±0.81,	  p=0.25,	  n=5;	  20	  min	  CPP:	  0.91±0.21,	  p=0.70,	  n=3;	  
Figure	  2.9:	  Primer	  design	  to	  determine	  pre-­‐miRNA	  expression	  adapted	  from	  Schmittgen	  et	  al.	  (2004).	  (A)	  
Using	   the	   same	   principles	   as	   above,	   the	   pri-­‐miRNA	   set	   of	   primers	   should	   profile	   only	   the	   primary	  
transcript	   and	   were	   based	   on	   those	   used	   in	   the	   TaqMan	   pri-­‐miRNA	   assays,	   while	   the	   pre-­‐miRNA	   set	  
should	  detect	  both	  the	  primary	  and	  precursor	  transcripts,	  as	  the	  hairpin	  is	  present	  in	  both	  and	  these	  were	  
designed	  by	  Qiagen.	  (B)	  The	  melting	  curve	  analysis	  of	  the	  primers	  for	  pri-­‐miR-­‐132	  based	  on	  the	  TaqMan	  
pri-­‐miRNA	  assays	  showed	  a	  single	  peak	  and	  amplification	  of	  one	  product.	  The	  standard	  curve	  showed	  a	  
slight	  above	  average	  efficiency	  of	  125%,	  but	  was	  suitable	  for	  RT-­‐qPCR.	  (C)	  The	  melting	  curve	  analysis	  for	  
the	   Qiagen	   pre-­‐miR-­‐132	   primers	   showed	   one	   peak,	   suggesting	   single	   product	   amplification	   and	   the	  
standard	  curve	  analysis	  showed	  an	  average	  efficiency	  of	  117%,	  which	  is	  suitable	  for	  RT-­‐qPCR.	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5	   h:	   1.22±0.48,	   p=0.66,	   n=5;	   24	  h:	   0.35±0.06,	   p<0.01,	   n=4;	   Figure	   2.10).	  However,	   the	  
validity	  of	  these	  results	  is	  unknown	  on	  several	  levels.	  	  
Firstly,	  the	  expression	  of	  the	  pre-­‐miR-­‐132	  includes	  the	  expression	  of	  the	  hairpin	  
present	  within	   the	  pri-­‐miR-­‐132.	  However,	   it	  was	  not	  possible	   to	   elucidate	   the	   level	   of	  
pre-­‐miR-­‐132	  specifically	  as	  it	  was	  detected	  in	  an	  amount	  less	  than	  that	  of	  the	  pri-­‐miR-­‐
132.	  In	  RT-­‐qPCR,	  the	  Cq	  values	  represent	  the	  number	  of	  cycles	  of	  amplification	  it	  takes	  
for	  the	  level	  of	  fluorescence	  generated	  by	  the	  SYBR	  Green	  dye	  when	  it	  binds	  to	  double	  
stranded	  RNA	  to	  cross	  a	   threshold	  above	  baseline.	  The	  more	  of	  a	  particular	   transcript	  
there	   is	   in	   the	   starting	   sample,	   the	   sooner	   it	   crosses	   the	   threshold,	  meaning	   a	   low	  Cq	  
value	   suggests	   a	   high	   abundance	   of	   a	   transcript,	   and	   a	   high	   Cq	   value	   suggests	   a	   low	  
abundance.	  The	  Cq	  value	  of	  the	  pre-­‐miR-­‐132	  was	  at	  least	  2	  cycles	  higher	  than	  that	  of	  the	  
pri-­‐miR-­‐132,	  which	   is	   illogical	   (Figure	  2.11).	  Considering	   the	   fact	   that	   the	  pri-­‐miR-­‐132	  
Figure	   2.11:	   Amplification	   curves	   of	   the	   products	   amplified	   by	   the	   pre-­‐miRNA	   and	   the	   pri-­‐miRNA	  
primers.	  As	  can	  bee	  seen,	  the	  product	  amplified	  by	  the	  pre-­‐miRNA	  primers	  reached	  threshold	  earlier	  (Cq	  
=	  31)	  than	  that	  of	  the	  product	  amplified	  by	  the	  pri-­‐miRNA	  earlier	  (Cq	  =	  33).	  
Figure	   2.10:	   Long-­‐term	   potentiation	   appeared	  
to	   regulate	   the	   expression	   of	   pre-­‐miR-­‐132	  
across	   time	   post-­‐LTP	   induction.	   A	   significant	  
down-­‐regulation	   was	   found	   24	   h	   post-­‐LTP	  
induction.	  However,	  the	  validity	  of	  these	  results	  
is	   unknown	   due	   to	   several	   factors.	   Expression	  
values:	   average	   fold	   change	   ±	  SEM;	   normalised	  
to	  Hprt;	   one	   sample	   two-­‐tailed	   t-­‐test	   *	   p<0.05;	  
n=3-­‐5.	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transcript	  contains	  the	  pre-­‐miR-­‐132	  hairpin,	  and	  that	  the	  primers	  for	  the	  hairpin	  cannot	  
distinguish	   between	   the	   two,	   the	   Cq	   value	   for	   pre-­‐miR-­‐132	   would	   be	   expected	   to	   be	  
lower	   than	   that	   of	   the	   primary	   transcript,	   but	   this	   is	   not	   the	   case.	   In	   light	   of	   these	  
findings,	   these	   results	   will	   not	   be	   considered	   as	   valid,	   and	   no	   further	   attempts	   were	  
made	  to	  profile	  the	  expression	  of	  pre-­‐miR-­‐34a	  or	  pre-­‐miR-­‐132	  using	  RT-­‐qPCR.	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2.4 Discussion	  
This	  work	   has	   demonstrated	   that	   there	   is	  NMDAR-­‐dependent	   regulation	   of	   the	  
primary	  transcript,	  pri-­‐miR-­‐132/212,	  and	  the	  mature	  transcripts	  miR-­‐34a-­‐5p	  and	  miR-­‐
132-­‐3p,	   across	   time	   following	   the	   induction	   of	   LTP.	   There	   appears	   to	   be	   a	   number	   of	  
different	  mechanisms	  underlying	  the	  expression	  of	  each	  of	  these	  transcripts,	  suggesting	  
that	  the	  regulation	  of	  these	  miRNA	  is	  as	  complex	  as	  the	  expression	  of	  their	  target	  genes	  
post-­‐LTP.	  
	  
2.4.1 Expression	  and	  Role	  of	  miR-­‐34a-­‐5p	  Following	  LTP	  Induction	  
The	   mature	   transcript	   of	   miR-­‐34a-­‐5p	   demonstrated	   a	   rapid	   down-­‐regulation	  
following	   LTP	   induction	   which	   returned	   to	   baseline	   by	   24	   h	   post-­‐LTP	   induction.	  
Additionally,	   this	   down-­‐regulation	   post-­‐LTP	   appears	   to	   be	   dependent	   on	   NMDAR	  
activation.	   Interestingly,	   NMDAR	   appears	   to	   be	   the	   dominant	   regulator,	   as	   when	   LTP	  
was	  induced	  in	  the	  presence	  of	  the	  NMDAR	  antagonist	  CPP,	  increased	  but	  highly	  variable	  
expression	   of	  miR-­‐13-­‐3p	   occurred	   in	   the	   tetanised	   hemisphere.	   A	   similar	   observation	  
was	  made	  by	  Wibrand	  et	  al.	  (2010)	  with	  the	  three	  differentially	  expressed	  miRNA	  miR-­‐
132-­‐3p,	  miR-­‐212-­‐3p	  and	  miR-­‐219a-­‐5p	  at	  2	  h	  post-­‐LTP	   in	   the	  presence	  of	  CPP.	  In	   their	  
study,	  they	  show	  that	  there	  may	  be	  another	  mechanism	  mediated	  by	  group	  1	  mGluR	  that	  
is	  outcompeted	  by	  the	  NMDAR.	  The	  relevance	  of	  a	  putative	  mGluR	  contribution	  in	  awake	  
freely	  moving	  animals	  though	  is	  yet	  to	  be	  tested.	  Thus,	  it	  could	  be	  concluded	  that	  these	  
two	   receptors	   and	   their	   associated	   signalling	   pathways	   could	   be	   involved	   together	   in	  
regulating	   the	  expression	  of	   these	  miRNA.	  What	   these	   signalling	  pathways	  are	   though	  
remains	  unknown.	  
As	  the	  primary	  transcript	  was	  not	  found	  to	  be	  regulated	  at	  any	  of	  the	  three	  time	  
points,	  post-­‐transcriptional	  mechanisms	  are	  likely	  to	  be	  involved	  in	  regulating	  miR-­‐34a-­‐
5p.	  Indeed,	  rapid	  turnover	  of	  miRNA	  has	  been	  observed	  in	  neuronal	  cells,	  and	  has	  been	  
described	   as	   a	   property	   of	   neuronal	   miRNA	   (Krol	   et	   al.,	   2010).	   As	   described	   above,	  
decreased	  stability	  of	  these	  miRNA	  could	  occur	  through	  a	  decrease	  in	  polyadenylation	  of	  
the	   transcripts	   by	   GLD2,	   a	   poly(A)	   polymerase	   previously	   linked	   to	   LTP	   (Katoh	   et	   al.,	  
2009;	  Kwak	  et	  al.,	  2008),	  or	  a	  decrease	   in	   loading	   into	  the	  miRISC	  which	   is	   thought	   to	  
help	  stabilise	  miRNA	  (Chatterjee	  &	  Großhans,	  2009;	  Kai	  &	  Pasquinelli,	  2010).	  Further,	  
although	   no	   change	   in	   the	   primary	   transcript	   occurs,	   there	  may	   be	   alterations	   to	   the	  
processing	   of	   the	   pre-­‐miRNA,	   leading	   to	   either	   an	   accumulation	   or	   increased	  
degradation	   of	   this	   transcript.	   Changes	   in	   this	   transcript	   could	   result	   in	   the	   down-­‐
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regulation	   of	   the	  mature	   transcript.	   However,	   the	   inability	   to	   profile	   the	   pre-­‐miR-­‐34a	  
transcripts	  leaves	  this	  to	  remain	  a	  hypothesis.	  
As	  mentioned	  above,	  miR-­‐34a-­‐5p	  was	  implicated	  as	  being	  a	  regulatory	  hub	  in	  the	  
LTP-­‐related	  networks	  at	  5	  h	  (Ryan	  et	  al.,	  2012).	  Additionally,	   it	  has	  been	  shown	   to	  be	  
involved	  in	  the	  LTP-­‐related	  process	  of	  neurotransmitter	  release	  through	  the	  regulation	  
of	  vesicle	  proteins	  that	  mediate	  the	  exocytosis	  process	  (Agostini	  et	  al.,	  2011).	  Increases	  
in	   neurotransmitter	   release	   contribute	   to	   LTP	   persistence	   (Bayazitov	   et	   al.,	   2007;	  
Macdougall	  &	  Fine,	  2014)	  and	  there	  is	  an	  associated	  increase	  in	  proteins	  associated	  with	  
synaptic	  vesicles	  (Lynch	  et	  al.,	  1994).	  The	  targeting	  of	  multiple	  genes	  regulating	  vesicle	  
release	   by	   miR-­‐34a-­‐5p	   suggests	   it	   is	   an	   important	   regulator	   of	   this	   process,	   and	  
decreased	   inhibition	   mediated	   by	   miR-­‐34-­‐5p	   may	   lead	   to	   persistent	   increases	   in	   the	  
released	  of	  neurotransmitter.	  
While	  few	  studies	  have	  investigated	  the	  role	  of	  LTP-­‐induced	  protein	  synthesis	  in	  
the	  presynaptic	  terminal,	  there	  is	  some	  evidence	  to	  suggest	  its	  occurrence	  is	  important	  
for	  LTP.	  One	  study	  found	  that	  application	  of	  the	  protein	  synthesis	  inhibitor	  anisomycin	  
blocked	   the	   increase	   of	   synaptophysin	   (Syp)	   puncta	   or	   clusters	   at	   the	   presynaptic	  
terminal	  observed	  3	  h	  after	  glutamate	  application	  in	  hippocampal	  slices	  (Antonova	  et	  al.,	  
2009).	   Interestingly,	  Syp	  was	  predicted	  by	  our	  previous	  analysis	   to	  be	  a	  target	  of	  miR-­‐
34a-­‐5p	   (Ryan	  et	  al.,	  2012).	  Additionally,	  using	  anisomycin	  has	  been	   found	   to	  decrease	  
the	   neurotransmitters	   norepinephrine,	   dopamine	   and	   serotonin	   in	   the	   amygdala	  
concurrent	   with	   decreased	   performance	   in	   the	   memory-­‐related	   inhibitory	   avoidance	  
task,	   though	   an	   effect	   on	   glutamate	   was	   not	   investigated	   (Canal	   et	   al.,	   2007).	  
Interestingly,	   it	   has	   also	   been	   suggested	   that	   the	   presynaptic	   enhancement	   of	  
neurotransmitter	   release	   may	   be	   stimulated	   by	   postsynaptic	   protein	   synthesis	  
(Johnstone	  &	  Raymond,	  2013).	  
Indeed,	   it	   should	   be	   noted	   that	   although	   these	   genes	   are	   active	   in	   regulating	  
processes	  in	  the	  presynaptic	  compartment,	  there	  is	  no	  suggestion	  to	  date	  that	  miR-­‐34a-­‐
5p	   expression	   is	   similarly	   limited.	   This	   study	   was	   conducted	   in	   whole	   dentate	   gyrus	  
lysate,	   comprising	   of	   both	   presynaptic	   and	   postsynaptic	   compartments.	   Therefore,	  
regulation	   and	   a	   possible	   role	   in	   the	   postsynaptic	   compartment	   is	   equally	   possible.	  
Indeed,	  it	  has	  been	  shown	  that	  there	  is	  vesicle	  release	  from	  postsynaptic	  compartments	  
important	  for	  the	  persistence	  of	  LTP	  (Lledo	  et	  al.,	  1998)	  and	  it	  is	  likely	  miR-­‐34a-­‐5p	  could	  
be	   involved	   in	   regulating	   this	   process	   postsynaptically	   as	   well.	   Furthermore,	   as	  
described	  above,	  in	  addition	  to	  miR-­‐34c-­‐5p,	  miR-­‐34a-­‐5p	  has	  been	  found	  to	  regulate	  the	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expression	  of	  Sirt1,	   a	   translational	   repressor	   that	   is	   involved	   in	   the	   regulation	  of	  both	  
dendritic	  spine	  size	  and	  transcription	  (Gao	  et	  al.,	  2010;	  Yamakuchi	  &	  Lowenstein,	  2009;	  
Zovoilis	   et	   al.,	   2011).	   Indeed,	   with	   elevated	   levels	   of	   miR-­‐34	   and	   decreased	   SIRT1	  
expression	   in	   an	   Alzheimer’s	   mouse	   model,	   application	   of	   miR-­‐34	   inhibitors	   rescued	  
SIRT1	   expression	   and	   improved	   memory	   performance.	   Therefore,	   the	   differential	  
expression	  of	  mature	  miR-­‐34a-­‐5p	  following	  LTP	  induction	  is	  likely	  to	  contribute	  to	  the	  
regulation	  of	  genes	  involved	  in	  strengthening	  the	  synapse	  on	  either	  side	  of	  the	  synaptic	  
cleft.	  
	  
2.4.2 Expression	  and	  Role	  of	  miR-­‐132-­‐3p	  Following	  LTP	  Induction	  
In	   contrast	   to	   miR-­‐34a-­‐5p,	   multiple	   mechanisms	   appear	   to	   underlie	   the	  
regulation	  of	  miR-­‐132-­‐3p	  in	  the	  time	  following	  LTP,	  though	  similarities	  do	  exist	  between	  
the	   two	   miRNA.	   While	   both	   are	   NMDAR	   regulated,	   the	   more	   transient	   nature	   of	   the	  
down-­‐regulation	   of	  miR-­‐132-­‐3p	   could	   be	   the	   result	   of	   increased	  maturation	   from	   the	  
increased	  abundance	  of	   its	  primary	   transcript,	  pri-­‐miR-­‐132/212,	  at	  20	  min,	   consistent	  
with	  previous	   studies	   (Wibrand	  et	   al.,	   2010).	  Whether	   this	   is	   the	   case	   could	  be	   tested	  
through	  inhibiting	  Dicer	  and	  the	  processing	  of	  the	  primary	  transcript.	  	  
As	  the	  expression	  of	  the	  pri-­‐miR-­‐132/212	  is	  under	  the	  transcriptional	  control	  of	  
CREB,	  a	  transcriptional	   factor	  crucial	   for	  the	  persistence	  of	  LTP	  (Abraham	  et	  al.,	  2002;	  
Nudelman	  et	  al.,	  2010),	  it	  is	  likely	  that	  this	  primary	  transcript	  is	  among	  the	  first	  wave	  of	  
new	  transcripts.	  As	  such,	  it	  appears	  that	  pri-­‐miR-­‐132/212	  could	  be	  classified	  as	  an	  IEG,	  
genes	  that	  are	  rapidly	  transcribed	  in	  the	  absence	  of	  new	  protein	  synthesis	  (Abraham	  et	  
al.,	  1991)	  and	  include	  genes	  such	  as	  Arc	  and	  Egr1.	  The	  rapid	  up-­‐regulation	  and	  its	  return	  
to	   baseline	   by	   5	   h	   certainly	   fits	   this	   definition,	   though	   the	   later	   down-­‐regulated	   24	   h	  
post-­‐LTP	  is	  unique	  to	  this	  pri-­‐miRNA.	  This	  pattern	  of	  expression	  suggests	  that	  the	  initial	  
up-­‐regulation	   of	   the	   primary	   transcript	   is	   a	   homeostatic	   mechanism	   to	   replenish	   the	  
pool	  of	  miR-­‐132-­‐3p	  back	  to	  baseline	  by	  5	  h.	  Such	  tight	  regulation	  of	  primary	  transcripts	  
have	  been	  observed	  in	  other	  studies	  (Port	  et	  al.,	  2011),	  and	  with	  the	  mRNA	  arrays	  that	  
showed	  specific	  temporal	  regulation	  of	  individual	  transcripts	  following	  LTP	  (Ryan	  et	  al.,	  
2011;	  Ryan	  et	  al.,	  2012).	  The	  discordant	  regulations	  of	  the	  primary	  and	  mature	  miRNA	  
therefore	  suggest	   that	   they	  may	  be	  required	  within	  discrete	   time	  windows	   in	  order	   to	  
contribute	  to	  the	  persistence	  of	  LTP.	  
Interestingly,	   while	   the	   increase	   in	   pri-­‐miR-­‐132/212	   may	   contribute	   to	   the	  
regulation	  of	  miR-­‐132-­‐3p,	  there	  appears	  to	  be	  no	  effect	  on	  miR-­‐212-­‐3p,	  suggesting	  that	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there	   is	   a	   specific	   post-­‐transcriptional	   mechanism	   targeting	   the	   miR-­‐132-­‐3p	   hairpin	  
loop	   to	   be	   selectively	   processed.	  While	   this	   is	   unusual,	   it	   is	   not	  without	   precedent,	   as	  
HNRNPA1,	  as	  mentioned	  above,	  causes	  preferential	  splicing	  of	  the	  miR-­‐18a	  hairpin	  over	  
those	  on	   the	  same	  primary	   transcript	   (Guil	  &	  Caceres,	  2007).	  However,	   the	  HNRNPA1	  
transcript	  was	  observed	  to	  be	  down-­‐regulated	  at	  the	  transcript	  level	  20	  min	  post-­‐LTP	  on	  
the	   arrays,	   though	   not	   confirmed	   with	   RT-­‐qPCR,	   possibly	   suggesting	   it	   may	   not	   be	  
involved	  in	  this	  process	  (Ryan	  et	  al.,	  2011;	  Ryan	  et	  al.,	  2012).	  Additionally,	  whether	  the	  
pri-­‐miRNA	  is	  constrained	  to	  the	  nucleus,	  or	   is	  able	  to	  be	  transported	  and	  processed	  at	  
the	  synapse	   is	  unknown.	  However,	   the	   return	  of	  miR-­‐132-­‐3p	  expression	  back	   to	  basal	  
levels	  suggest	  that	  the	  expression	  of	  its	  target	  genes	  could	  be	  important	  in	  the	  early	  gene	  
response	  following	  LTP	  induction	  and	  not	  necessarily	  later	  time	  points.	  	  
In	  previous	  studies,	  miR-­‐132-­‐2p	  has	  been	  linked	  to	  many	  LTP-­‐related	  processes,	  
including	   the	   regulation	  of	   glutamate	   receptors,	   dendritic	   spine	   size	   and	   transcription	  
(Impey	   et	   al.,	   2010;	   Kawashima	   et	   al.,	   2010;	   Klein	   et	   al.,	   2007;	  Wayman	   et	   al.,	   2008).	  
Interestingly,	  a	  number	  of	  the	  genes	  regulated	  by	  miR-­‐132-­‐3p	  are	  detrimental	  to	  LTP,	  or	  
appear	   to	   require	   its	   up-­‐regulation.	   For	   example,	   MECP2	   is	   a	   plasticity	   related	  
transcriptional	  repressor	  inhibited	  by	  miR-­‐132-­‐3p,	  while	  the	  glutamate	  receptors	  GluA1,	  
GluN2A,	  and	  GluN2B	  are	  up-­‐regulated	  with	  increases	  in	  miR-­‐132-­‐3p.	  This	  would	  suggest	  
that	  a	  decrease	  in	  miR-­‐132-­‐3p	  may	  have	  negative	  effects	  towards	  the	  persistence	  of	  LTP	  
with	  increased	  transcriptional	  repression	  and	  decreased	  glutamate	  receptor	  expression.	  
However,	  it	  may	  be	  that	  miR-­‐132-­‐3p	  mediates	  a	  homeostatic	  mechanism,	  ensuring	  that	  
only	  synapses	  that	  undergo	  strong	  potentiation	  result	  in	  persistent	  LTP,	  similar	  to	  Arc.	  
This	  may	  explain	  its	  regulation	  post-­‐LTP,	  with	  the	  early	  down-­‐regulation	  allowing	  these	  
detrimental	  effects	  to	  compete	  with	  the	  strengthening	  mechanisms.	  However,	  if	  LTP3	  is	  
induced	   and	   the	   resultant	   transcription	   occurs,	   this	   homeostatic	   mechanism	   will	   be	  
deactivated	  with	   the	  processing	  of	   the	   increased	  abundance	  of	   the	  primary	   transcript.	  
With	   the	   return	   to	   basal	   levels,	  miR-­‐132-­‐3p-­‐mediated	   inhibition	   on	   its	   target	   genes	   is	  
conducive	   to	   facilitating	  LTP.	  To	   test	   this	  hypothesis,	   future	   studies	  would	   involve	   the	  
application	   of	   sub-­‐threshold	   LTP	   and	  measurement	   of	  miR-­‐132-­‐3p	   expression	   and	   its	  
targets	   over	   time	   to	   determine	   whether	   this	   does	   occur.	   However,	   the	   differential	  
expression	   of	   the	   primary	   and	   mature	   transcripts	   of	   miR-­‐132-­‐3p	   following	   LTP	  
induction	   and	   its	   LTP-­‐related	   targets	   suggest	   that	   it	   is	   likely	   to	   play	   a	   role	   in	   the	  
persistence	  of	  LTP.	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2.4.3 Profiling	  the	  Expression	  of	  pre-­‐miRNA	  was	  Unsuccessful	  
The	  inability	  to	  profile	  the	  precursor	  transcripts	  of	  these	  two	  miRNA	  prevents	  a	  
full	  understanding	  of	  how	  they	  are	  regulated	  along	  their	  biogenesis	  pathway	  post-­‐LTP.	  
While	  for	  miR-­‐132-­‐3p	  the	  regulation	  of	  the	  primary	  transcript	  provides	  clues	  as	  to	  how	  
the	  mature	  transcript	  may	  be	  regulated	  across	  time,	  miR-­‐34a-­‐5p	  is	  less	  clear.	  Attempts	  
to	  profile	   the	  pre-­‐miRNA	  were	  undertaken	   to	   see	  whether	   changes	  at	   this	   stage	   could	  
explain	  the	  regulation	  of	  miR-­‐34a-­‐5p	  using	  the	  techniques	  suggested	  by	  Schmittgen	  et	  al.	  
(2004).	  However,	   they	  were	  not	   successful,	   and	  a	   number	  of	   explanations	  of	  how	   this	  
might	  have	  occurred	  are	  possible.	  	  
Firstly,	   with	   the	   profiling	   of	   pre-­‐miR-­‐132,	   there	   were	   differences	   in	   the	  
efficiencies	   of	   the	   primers	   used	   in	   the	   second	   attempt,	   which	   may	   contribute	   to	   this	  
disparity.	   However,	   even	   when	   taking	   these	   into	   account,	   the	   data	   still	   suggests	   that	  
there	   was	   more	   pri-­‐miR-­‐132	   than	   pre-­‐miR-­‐132.	   Secondly,	   the	   hairpin	   structure	   that	  
makes	   up	   the	   pre-­‐miRNA	   may	   not	   be	   denaturing.	   The	   pri-­‐miR-­‐132	   hairpin	   may	   be	  
tightly	   bound,	   requiring	  more	   energy	   in	   the	   form	   of	   heat	   during	   the	   PCR	   reaction	   to	  
break	   the	   bonds	   sufficiently.	   Furthermore,	   during	   the	   annealing	   stage	   of	   the	   PCR	  
reaction,	  there	  may	  be	  competitive	  binding	  between	  the	  primer	  and	  hairpin	  reforming,	  
thereby	  restricting	   the	  amount	  of	  PCR	  product	  being	  amplified.	  To	  help	  mitigate	   these	  
potential	  problems,	  increases	  in	  temperature	  and	  time	  during	  these	  stages	  were	  made.	  
However,	  these	  changes	  made	  little	  or	  no	  effect	  to	  the	  relative	  Cq	  values.	  	  
Another	   possibility	   is	   that	   the	   hairpin	   structure	   prevented	   cDNA	   of	   the	   pre-­‐
miRNA	   to	   be	   synthesised.	   If	   the	   temperature	   was	   not	   high	   enough	   to	   break	   the	  
secondary	   structure,	   it	   is	   possible	   the	   reverse	   transcriptase	   was	   unable	   to	   form	   a	  
complimentary	   strand	   for	   the	   pre-­‐miRNA,	   preventing	   it	   from	   later	   being	   efficiently	  
amplified	  to	  the	  same	  degree	  as	  the	  pri-­‐miRNA.	  While	  an	  initial	  80°C	  step	  for	  1	  min	  was	  
added	  to	  a	  SuperScript	  III	  RT	  reaction,	  as	  done	  in	  Wibrand	  et	  al.	  (2010),	  no	  change	  was	  
detected.	  As	  a	  result,	  using	  this	  approach	  to	  profile	  the	  expression	  of	  the	  pre-­‐miRNA	  was	  
abandoned.	  
However,	   there	  are	  a	  number	  of	  other	  ways	  in	  which	  the	  expression	  of	  the	  pre-­‐
miRNA	   could	   be	  measured.	   One	   technique	   is	   using	   Northern	   blots,	   as	   they	   would	   be	  
separated	  by	  size,	  but	   the	  sensitivity	  of	   the	   technique	  makes	   it	  poor	   for	  quantification	  
and	   the	   amount	   of	   RNA	   required	   makes	   it	   impractical	   (Chen	   et	   al.,	   2005;	   Kim	   et	   al.,	  
2010).	  Another	  technique	  utilising	  use	  the	  size	  of	  the	  pre-­‐miRNA	  is	  by	  fractionating	  the	  
RNA	   sample	   to	   remove	   large	   RNA	   transcripts,	   including	   the	   pri-­‐miRNA.	   This	   would	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mean	  that	  any	  detection	  of	   the	  hairpin	  would	  be	  of	   the	  pre-­‐miRNA.	  However,	   this	  was	  
not	  attempted	  as	  sufficient	  sample	  was	  not	  available.	  Further,	  this	  method	  would	  still	  be	  
dependent	  on	  the	  primers	  being	  able	  to	  bind	  within	  the	  hairpin.	  This	  may	  be	  overcome	  
as	  above	  by	  using	  higher	   temperatures	  during	   the	  cDNA	  synthesis	   to	  keep	   the	  hairpin	  
open	  and	  using	   a	   reverse	   transcriptase	   active	   at	   these	   temperatures	   to	   synthesise	   the	  
transcript	  into	  cDNA.	  
Use	   of	   Nanostring,	   a	   relatively	   new	   technology	   that	   involves	  
hybridising	  fluorescently	  coded	  probes	  specific	  for	  a	  mRNA	  or	  miRNA	  transcript	  within	  
a	   sample	   was	   also	   investigated.	   These	   probes	   then	   attach	   to	   the	   transcripts	   and	   are	  
distributed	   across	   a	   2D	   plane	   and	   are	   detected.	   The	   fluorescent	   probe	   allows	   for	   the	  
transcript	  to	  be	   identified	  and	  is	  sensitive	  enough	  to	  measure	  single	  molecules.	  Part	  of	  
the	  technology	  to	  profile	  miRNA	  involves	  using	  junction	  fragments,	  where	  a	  portion	  of	  a	  
probe	  binds	   to	   the	  end	  of	  a	  sequence,	  and	  recruits	  another	  probe	  with	   the	   fluorescent	  
probe	  to	  bind	  to	   its	  other	  portion.	  Using	  this	  may	  allow	  for	  the	  profiling	  of	  specifically	  
pre-­‐miRNA	  by	  designing	  a	  junction	  fragment	  for	  the	  end	  of	  the	  pre-­‐miRNA	  that	  would	  be	  
unable	   to	   bind	   to	   the	   pri-­‐miRNA	   without	   significant	   interference	   from	   the	   adjacent	  
continuation	  of	  the	  transcript	  and	  recruit	  the	  fluorescent	  code	  (Figure	  2.12).	  However,	  
this	  again	  requires	  the	  probe	  to	  bind	  within	  the	  hairpin,	  and	  thus	  may	  be	  prohibited	  by	  
the	  tight	  association	  of	  this	  hairpin,	  which	  would	  require	  adaptations	  to	  the	  protocol	  to	  
be	  made.	  
	  
2.4.4 Potential	  Mechanisms	  for	  microRNA	  Regulation	  Following	  HFS	  
It	  was	  hypothesised	  that	  changes	  in	  the	  biogenesis	  of	  miR-­‐34a-­‐5p	  and	  miR-­‐132-­‐
3p	  could	  explain	  their	  regulation	  following	  the	  induction	  of	  LTP	  by	  HFS	  in	  vivo.	  For	  both	  
miRNA,	   changes	   in	   the	   transcription	   of	   the	   primary	   transcript	   are	   unlikely	   to	   explain	  
their	   rapid	  down-­‐regulation.	  Another	  possibility	   is	   a	  decrease	   in	   the	  processing	  of	   the	  
pre-­‐miRNA	   into	   the	  mature	   transcript,	  which	   in	  combination	  with	   the	  continued	  rapid	  
turnover	  of	  mature	  miRNA	   in	  neurons	   (Krol	   et	   al.,	   2010),	  would	   result	   in	   observing	   a	  
Figure	   2.12:	   Schematic	   of	   how	   Nanostring	   junction	   fragments	   may	   allow	   for	   profiling	   pre-­‐miRNA	  
expression.	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down-­‐regulation.	  These	  may	  act	  in	  concert	  with	  other	  mechanisms	  previously	  described	  
such	  as	  dual	  degradation	  of	   the	   target	  by	  separate	  miRNA	  species,	  or	  binding	  of	   these	  
miRNA	  to	  circular	  RNA	  transcripts.	  
However,	  while	   it	  has	  been	  assumed	   that	   the	  changes	   in	  miRNA	  expression	  are	  
the	   result	   of	   LTP	   induction	   in	   neurons	   following	   HFS,	   this	   may	   not	   be	   the	   case.	   For	  
example,	  alternate	  explanations	  could	   include	  that	   these	  miRNA	  are	  regulated	  as	  a	  by-­‐
product	  of	  neuronal	  stimulation.	  To	  control	  for	  neuronal	  stimulation,	  application	  of	  the	  
NMDAR	  antagonist	  CPP	  was	  administered	  prior	   to	   the	   induction	  of	  LTP,	   thus	  allowing	  
neuronal	  stimulation	  to	  occur	  while	  blocking	  the	  induction	  of	  NMDAR-­‐related	  signalling	  
that	   is	   crucial	   for	   LTP	   persistence	   (Abraham	   et	   al.,	   2002;	   Abraham	   &	   Mason,	   1988).	  
Application	  of	  CPP	  blocked	  the	  changes	   in	  the	  miRNA,	  supporting	  the	  observation	  that	  
regulation	   of	   these	   miRNA	   occur	   following	   LTP	   induction.	   However,	   other	   receptors	  
could	  compensate	  for	  the	  loss	  of	  NMDAR	  function	  such	  as	  VGCC.	  
Further	   attempts	   to	   control	   for	   this	   could	   be	   made	   by	   using	   low-­‐frequency	  
stimulation,	  but	   this	  can	   induce	   long-­‐term	  depression	  (LTD)	  which	  has	  been	  shown	  to	  
have	  its	  own	  gene	  response.	  Indeed,	  NMDA	  receptor-­‐dependent	  LTD	  requires	  miR-­‐191a-­‐
5p	  and	  miR-­‐135a-­‐5p	  for	  its	  maintenance	  (Hu	  et	  al.,	  2014).	  Additionally,	  the	  regulation	  of	  
miRNA	  expression	  could	  be	  the	  result	  of	  other	  activity-­‐dependent	  synaptic	  plasticity	  at	  
synapses	  that	  are	  not	  undergoing	  LTP.	  These	  forms	  of	  synaptic	  plasticity,	  including	  LTD	  
and	   depotentiation,	   are	   likely	   to	   be	   activated	   concurrently	   to	   scale	   synapses	   in	  
neighbouring	  spines,	  dendrites,	  and/or	  neurons	  (Perez-­‐Otano	  &	  Ehlers,	  2005).	  However,	  
LTP	  induced	  at	  neuronal	  synapses	   is	   likely	  to	  be	  the	  dominant	  process	  being	  activated	  
by	   the	   application	   of	   HFS,	   and	   therefore	   the	   dominant	   process	   regulating	   miRNA	  
expression.	  
It	  is	  even	  possible	  that	  the	  regulation	  of	  these	  miRNA	  could	  be	  happening	  in	  other	  
cell	   types	   like	   glial	   cells.	   Indeed,	   LTP	   can	  occur	  between	  neurons	   and	  glial	   cells	   in	   rat	  
hippocampal	  slices	  (Ge	  et	  al.,	  2006).	  With	  calcium	  permeable	  AMPAR	  required	  for	  this	  to	  
occur,	   it	   is	   likely	   that	   changes	   in	   miRNA	   expression	   could	   occur.	   Therefore,	   further	  
research	  that	  takes	  into	  account	  cell	  type	  is	  needed	  to	  resolve	  these	  issues.	  	  
	  
2.4.5 Conclusions	  
This	   work	   has	   demonstrated	   that	   miRNA	   can	   be	   rapidly	   and	   dynamically	  
regulated	   across	   time	   in	   our	   in	   vivo	   awake	   rat	   LTP	   model.	   While	   the	   pre-­‐miRNA	  
transcripts	  of	  these	  miRNA	  could	  not	  be	  investigated,	  the	  regulation	  of	  miR-­‐34a-­‐5p	  and	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miR-­‐132-­‐3p	   was	   shown	   to	   be	   NMDAR-­‐dependent	   and	   mechanistically	   different	   from	  
each	  other	  at	  both	  the	  primary	  and	  mature	  transcript	  level.	  Therefore,	  with	  these	  miRNA	  
validated	  to	   interact	  with	  LTP-­‐related	  genes,	   the	  differential	  expression	  of	  miR-­‐34a-­‐5p	  
and	  miR-­‐132-­‐3p	  may	   be	   involved	   in	   the	   regulation	   of	   gene	   expression	   following	   LTP	  
induction.	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3.1 Introduction	  
Bioinformatic	   analysis	   of	   the	   mRNA	   microarray	   data	   following	   LTP	   induction	  
predicts	   that	   specific	   miRNA	   operate	   as	   important	   regulators	   of	   LTP-­‐related	   gene	  
networks.	   Thus	   if	   miRNA	   concurrently	   regulate	   the	   expression	   of	   genes	   within	   LTP-­‐
regulated	  networks,	  miRNA	  and	  mRNA	  expression	  will	   be	   negatively	   correlated	   (anti-­‐
correlated).	   Therefore,	  miRNA	   important	   to	   LTP	   could	   be	   identified	   based	   on	   the	   co-­‐
expression	  of	  their	  targets.	  The	  aim	  of	  this	  chapter	  is	  to	  use	  a	  number	  of	  bioinformatic	  
tools	  to	  identify	  genes	  that	  are	  co-­‐regulated	  across	  time	  following	  LTP,	  and	  to	  determine	  
whether	  they	  are	  regulated	  by	  one	  or	  more	  miRNA.	  We	  hypothesise	  that	  some	  groups	  of	  
genes	  will	   be	   regulated	   by	   specific	  miRNA	   and	   that	  may	   suggest	   a	   functional	   role	   for	  
these	  miRNA	  following	  LTP	  induction.	  
	  
3.1.1 Anti-­‐Correlative	  Expression	  Between	  microRNA	  and	  Gene	  Expression	  
A	   number	   of	   studies	   have	   observed	   inverse	   relationships	   in	   the	   expression	   of	  
miRNA	   and	   their	   targets,	   consistent	   with	   miRNA	   as	   negative	   regulators	   of	   gene	  
expression.	  One	  study	  investigated	  the	  relationship	  between	  the	  expression	  of	  a	  number	  
of	  genes	  and	  miRNA	  in	  human	  liver	  tissues	  infected	  with	  the	  Hepatitis	  C	  virus	  (Song	  et	  
al.,	   2015).	   Using	   Pearson’s	   correlation	   coefficients	   to	   investigate	   the	   relationship	  
between	  19	  pairs	  of	  miRNA	  and	  mRNA	  across	  30	  patients,	  it	  was	  found	  that	  the	  majority	  
of	   these	   relationships	   demonstrated	   an	   anti-­‐correlation	   as	   expected.	   However,	   one	  
mRNA,	   GDNF	   family	   receptor	   alpha-­‐2	   (Gfra2)	   had	   a	   correlative	   relationship	   with	   its	  
targeting	  miRNA,	  miR-­‐17-­‐3p,	  miR-­‐557,	  and	  miR-­‐765.	  These	  interactions	  were	  predicted	  
to	  occur	  with	  a	  non-­‐canonical	  miRNA	  response	  element	  (MRE)	  located	  on	  the	  5’	  UTR	  of	  
the	  target	  transcript,	  suggesting	  these	  three	  miRNA	  may	  mediate	  positive	  regulation	  of	  
the	  transcript,	  a	  rare	  phenomenon	  (Orom	  et	  al.,	  2008).	  Whether	  these	  interactions	  hold	  
up	   experimentally	   is	   unknown	   as	   no	   functional	   validation	   was	   undertaken	   for	   these	  
miRNA-­‐target	   pairs,	   although	   one	   anti-­‐correlative	   relationship	   had	   been	   previously	  
reported	  in	  TarBase.	  	  
Similar	  analyses	  have	  looked	  at	  the	  relationship	  between	  miRNA	  and	  their	  target	  
genes	  in	  brain	  tissue	  of	  a	  number	  of	  species,	   including	  human	  and	  chimpanzees	  (Hu	  et	  
al.,	   2011).	   It	  was	  demonstrated	   that	   36	  miRNA	  were	  differentially	   expressed	  between	  
human	  and	  chimpanzees.	  These	  differences	   in	  miRNA	  expression	  had	  a	  negative	  effect	  
on	  their	  target	  genes,	  contributing	  potentially	  to	  differences	  of	  2-­‐4%	  and	  4-­‐6%	  in	  mRNA	  
and	  protein	  expression	  respectively.	  However,	  while	  positively	  correlated	  miRNA-­‐target	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relationships	  were	  not	  considered,	  these	  predictions	  were	  validated	  in	  vitro	  with	  miRNA	  
inhibitors,	   showing	   significant	   inhibition	   of	   gene	   expression	   for	   predicted	   targets	  
enriched	  for	  neuronal	  targets.	  Further,	  it	  was	  found	  that	  there	  were	  genetics	  markers	  in	  
the	  human	  genome	  upstream	  of	   the	  primary	  transcripts	   for	  miR-­‐34c-­‐5p.	  This	  suggests	  
the	   increased	   expression	   of	   miR-­‐34c-­‐5p	   in	   humans	   compared	   to	   chimpanzees	   was	  
positively	   selected	   in	   humans,	   suggesting	   this	   miRNA	   was	   evolutionally	   important.	  
Further,	   it	   was	   suggested	   it	   was	   important	   for	   our	   brain	   development	   through	   its	  
predicted	   regulation	   of	   important	   neurological	   processes	   such	   as	   neurotransmitter	  
secretion	  and	  synapse	  function	  (Hu	  et	  al.,	  2011).	  Indeed,	  this	  miRNA	  has	  been	  shown	  to	  
be	   an	   important	   regulator	   in	   memory-­‐related	   processes	   (Zovoilis	   et	   al.,	   2011).	  
Therefore,	  this	  study	  hypothesised	  that	  the	  differences	  in	  gene	  expression	  mediated	  by	  
miRNA	  contributed	  to	  the	  evolution	  of	  cognitive	  function	  in	  humans.	  
In	  a	  study	  of	  myocardial	  infarction	  (MI),	  changes	  in	  miRNA	  and	  mRNA	  expression	  
profiles	  were	  observed	  across	  time	  (Port	  et	  al.,	  2011).	  Profiling	  the	  change	  in	  expression	  
of	  the	  mRNA	  and	  miRNA	  transcripts	  two	  days,	  two	  weeks,	  and	  two	  months	  following	  MI	  
insult	   showed	   multiple	   miRNA	   and	   mRNA	   were	   distinctly	   temporally	   regulated	   in	   a	  
phenotype-­‐specific	   manner.	   Using	   the	   miRNA	   and	   mRNA	   integrated	   analysis	   (MMIA)	  
software	   that	   associates	   expression	   data	   for	   miRNA	   and	   mRNA	   based	   on	   predicted	  
interactions,	  they	  found	  that	  a	  large	  number	  of	  genes	  that	  were	  up-­‐	  and	  down-­‐regulated	  
at	   the	   three	   time	   points	   post-­‐MI	   were	   negatively	   correlated	   to	   the	   expression	   of	   the	  
targeting	  miRNA.	  The	  expression	  of	  one	  miRNA,	  miR-­‐29a-­‐3p	  was	  found	  to	  be	  temporally	  
correlated	  with	  a	  number	  of	  collagen	  genes	  it	  was	  predicted	  to	  target,	  suggesting	  a	  role	  
in	  regulating	  cardiac	  fibrosis,	  a	  thickening	  of	  the	  heart	  valves	  that	  occurs	  following	  a	  MI.	  
Therefore,	   it	   is	   possible	   to	   elicit	   potential	   relationships	   between	   miRNA	   and	   target	  
mRNA	  by	   looking	   at	   their	   expression	   across	   time,	  which	  may	  provide	   insight	   into	   the	  
role	  of	  miRNA	  expression	  in	  a	  particular	  system.	  
	  
3.1.2 Genes	  Regulated	  Following	  LTP	  Induction	  
As	  described	  above,	  our	  lab	  has	  demonstrated	  that	  there	  is	  differential	  expression	  
of	  a	  large	  number	  of	  genes	  following	  the	  induction	  of	  LTP	  (Ryan	  et	  al.,	  2011;	  Ryan	  et	  al.,	  
2012).	   Using	   dual	   selection	   criteria	   (average	   fold	   change:	   ±0.15;	   one-­‐sample	   paired	   t-­‐
test	  p<0.05),	  it	  was	  found	  that	  the	  majority	  of	  mRNA	  transcripts	  differentially	  expressed	  
at	   20	   min	   post-­‐LTP	   were	   up-­‐regulated	   (up-­‐regulated:	   197	   genes,	   1.92	   average	   fold	  
change;	   down-­‐regulated:	   29	   genes,	   0.81	   fold	   change).	   At	   5	   h,	   a	   similar	   majority	   was	  
microRNA	  and	  Co-­‐Regulated	  LTP	  Genes	   	   68	  
observed,	   albeit	   slightly	   smaller	   (up-­‐regulated:	   139	   genes,	   1.26	   average	   fold	   change;	  
down-­‐regulated:	  51	  genes,	  0.78	  average	  fold	  change).	  In	  contrast,	  the	  majority	  of	  those	  
at	  24	  h	  were	  down-­‐regulated	  (up-­‐regulated:	  215	  genes,	  1.19	  average	  fold	  change;	  down-­‐
regulated:	   476	   genes,	   0.72	   average	   fold	   change).	   While	   the	   number	   of	   genes	  
differentially	  regulated	  at	  the	  20	  min	  and	  5	  h	  time	  points	  were	  similar	  (20	  min:	  226;	  5	  h:	  
190	  genes),	  the	  number	  of	  genes	  regulated	  at	  24	  h	  were	  more	  than	  these	  two	  time	  points	  
combined	  (24	  h:	  691	  genes).	  Interestingly,	  there	  was	  little	  crossover	  of	  genes	  across	  the	  
three	   time	   points,	   suggesting	   that	   there	  was	   high	   temporal	   regulation	   of	   these	   genes	  
following	   LTP	   induction.	   Only	   45	   genes	   were	   significantly	   differentiated	   across	   more	  
than	  one	  time	  point,	  with	  only	  one	  gene,	  DnaJ	  (Hsp40)	  homology,	  subfamily	  B,	  member	  
5	  (Dnajb5),	  a	  predicted	  chaperone	  transcription	  protein,	  regulated	  across	  all	  three	  time	  
points,	  being	  up-­‐regulated	  at	  20	  min	  and	  5	  h,	  and	  down-­‐regulated	  at	  24	  h.	  
As	   shown	   with	   the	   average	   fold	   changes,	   very	   few	   genes	   demonstrated	   large	  
changes	  in	  expression,	  with	  40,	  5,	  and	  0	  genes	  showing	  at	  least	  a	  two-­‐fold	  change	  at	  20	  
min,	   5	   h,	   and	   24	   h	   post-­‐LTP	   respectively.	   However,	   it	  may	   not	   be	   surprising	   that	   the	  
average	  fold	  change	  of	  these	  regulated	  transcripts	  is	  small.	  There	  are	  a	  large	  number	  of	  
inputs	  regulating	  the	  expression	  of	  these	  mRNA,	  extending	  from	  not	  just	  miRNA,	  but	  to	  
transcription	   and	   RNA	   degradation	   factors,	   themselves	   regulated	   through	   HDAC	   and	  
methylation	   sites,	   or	   deadenylation.	   The	   resulting	   expression	   of	   a	   mRNA	   transcript	  
therefore	  is	  the	  sum	  of	  the	  effects	  mediated	  by	  these	  regulators.	  However,	  it	  is	  possible	  
for	  miRNA	  to	  have	  a	  dominant	  effect	  on	  the	  expression	  of	  their	  targets	  as	  demonstrated	  
by	  studies	  manipulating	  miRNA	  expression.	  	  
Therefore,	   the	  predictions	  made	  by	   the	   IPA	  bioinformatic	   software	   that	  miRNA	  
could	  play	  a	  role	  in	  regulating	  the	  expression	  of	  multiple	  genes	  following	  LTP	  induction	  
is	   not	   unfounded.	   While	   these	   predictions	   were	   made	   discretely	   at	   each	   time	   point,	  
looking	   at	   genes	   that	   are	   co-­‐regulated	   across	   time	   could	   identify	   potential	   regulatory	  
miRNA.	  Therefore,	  using	  the	  expression	  profile	  of	  these	  mRNA	  transcripts	  across	  time,	  it	  
may	  be	  possible	  to	  identify	  the	  miRNA	  that	  may	  potentially	  regulate	  them.	  Inversely,	  it	  
could	   also	   identify	   potential	   targets	   for	  miR-­‐34a-­‐5p	   and	  miR-­‐132-­‐3p,	  whose	   temporal	  
profiles	  are	  known	  post-­‐LTP.	  
	  
3.1.3 Current	  Study	  
The	  aim	  of	  this	  chapter	  was	  to	  establish	  whether	  there	  are	  clusters	  of	  genes	  that	  
are	  co-­‐regulated	  following	  the	  induction	  of	  LTP	  and	  if	  one	  or	  a	  small	  number	  of	  miRNA	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commonly	   regulates	   them.	   Additionally,	   bioinformatics	   was	   used	   to	   explore	   whether	  
mRNA	  within	  identified	  mRNA	  clusters	  are	  biologically	  related.	  Together	  these	  analyses	  
will	   test	  whether	   specific	  miRNA	   regulate	   a	   specific	   biological	   functions	   post-­‐LTP	   and	  
shed	   light	   on	   the	   potential	   role	  miRNA	  may	  play	   in	   the	   regulation	   of	   gene	   expression	  
following	  LTP	  induction.	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3.2 Materials	  and	  Methods	  
All	  DAVID	  and	  miRvestigator	  analysis	  were	  completed	  by	  10	  March	  2015.	  
	  
3.2.1 Processing	  of	  Array	  Datasets	  
Normalised	   data	   from	   the	   Affymetrix	   RAT	   230	   2.0	   arrays	   carried	   out	   on	   RNA	  
isolated	  from	  HFS	  stimulated	  rat	  dentate	  gyrus	  samples	  20	  min,	  5	  h,	  and	  24	  h	  post-­‐LTP	  
previously	  published	  (Ryan	  et	  al.,	  2011;	  Ryan	  et	  al.,	  2012)	  was	  used	  for	  this	  study.	  Genes	  
were	   previously	   determined	   to	   be	   differentially	   expressed	   in	   these	   studies	   using	   dual	  
selection	   criteria	   (average	   fold	   change:	   ±0.15;	   one-­‐sample	   paired	   t-­‐test	   p<0.05).	   This	  
resulted	  in	  232,	  198,	  and	  739	  gene	  probes	  determined	  to	  be	  differentially	  expressed	  20	  
min,	  5	  h	  and	  24	  h	  post-­‐LTP	  respectively,	  and	  totalled	  to	  1,137	  unique	  gene	  probes.	  These	  
numbers	  differ	  from	  those	  published,	  as	  genes	  with	  multiple	  probes	  sets	  were	  averaged	  
together	  and	  counted	  once	  for	  the	  final	  count	  of	  genes	  differentially	  expressed,	  whereas	  
in	  this	  analysis,	  these	  probes	  were	  kept	  separate.	  For	  every	  gene	  probe	  set	  differentially	  
expressed	  at	  one	  of	  the	  three	  time	  points,	  Affymetrix	  probe	  set	  names	  and	  fold	  changes	  
for	  these	  1,137	  genes	  were	  placed	  into	  a	  tab	  separated	  text	  file.	  
	  
3.2.2 Weighted	  Gene	  Co-­‐Expression	  Network	  Analysis	  (WGCNA)	  	  
R	  64	  bit	  v2.14	  (R	  Development	  Core	  Team)	  was	  used	   to	  run	   the	  weighted	  gene	  
co-­‐expression	  network	  analysis	  (WGCNA)	  package	  v1.20	  (Langfelder	  &	  Horvath,	  2008)	  
with	  all	  prerequisite	  packages	  and	  required	  settings.	  The	  script	  used	  was	  a	  combination	  
of	   prior	   work	   carried	   out	   by	   Gonzalo	   Nido	   (University	   of	   Otago)	   and	   the	   WGCNA	  
tutorials	  provided	  (Langfelder	  &	  Horvath,	  2008).	  In	  short,	  the	  analysis	  file	  containing	  the	  
Affymetrix	  probe	  set	  names	  and	  the	  fold	  changes	  were	  uploaded.	  Correlations,	  adjacency	  
(correlation	  to	  the	  power	  of	  six),	  and	  p	  values	  between	  each	  probe	  pair	  were	  calculated,	  
and	  were	  clustered	  according	  to	  their	  adjacency.	  Clusters	  of	  genes	  with	  high	  adjacency	  
were	   grouped	   together	   on	   the	   same	   branch	   within	   a	   hierarchical	   clustering	   tree,	   or	  
dendrogram,	   of	   the	   differentially	   expressed	   genes.	   Branches	   were	   then	   cut	   using	   the	  
Dynamic	  Tree	  Cut	   function	  within	  WGCNA	  to	  create	  clusters	  containing	  at	   least	  30	  co-­‐
regulated	   genes.	   The	   probes	   in	   the	   clusters	  were	  matched	  with	   their	   annotations	   and	  
their	   expression	   across	   time.	   Clusters	  were	   then	   separated	   into	   the	   two	   distinct	   gene	  
sets	   as	   each	   cluster	   contains	   both	   the	   positive	   and	   negative	   patterns	   of	   expression	  
across	  time.	  The	  script	  used	  can	  be	  found	  in	  Appendix	  B.	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3.2.3 DAVID	  Analysis	  
Database	   for	  Annotation,	  Visualization	  and	  Integrated	  Discovery	  (DAVID)	  v6.7	   is	  
a	  tool	  that	  can	  be	  used	  to	  find	  common	  functions	  based	  on	  annotations	  among	  a	  group	  of	  
genes	   and	   cluster	   these	   together	   (Huang	  da	   et	   al.,	   2009a,	   2009b).	   Lists	   of	   genes	  were	  
uploaded	  to	  the	  web	  interface	  as	  their	  Entrez	  gene	  IDs	  for	  rat	  as	  annotated	  by	  Affymetrix	  
for	   their	   arrays,	   with	   a	   rat	   gene	   background	   selected	   to	   enable	   calculation	   of	   the	  
enrichment	   scores.	   The	   functional	   annotation	   clustering	   tools	   were	   used	   to	   identify	  
common	   functions	   among	   the	   genes	   present.	   Enrichment	   scores	  were	   calculated	   as	   a	  
negative	   log	   of	   p	   values	   determined	   by	   a	  modified	   Fisher’s	   exact	   test,	   comparing	   the	  
proportion	  of	  genes	  annotated	  with	  that	  term	  in	  the	  submitted	  list	  with	  the	  proportion	  
in	  the	  whole	  rat	  genome,	  with	  a	  score	  of	  2.0	  the	  equivalent	  to	  p<0.01.	  These	  enrichment	  
scores	   were	   averaged	   across	   the	   cluster	   of	   annotation	   terms	   to	   give	   the	   overall	  
enrichment	  score.	  
	  
3.2.4 miRvestigator	  Analysis	  
MiRvestigator	   is	   a	   tool	   that	   looks	   for	   an	   over-­‐represented	  motif,	   or	   a	   common	  
sequence,	  within	  the	  3’	  UTR	  of	  a	  group	  of	  transcripts,	  and	  determines	  whether	  a	  miRNA	  
is	  able	  to	  target	  that	  site	  (Plaisier	  et	  al.,	  2011;	  Plaisier	  et	  al.,	  2012).	  Lists	  of	  genes	  were	  
inputted	   into	   the	   web	   interface	   as	   their	   Entrez	   gene	   IDs	   for	   rat	   as	   annotated	   by	  
Affymetrix	  for	  their	  arrays.	  Viral	  miRNA	  were	  selected	  to	  be	  excluded	  from	  the	  analysis.	  
Motif	  sizes	  on	  the	  3’	  UTR	  of	  the	  inputted	  gene	  sequences	  were	  selected	  to	  be	  either	  6	  or	  
8	   bp,	   and	  were	   identified	   using	   the	   default	  Weeder	   algorithm,	  with	   sites	   requiring	   at	  
least	  95%	   identity	  with	   the	  motif,	  normally	  allowing	  one	  nucleotide	  mismatches.	   Seed	  
models	  from	  6mer	  to	  8mer	  were	  used	  for	  miRNA	  with	  no	  base	  pairing	  wobble	  to	  match	  
to	   the	   identified	   motif.	   At	   least	   50%	   of	   the	   genes	   inputted	   had	   to	   be	   analysed	   by	  
miRvestigator,	   and	   the	   motif	   was	   required	   to	   be	   present	   on	   at	   least	   50%	   of	   these	  
sequences	  to	  be	  considered	  as	  a	  potential	  microRNA	  recognition	  element	  (MRE)	  of	  that	  
set	  of	  genes.	  The	  one	  or	  set	  of	  miRNA	  that	  had	  the	  highest	  complementarity	  score	  was	  
considered	  as	  the	  regulators	  of	  that	  potential	  motif	  on	  that	  set	  of	  genes.	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3.3 Co-­‐Regulation	  of	  LTP	  Genes	  
To	  determine	  whether	  miRNA	  are	  able	  to	  co-­‐regulate	  the	  expression	  of	  multiple	  
genes	  following	  the	  induction	  of	  LTP,	  bioinformatic	  analysis	  was	  undertaken	  to	  cluster	  
genes	   together	   according	   to	   their	   expression.	   Following	   this,	   whether	   they	   had	   a	  
common	  miRNA	  regulator	  and/or	  function	  was	  determined.	  	  
	  
Figure	  3.1:	  Heatmap	  and	  dendrogram	  showing	  the	  clustering	  of	  genes	  according	  to	  their	  expression	  post-­‐
LTP	   following	   a	   WGCNA	   analysis.	   In	   the	   heatmap,	   red	   denotes	   gene	   pair	   with	   a	   high	   adjacency	   or	  
expression	  similarity,	  yellow	  a	  low	  adjacency.	  The	  dendrogram	  shows	  how	  the	  gene	  pairs	  cluster	  together,	  
with	   the	  bar	  of	   colour	  underneath	  denoting	   the	  11	   clusters	   created	   that	   contain	  genes	   that	  have	  a	  high	  
adjacency	  to	  each	  other.	  Genes	  used	  in	  this	  analysis	  were	  differentially	  expressed	  at	  one	  of	  the	  three	  time-­‐
points	  with	  a	  fold	  change	  of	  ±0.15	  and	  a	  p<0.05,	  adapted	  from	  Ryan	  et	  al.,	  (2011,	  2012).	  Clusters	  denoted	  
in	   the	   bar	   under	   dendrogram	   from	   left	   to	   right:	   pink,	   magenta,	   purple,	   lime,	   black,	   red,	   blue,	   yellow,	  
turquoise,	  green,	  and	  brown.	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3.3.1 Identification	  of	  Co-­‐Regulated	  Clusters	  
Previously,	  Affymetrix	  microarrays	  have	  profiled	  the	  gene	  expression	  20	  min,	  5	  h	  
and	  24	  h	  following	  the	  induction	  of	  LTP.	  Using	  a	  differential	  expression	  criteria	  of	  a	  fold	  
change	  of	  ±0.15	  and	  a	  Student’s	   t-­‐test	  p	  value	  of	  0.05,	  1137	  unique	  gene	  probes	  were	  
identified	   as	   being	   regulated	   at	   one	   of	   the	   three	   time	   points.	   As	   no	   screen	   of	  miRNA	  
Figure	   3.2:	  Clusters	   of	   genes	   differentially	   expressed	   post-­‐LTP.	   The	   lines	   on	   each	   graph	   represent	   the	  
average	  expression	  of	  genes	  within	  that	  set	  of	  genes	  within	  each	  cluster,	  with	  the	  number	  of	  genes	  noted	  
to	  the	  right.	  In	  total,	  22	  sets	  of	  genes	  across	  11	  clusters	  were	  identified.	  Genes	  used	  in	  this	  analysis	  were	  
differentially	  expressed	  at	  one	  of	  the	  three	  time-­‐points	  with	  a	  fold	  change	  of	  ±0.15	  and	  a	  p<0.05.	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expression	  at	   the	   later	   time	  points	   following	  LTP	  has	  been	   carried	  out,	   only	   the	   three	  
microarrays	  of	  mRNA	  expression	  post-­‐LTP	  can	  be	  used	  for	  this	  anti-­‐correlative	  analysis.	  
This	   prevents	   the	   use	   of	   the	   bioinformatic	   tools	   described	   above	   in	   previous	   studies	  
such	   as	   the	   MMIA	   or	   a	   Pearson’s	   correlation	   (Port	   et	   al.,	   2011;	   Song	   et	   al.,	   2015).	  
Therefore,	  using	  these	  lists	  of	  differentially	  expressed	  mRNA	  and	  their	  expression	  across	  
the	   three	   time	   points,	   a	  WGCNA	   analysis	   was	   undertaken	   to	   cluster	   the	   gene	   probes	  
together	   based	   on	   how	   alike	   their	   expression,	   or	   adjacency,	   was	   across	   time.	  With	   a	  
minimal	   requirement	  of	  30	  gene	  probes	  per	   cluster	   and	  gene	  probes	   assigned	   to	  only	  
one	   cluster,	   11	   clusters	   were	   automatically	   generated	   from	   those	   gene	   probes	  
differentially	  expressed	  post-­‐LTP,	  and	  gene	  annotations	  assigned.	  
The	   heatmap	   of	   the	   adjacency	   of	   the	   expression	   between	   pairs	   of	   genes	  
demonstrates	  the	  clusters,	  with	  those	  with	  high	  adjacency	  clustered	  together	  in	  squares	  
of	   red	   (Figure	   3.1).	   While	   some	   clusters	   are	   clearly	   defined	   in	   comparison	   to	   other	  
clusters,	  such	  as	  those	  in	  the	  ‘Red’	  and	  ‘Black’	  clusters,	  in	  contrast,	  other	  clusters	  contain	  
genes	  that	  share	  adjacency	  with	  others	  outside	  their	  cluster.	  For	  example,	  those	  genes	  in	  
the	   ‘Turquoise’	   cluster	   share	   some	   adjacency	   with	   those	   in	   the	   ‘Blue’	   and	   ‘Brown’	  
clusters,	  which	  share	  similarities	   in	   their	   temporal	  gene	  expression	  profile.	  This	   is	   the	  
result	  of	  the	  WGCNA	  analysis	  only	  able	  to	  place	  each	  genes	  into	  only	  one	  cluster,	  which	  
may	  artificially	  separate	  genes	  that	  are	  co-­‐regulated	  but	  do	  not	  share	  a	  high	  enough	  level	  
of	  adjacency.	  Further,	  the	  analysis	  placed	  genes	  into	  the	  same	  cluster	  that	  had	  both	  the	  
same	  and	  opposing	  temporal	  expression,	  on	  the	  basis	  genes	  and	  those	  involved	  in	  their	  
regulation	  would	  have	  same	  but	  opposing	  expression.	  Therefore,	  each	  cluster	  could	  be	  
separated	   into	   two	  distinct	   sets	   of	   genes,	   resulting	   in	   22	   clusters	   overall	   (Figure	   3.2).	  
Each	  new	  cluster	  was	  named	  after	  the	  colour	  of	  the	  original	  cluster,	  and	  the	  number	  of	  
genes	  present	  in	  that	  set.	  A	  full	  list	  of	  genes	  in	  each	  set	  can	  be	  found	  in	  Appendix	  B.	  The	  
size	  of	  the	  clusters	  varied	  from	  6	  to	  249	  genes.	  
The	  ‘Black	  (60)’	  cluster	  has	  a	  distinct	  expression	  profile	  of	  a	  large	  increase	  at	  20	  
min,	   followed	  by	  basal	  expression	  at	  5	  h	  and	  24	  h,	  consistent	  with	  those	  of	   immediate	  
early	   genes.	   Indeed,	   previously	   noted	   genes	   such	   as	  Arc,	  Egr1,	   and	   JunB	   can	   be	   found	  
within	  this	  group	  of	  genes,	  suggesting	  others	  might	  be	  novel	  IEGs	  such	  as	  growth	  arrest	  
and	  DNA-­‐damage-­‐inducible,	  gamma	  (Gadd45g),	  a	  regulator	  of	  DNA	  methylation	  that	  has	  
been	   previously	   linked	   to	   synaptic	   plasticity	   (Sultan	   et	   al.,	   2012).	   ‘Magenta	   (47)’	   is	  
similar	   in	   its	   expression	   profile,	   though	   its	   general	   up-­‐regulation	   at	   20	   min	   is	   less	  
pronounced	  as	  ‘Black	  (86)’.	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The	   ‘Brown’	   and	   ‘Turquoise’	   clusters	   have	   similar	   expression	   profiles,	   with	  
regulation	  in	  one	  direction	  for	  20	  min	  and	  5	  h,	  before	  being	  differentially	  expressed	  in	  
the	   opposite	   direction.	   The	   ‘Lime’,	   ‘Purple’,	   and	   ‘Red’	   clusters	   all	   show	   regulation	  
occurring	  at	  either	  20	  min	  or	  5	  h,	  before	  returning	  to	  baseline,	  suggesting	  some	  form	  of	  
homeostatic	   mechanism	   underlying	   the	   expression	   of	   these	   genes.	   Whether	   the	  
transcripts	  of	  other	  genes	  in	  other	  clusters	  return	  to	  baseline	  eventually	  would	  require	  a	  
later	  time	  point	  than	  24	  h	  to	  assess	  this.	  
	  
3.3.2 Some	  Clusters	  are	  Enriched	  for	  Biological	  Functions	  that	  are	  LTP-­‐Related	  
To	  determine	  whether	  these	  co-­‐regulated	  genes	  are	  related	  in	  function,	  a	  DAVID	  
analysis	  was	  run	  on	  the	  genes	  within	  each	  cluster	  to	  see	  whether	  there	  was	  enrichment	  
of	   function.	   Data	   was	   entered	   as	   rat	   genes,	   analysis	   set	   to	   the	   highest	   classification	  
strategy,	  and	  only	  enrichment	  considered	  with	  scores	  above	  2.0,	  equivalent	   to	  p<0.01.	  
For	  the	  majority	  of	   the	  clusters,	  no	  enrichment	  of	   function	  reaching	  the	  threshold	  was	  
found.	   However,	   despite	   the	   low	   number	   of	   genes	   present	   in	   some	   of	   the	   clusters,	  
enrichment	  of	  function	  was	  detected	  for	  the	  other	  seven	  clusters	  (Table	  3.1).	  	  
Starting	   with	   the	   ‘Black	   (60)’	   cluster,	   functions	   enriched	   within	   these	   genes	  
included	   positive	   regulation	   of	   transcription	   (3.87;	   11	   genes),	   and	   synaptic	   plasticity	  
(2.09;	   4	   genes),	   underscoring	   the	   hypothesis	   that	   this	   cluster	   is	   comprised	   of	   LTP-­‐
Table	  3.1:	  Functional	  terms	  of	  clusters	  that	  showed	  enrichment	  of	  function.	  
Cluster	   Functional	  Term	   Enrichment	  Score	  
Number	  
of	  Genes	  
Black	  (60)	   Positive	  regulation	  of	  transcription	   3.87	   11	  
	   Regulation	  of	  synaptic	  plasticity	   2.09	   4	  
Blue	  (122)	   Membrane-­‐bound	   2.05	   13	  
Brown	  (99)	   Neuron	  projection	  morphogenesis	   2.08	   6	  
Magenta	  (47)	   Basic-­‐leucine	  zipper	  binding	   3.39	   4	  
	   Positive	  regulation	  of	  transcription	   2.79	   8	  
Purple	  (29)	   Negative	  regulation	  of	  transcription	   2.26	   5	  
Turquoise	  (91)	   Cation	  binding	   2.92	   24	  
Turquoise	  (249)	   Respiratory	  system	  development	   3.05	   8	  
	   RNA	  splicing	   2.85	   8	  
	   RNP1	  RNA	  recognition	  motif	   2.42	   8	  
	   Serine/threonine	  protein	  kinase	   2.27	   10	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related	  IEGs	  and	  their	  synthesis.	  Additionally,	  ‘Magenta	  (47)’	  which	  shows	  a	  similar	  but	  
reduced	   up-­‐regulation	   at	   20	   min	   showed	   enrichment	   for	   positive	   regulation	   of	  
transcription	  (2.79;	  8	  genes)	  in	  addition	  to	  basic-­‐leucine	  zipper	  binding	  (3.39;	  4	  genes),	  
which	  is	  a	  feature	  of	  CREB	  that	  allows	  it	  to	  bind	  to	  the	  DNA	  (Mayr	  &	  Montminy,	  2001;	  
Mayr	  et	  al.,	  2005).	  Another	  cluster	  of	  interest	  is	  ‘Purple	  (29)’,	  as	  it	  has	  an	  enrichment	  for	  
negative	  regulation	  of	  transcription	  (2.26;	  5	  genes),	  which	  had	  an	  expression	  peak	  at	  5	  h.	  
Additionally,	   ‘Brown	   (99)’	   can	   be	   seen	   to	   contain	   some	   genes	   involved	   in	   neuron	  
projection	  morphogenesis	   (2.08;	   6	   genes),	   indicating	   the	   early	   up-­‐regulation	   of	   genes	  
involved	  in	  modifying	  dendritic	  spine	  morphology.	  It	  is	  important	  to	  note	  that	  multiple	  
clusters	   showed	   common	   functions	   across	   their	   genes,	   but	   were	   not	   significantly	  
enriched	   above	   chance,	   suggesting	   that	   these	   clusters	   of	   co-­‐expressed	   genes	   are	   not	  
necessarily	  functionally	  related.	  
	  
3.3.3 Few	  Clusters	  are	  Targeted	  by	  Common	  microRNA	  	  
To	  determine	  whether	  any	  of	  the	  clusters,	  including	  the	  seven	  above	  shown	  to	  be	  
functionally	  enriched,	  are	  commonly	  targeted	  by	  one	  or	  more	  miRNA,	  the	  bioinformatic	  
tool	   miRvestigator	   was	   used	   to	   investigate	   this.	   MiRvestigator	   searches	   for	   an	   over-­‐
represented	   sequence,	   or	  motif,	  within	   the	   3’	  UTR	  of	   genes	  within	   a	   group.	   This	  MRE	  
was	  expected	  to	  be	  at	  least	  six	  nucleotides	  in	  length	  and	  could	  differ	  by	  one	  nucleotide	  
within	  a	  3’	  UTR	  sequence	  when	  compared	  to	  the	  motif.	  A	  minimal	  6mer	  seed	  site	  from	  
any	  miRNA	  that	  could	  interact	  with	  this	  MRE	  was	  also	  required.	  Further,	  at	  least	  50%	  of	  
the	  genes	  within	  a	  cluster	  to	  contain	  a	  motif	  was	  set,	  to	  ensure	  there	  was	  a	  central	  role	  
for	   the	   predicted	   miRNA	   in	   regulating	   these	   genes.	   This	   resulted	   in	   eight	   clusters	   of	  
genes	  where	  the	  majority	  of	  their	  transcripts	  analysed	  were	  predicted	  to	  be	  commonly	  
regulated	  by	  one	  or	  more	  miRNA	  (Table	  3.2).	  However,	  miRvestigator	  did	  not	   contain	  
the	   sequences	   for	   all	   the	   genes	   uploaded.	   Therefore,	   taking	   into	   account	   genes	   in	   the	  
cluster	   not	   included	   in	   the	   analysis,	  when	   the	   true	   proportion	   of	   transcripts	  with	   the	  
motif	   is	   calculated,	   five	   clusters	   with	   a	   majority	   of	   genes	   regulated	   by	   one	   or	   more	  
miRNA	  remained,	  with	  ‘Lime	  (6)’	  demonstrating	  two	  common	  motifs.	  
None	  of	  these	  five	  clusters	  contained	  motifs	  that	  could	  be	  targeted	  by	  miR-­‐34a-­‐5p	  
or	  miR-­‐132-­‐3p,	   the	   two	  miRNA	   previously	   profiled	   in	   this	   study.	   However,	   of	   the	   14	  
miRNA	  targeting	  the	  six	  motifs	  in	  the	  five	  clusters,	  two	  have	  been	  shown	  to	  be	  regulated	  
20	  min	  post-­‐LTP	  on	  the	  Affymetrix	  miRNA	  arrays.	  MiR-­‐193-­‐3p	  (0.56±0.05,	  p=0.02,	  n=3)	  
is	  predicted	  to	  target	  a	  6mer	  motif	  present	  on	  the	  3’	  UTR	  of	  54%	  or	  13	  genes	  in	  the	  ‘Lime	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(24)’	   cluster,	   which	   is	   characterised	   by	   a	   general	   up-­‐regulation	   at	   20	   min	   before	  
returning	  to	  baseline	  by	  5	  h,	  concurrent	  with	  the	  down-­‐regulation	  of	  this	  miRNA	  at	  20	  
min.	  Meanwhile,	  miR-­‐31a-­‐5p	   (0.84±0.01,	  p=0.02,	  n=3)	  was	  predicted	   to	   target	   a	  6mer	  
motif	   present	   on	   the	   3’	   UTR	   of	   55%	   or	   11	   genes	   in	   the	   ‘Red	   (20)’	   cluster.	   Here,	   the	  
regulation	  of	   the	  miRNA	  in	  relation	  to	   its	   targeted	  gene	  transcripts	   is	   less	  clear	  as	  this	  
cluster	   shows	   a	   general	   transient	  down-­‐regulation	   at	   5	  h.	  How	   these	  miRNA	  are	   later	  
regulated	   is	   unknown,	   though	   screens	   of	  miRNA	   5	   h	   post-­‐LTP	   have	   not	   detected	   any	  
changes	  in	  these	  two	  miRNA	  (Ryan,	  unpublished).	  	  
It	   is	   important	   to	   note	   that	   of	   the	   clusters	   predicted	   to	   be	   targets	   by	   common	  
miRNA,	   only	   one	   cluster,	   ‘Brown	   (41)’,	   contained	  more	   than	   34	   genes,	   the	   geometric	  
average	  number	  of	   genes	   in	   the	  22	   clusters;	  however	   the	  majority	  of	   the	  genes	   in	   the	  
cluster	  did	  not	  contain	  the	  motif.	  The	  other	  seven	  clusters	  how	  lower	  number	  of	  genes	  
below	  the	  geometric	  average,	  with	  two	  clusters	  containing	  only	  six	  genes.	  With	  a	  lower	  
number	  of	  genes,	  it	  is	  more	  likely	  for	  them	  to	  reach	  the	  minimal	  threshold	  for	  the	  motif	  
to	  be	  present	  on	  50%	  of	  the	  genes	  in	  the	  cluster.	  Further,	  none	  of	  the	  clusters	  that	  were	  
found	  to	  be	  enriched	  for	  biological	  function	  with	  the	  DAVID	  analysis	  showed	  a	  common	  
targeting	   miRNA.	   Additionally,	   the	   genes	   in	   the	   five	   clusters	   among	   the	   majority	  
commonly	  regulated	  by	  one	  or	  a	  group	  of	  miRNA	  showed	  no	  enrichment	  of	  function.	   	  
Table	  3.2:	  Over-­‐represented	  motifs	  present	  in	  genes	  in	  each	  cluster	  and	  its	  targeting	  miRNA.	  Percentage	  
of	  the	  prevalence	  of	  the	  motif	  within	  sequences	  for	  those	  analysed	  and	  for	  the	  total	  cluster.	  
Cluster	   Motif	  
Transcripts	  with	  
Motif	  (%)	   Targeting	  miRNA	  
Analysed	   True	  
Black	  (5)	   UUGUAUGA	   100	   50	   miR-­‐539-­‐3p	  
Brown	  (41)	   UGCUGU	   51	   46	   miR-­‐21-­‐3p,	   miR-­‐214-­‐3p,	   miR-­‐
383-­‐3p,	  miR-­‐3120	  
Lime	  (24)	   UGGCCA	   68	   54	   miR-­‐193a-­‐3p,	   miR-­‐328a-­‐3p,	  
miR-­‐328b-­‐3p	  
Lime	  (6)	   UACUGU	   80	   67	   miR-­‐101a-­‐3p,	   miR-­‐101b-­‐3p,	  
miR-­‐144-­‐3p,	  miR-­‐199a-­‐3p	  
	   UACAGUUU	   60	   50	   miR-­‐881-­‐3p	  
Magenta	  (8)	   UGCAUUUC	   50	   40	   miR-­‐500-­‐3p,	  miR-­‐501-­‐3p	  
	   	   	   	   	  
Pink	  (18)	   GCUAUU	   53	   44	   miR-­‐320-­‐3p	  
Purple	  (16)	   UGUAUU	   57	   50	   miR-­‐200b-­‐3p,	   miR-­‐200c-­‐3p,	  
miR-­‐369-­‐3p,	  miR-­‐429	  
Red	  (20)	   UUGCCU	   69	   55	   miR-­‐31a-­‐5p	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3.4 Discussion	  
The	   aim	  of	   this	   chapter	  was	   to	   determine	  whether	   there	  were	   groups	   of	   genes	  
that	   could	   be	   co-­‐expressed	   following	   the	   induction	   of	   LTP	   and	   whether	   they	   were	  
regulated	   by	   one	   or	  more	  miRNA.	   Clusters	   of	   genes	   that	  were	   co-­‐expressed	   post-­‐LTP	  
were	   identified,	   and	   a	   number	   of	   clusters	   that	   showed	   an	   enrichment	   of	   function.	  
However,	  these	  clusters	  were	  separate	  from	  those	  predicted	  to	  have	  common	  regulatory	  
miRNA.	  
	  
3.4.1 Some	  Co-­‐Expressed	  LTP-­‐Regulated	  Genes	  are	  Related	  by	  Function	  
Previously,	  the	  mRNA	  differentially	  expressed	  20	  min,	  5	  h	  or	  24	  h	  following	  the	  
induction	  of	   LTP	  have	  been	   investigated	   in	   terms	  of	   function	  and	  potential	   regulatory	  
mechanisms.	   This	   analysis	   is	   not	   without	   merit	   considering	   the	   temporally-­‐specific	  
regulation	  of	   the	  majority	   of	   the	   transcripts	   at	   one	   time	  point.	  However,	   investigating	  
the	   genes	   and	   their	   expression	   across	   time	   may	   show	   how	   different	   processes	   are	  
activated	  and	   inhibited	   following	   the	   induction	  of	  LTP.	  This	  analysis	  may	  also	  provide	  
insight	   into	  whether	  commonly	  regulated	  genes	  could	  be	  targeted	  by	  common	  miRNA.	  
To	  this	  end,	  using	  the	  WGCNA	  package,	  22	  clusters	  of	  genes	  containing	  between	  6	  and	  
249	  genes	  were	  created	  according	  to	  their	  expression	  profile	  across	  time.	  	  
However,	   the	   biological	   significance	   of	   these	   genes	   being	   similarly	   expressed	  
across	   time	   is	   unknown.	   The	  majority	   of	   the	   clusters	   did	   not	   show	   an	   enrichment	   of	  
function	   according	   to	   the	   DAVID	   analysis.	   Only	   seven	   clusters	   showed	   significant	  
enrichment	   of	   function,	   suggesting	   that	   in	  most	   cases,	   similarity	   in	   expression	   across	  
time	  does	  not	  mean	  that	  the	  genes	  are	  similarly	  related	  in	  function.	  To	  a	  degree,	  this	  is	  
not	  surprising	  as	  this	  analysis	  is	  looking	  at	  the	  transcript	  expression	  of	  a	  gene,	  which	  is	  
not	   necessarily	   correlated	   to	   its	   protein	   expression	   nor	   its	   activity.	   Furthermore,	   this	  
analysis	  only	  used	  DAVID	  to	  detect	  for	  functional	  enrichment.	  Other	  tools	  might	  be	  able	  
to	  detect	  functional	  enrichment	  among	  these	  genes	  in	  the	  clusters,	  but	  the	  wide	  scope	  of	  
annotations	   in	   the	   database	   of	   DAVID	   suggest	   any	   differences	   would	   be	   due	   to	   the	  
methodology	  of	  identifying	  and	  calculating	  this	  enrichment.	  Alternatively,	  the	  small	  size	  
of	  some	  of	  the	  clusters	  may	  have	  prevented	  any	  functional	  enrichment	  to	  be	  detected.	  
Nevertheless,	   those	   clusters	   that	   did	   show	   enrichment	   of	   function	   among	   their	  
genes	   showed	   involvement	   of	   transcription	   and	   macromolecule	   biosynthesis,	   which	  
includes	  mRNA	  and	  protein,	  processes	  that	  are	  crucial	   for	  LTP	  persistence	  (Frey	  et	  al.,	  
1996;	  Frey	  et	  al.,	  1988).	  When	   looking	  at	   the	  average	  expression	  of	   the	  genes	   in	   these	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clusters,	   clusters	   showing	   enrichment	   for	   transcription	   showed	   an	   average	   up-­‐
regulation	  at	  20	  min,	  especially	   the	   ‘Black	  (60)’	  cluster,	  suggesting	  rapid	  expression	  of	  
transcription-­‐related	  genes.	  These	  transcription-­‐related	  genes,	  which	   include	  Egr1	  and	  
JunB,	   are	   likely	   to	   be	   crucial	   for	   the	   persistence	   of	   LTP,	   which	   is	   dependent	   on	  
transcription	  occurring	  and	  facilitated	  by	  the	  expression	  of	  the	  proteins	  of	  these	  genes.	  
Additionally,	  the	  genes	  within	  the	  ‘Black	  (60)’	  cluster	  could	  be	  classified	  as	  IEGs	  due	  to	  
their	   rapid	   transcription	   following	   LTP	   induction	   despite	   no	   new	   protein	   synthesis.	  
While	  the	  IEGs	  Arc,	  Egr1,	  and	  JunB	  in	  this	  cluster	  have	  been	  shown	  to	  be	  crucial	  for	  LTP	  
persistence,	   whether	   the	   other	   genes	   in	   this	   cluster,	   which	   include	   members	   of	   dual	  
dephosphorylation	  protein	  (Dusp)	  family,	  are	  just	  as	  important	  remains	  to	  be	  seen.	  
One	  flaw	  with	  this	  analysis	  is	  the	  inclusion	  of	  a	  probe	  representing	  a	  gene	  in	  one	  
cluster	   only.	   As	   could	   be	   seen	   by	   the	   heatmap	   in	   Figure	   3.1,	   some	   genes	   in	   separate	  
clusters	  shared	  high	  adjacency,	  suggesting	  that	  they	  could	  be	  in	  multiple	  clusters.	  Genes	  
in	   the	   ‘Blue’,	   ‘Brown’,	   and	   ‘Turquoise’	   clusters	   showed	   adjacency	   across	   these	   groups,	  
reflected	   in	   their	   similar	   temporal	   gene	   expression	   profile.	   As	   the	   WGCNA	   analysis	  
requires	  each	  gene	  to	  be	  segregated	  into	  one	  cluster	  only,	  this	  may	  separate	  genes	  that	  
are	  biologically	  commonly	  regulated,	  but	  are	  not	  similar	  enough	  at	  an	  expression	  level,	  
and	  may	  contribute	  partially	  to	  the	  lack	  of	  functional	  enrichment	  in	  some	  of	  the	  clusters.	  
While	  allowing	  genes	  to	  be	  present	  in	  multiple	  clusters	  could	  be	  done,	  determining	  the	  
suitable	   threshold	   to	   allow	   for	   this	   may	   result	   in	   clusters	   of	   genes	   with	   a	   loose	   co-­‐
expression	   pattern	   across	   time,	   which	   may	   affect	   how	   biologically	   relevant	   these	  
clusters	   are	   in	   a	  miRNA	   context.	   It	   should	   be	   noted	   though	   for	   some	   genes,	   multiple	  
probes	  sets	  for	  the	  same	  gene	  showed	  different	  expression	  profiles,	  which	  may	  result	  in	  
the	  same	  gene	  being	  present	  in	  different	  clusters.	  The	  cause	  of	  the	  different	  expression	  
profiles	  is	  unknown	  and	  could	  be	  related	  to	  the	  sensitivity	  of	  the	  arrays.	  
	  
3.4.2 Co-­‐Expressed	  LTP-­‐Regulated	  Genes	  are	  not	  Targeted	  by	  Common	  microRNA	  
While	  few	  of	  the	  clusters	  of	  co-­‐expressed	  genes	  are	  functionally	  related,	  this	  does	  
not	   suggest	   that	   these	   few	   clusters	   could	  be	   the	  only	   clusters	   regulated	  by	   a	   common	  
miRNA.	  Only	  five	  of	  the	  22	  clusters	  had	  one	  or	  more	  miRNA	  that	  could	  target	  a	  majority	  
of	  the	  transcripts.	  Of	  these,	  two	  clusters	  were	  predicted	  to	  be	  regulated	  by	  a	  miRNA	  that	  
has	   been	   found	   to	   be	   differentially	   expressed	   20	   min	   post-­‐LTP,	   though	   only	   the	  
regulation	  of	  miR-­‐193a-­‐5p	  is	  consistent	  with	  the	  average	  up-­‐regulation	  of	  the	  genes	  at	  
20	  min	   in	   the	   ‘Lime	  (24)’	  cluster.	  Whether	  miR-­‐31a-­‐5p	   is	   involved	   in	   the	  regulation	  of	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the	   genes	   in	   the	   ‘Red	   (20)’	   cluster	   is	   unknown	   as	   the	   array	   suggests	   regulation	  
inconsistent	  with	   its	  potential	   targets,	   though	   investigation	  of	   its	  expression	  and	  these	  
genes	   using	   more	   sensitive	   methods	   such	   as	   RT-­‐qPCR	   may	   elucidate	   a	   potential	  
relationship	  between	  the	  two.	  
Interestingly,	  none	  of	   the	  clusters	   that	  were	   found	   to	  be	  enriched	   for	  biological	  
function	  with	  the	  DAVID	  analysis	  showed	  a	  common	  targeting	  miRNA,	  suggesting	  that	  if	  
these	  clusters	  are	  commonly	  regulated,	  this	  may	  be	  through	  other	  mechanisms	  affecting	  
the	  abundance	  of	  these	  transcripts.	  However,	  as	  a	  large	  number	  of	  genes	  were	  present	  in	  
these	  clusters,	  this	  may	  make	  it	  less	  likely	  for	  miRvestigator	  to	  identify	  a	  common	  motif	  
that	  met	  the	  stringent	  majority	  criteria	  used.	  Indeed,	  the	  small	  size	  of	  the	  clusters	  that	  
did	  demonstrate	  common	  targeting	  by	  one	  or	  more	  miRNA	  made	  it	  easier	  for	  the	  50%	  
threshold	   to	   be	   reached.	   However,	   while	   they	   demonstrated	   both	   co-­‐regulation	   and	  
common	  targeting,	  the	  small	  cluster	  sizes	  of	  ‘Lime	  (6)’	  and	  ‘Magenta	  (8)’,	  in	  combination	  




This	  work	  has	  demonstrated	  that	  there	  are	  a	  number	  of	  groups	  of	  genes	  that	  are	  
similarly	   expressed	   following	   the	   induction	   of	   LTP.	   However,	   the	   majority	   of	   these	  
groups	  of	  genes	  were	  functionally	  unrelated.	  Furthermore,	  a	  lack	  of	  a	  common	  targeting	  
sequence	   on	   the	   genes	  within	  most	   of	   these	   clusters	   suggests	   that	  miRNA	   do	   not	   co-­‐
ordinately	   regulate	   the	   expression	   of	   similarly	   expressed	   genes	   across	   time	   following	  
LTP	  induction.	  However,	  it	  does	  not	  suggest	  that	  miRNA	  do	  not	  target	  LTP-­‐related	  genes	  
following	   its	   induction.	   Therefore,	   other	   techniques	   and	   tools,	   such	   as	   miRNA	   target	  
prediction	  algorithms,	  are	  required	  to	  be	  used	  to	  investigate	  whether	  miRNA	  do	  target	  
and	  regulate	  LTP-­‐related	  genes.	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4.1 Introduction	  
In	   order	   to	   understand	   the	   contribution	   of	   microRNA	   to	   the	   gene	   expression	  
underlying	   LTP,	   identifying	   the	   target	   genes	   that	   they	   interact	  with	   and	   consequently	  
regulate	   is	   required.	   While	   mass	   identification	   of	   miRNA	   targets	   can	   be	   carried	   out	  
through	   immunoprecipitation	   and	   RNA	   sequencing,	   these	   techniques	   can	   be	   time	  
consuming	  and	  expensive,	  resulting	  in	  the	  identification	  of	  few	  validated	  miRNA-­‐target	  
interactions.	   Therefore,	   a	   number	   of	   computational	   methods	   have	   been	   developed	   to	  
predict	   these	   interactions	  based	  on	  the	  features	  of	   the	  miRNA	  and	  target	  sequences	  to	  
help	  identify	  potential	  targets	  of	  a	  miRNA	  prior	  to	  experimental	  validation	  and	  provide	  
possible	   insight	   into	   their	   function.	   The	   aim	   of	   this	   chapter	   is	   to	   evaluate	   the	   data	  
generated	   by	   various	   target	   identification	   algorithms,	   and	   design	   new	   methods	   to	  
integrate	  these	  data	  together.	  This	  will	  then	  focus	  to	  predict	  LTP-­‐related	  targets	  of	  miR-­‐
34a-­‐5p	  and	  miR-­‐132-­‐3p	  for	  further	  study.	  
	  
4.1.1 Current	  Methods	  to	  Experimentally	  Validate	  microRNA	  Targets	  
The	   effect	   of	   knockdown	   or	   over-­‐expression	   of	   a	   miRNA	   can	   be	   measured	  
through	   changes	   to	   putative	   target	   RNA	   or	   protein	   expression.	   These	   studies	   are	  
correlative	  and	  do	  not	  necessarily	  show	  direct	  interactions,	  demonstrating	  what	  may	  be	  
an	  end	  point	  of	  a	  number	  of	  changes.	  These	  studies	  can	  imply	  that	  an	  interaction	  occurs,	  
even	  if	   it	  could	  be	  indirect.	  Therefore,	  a	  number	  of	  experimental	  techniques	  have	  been	  
developed	  that	  use	  the	  miRNA	  of	  interest	  or	  the	  proteins	  involved	  in	  its	  function	  to	  help	  
identify	  potential	  targets	  in	  a	  causative	  manner.	  These	  include	  luciferase	  assays,	  which	  
are	  able	  to	  investigate	  one	  specific	  interaction	  between	  a	  miRNA	  and	  a	  potential	  target.	  
However,	  this	  is	  time	  consuming	  if	  used	  to	  screen	  multiple	  targets,	  and	  so	  is	  used	  more	  
as	  a	  validation	  tool.	  
In	  contrast,	  one	  experimental	  approach	  to	  screen	  for	  multiple	  targets	  of	  miRNA	  is	  
immunoprecipitation.	   In	   this	   technique,	   either	   biotin-­‐labelled	   miRNA	   of	   interest	   or	  
antibodies	  against	  the	  proteins	  involved	  in	  the	  miRISC	  are	  used	  to	  isolate	  miRNA-­‐target	  
complexes.	   By	   using	   the	  miRNA	   or	   the	   proteins	   of	   the	  miRISC,	   targets	   that	   are	   being	  
actively	   regulated	   by	   the	   miRNA	   of	   interest	   can	   be	   identified	   by	   RT-­‐qPCR	   or	   RNA	  
sequencing.	  For	  example,	  assuming	  that	   the	  biotin	  does	  not	  affect	   the	   incorporation	  of	  
the	  miRNA	  into	  the	  miRISC,	  these	  biotin-­‐labelled	  miRNA	  will	  bind	  to	  their	  targets	  (Orom	  
&	  Lund,	   2007).	   The	   biotin-­‐labelled	  miRNA	  bound	   to	   the	   target	   is	   then	   captured	   using	  
streptavidin	   which	   binds	   strongly	   to	   the	   biotin	   tag,	   an	   interaction	   often	   used	   in	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histological	   techniques.	  The	  resulting	  miRNA-­‐target	  complex	   is	   then	  separated	  and	  the	  
RNA	   extracted	   to	   identify	   targets	   in	   a	   screen	   by	   sequencing	   or	   microarrays,	   or	  
specifically	  using	  RT-­‐qPCR	  for	  specific	  genes	  of	  interest.	  
Alternatively,	  instead	  of	  the	  miRNA	  being	  labelled,	  one	  of	  the	  proteins	  within	  the	  
miRISC,	   such	  as	   the	  AGO	  proteins	  which	   interact	  with	  both	   the	  miRNA	  and	   the	   target,	  
can	  be	  bound	  with	  an	  antibody	  and	  captured.	  One	  technique	  using	  this	  approach	  is	  high-­‐
throughput	  sequencing	  of	  RNA	  isolated	  by	  crosslinking	  and	  immunoprecipitation	  (HITS-­‐
CLIP).	  It	  involves	  crosslinking,	  or	  strengthening,	  the	  interaction	  between	  the	  miRNA	  and	  
the	  target	  RNA,	  and	  splicing	  portions	  of	  the	  transcripts	  extending	  outside	  of	  the	  miRISC	  
complex,	   resulting	   in	   a	   100	   bp	   fragment	   of	   the	   target	   that	  was	   located	   in	   the	  miRISC	  
(Thomson	  et	  al.,	   2011).	  These	   fragments	  are	   then	  separated,	   amplified	  and	  sequenced	  
for	   identification.	   If	   the	   miRNA	   and	   target	   can	   be	   identified,	   the	   target	   site	   can	   be	  
computationally	   identified	   by	   the	   complementarity	   of	   the	   sequence.	   However,	   with	  
photoactivatable-­‐ribonucleoside-­‐enhanced	   CLIP	   (PAR-­‐CLIP),	   the	   addition	   of	   the	  
photoactivatable	   nucleoside,	   4-­‐thiouridine,	   allows	   the	   site	   to	   be	   identified	   within	   the	  
sequence	   (Hafner	   et	   al.,	   2010).	   Under	   UV	   cross-­‐linking,	   a	   number	   of	   thymidine	   to	  
cytidine	  (T	  to	  C)	  transitions	  occur	  in	  cross-­‐linked	  sites,	  allowing	  identification	  of	  where	  
the	  miRNA	  bound	  to	   the	   target.	  A	   further	  extension	  of	   this	  has	  been	  developed	  by	  not	  
only	  immunoprecipitating	  the	  AGO	  protein,	  but	  also	  biotin-­‐labelling	  the	  miRNA	  (Imig	  et	  
al.,	   2015).	   Called	   miRNA	   crosslinking	   and	   immunoprecipitation	   (miR-­‐CLIP),	   this	  
approach	  allows	  for	  the	  selective	  identification	  of	  targets	  actively	  targeted	  by	  a	  specific	  
miRNA.	  With	   these	   techniques,	  not	  only	  will	  more	   targets	  of	  miRNA	  be	   identified,	   but	  
more	  clarity	  about	  the	  nature	  of	  the	  interaction	  can	  be	  gleaned.	  
An	  alternative	  approach	  to	  mass	  identifying	  potential	  targets	  of	  a	  miRNA	  is	  using	  
antibiotic	  resistance	  in	  a	  cell	  culture	  model	  (Gaken	  et	  al.,	  2012).	  This	  approach	  involves	  
the	  generation	  of	  constructs	  where	  the	  3’	  UTR	  of	  genes	  are	  ligated	  with	  a	  TKzeo	  fusion	  
protein.	  Cells	  expressing	  these	  constructs	  become	  resistant	  to	  the	  antibiotic	  zeocin	  and	  
sensitive	  to	  antibiotic	  ganciclovir.	  Following	  selection	  for	  successfully	  transfected	  cells,	  
the	   miRNA	   of	   interest	   is	   cloned	   into	   the	   cells	   where	   binding	   to	   the	   target	   sequence	  
prevents	  the	  cell	  being	  sensitive	  to	  ganciclovir.	  This	  results	  in	  the	  selection	  of	  cells	  that	  
have	   expressed	   the	   constructs	   and	   have	   successfully	   been	   regulated	   by	   the	  miRNA	   of	  
interest,	   the	   RNA	   of	   which	   can	   then	   be	   extracted	   and	   identified	   through	   PCR	   or	  
sequencing.	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These	  approaches	  have	  been	  used	  to	  help	  identify	  targets	  for	  miRNA	  and	  further	  
understand	  the	  properties	  of	  these	  interactions.	  PAR-­‐CLIP	  has	  been	  used	  to	  investigate	  
the	  properties	  of	  miRNA-­‐target	  interactions	  and	  how	  they	  are	  influenced	  by	  the	  location	  
of	   the	   MRE	   along	   the	   target	   transcript	   (Hafner	   et	   al.,	   2010),	   while	   the	   antibiotic	  
approach	  has	  been	  used	  to	  identify	  five	  target	  genes	  of	  miR-­‐130a,	  later	  validated	  further	  
with	  Western	   blots	   and	   knockdown	   experiments	   (Gaken	   et	   al.,	   2012).	   However,	   each	  
technique	   is	  unlikely	   to	  be	  able	   to	  capture	  all	   targets	   for	  one	  miRNA	   in	  one	  particular	  
tissue	   type	   or	   biology.	   Multiple	   replicates	   and/or	   techniques	   may	   be	   needed	   to	  
accomplish	   this,	   which	   would	   be	   both	   time	   and	   cost	   prohibitive.	   Furthermore,	   while	  
these	  techniques	  may	  give	  solid	  conclusions	  about	  the	  interactions	  between	  miRNA	  and	  
their	  targets,	  they	  are	  unable	  to	  provide	  any	  insight	  into	  the	  possible	  biological	  function	  
of	  a	  miRNA	  of	  interest	  before	  undertaking	  experiments	  using	  these	  techniques,	  allowing	  
the	  possibility	  of	  investigating	  a	  miRNA	  that	  may	  target	  genes	  minimally	  involved	  with	  
the	   biology	   of	   interest.	   Nevertheless,	   these	   techniques	   are	   the	   best	   approaches	   to	  
generating	  miRNA-­‐target	  interaction	  predictions	  experimentally.	  	  
	  
4.1.2 Databases	  of	  Experimentally	  Validated	  Targets	  
A	  number	  of	  databases	  have	  been	  created	  that	  list	  validated	  interactions	  between	  
miRNA	  and	  their	  targets	  using	  the	  techniques	  described	  above.	  These	  databases	  draw	  on	  
data	   derived	   from	   a	   wide	   variety	   of	   techniques,	   from	   those	   investigating	   a	   singular	  
interaction	   using	   luciferase	   assays,	   to	   those	   using	   broader	   screens	   such	   as	   PAR-­‐CLIP.	  
However,	   these	  databases	  are	  only	  useful	   if	   they	  are	   regularly	  updated	  with	   the	   latest	  
data.	  One	  approach	  to	  maintaining	  these	  databases	  is	  manually	  curating	  the	  database	  by	  
searching	  and	  entering	  information	  about	  miRNA-­‐target	  interactions	  into	  the	  database.	  
Alternatively,	   an	   automated	   text	   mining	   search	   through	   the	   literature	   that	   extracts	  
potential	  miRNA-­‐target	   interaction	  could	  be	  used.	  Both	  of	   these	  approaches	  have	  their	  
strengths	  and	  flaws.	  While	  some	  interactions	  may	  be	  missed	  with	  manual	  curation	  and	  
take	  a	   considerable	   time	   to	  undertake,	   incorrect	   conclusions	  may	  be	  generated	  by	   the	  
automated	  search.	  Therefore,	  to	  take	  advantage	  of	  both,	  most	  databases	  manually	  curate	  
interactions	   that	   are	   generated	   from	   an	   automated	   text	   mining	   search	   to	   improve	  
accuracy.	  Utilising	   this	   approach,	  miRTarBase	  4	  has	  over	  51,000	   interactions	  between	  
1,232	  miRNA	  and	  17,520	  targets	  (Hsu	  et	  al.,	  2014),	  while	  version	  7	  of	  DIANA	  TarBase	  
contains	   more	   than	   half	   a	   million	   interactions	   (Vlachos	   et	   al.,	   2014),	   with	   these	  
databases	  regularly	  updated.	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These	   databases	   are	   useful	   tools	   to	   investigate	   targets	   of	   miRNA	   and	   their	  
possible	   biological	   function	   but	   these	   data	   sets	   can	   contain	   bias.	   For	   example,	   a	   large	  
proportion	   of	   miRNA	   research	   is	   dedicated	   to	   disease	   biology	   such	   as	   cancer.	   This	  
means	   that	   there	   is	  potentially	  a	   large	  number	  of	   investigated	   targets	   that	  are	  disease	  
specific,	   possibly	   skewing	   the	   database	   and	   limiting	   relevant	   targets	   outside	   of	   these	  
fields.	  Additionally,	  it	  is	  likely	  a	  large	  number	  of	  interactions	  have	  been	  investigated	  but	  
have	   not	   been	   validated	   and	   not	   reported	   in	   publications,	   resulting	   possibly	   in	  
unnecessary	   replication	   of	   experiments.	   Nevertheless,	   these	   databases	   play	   a	   crucial	  
role	   in	   miRNA	   research.	   However,	   in	   order	   to	   find	   novel	   targets,	   a	   number	   of	  
computational	  algorithms	  have	  been	  developed.	  
	  
4.1.3 Features	  of	  microRNA-­‐Target	  Interactions	  	  
It	  is	  simplistic	  to	  think	  that	  in	  order	  for	  a	  miRNA	  to	  have	  an	  effect	  on	  a	  target,	  the	  
sequences	  only	  need	  to	  be	  complementary.	  In	  fact,	  there	  are	  a	  number	  of	  characteristics	  
that	   underlie	   the	   interactions	   between	  miRNA	   and	   their	   targets	   and	   are	   modelled	   in	  
these	  target	  identification	  algorithms	  (summarised	  in	  Figure	  4.1).	  The	  majority	  of	  these	  
characteristics	   are	   properties	   of	   the	   miRNA	   response	   element	   (MRE)	   on	   the	   target	  
transcript	   and	   the	   seed	   site	   on	   the	   miRNA.	   These	   two	   sequences	   are	   where	   the	   two	  
transcripts	  bind	  to	  each	  other,	  and	  so	  the	  length	  of	  interaction	  sequence,	  the	  strength	  of	  
their	   binding,	   and	   their	   conservation	   across	   multiple	   species	   are	   important	  
considerations	  in	  determining	  whether	  an	  interaction	  could	  occur	  or	  not.	  Furthermore,	  
the	   location	   and	   number	   of	   the	   MRE	   along	   the	   target	   transcript,	   and	   the	   secondary	  
Figure	  4.1:	  Properties	  of	  microRNA-­‐target	  interactions	  considered	  by	  targeting	  algorithms.	  
Figure	  4.2:	  Location	  of	  the	  microRNA	  response	  element	  (MRE)	  
and	  seed	  site	  relative	  to	  each	  other	  on	  the	  target	  and	  microRNA	  
respectively.	  Position	  numbers	  for	  the	  nucleotides	  on	  the	  seed	  
site	  are	  noted	  underneath	  the	  miRNA.	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structure	  surrounding	  the	  site	  also	  play	  a	  role.	  
Starting	  with	  the	  miRNA	  itself,	  it	  has	  been	  found	  that	  the	  seed	  site,	  the	  first	  eight	  
nucleotides	   from	   the	   5’	   end	   of	   the	   miRNA,	   is	   crucial	   for	   interacting	   with	   the	  
complimentary	  sequence	  on	  the	  target,	  or	  the	  MRE	  (Lewis	  et	  al.,	  2005;	  Saito	  &	  Saetrom,	  
2010)	  (Figure	  4.2).	  There	  are	  different	  seed	  types	  based	  on	  the	  number	  of	  nucleotides	  
binding	  to	   the	  target	  and	  which	  nucleotide	  base	   is	  present	  at	  certain	  positions	  (Figure	  
4.3).	  The	   strongest	   seed	   type	   is	   an	  8mer,	  which	   involves	   the	   first	  8	  nucleotides	  of	   the	  
miRNA	   interacting	  with	   the	  MRE	  on	   the	   target,	   and	   generally	   involves	   an	   adenine	   (A)	  
nucleotide	   at	   position	   1.	   The	   next	   step	   down	   are	   7mer-­‐A1	   and	   7mer-­‐m8	   seed	   sites,	  
which	   involve	   one	   less	   nucleotide	   binding,	   normally	   at	   positions	   1	   or	   8,	   the	   suffixes	  
referring	  to	  whether	  the	  adenine	  is	  in	  position	  1	  or	  the	  binding	  is	  at	  position	  8.	  The	  6mer	  
seed	  type	  is	  the	  weakest	  of	  the	  four,	  with	  the	  miRNA	  binding	  only	  at	  positions	  2	  through	  
7	  to	  the	  MRE	  on	  the	  target	  transcript.	  
	  However,	   these	   seed	   binding	   requirements	   are	   not	   completely	   robust.	   Less	  
stringent	   interactions	  between	  the	  seed	  and	  MRE	  can	  occur,	  with	  small	  mismatches	   in	  
the	  seed	  sequence	  possible	  through	  G:U	  wobbles,	  an	  example	  of	  non-­‐Watson-­‐Crick	  base	  
pairing.	   Furthermore,	   while	   the	   majority	   of	   interactions	   involve	   strong	   binding	  
occurring	  between	  the	  seed	  sites	  of	  the	  miRNA	  and	  its	  target	  MRE,	  additional	  binding	  at	  
Figure	  4.3:	  Different	  seed	  type	  interactions	  with	  MRE	  on	  the	  target.	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the	  3’	  of	  the	  miRNA	  can	  supplement	  the	  binding	  at	  the	  5’	  end,	  creating	  a	  stronger	  bond	  
between	  the	  miRNA	  and	  mRNA.	  Indeed,	  this	  supplementary	  binding	  can	  compensate	  for	  
poor	  binding	  at	  the	  seed	  site,	  with	  a	  5mer	  seed	  sufficient	  for	  a	  functional	  interaction	  if	  a	  
substantial	   3’	   compensatory	   binding	   site	   is	   present	   (Brennecke	   et	   al.,	   2005).	   This	   is	  
normally	  reflected	  in	  the	  change	  in	  free	  energy	  (ΔG)	  during	  the	  interaction	  (Peterson	  et	  
al.,	   2014).	   Interactions	   between	   the	   miRNA	   and	   target	   that	   result	   in	   stable	   reactions	  
have	  a	  large	  negative	  ΔG,	  representing	  a	  spontaneous	  reaction	  where	  the	  two	  together	  is	  
thermodynamically	   favoured.	   Therefore,	   calculations	   of	   ΔG	   can	   suggest	   whether	   an	  
interaction	  occurs,	  even	  if	  there	  is	  little	  binding	  within	  the	  seed	  region	  to	  the	  MRE.	  
Interestingly,	  as	  miRNA	  are	  highly	  conserved	  across	  species	  and	  time,	  so	  are	  the	  
MREs	   to	   which	   they	   bind.	   Conservation	   of	   the	   MRE	   would	   suggests	   that	   the	   site	   is	  
evolutionarily	   important	   and	   biologically	   functional.	   Indeed,	   it	   has	   been	   found	   that	   at	  
least	  60%	  of	  all	  mRNA	  in	  human	  have	  been	  shown	  to	  have	  conserved	  MRE	  present,	  with	  
target	   sites	   for	  broadly	   conserved	  miRNA	  more	  prevalent	   that	   that	  of	  miRNA	   that	   are	  
mammalian	  specific	  (Friedman	  et	  al.,	  2009).	  However,	  some	  studies	  have	  suggested	  that	  
up	  to	  50%	  of	  experimentally	  validated	  interactions	  do	  not	  take	  place	  on	  conserved	  sites	  
(Sethupathy	  et	  al.,	  2006;	  Wang	  &	  El	  Naqa,	  2008).	  This	  suggests	  that	  the	  conservation	  of	  
the	  target	  site	  can	  be	  used	  to	  determine	  how	  probable	  an	  interaction	  may	  be,	  but	  a	  lack	  
of	  conservation	  does	  not	  necessarily	  discount	  it.	  
The	  positioning	  of	  the	  MRE	  within	  the	  greater	  target	  transcript	  is	  also	  important.	  
Firstly,	  mRNA	  transcripts	  are	  able	  to	  form	  secondary	  structures	  through	  base	  pairing	  of	  
disparate	   sections	   of	   the	   transcript.	   The	   secondary	   structure	   of	   the	   transcript	   may	  
occlude	  the	  accessibility	  of	  the	  MRE	  site	  to	  the	  miRNA	  because	  of	  the	  energy	  required	  to	  
free	  the	  structure.	  There	  are	  some	  exceptions,	  with	  binding	  occurring	  and	  the	  secondary	  
structures	  disrupted,	  but	  in	  most	  cases,	  the	  presence	  of	  secondary	  structures	  does	  affect	  
MRE	  accessibility	  and	  miRNA	  activity	  (Long	  et	  al.,	  2007).	  This	  results	  in	  a	  preference	  for	  
miRNA	  seeds	  to	  interact	  with	  sites	  located	  in	  accessible	  regions	  (Kertesz	  et	  al.,	  2007).	  
Further,	  most	  coding	  mRNA	  transcripts	  can	  be	  subdivided	  into	  four	  regions:	  the	  
promoter,	   5’	   untranslated	   region	   (UTR),	   protein	   coding	   region	   (CDS)	   and	   the	   3’	   UTR.	  
Canonically,	   the	   MREs	   are	   found	   within	   the	   3’	   UTR	   (Xie	   et	   al.,	   2005),	   with	   3’UTR	  
mediated	   inhibition	  generally	   found	  to	  be	  more	  effective	  (Baek	  et	  al.,	  2008).	  However,	  
binding	   sites	   have	   also	   been	   located	   throughout	   the	   other	   three	   regions	   (Place	   et	   al.,	  
2008;	  Tay	  et	  al.,	  2008),	  and	  can	  co-­‐exist	  with	  those	   in	  the	  3’	  UTR.	  Indeed,	   in	   the	  study	  
that	  developed	  PAR-­‐CLIP,	   they	   found	  50%	  of	  binding	   sites	   identified	  as	  being	  actively	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targeted	   by	  miRNA	  were	   present	  within	   CDS	   sequences,	   though	   their	   effectiveness	   at	  
down-­‐regulating	   their	   mRNA	   targets	   was	   minimal	   compared	   to	   3’UTR	   located	   sites	  
(Hafner	  et	  al.,	  2010).	  Further,	  although	  the	   location	  of	  MRE	   in	   the	  coding	  region	  could	  
have	  a	  greater	  effect	  on	  translation	  by	  disrupting	  ribosomal	  binding,	  these	  binding	  sites	  
were	  again	  less	  effective	  in	  regulating	  target	  protein	  expression	  when	  compared	  to	  sites	  
present	  in	  the	  3’UTR	  (Baek	  et	  al.,	  2008).	  	  
However,	   it	   appears	   that	   transcripts	  with	  actively	   targeted	  MREs	   in	  both	   the	  3’	  
UTR	  and	  CDS	  are	  more	  strongly	  regulated	  than	  those	  with	  a	  3’	  UTR	  MRE	  alone	  (Fang	  &	  
Rajewsky,	   2011).	   With	   multiple	   MREs	   possible	   within	   one	   transcript	   targeted	   by	   the	  
same	  or	  different	  miRNA,	  there	  are	  multiple	  opportunities	  for	  regulation	  that	  can	  result	  
in	   a	   graded	   regulation	   of	   the	   target.	   Furthermore,	   MRE	   sites	   separated	   by	   14	   to	   46	  
nucleotides	  show	  increased	  efficacy	  of	  the	  inhibition	  (Saetrom	  et	  al.,	  2007;	  Selbach	  et	  al.,	  
2008).	   It	  has	  been	  proposed	  this	   is	   the	  result	  of	  multiple	  miRISC	  complexes	  stabilising	  
each	  other	  through	  their	  close	  proximity.	  Indeed,	  this	  is	  likely	  to	  happen	  with	  MRE	  sites	  
within	   the	   CDS,	   which	   are	   often	   clustered	   together.	   This	   increased	   stabilisation	   is	  
thought	   to	   prevent	   the	   miRISC	   from	   being	   displaced	   by	   the	   translational	   ribosomes	  
binding	   to	   the	   transcript	   and	   synthesising	   proteins.	   Therefore,	   these	   properties	   of	  
miRNA-­‐target	  interactions	  are	  important	  to	  consider	  when	  predicting	  targets.	  
	  
4.1.4 Current	  microRNA	  Target	  Prediction	  Algorithms	  
While	   it	   is	  possible	   to	  go	  through	  the	  genome	  and	   identify	  potential	  sites	  based	  
purely	  on	  the	  sequence	  for	  miRNA	  binding,	  this	  is	  a	  highly	  simplistic	  approach	  that	  does	  
not	  take	  into	  consideration	  the	  various	  components	  of	  the	  miRNA-­‐target	  interaction.	  As	  
a	   result,	   characteristics	   of	   the	  miRNA-­‐target	   interactions	   based	   on	   observations	   from	  
actual	   validated	   interactions	   have	   been	   programmed	   into	   a	   number	   of	   computational	  
algorithms	  to	  predict	  further	  possible	  interactions	  for	  experimental	  validation.	  
TargetScan	   and	   its	   successor	   TargetScanS	   are	   two	   of	   the	  most	   commonly	   used	  
targeting	  algorithms	  (Friedman	  et	  al.,	  2009;	  Lewis	  et	  al.,	  2005;	  Lewis	  et	  al.,	  2003).	  First	  
developed	   in	  2003,	  TargetScan	  6.2	  (June	  2012)	  covers	  miRNA-­‐target	  predictions	  of	  23	  
species,	   including	  human,	  mouse,	  nematode,	   fruit	   fly,	  and	  zebrafish.	  TargetScan	   is	  also	  
considered	   to	   be	   the	   more	   conservative	   of	   the	   target	   prediction	   algorithms	   through	  
strict	  conservation	  and	  seed	  requirements,	  and	  requires	  a	  minimal	  6mer	  seed	  with	  no	  
mismatches.	  TargetScan	  only	  considers	  the	  3’	  UTR	  for	  MRE,	  and	  takes	  into	  consideration	  
its	   location	   from	   the	   stop	   codon,	   requiring	   conservation	   across	   multiple	   species	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determined	  by	   the	  summation	  of	  branch	  score	   in	  a	  phylogenetic	   tree	   (Friedman	  et	  al.,	  
2009).	   These	   features	   are	   combined	   to	   generate	   a	   score	   to	   help	   rank	   the	   interactions	  
(Grimson	  et	  al.,	  2007).	  
MiRanda	  was	  the	  second	  algorithm	  developed	  for	  predicting	  interactions,	  whose	  
latest	   release	  was	   in	  August	   2010	   (Betel	   et	   al.,	   2010;	  Betel	   et	   al.,	   2008;	   Enright	   et	   al.,	  
2003;	   John	  et	  al.,	  2004).	  The	  algorithm,	  which	  covers	  human,	   rat,	  mouse,	   fruit	   fly,	   and	  
nematode,	   has	   a	   less	   strict	   criteria	   surrounding	   the	   MRE,	   requiring	   only	   90%	  
conservation	   between	   vertebrates,	   and	   a	   minimal	   6mer	   seed.	   Furthermore,	   the	  
algorithms	  also	  considers	  complementary	  binding	  beyond	  the	  seed	  sequence	  onto	  the	  3’	  
UTR,	  with	   the	   thermodynamic	   stability	  of	   the	   interaction	   calculated	   though	   the	  use	  of	  
the	  Vienna	  RNA	  folding	  program,	  which	  finds	  the	  minimal	  suboptimal	  structure	  between	  
two	  set	  free	  energy	  values	  (Wuchty	  et	  al.,	  1999).	  
PicTar2	   predicts	   targets	   sites	   on	   the	   3’	   UTR	   in	   human,	   mouse,	   fruit	   fly,	   and	  
nematode	  (Anders	  et	  al.,	  2012;	  Krek	  et	  al.,	  2005).	  Requiring	  a	  minimal	  6mer	  match	  in	  the	  
seed	  but	  allowing	  for	  one	  nucleotide	  mismatch,	  there	  are	  three	  levels	  of	  conservation	  of	  
the	   MRE	   from	   mammals	   only	   to	   conserved	   sites	   in	   mammals,	   chicken,	   and	   fish.	  
Additionally,	  the	  free	  energy	  of	  the	  duplex	  created	  by	  the	  interaction	  is	  calculated	  using	  
RNAhybrid,	   with	   low	   values	   representing	   strong	   interactions.	   RNAhybrid,	   first	  
developed	  as	  an	  algorithm	  to	  determine	  the	  secondary	  structures	  of	  one	  RNA	  transcript,	  
has	   since	   been	   adapted	   for	   interactions	   between	   the	   two	   RNA	   sequences	   and	   can	   be	  
used	  by	   itself	   to	   find	   interactions,	  albeit	   in	  an	  manual	  manner	  (Kruger	  &	  Rehmsmeier,	  
2006;	   Zuker	   &	   Stiegler,	   1981).	   Another	   algorithm	   that	   heavily	   considers	   the	  
thermodynamics	   of	   the	   miRNA-­‐target	   interaction	   is	   PITA	   (Kertesz	   et	   al.,	   2007).	   In	  
addition	  to	  the	  minimal	  3’UTR	  and	  6mer	  seed	  requirements,	  and	  variable	  conservation	  
requirements	   for	  MREs	  within	  human,	  mouse,	   fruit	   fly,	   and	  nematode	   transcripts,	   this	  
algorithm	   considers	   the	   secondary	   structure	   of	   the	   transcript.	   However,	   instead	   of	  
considering	  whether	  or	  not	  the	  MRE	  is	  in	  a	  secondary	  structure,	  it	  determines	  whether	  
the	  energy	  required	  to	  break	  the	  secondary	  structure	  open	  is	  less	  than	  that	  to	  maintain	  
the	  secondary	  structure.	  
	   MiRWalk	  differs	  from	  other	  algorithms	  through	  considering	  regions	  of	  the	  mRNA	  
other	  than	  the	  3’	  UTR	  in	  human,	  mouse,	  and	  rat	  transcripts	  (Dweep	  et	  al.,	  2011).	  Target	  
MREs	   that	  bind	   to	  a	  minimal	  7mer	  seed	  are	  searched	   for	  sequentially	  along	   the	  entire	  
mRNA	  transcript,	  thus	  including	  the	  promoter,	  5’	  UTR,	  and	  CDS	  regions.	  DIANA-­‐microT	  
also	  predicts	  targets	  outside	  of	  the	  3’	  UTR,	  with	  the	  CDS	  regions	  of	  human,	  mouse,	  fruit	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fly,	   and	   nematode	   interrogated	   (Paraskevopoulou	   et	   al.,	   2013;	   Reczko	   et	   al.,	   2012).	  
Requiring	   a	   minimal	   4mer	   seed	   within	   the	   first	   nine	   5’	   nucleotides,	   conservation	   is	  
considered	   across	   16	   species	   with	   the	   free	   energy	   of	   the	   duplex	   calculated	   by	  
RNAhybrid.	  
The	   above	   algorithms	   identify	   targets	   by	   matching	   miRNA	   seed	   sites	   to	   the	  
transcript.	   However,	   in	   contrast,	   RNA22,	   which	   has	   no	   conservation	   filter,	   utilises	  
patterns	   in	  mature	  miRNA	  sequences	   to	   identify	  potential	  MRE	  binding	  sites	  on	  target	  
sequences	  (Miranda	  et	  al.,	  2006).	  Once	  identified,	   it	  then	  determines	  which	  miRNA	  are	  
suitable	  to	  bind	  to	  them.	  Another	  alternative	  approach	  for	  identification	  is	  MirTarget2,	  
which	   underlies	   miRDB	   (Wang,	   2008;	   Wang	   &	   El	   Naqa,	   2008).	   MirTarget2	   utilises	  
machine	   learning,	   specifically	   support	   vector	   machines	   (SVM)	   which	   categorise	  
interactions	   into	   different	   categories.	   Using	   data	   sets	   from	   experimentally	   validated	  
targets	   from	   data	   sources,	   including	   microarrays	   of	   genes	   following	   miRNA	  
manipulation,	   these	   SVM	   can	   identify	   the	   common	   features	   underlying	   these	  minimal	  
7mer	   interactions	   including	   base	   composition,	   secondary	   structure,	   conservation	   and	  
seed	  type	  for	  common	  features.	  From	  this,	  predictions	  can	  then	  be	  made	  on	  interactions	  
between	  miRNA	  and	  transcripts	  that	  show	  similarity	  in	  these	  features.	  These	  algorithms	  
therefore	  will	  be	  influenced	  by	  experimental	  data	  and	  the	  potential	  bias	  present	  from	  an	  
abundance	  of	  cancer-­‐related	  miRNA	  studies.	  
This	   is	   no	   means	   a	   complete	   list	   of	   targeting	   algorithms	   that	   have	   been	  
developed.	  There	  are	  minimally	  38	  different	  algorithms,	  of	  which	  only	  nine	  have	  been	  
described	   above	   (Fan	   &	   Kurgan,	   2014).	   Each	   algorithm	   will	   differ	   in	   its	   their	  
consideration	  of	  the	  seed	  sequence,	  conservation,	  and/or	  thermodynamics,	  resulting	  in	  
different	  output	  target	  genes.	  However,	  the	  nine	  selected	  are	  the	  most	  commonly	  used	  
algorithms	  and	  cover	  a	  wide	  range	  of	  features	  used	  in	  target	  prediction,	  encompassing	  a	  
range	   of	   different	   interactions	   between	  miRNA	   and	   their	   targets.	   Therefore,	   the	   nine	  
algorithms	   described	   above	   (DIANA-­‐microT,	   miRanda,	   miRWalk,	   MiTarget2,	   PicTar2,	  
PITA,	  RNA22,	  RNhybrid,	  TargetScanS)	  and	  summarised	  in	  Table	  4.1	  will	  be	  the	  focus	  of	  
the	   following	  analysis	   to	  compare	   the	   targets	  predicted	  by	   the	  algorithms	  and	   identify	  
potential	  targets	  for	  miR-­‐34a-­‐5p	  and	  miR-­‐132-­‐3p.	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Table	  4.1:	  Characteristics	  underlying	  multiple	  miRNA	  targeting	  algorithms.	  




Location	  Seed	   Additional	  
DIANA-­‐
microT	  
3.0	   Reczko	   et	   al.,	  
2012	  
6mer	   N/A	   RNAhybrid	   16	  species	   Yes	   3’	  UTR	  
miRanda	   August	  
2010	  
Betel	  et	  al.,	  2008;	  
2010	  
6mer	   3’	  
complement	  
RNAplfold	   Vertebrates	   Yes	   3’	  UTR	  
miRwalk	   March	  
2011	  
Dweep	   et	   al.,	  
2011	  
7mer	   N/A	   No	   No	   Yes	   3’	  UTR,	  5’	  UTR,	  
CDS,	  Promoter	  
MiTarget2	   4.0	   Wang	  et	  al.,	  2008	   7mer	   Pattern	  
identification	  
RNAfold	   No;	   though	   it	   was	  
calculated	  
No	   3’	  UTR	  
PicTar2	   December	  
2012	  
Anders	   et	   al.,	  
2012	  
7mer	   1	  nt	  mismatch	  
6mer	  




No	   3’	  UTR	  
PITA	   6.0	   Kertesz	   et	   al.,	  
2007	  




No	   Yes	   3’	  UTR	  
RNA22	   May	  2008	   Miranda	   et	   al.,	  
2006	  
N/A	   Pattern	  
identification	  
No	   No	   No	   3’	  UTR,	  5’	  UTR,	  
CDS	  
RNAhybrid	   2.1	   Kruger	   et	   al.,	  
2006	  
N/A	   Sufficient	  
binding	  
RNAhybrid	   No	   Yes	   N/A	  
TargetScanS	   6.2	   Lewis	  et	  al.,	  2005	   6mer	   N/A	   Vienna	   Yes;	  five	  species	   Yes	   3’	  UTR	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4.1.5 Previous	  Evaluation	  of	  Target	  Prediction	  Algorithms	  
With	   multiple	   algorithms	   having	   been	   developed	   to	   help	   identify	   targets	   for	  
miRNA,	  which	  algorithm	  to	  use	  is	  an	  important	  consideration.	  A	  number	  of	  studies	  have	  
been	  undertaken	  to	  evaluate	   these	  algorithms	  and	  determine	  their	  performance	  based	  
on	   their	  sensitivity	  and	  specificity	  of	   their	  generated	  results,	  or	   the	  proportion	  of	   true	  
positive	  and	  negative	  results	  respectively.	  This	  is	  quite	  important	  for	  those	  studies	  that	  
use	   only	   one	   targeting	   algorithm	   to	   predict	   targets	   for	   their	  miRNA	  of	   interest.	   There	  
may	  be	  many	  reasons	  for	  choosing	  a	  particular	  algorithm,	  from	  experience	  with	  its	  use	  
within	  a	   lab,	   to	  recommendations	   from	  colleagues	  or	  other	  papers	   in	  the	   field.	   Indeed,	  
some	  studies	  have	  used	  one	  algorithm	  and	  have	  resulted	  in	  biologically	  meaningful	  data	  
(Grun	  et	  al.,	  2005;	  Huang	  et	  al.,	  2015;	  Schmitz	  et	  al.,	  2014;	  Vo	  et	  al.,	  2005;	  Zhou	  et	  al.,	  
2009).	  However,	  getting	  these	  results	  may	  have	  been	  the	  result	  of	  multiple	  attempts	  at	  
finding	  potential	  targets	  or	  chance.	  Therefore,	  determining	  whether	  there	  is	  an	  optimal	  
algorithm	  to	  use	  is	  a	  valid	  exercise	  to	  carry	  out.	  
In	  one	  of	  the	  first	  studies	  to	  compare	  and	  contrast	  the	  targeting	  algorithms,	  it	  was	  
found	  that	  the	  earliest	  developed	  programs	  like	  DIANA-­‐microT	  and	  TargetScan	  had	  the	  
lowest	  sensitivity	  when	  compared	  to	  their	  more	  contemporary	  algorithms	  (Sethupathy	  
et	  al.,	  2006).	  This	  was	  likely	  the	  result	  of	  less	  refined	  requirements	  in	  the	  predictions	  of	  
the	  algorithms,	  reflected	  in	  low	  numbers	  of	  interactions	  being	  predicted	  and	  the	  result	  
of	   the	   lack	   of	   knowledge	   about	   the	   properties	   of	   the	   interaction	   between	  miRNA	   and	  
their	   targets.	   The	   newer	   algorithms,	   including	   PicTar,	   miRanda,	   and	   the	   updated	  
TargetScanS,	   all	   had	   identical	   increased	   sensitivity.	   However,	   this	   occurred	   with	   an	  
increase	  in	  the	  number	  of	  predicted	  targets,	  with	  miRanda	  predicting	  several	  thousand	  
more	  interactions	  that	  PicTar	  and	  TargetScanS,	  though	  whether	  there	  was	  an	  effect	  on	  
the	  specificity	  of	  the	  algorithms,	  while	  likely,	  is	  unknown.	  
A	  more	  recent	  study	  investigating	  38	  different	  target	  prediction	  algorithms	  found	  
that	   no	   one	   algorithm	  was	   rated	   the	   best	   (Fan	  &	   Kurgan,	   2014).	  While	   some	   such	   as	  
PicTar	  and	  miTarget2	  provide	  high	  specificity,	  TargetScan	  was	  found	  to	  more	  accurately	  
estimate	   the	   total	   number	   of	   miRNA	   targets.	   Further,	   those	   that	   consider	   multiple	  
binding	   sites	   are	  more	   likely	   to	   predict	   functional	   interactions.	   It	  was	   concluded	   that	  
selecting	   an	   algorithm	   should	   be	  made	   based	   on	  whether	   a	  more	   accurate	   or	   a	  more	  
complete	  set	  of	  targets	  was	  required.	  	  
One	  method	   that	   could	   increase	   the	   specificity	  of	   the	   targets	  predicted	  without	  
sacrificing	  sensitivity	  may	  be	  to	  use	  multiple	  algorithms.	  In	  Sethupathy	  et	  al.	  (2006),	  the	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intersection,	  or	  overlap,	  of	  targets	  predicted	  by	  PicTar	  and	  TargetScanS	  were	  only	  able	  
to	   predict	   41.7%	   of	   the	   validated	   interactions	   in	   the	   dataset,	   less	   than	   that	   of	   them	  
individually	   (47.6%	   for	   both).	   With	   the	   addition	   of	   other	   algorithms	   into	   the	  
intersection,	   this	   decreases	   dramatically	   (DIANA-­‐microT:	   3.6%;	   miRanda:	   28.6%).	   As	  
such,	  in	  this	  example,	  sensitivity	  is	  dramatically	  impaired	  even	  though	  any	  target	  that	  is	  
predicted	  it	  likely	  to	  be	  true.	  	  
In	   contrast,	   another	   study	   demonstrated	   the	   intersection	   of	   miRanda	   and	  
TargetScan	   showed	   the	   highest	   sensitivity	   and	   specificity,	   thought	   to	   be	   the	   result	   of	  
similarities	   in	   consideration	   of	   conservation	   (Zhang	   &	   Verbeek,	   2010).	   This	   is	   not	  
surprising	   that	   algorithms	   that	   have	   similar	   consideration	   of	   the	   characteristics	   of	  
miRNA-­‐target	  interactions	  would	   identify	  similar	  gene	  sets.	  However,	   it	  was	  evident	  in	  
both	   studies	   that	   the	   addition	   of	  more	   algorithms	   into	   the	   intersection	   decreased	   the	  
number	  of	  predictions	  made,	  and	  the	  addition	  of	   too	  many	  algorithms	  can	   lead	  to	   tjhe	  
identification	   of	   no	   interactions.	   This	   is	   exemplified	   with	   the	   intersection	   between	  
PicTar,	  miRanda,	  DIANA-­‐microT,	  TargetScanS	  and	  its	  predecessor	  TargetScan	  resulting	  
in	  no	   experimentally	   supported	   interactions	   listed	   in	  TarBase	   (2006)	  being	  predicted.	  
While	   the	   union	   or	   combined	   targets	   predicted	   by	   each	   algorithm	   predicted	   every	  
validated	   interaction,	   over	   27,000	   predicted	   interactions	  were	  made	   that	  would	  most	  
likely	  contain	  a	  high	  number	  of	  false	  positives	  (Sethupathy	  et	  al.,	  2006).	  	  
One	   possible	   solution	   to	   using	   the	   union	   of	   multiple	   targeting	   algorithms	   and	  
having	  high	   sensitivity	  without	   sacrificing	   specificity,	   is	   to	  use	   the	  probabilistic	   scores	  
generated	  by	   the	  majority	  of	   the	  algorithms	  as	   to	  how	   likely	   it	   is	   that	   interactions	  are	  
real.	   The	   database	   miRDIP	   uses	   this	   approach	   to	   integrate	   these	   scores	   into	   the	  
prediction	   of	   targets	   (Shirdel	   et	   al.,	   2011).	   MiRDIP	   is	   an	   online	   database	   that	   allows	  
predictions	   from	   different	   algorithms	   to	   be	   compared	   and	   restricted	   according	   to	   the	  
algorithm	  or	  the	  characteristics	  of	  the	  interaction	  for	  example.	  For	  each	  interaction,	  the	  
data	   provides	   the	   score	   generated	   by	   the	   algorithm	   and	   normalises	   it	   to	   allow	  
predictions	   to	   be	   compared	   between	   algorithms.	   This	   allows	   for	   interactions	   to	   be	  
ranked	  according	  to	  score,	  and	  may	  help	  to	  narrow	  down	  large	  lists.	  However,	  with	  the	  
algorithms	   all	   considering	   various	   properties	   to	   different	   degrees,	   the	   scores	   are	   not	  
wholly	   comparable,	   and	   therefore	   bias	   may	   be	   introduced	   into	   the	   list	   of	   predicted	  
targets.	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4.1.6 Current	  Study	  
The	   first	  aim	  of	   this	  chapter	  was	   to	  evaluate	   the	  nine	  selected	  target	  prediction	  
algorithms.	  How	  effective	   the	  nine	  algorithms	  were	  at	  predicting	   interactions	  between	  
miRNA	  and	  their	  targets	  were	  compared	  both	  together	  and	  separately.	  The	  second	  aim	  
was	  to	  identify	  potential	  targets	  of	  the	  LTP-­‐regulated	  miRNA,	  miR-­‐34a-­‐5p	  and	  miR-­‐132-­‐
3p,	   which	   can	   later	   be	   validated	   experimentally.	   As	   these	   algorithms	   consider	   the	  
properties	  underlying	  miRNA-­‐target	  interactions	  differently	  between	  them,	  whether	  any	  
of	   the	   nine	   algorithms	  were	  more	   suitable	   for	   identifying	   LTP-­‐related	   targets	   will	   be	  
determined.	   Alternatively,	   new	   methods	   using	   annotations	   and	   LTP	   gene	   expression	  
data	   to	   identify	   these	   genes	   were	   considered.	   Through	   these	   analyses,	   an	   optimal	  
workflow	   for	   identifying	   targets	   related	   to	   LTP	   for	   experimental	   validation	   in	   a	   non-­‐
biased	  manner	  was	  established.	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4.2 Methods	  and	  Materials	  
The	  lists	  of	  targets	  predicted	  by	  the	  nine	  algorithms	  or	  validated	  in	  TarBase	  6	  for	  
each	   miRNA,	   and	   the	   lists	   of	   genes	   annotated	   with	   the	   terms	   of	   interest,	   were	  
downloaded	   and	   current	   on	   1	   March	   2014.	   All	   analysis	   for	   predictive	   and	   validated	  
interactions	  were	  conducted	  using	  human	  miRNA	  and	  mRNA	  transcripts.	  
	  
4.2.1 microRNA	  Datasets	  
To	  evaluate	   the	   target	   algorithms,	   a	   subset	  of	  miRNA	   related	   to	  LTP	  have	  been	  
selected.	   There	   were	   five	   groups	   of	   miRNA:	   two	   miRNA	   known	   to	   be	   differentially	  
regulated	  temporally	  following	  LTP	  induction	  using	  RT-­‐qPCR	  as	  shown	  in	  Chapter	  2	  that	  
are	   of	   interest	   for	   this	   study,	   five	  miRNA	   found	   to	   be	   differentially	   expressed	   20	  min	  
post-­‐LTP	   on	   Affymetrix	   miRNA	   arrays	   (Joilin	   et	   al.,	   2014),	   five	   miRNA	   found	   to	   be	  
differentially	   expressed	   5	   h	   post-­‐LTP	   in	   TaqMan	   RT-­‐qPCR	   array	   data	   (Ryan,	  
unpublished),	  and	  three	  miRNA	  shown	  to	  have	  low	  expression	  in	  the	  brain	  (Shao	  et	  al.,	  
2010)	  and	  two	  randomly	  chosen	  miRNA	  collectively	  chosen	  to	  act	  as	  controls.	  These	  are	  
shown	  in	  Table	  4.2.	  	  
	  
4.2.2 Target	  Algorithm	  and	  Validated	  Targets	  Datasets	  
Nine	   algorithms	   were	   investigated:	   DIANA-­‐microT,	   miRanda,	   miRWalk,	  
MiTarget2,	   PicTar2,	   PITA,	   RNA22,	   RNAhybrid,	   and	   TargetScanS.	   The	   latest	   releases	   of	  
data	  from	  their	  sources	  (excluding	  RNAhybrid	  and	  RNA22,	  of	  which	  data	  was	  obtained	  
from	  the	  miRWalk	  Multiple	  Algorithms	  database)	  were	  obtained	  and	  are	  noted	  in	  Table	  
4.1.	  Furthermore,	  datasets	  of	  validated	  targets	  for	  the	  17	  miRNA	  were	  obtained	  from	  the	  
latest	  version	  of	  TarBase	  available	  at	  the	  time	  of	  the	  analysis	  (version	  6).	  
















miR-­‐34a-­‐5p	   miR-­‐9-­‐5p	   miR-­‐23a-­‐3p	   miR-­‐29a-­‐3p	   miR-­‐141-­‐3p	  
miR-­‐132-­‐3p	   miR-­‐24-­‐3p	   miR-­‐28-­‐5p	   miR-­‐101-­‐3p	   miR-­‐365a-­‐3p	  
	   miR-­‐181c-­‐5p	   miR-­‐129-­‐3p	   miR-­‐103a-­‐3p	   	  
	   miR-­‐214-­‐3p	   miR-­‐129-­‐5p	   	   	  
	   miR-­‐708-­‐5p	   miR-­‐151-­‐3p	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4.2.3 KEGG	  Pathway,	  Gene	  Ontology	  and	  Array	  Datasets	  
Five	   comparison	   datasets	   containing	   genes	   related	   to	   LTP	  were	   used.	   The	   first	  
dataset	   included	  70	  genes	  annotated	  to	  the	  LTP	  pathway	   in	  the	  Kyoto	  Encyclopedia	  of	  
Genes	   and	  Genomes	   (KEGG),	  which	   contains	  manually	   created	   canonical	  pathways	   for	  
processes	   within	   the	   human	   body,	   while	   the	   second	   data	   set	   contained	   genes	   in	   the	  
KEGG	   pathways	   related	   to	   LTP,	   containing	   a	   total	   of	   896	   unique	   genes	   (Table	   4.3)	  
(Kanehisa	  &	  Goto,	  2000).	  These	  pathways	  were	  selected	  as	  they	  reflect	  processes	  known	  
to	  be	  active	  following	  the	  induction	  of	  LTP.	  The	  third	  data	  set	  included	  genes	  annotated	  
to	   LTP	   related	   processes	   in	   the	   Gene	   Ontology	   (GO)	   database,	   containing	   513	   unique	  
genes	  and	  downloaded	  through	  QuickGO	  (Table	  4.3)	  (Ashburner	  et	  al.,	  2000;	  Binns	  et	  al.,	  
2009;	  du	  Plessis	  et	  al.,	  2011).	  These	  categories	  are	  not	  restrained	  by	  pathway	  and	  thus	  
contain	   genes	   from	   the	   LTP-­‐related	   KEGG	   pathways	   that	   were	   not	   in	   the	   LTP	   KEGG	  
pathway.	   The	   fourth	   data	   set	   included	   the	   1,026	   genes	   shown	   to	   be	   differentially	  
expressed	  on	  microarrays	  20	  min,	  5	  h	  and	  24	  h	  post-­‐LTP	  (Ryan	  et	  al.,	  2011;	  Ryan	  et	  al.,	  
2012).	  Lastly,	  the	  fifth	  set	  is	  the	  union	  of	  all	   four	  sets,	  totalling	  2,220	  unique	  genes.	  All	  
genes	  in	  these	  sets	  are	  human	  homologs	  of	  the	  genes.	  A	  list	  of	  these	  genes	  can	  be	  found	  
in	  Appendix	  C.	  	  
	  
4.2.4 R	  and	  Data	  Analysis	  Scripts	  
Excel	  (Mac:	  2011;	  Windows:	  2013;	  Microsoft)	  and	  R	  64-­‐bit	  v2.14	  (R	  Development	  
Core	  Team)	  were	  used	  to	  create	  the	  files	  used	  for	  analysis.	  Each	  file	  used	  for	  comparison	  
was	   created	   in	   Excel	   and	   contained	   a	   list	   of	   19,701	   human	   genes	   obtained	   from	   the	  
HUGO	   Gene	   Nomenclature	   Committee,	   who	   are	   responsible	   for	   assigning	   individual	  
Table	  4.3:	  Pathway	  and	  annotation	  terms	  used	  in	  the	  KEGG	  pathway	  and	  gene	  ontology	  data	  sets.	  
KEGG	  Pathways	   Gene	  Ontology	  Annotations	  
Alzheimer’s	  disease	   Long-­‐term	  memory	  
Axon	  guidance	   Memory	  
Calcium	  signalling	   Regulation	  of	  synaptic	  plasticity	  
Long-­‐term	  depression	   Long-­‐term	  synaptic	  potentiation	  
Long-­‐term	  potentiation	   	  
MAPK	  signalling	   	  
RNA	  degradation	   	  
RNA	  transport	   	  
Regulation	  of	  actin	  cytoskeleton	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genes	  names	  and	  abbreviations	  (Gray	  et	  al.,	  2015).	  With	  each	  file	  relating	  to	  a	  particular	  
miRNA,	   each	   gene	   was	   annotated	   with	   whether	   it	   is	   a	   target	   of	   that	   miRNA,	   which	  
algorithm	  predicts	  it,	  and	  whether	  it	   is	  involved	  in	  one	  of	  the	  LTP-­‐related	  processes	  as	  
described	  above.	  These	  files	  are	  then	  processed	  by	  R.	  The	  files	  include	  the	  total	  number	  
of	  genes	  predicted	  by	  an	  algorithm,	  the	  total	  number	  of	  genes	  annotated	  to	  a	  pathway	  or	  
process,	  and	  the	  total	  number	  of	  genes	  in	  the	  intersection	  between	  the	  two	  algorithms.	  
A	  script,	  adapted	  from	  one	  written	  by	  Associate	  Professor	  Cris	  Print	  (University	  
of	  Auckland),	  was	  used	  to	  test	  the	  algorithms	  for	  LTP	  enrichment	  (included	  in	  Appendix	  
C).	  The	  script	  can	  read	  in	  the	  file,	  and	  search	  within	  the	  file	  to	  find	  genes	  predicted	  by	  
each	   algorithm	   that	   are	   annotated	   as	   being	   related	   to	   LTP.	   The	   script	   compiles	   this	  
together	  into	  a	   list,	  which	  can	  then	  be	  used	  for	   identifying	  target	  genes	  related	  to	  LTP.	  
The	   script	   can	   also	   calculate	   enrichment	   based	   on	   a	   Fisher’s	   exact	   test,	   testing	   for	  
whether	  there	  are	  more	  genes	  predicted	  by	  an	  algorithm	  to	  be	  targets	  of	  a	  miRNA	  and	  
involved	   in	   LTP	   than	   expected	   by	   chance.	   While	   a	   multiple	   testing	   correction	   was	  
applied	  to	  the	  p	  value,	  due	  to	  the	  number	  of	  variables	  that	  could	  be	  considered	  in	  this	  
adjustment,	  the	  adjusted	  p	  value	  was	  not	  considered.	  Significance	  was	  determined	  if	  the	  
unadjusted	  p	  <	  0.01.	  	  
	  
4.2.5 DAVID	  Analysis	  
Database	   for	  Annotation,	  Visualization	  and	  Integrated	  Discovery	  (DAVID)	  v6.7	   is	  
a	   tool	   that	   finds	   common	   annotations	   among	   a	   group	   of	   genes	   and	   clusters	   these	  
annotations	  together	  (Huang	  da	  et	  al.,	  2009a,	  2009b).	  Lists	  of	  genes	  were	  inputted	  into	  
the	   web	   interface	   as	   official	   gene	   symbols	   for	   human	   genes	   and	   with	   a	   human	   gene	  
background.	  The	   functional	   annotation	   clustering	   tools	  were	  used	   to	   identify	   common	  
functions	  among	  the	  genes	  present.	  Enrichment	  scores	  calculated	  as	  a	  negative	  log	  of	  p	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4.3 Evaluation	  of	  Current	  microRNA	  Target	  Prediction	  Algorithms	  
While	   algorithms	   have	   been	   developed	   to	   computationally	   predict	   targets	   of	  
miRNA,	   it	   is	   challenging	   to	  use	   these	  algorithms	   to	  generate	  meaningful	  and	  confident	  
predictions.	  Key	  questions	  into	  which	  and/or	  how	  many	  algorithms	  should	  be	  used	  and	  
how	  this	  data	  should	  be	  integrated	  need	  to	  be	  considered.	  
	  
4.3.1 Target	  Prediction	  Algorithms	  Have	  Minimal	  Intersection	  
To	  compare	  and	  contrast	  the	  nine	  miRNA	  targeting	  algorithms,	  targets	  predicted	  
for	   17	   miRNA	   were	   evaluated.	   These	   miRNA	   selected	   included	   12	   differentially	  
expressed	  miRNA	  20	  min	  or	  5	  h	  post-­‐LTP,	  and	  five	  miRNA	  that	  were	  lowly	  expressed	  in	  
the	  brain	  or	  randomly	  chosen	  to	  act	  as	  a	  form	  of	  controls.	  Despite	  our	  biological	  study	  
being	  conducted	  in	  rat,	  human	  miRNA	  and	  mRNA	  transcripts	  were	  used	  for	  this	  analysis.	  
This	  was	  because	  all	  the	  algorithms	  consider	  miRNA-­‐target	  interactions	  for	  human,	  but	  
not	  necessarily	  rodent.	  Further,	  there	  are	  a	  greater	  number	  of	  interactions	  validated	  in	  
human	  than	  compared	  to	  rodents.	  Combined,	  this	  allows	  a	  more	  complete	  evaluation	  of	  
the	  algorithms	  to	  be	  undertaken.	  	  
On	   average,	   7,195	   targets	  were	   predicted	   per	  miRNA	   (Figure	   4.4A),	   with	  miR-­‐
151-­‐3p	   predicted	   to	   target	   the	   fewest	   targets	   (3,604)	   and	   miR-­‐214-­‐3p	   the	   most	  
(11,009).	   Both	   of	   these	   miRNA	   were	   detected	   to	   be	   regulated	   in	   screens	   of	   miRNA	  
expression	  at	  20	  min	  and	  5	  h	  (Joilin	  et	  al.,	  2014)(Ryan,	  unpublished).	   Indeed,	   the	  total	  
number	  of	   targets	  predicted	   to	  be	   regulated	  by	   a	  miRNA	  did	  not	   segregate	   those	   that	  
were	  regulated	  post-­‐LTP	  and	  those	  that	  were	  not,	  suggesting	  that	  the	  potential	  influence	  
Figure	   4.4:	  Targets	   predicted	   per	  miRNA	   and	  algorithm.	   (A)	   The	   total	  number	   of	   targets	  predicted	   for	  
each	  miRNA	   by	   all	   nine	   algorithms.	   (B)	   The	   average	   number	   of	   targets	   predicted	   per	  miRNA	   by	   each	  
algorithm.	  All	  data	  is	  for	  human	  miRNA	  and	  mRNA	  transcripts.	  Expression	  values:	  average	  ±	  SEM.	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on	  gene	  regulation	  by	  a	  miRNA	  in	  a	  process	  is	  not	  necessarily	  related	  to	  its	  regulation.	  	  
When	  looking	  at	  the	  average	  number	  of	  targets	  predicted	  per	  miRNA	  by	  each	  of	  
the	   algorithms,	   there	   appears	   to	   be	   two	   distinct	   groups	   (Figure	   4.4B).	   Five	   of	   the	  
algorithms	  predict	   under	  1,000	   targets	  per	  miRNA	   (DIANA-­‐microT,	  miRanda,	   PicTar2,	  
RNA22,	  RNAhybrid),	  while	  the	  other	  four	  predict	  over	  2,000	  (miRwalk,	  MiTarget2,	  PITA,	  
TargetScanS).	  It	  should	  be	  noted	  predicted	  targets	  for	  five	  miRNA	  (miR-­‐38-­‐5p,	  miR-­‐129-­‐
3p,	  miR-­‐129-­‐5p,	  miR-­‐151-­‐3p,	  miR-­‐708-­‐5p)	  were	  not	  present	  for	  RNA22	  and	  RNAhybrid	  
in	  the	  miRWalk	  database.	  Further,	  these	  algorithms	  and	  their	  web	  service	  were	  unable	  
to	  be	  run	  to	  obtain	  these	  targets.	  	  
Next,	  a	  consensus	  approach	  was	  investigated	  to	  determine	  if	  the	  total	  number	  of	  
targets	   predicted	   across	   these	   nine	   algorithms	   could	   be	   reduced	   for	   each	   of	   the	   17	  
miRNA.	   While	   the	   total	   number	   of	   predictions	   were	   different	   per	   miRNA,	   the	  
proportions	  predicted	  by	  one	  or	  more	  algorithms	  were	   relatively	   consistent	  across	  all	  
17	  miRNA	  (Figure	  4.5).	  On	  average,	  just	  under	  half	  (48%)	  of	  all	  targets	  were	  predicted	  
by	   just	  one	  of	  nine	  algorithms.	   In	  contrast,	   less	  than	  10%	  of	  all	   targets	  predicted	  were	  
made	  by	   five	   or	  more	   algorithms.	   Furthermore,	   on	   average,	   0.05%	  of	   all	   targets	  were	  
predicted	  by	  all	  nine	  algorithms,	  though	  seven	  of	  the	  17	  miRNA	  had	  no	  targets	  predicted	  
by	  all	  nine.	  This	  quite	  clearly	  demonstrates	  that	  although	  these	  nine	  algorithms	  all	  have	  
Figure	  4.5:	  Proportion	  of	  targets	  predicted	  by	  one	  or	  more	  algorithms	  across	  the	  17	  miRNA	  investigated.	  
On	  average,	  just	  under	  half	  of	  targets	  predicted	  for	  these	  miRNA	  were	  only	  predicted	  by	  one	  of	  the	  nine	  
algorithms	  used	  (red)	  with	  only	  0.05%	  predicted	  by	  all	  nine	  (light	  blue).	  All	  data	  is	  for	  human	  miRNA	  and	  
mRNA	  transcripts.	  
Identification	  of	  miRNA	  Targets	   	   100	  
the	   same	   purpose,	   they	   appear	   to	   be	   looking	   at	   different	   subsets	   of	   the	   total	   pool	   of	  
targets	  of	  these	  miRNA.	  	  
	  	  To	   clearly	   demonstrate	   this,	   the	   intersection	   between	   each	   algorithm	   was	  
compared.	  On	  average	  across	  the	  17	  miRNA,	  for	  the	  majority	  of	  intersections,	  there	  were	  
very	  few	  targets	  that	  overlapped	  between	  two	  different	  algorithms,	  with	  an	  average	  of	  
12%	  (Figure	  4.6).	  While	   the	   smallest	  overlap	  was	  between	  DIANA-­‐microT	  and	  RNA22	  
(4.03%),	  any	   intersection	  with	  RNA22	  consistently	  had	  the	   lowest	  number	  of	  common	  
targets.	  On	  the	  other	  hand,	  TargetScanS	  showed	  the	  greatest	  similarity	  with	  most	  other	  
Figure	  4.6:	  Heatmap	  of	  the	  intersection	  between	  targets	  predicted	  by	  each	  algorithm.	  Targets	  predicted	  
by	  each	  algorithm	  were	  compared	  for	  each	  of	  the	  17	  miRNA	  between	  two	  different	  algorithms	  and	  were	  
averaged	   to	   give	   an	   overall	   percentage	   of	   targets	   predicted	   by	   each	   combination	   of	   two	   targeting	  
algorithms.	  All	  data	  is	  for	  human	  miRNA	  and	  mRNA	  transcripts.	  Expression	  values:	  average	  percentages	  
of	  overlap	  across	  the	  17	  miRNA.	  
Figure	   4.7:	   Heatmap	   of	   the	   intersection	   between	   targets	   predicted	   by	   each	   algorithm	   when	  
TargetScanS	  only	  included	  targets	  with	  conserved	  sites,	  dramatically	  altering	  the	  overlap	  between	  the	  
two	  datasets.	  Targets	  predicted	  by	  each	  algorithm	  were	  compared	  for	  each	  of	  the	  17	  miRNA	  between	  
the	  two	  different	  algorithms	  and	  were	  averaged	  to	  give	  an	  overall	  percentage	  of	   targets	  predicted	  by	  
each	   combination	   of	   two	   targeting	   algorithms.	   All	   data	   is	   for	   human	  miRNA	   and	  mRNA	   transcripts.	  
Expression	  values:	  average	  percentages	  of	  overlap	  across	  the	  17	  miRNA.	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algorithms,	  including	  miRanda	  (37.99%)	  and	  PITA	  (44.10%),	  that	  could	  be	  attributed	  to	  
similar	  minimal	  seed	  requirements	  of	  a	  6mer	  interaction.	  DIANA-­‐microT	  also	  shares	  this	  
with	   these	   algorithms,	   but	   its	   strict	   conservation	   requirement	  may	   limit	   its	   potential	  
targets.	  	  
Interestingly,	  changing	  whether	  an	  MRE	  site	  is	  conserved	  across	  species	  or	  not	  in	  
TargetScanS	  dramatically	  changes	  how	  it	  intersects	  with	  the	  targets	  predicted	  by	  other	  
algorithms	  (Figure	  4.7).	  When	  only	  conserved	  sites	  are	  considered,	  TargetScanS	  aligns	  
more	  with	  PicTar2,	  most	  likely	  as	  a	  result	  of	  strong	  conservation	  considerations.	  It	  also	  
highlights	  the	  number	  of	  unconserved	  sites	  that	  are	  common	  with	  other	  algorithms	  with	  
their	   removal	   reducing	   the	   overlap,	   despite	   a	   concurrent	   decrease	   in	   the	   number	   of	  
targets	  predicted	  by	  TargetScanS	  (average	  number	  of	   targets:	  630).	  Whether	  a	  MRE	   is	  
conserved	   or	   not	   is	   important	   is	   debatable,	   but	   changing	   the	   parameters	   underlying	  
miRNA-­‐target	   interactions	  considered	  by	  the	  algorithms	  clearly	  affects	   the	  targets	  that	  
are	  predicted	  by	  them.	  Therefore,	  this	  analysis	  begins	  to	  explain	  the	  lack	  of	  intersection	  
between	   the	   algorithms,	   suggesting	   that	   due	   to	   the	   variation	   in	   consideration	   of	   the	  
properties	  of	  miRNA-­‐target	  interactions,	  these	  algorithms	  interrogate	  different	  parts	  of	  
the	  miRNA-­‐target	  interactome.	  
	  
4.3.2 Consensus	  Does	  Not	  Predict	  Validated	  Target	  Interactions	  
A	   number	   of	   targets	   of	   miRNA	   have	   been	   validated	   and	   are	   compiled	   into	  
databases	  such	  as	  TarBase,	  of	  which	  the	  latest	  version	  available	  at	  the	  time	  of	  analysis	  
contained	   65,000	   interactions	   (Vergoulis	   et	   al.,	   2012).	   Some	  miRNA	   are	  more	   studied	  
than	  others,	  with	   several	  hundred	   interactions	  validated	   for	   some	  miRNA,	  while	   some	  
have	  few,	  with	  miR-­‐129-­‐3p	  and	  miR-­‐708-­‐5p	  having	  zero	  validated	  interactions	  (Figure	  
4.8).	  Furthermore,	  the	  majority	  of	  these	  interactions	  have	  been	  shown	  in	  human	  tissue	  
and	  cell	   cultures	  with	  very	   few	   in	  rodent.	  For	  example,	  while	  only	  11	   targets	   for	  miR-­‐
34a-­‐5p	   have	   been	   validated	   in	   rat,	   over	   900	   targets	   have	   been	   validated	   in	   human.	  
However,	  some	  of	  these	  validated	  human	  interactions	  may	  be	  valid	  targets	  in	  rat,	  though	  
this	  depends	  on	  whether	  the	  MRE	  is	  conserved	  between	  the	  species.	  Nevertheless,	   just	  
as	   above,	   all	  miRNA	   and	   their	   validated	   targets	   used	   in	   this	   analysis	  were	   for	   human	  
transcripts.	  
To	  determine	  whether	  a	  consensus	  approach	  is	  a	  valid	  approach,	  a	  key	  question	  
was	   whether	   multiple	   algorithms	   were	   more	   likely	   to	   predict	   validated	   targets.	  
Comparing	  across	  the	  nine	  algorithms	  and	  for	  each	  of	  the	  17	  miRNA,	  it	  was	  found	  that	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there	   were	   half	   of	   all	   validated	   targets	   identified	   that	   were	   not	   predicted	   by	   any	  
algorithm	   (Figure	   4.9).	   There	   could	   be	   a	   number	   of	   reasons	   for	   this.	   Firstly,	   the	  
algorithms	   may	   not	   predict	   these	   interactions	   as	   they	   have	   low	   binding	   in	   the	   seed	  
region	  and	   compensatory	  binding	  elsewhere,	  which	  many	  algorithms	  do	  not	   consider.	  
Furthermore,	   these	  sites	  may	  not	  be	  conserved	  or	  not	  present	   in	   the	  3’UTR	  where	  the	  
majority	   of	   algorithms	   predict	   targets.	   Additionally,	   a	   majority	   of	   these	   listed	  
unpredicted	   interactions	   come	   from	   microarray	   or	   sequencing	   studies	   conducted	  
following	  a	  miRNA	  knockdown	  or	  overexpression	  study	  (Grimson	  et	  al.,	  2007;	  Hafner	  et	  
al.,	  2010).	  While	  these	  targets	  have	  been	  identified	  as	  being	  regulated	  and	  there	  may	  be	  
Figure	   4.8:	  Total	  number	  of	   interactions	   that	  have	   been	   validated	   for	   the	   17	  miRNA	   investigated,	  
according	  to	  TarBase	  6.0	  in	  human	  data	  sets.	  All	  data	  is	  for	  human	  miRNA	  and	  mRNA	  transcripts.	  
Figure	   4.9:	   Comparison	   of	   validated	   targets	   for	   the	   17	   miRNA	   and	   whether	   they	   were	   predicted	  
computationally.	  This	  is	  presented	  as	  both	  total	  (A)	  and	  proportionally	  (B).	  Note	  that	  some	  targets	  are	  not	  
predicted	  by	  any	  of	  the	  nine	  algorithms.	  All	  data	  is	  for	  human	  miRNA	  and	  mRNA	  transcripts.	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indications	   from	  bioinformatic	   analysis	   that	   an	   interaction	  may	  exist,	   there	   is	   also	   the	  
chance	   these	   targets	  could	  be	   indirectly	  regulated.	  As	  such,	   for	   these	  possible	  reasons,	  
the	   target	  genes	  predicted	  by	  none	  of	   the	  nine	  algorithms	  were	  excluded	   from	  further	  
analysis.	  This	  exclusion	  most	  affected	  the	  number	  of	  targets	  predicted	  for	  miR-­‐34a-­‐5p,	  
losing	  approximately	  700	  targets,	  with	  a	  large	  number	  of	  these	  targets	  validated	  through	  
screening	  techniques	  following	  miRNA	  expression	  alteration.	  Nevertheless,	  miR-­‐34a-­‐5p	  
continued	  to	  have	  the	  highest	  number	  of	  validated	  targets	  of	  the	  17	  miRNA	  investigated.	  	  
Analysing	  the	  remaining	  data	  showed	  that	  using	  a	  consensus	  approach	  does	  not	  
predict	   validated	   target	   interactions.	   On	   average,	   only	   1.4%	   of	   validated	   targets	  
predicted	  by	  at	  least	  one	  algorithm	  were	  predicted	  by	  all	  nine	  algorithms	  (Figure	  4.10).	  
In	  fact,	  26.7%	  of	  all	  these	  targets	  could	  be	  predicted	  by	  five	  or	  more	  of	  the	  algorithms.	  In	  
contrast,	  27%	  of	  validated	  targets	  were	  predicted	  by	  only	  one	  algorithm,	  a	  pattern	  that	  
Figure	   4.10:	   Comparison	   of	  
validated	  targets	   for	  the	  17	  miRNA	  
predicted	  by	  at	  least	  one	  algorithm.	  
This	   is	   presented	   as	   both	   total	   (A)	  
and	   proportionally	   (B).	   All	   data	   is	  
for	   human	   miRNA	   and	   mRNA	  
transcripts.	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was	   consistently	   seen	   across	   all	   miRNA	   that	   had	   more	   than	   50	   targets	   validated.	  
Therefore,	   while	   looking	   only	   at	   the	   intersection	   between	   algorithms	   can	   reduce	   the	  
number	  of	  potential	   targets	   to	   investigate,	   it	  may	  also	  preclude	  a	   large	  number	  of	  real	  
targets.	  
	  
4.3.3 No	   Algorithm	   Individually	   Predicts	   the	   Majority	   of	   Validated	   Target	  
Interactions	  	  
One	   possibility	   of	   the	   above	   analysis	   may	   be	   that	   one	   of	   the	   algorithms	   may	  
predict	   the	   majority	   of	   validated	   targets.	   To	   determine	   whether	   one	   algorithm	  
outperforms	  the	  others	  in	  predicting	  validated	  targets,	  comparisons	  between	  all	  targets	  
predicted	  by	  the	  algorithm	  across	  the	  17	  miRNA	  and	  those	  validated	  were	  carried	  out.	  
Naturally,	   this	   analysis	   excluded	   those	   targets	   not	   predicted	   by	   any	   algorithm.	   This	  
showed	  that	  miRanda,	  PITA	  and	  TargetScanS	  predicted	  over	  50%	  of	  all	  validated	  targets,	  
with	  miRWalk	  on	  40%	  (Figure	  4.11A).	  From	  these	   results,	   it	  would	  suggest	   that	   these	  
Figure	   4.11:	   Validated	   targets	   predicted	   by	   miRNA	   targeting	   algorithms.	   (A)	   The	   percentage	   of	   all	  
validated	  targets	  that	  are	  predicted	  by	  the	  nine	  algorithms.	  MiRanda,	  PITA	  and	  TargetScan	  predict	  more	  
than	  50%	  of	  all	  the	  targets	  individually.	  (B)	  The	  total	  number	  of	  targets	  predicted	  across	  all	  17	  miRNA	  per	  
algorithm.	   MiRanda,	   miRWalk,	   PITA	   and	   TargetScan	   each	   predict	   over	   40,000	   targets	   across	   the	   17	  
miRNA.	   (C)	   Percentage	   of	   validated	   targets	   of	   the	   total	   number	   of	   targets	   predicted	   by	   that	   algorithm.	  
DIANA-­‐microT	  predicts	   the	  most	  validated	  targets	   among	  its	   total	  number	  of	  predictions.	  All	  data	   is	   for	  
human	  miRNA	  and	  mRNA	  transcripts.	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three	  algorithms	  performed	  the	  best	  in	  predicting	  validated	  targets.	  	  
However,	  when	  the	  total	  number	  of	  targets	  that	  these	  algorithms	  predict	  is	  taken	  
into	   consideration,	   a	   different	   story	   is	   told.	   With	   these	   four	   algorithms,	   miRanda,	  
miRwalk,	   PITA,	   and	   TargetScanS	   all	   predicting	   the	   largest	   number	   of	   targets,	   the	  
percentage	  of	  their	  predictions	  actually	  validated	  is	  approximately	  1%	  (Figure	  4.11B-­‐C).	  
These	  results	  would	  suggest	  therefore	  that	  the	  high	  percentage	  of	  validated	  targets	  that	  
they	   predicted	   is	   a	   result	   of	   them	   simply	   predicting	   more	   targets.	   The	   other	   five	  
algorithms	  had	  percentages	  between	  2	  and	  4%,	  with	  DIANA-­‐microT	  predicting	  the	  most	  
validating	  targets	  from	  its	  total	  number,	  with	  PicTar2	  not	  far	  behind.	  	  
These	   results	   would	   suggest	   that	   DIANA-­‐microT	   and	   PicTar	   would	   have	   the	  
highest	  sensitivity	  among	  the	  nine	  algorithms.	  However,	  the	  true	  number	  of	  predictions	  
that	   are	   false	   positives	   is	   unknown,	   as	   reporting	   of	   interactions	   between	  miRNA	   and	  
their	  predicted	  targets	  is	  not	  common	  practice.	  Therefore,	  an	  accurate	  assessment	  of	  the	  
performance	  of	  these	  algorithms	  is	  unable	  to	  be	  carried	  out.	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4.4 Identification	  of	  LTP-­‐Related	  Genes	  Using	  Targeting	  Algorithms	  
As	  shown,	  large	  numbers	  of	  valid	  targets	  of	  miRNA	  predicted	  by	  these	  algorithms	  
are	   excluded	   by	   only	   considering	   those	   within	   their	   intersection.	   Further,	   no	   one	  
algorithm	  is	  able	  to	  predict	  all	  validated	  targets.	  Therefore,	  determining	  a	  method	  that	  
can	   use	   all	   the	   targets	   predicted	   by	   these	   algorithms	   to	   identify	   targets	   for	   further	  
investigation	  is	  needed.	  	  
	  
4.4.1 Target	  Prediction	  Algorithms	  are	  Not	  Enriched	  for	  LTP-­‐Related	  Genes	  
While	  no	  one	  algorithm	  predicts	  all	  validated	  targets,	  there	  is	  the	  possibility	  that	  
one	   of	   the	   algorithms	   may	   be	   enriched	   for	   LTP-­‐related	   targets.	   The	   algorithms	   have	  
been	  built	  using	  specific	  sets	  of	  parameters,	  which	  may	  be	  influenced	  by	  experimentally	  
validated	   targets,	   such	   is	   the	   case	   with	   RNA22	   and	   miRTarget2.	   If	   these	   validated	  
interactions	  used	  to	  create	  these	  algorithms	  were	  biased	  towards	  any	  particular	  biology,	  
such	  as	  cancer	   for	  example,	  and	  the	  characteristics	  underlying	  these	   interactions	  were	  
specific	   to	  cancer,	   then	   it	  may	  be	  possible	   this	  particular	  algorithm	  is	  better	  suited	   for	  
predicting	  other	  cancer-­‐related	  interactions.	  Indeed,	  it	  has	  been	  shown	  that	  interactions	  
between	  miRNA	   and	   their	   targets	   can	   be	   tissue	   or	   cell	   specific	   as	   a	   result	   of	   specific	  
miRNA	   biogenesis	   processes	   or	   functional	   properties	   (Akbari	   Moqadam	   et	   al.,	   2013;	  
Hsieh	  et	  al.,	  2014;	  Lerner	  et	  al.,	  2011).	  Furthermore,	   early	  algorithms	  were	  developed	  
searching	  for	  binding	  sites	  within	  the	  3	  ’UTR,	  but	  as	  described	  above,	  alternate	  locations	  
of	   the	  mRNA	  have	  been	   found	   for	  miRNA	  binding.	  Therefore,	   it	   could	  be	  hypothesised	  
that	  one	  particular	  algorithm	  may	  be	  enriched	   for	  a	  particular	  biology	  of	   interest,	   like	  
LTP.	  
To	   test	   this,	   targets	   predicted	   by	   each	   of	   the	   nine	   algorithms	   for	   all	   17	  miRNA	  
were	   compared	   to	   those	   genes	   annotated	   in	   the	  manually	   curated	   KEGG	   pathway	   for	  
LTP,	  which	  contains	  70	  genes	  (Kanehisa	  &	  Goto,	  2000).	  Results	  for	  miR-­‐34a-­‐5p	  and	  miR-­‐
132-­‐3p,	  shown	  to	  be	  regulated	  post-­‐LTP	  in	  Chapter	  2	  are	  shown	  in	  Table	  4.4	  and	  Table	  
4.5	   respectively,	   with	   the	   remaining	   15	   miRNA	   shown	   in	   Appendix	   C.	   In	   general,	   no	  
enrichment	  was	  found	  for	  targets	  predicted	  by	  any	  algorithm	  for	  any	  miRNA	  in	  the	  LTP	  
KEGG	  pathway.	  While	  individual	  miRNA	  showed	  enrichment	  for	  LTP-­‐related	  targets	  for	  
one	  or	  two	  algorithms	  (p	  <	  0.01),	  this	  was	  not	  consistent	  across	  any	  of	  the	  five	  groups	  of	  
miRNA	   or	   algorithms.	   Extending	   this	   analysis	   further	   to	   include	   eight	   other	   KEGG	  
pathways	  related	  to	  LTP,	  such	  as	  long-­‐term	  depression	  which	  contain	  896	  unique	  genes,	  
continued	   to	   show	   no	   miRNA	   nor	   algorithm	   showing	   enrichment.	   Another	   database	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containing	  annotations	  for	  genes	  is	  Gene	  Ontology	  (GO).	  While	  there	  is	  a	  small	  amount	  of	  
manual	  curation,	  most	  of	   these	  annotations	  are	  computationally	  assigned	   through	   text	  
mining	  of	  published	  studies	  (Ashburner	  et	  al.,	  2000;	  du	  Plessis	  et	  al.,	  2011).	  While	  there	  
is	  no	  direct	  LTP	  annotation,	  there	  are	  related	  annotations	  including	  long-­‐term	  synaptic	  
potentiation,	  and	  the	  four	  annotations	  used	  in	  the	  analysis	  totalled	  513	  unique	  genes	  but	  
this	  similarly	  showed	  no	  enrichment	  per	  miRNA	  or	  algorithm.	  	  
Table	  4.4:	  Enrichment	  analysis	  of	  LTP-­‐related	  targets	  predicted	  by	  targeting	  algorithms	  of	  miR-­‐34a-­‐5p.	  
Number	  of	  genes	  predicted	  by	  each	  algorithm	  present	   in	   the	   selected	  annotation	  set	  (n)	   and	  whether	  
this	  was	  determined	  to	  be	  enriched	  by	  a	  Fisher’s	  exact	  test	  (p).	  
miR-­‐34a-­‐5p	  
LTP	  KEGG	   KEGG	   GO	   Array	   Combined	  
n	   p	   n	   p	   n	   p	   n	   p	   n	   p	  
DIANA-­‐
microT	   1	   0.67	   14	   1.00	   5	   0.67	   21	   0.00	   36	   0.01	  
miRanda	   12	   0.40	   153	   1.00	   46	   1.00	   172	   0.00	   312	   0.12	  
miRWalk	   7	   0.91	   155	   1.00	   53	   0.98	   162	   0.00	   294	   0.67	  
MiTarget2	   3	   0.18	   22	   1.00	   10	   0.25	   27	   0.00	   53	   0.00	  
PicTar2	   4	   0.20	   39	   1.00	   15	   0.43	   61	   0.00	   99	   0.00	  
PITA	   20	   0.15	   222	   1.00	   77	   0.95	   265	   0.00	   468	   0.00	  
RNA22	   12	   0.06	   122	   1.00	   43	   0.25	   114	   0.00	   225	   0.00	  
RNAhybrid	   4	   0.09	   28	   1.00	   13	   0.13	   34	   0.00	   61	   0.00	  
TargetScanS	   19	   0.11	   206	   1.00	   74	   0.87	   225	   0.00	   419	   0.00	  
	  
Table	  4.5:	  Enrichment	  analysis	  of	  LTP-­‐related	  targets	  predicted	  by	  targeting	  algorithms	  of	  miR-­‐132-­‐3p.	  
Number	  of	  genes	  predicted	  by	  each	  algorithm	  present	   in	   the	   selected	  annotation	   set	   (n)	   and	  whether	  
this	  was	  determined	  to	  be	  enriched	  by	  a	  Fisher’s	  exact	  test	  (p).	  
miR-­‐132-­‐3p	  
LTP	  KEGG	   KEGG	   GO	   Array	   Combined	  
n	   p	   n	   p	   n	   p	   n	   p	   n	   p	  
DIANA-­‐
microT	   2	   0.16	   13	   1.00	   2	   0.88	   12	   0.00	   23	   0.04	  
miRanda	   13	   0.30	   158	   1.00	   42	   1.00	   184	   0.00	   322	   0.52	  
miRWalk	   6	   0.44	   80	   1.00	   17	   1.00	   72	   0.00	   129	   0.97	  
MiTarget2	   1	   0.75	   22	   1.00	   4	   0.99	   26	   0.00	   44	   0.36	  
PicTar2	   4	   0.06	   33	   1.00	   8	   0.70	   38	   0.00	   66	   0.00	  
PITA	   29	   0.01	   253	   1.00	   78	   1.00	   310	   0.00	   537	   0.40	  
RNA22	   3	   0.65	   57	   1.00	   17	   0.74	   54	   0.00	   112	   0.00	  
RNAhybrid	   3	   0.05	   19	   1.00	   4	   0.74	   20	   0.00	   35	   0.00	  
TargetScanS	   19	   0.02	   154	   1.00	   46	   1.00	   212	   0.00	   341	   0.11	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The	  next	  step	  was	  to	  use	  the	  LTP	  microarray	  data	  described	  earlier	  (Ryan	  et	  al.,	  
2011;	   Ryan	   et	   al.,	   2012)	   to	   determine	   if	   there	   was	   enrichment	   among	   the	  miRNA	   or	  
algorithms	   for	   LTP-­‐regulated	   genes.	   Using	   the	   1,026	   genes	   were	   shown	   to	   be	  
differentially	   expressed	   on	   the	   microarrays	   20	   min,	   5	   h	   and	   24	   h	   post-­‐LTP,	   broad	  
enrichment	   across	   miRNA	   and	   algorithms	   was	   observed.	   This	   included	   for	   the	   three	  
miRNA	  shown	  to	  have	  low	  or	  no	  expression	  in	  the	  brain,	  thus	  suggesting	  these	  miRNA	  
are	  involved	  in	  LTP-­‐related	  processes,	  which	  is	  unlikely	  considering	  their	  absence	  from	  
brain	   tissue.	   It	   is	   possible	   that	   these	  miRNA	   are	   targeting	   genes	   that	   are	   involved	   in	  
common	  cellular	  processes	  like	  transcription	  or	  translation	  that	  are	  regulated	  post-­‐LTP.	  
Therefore,	   enrichment	   determined	   by	   this	   set	   of	   genes	   may	   not	   be	   functionally	  
significant.	  
Lastly,	   a	   combination	  of	   the	  KEGG	  pathways,	  GO	  processes,	   and	   the	  microarray	  
data	  were	  combined	  together	  to	  determine	  whether	  there	  was	  any	  enrichment	  of	  LTP-­‐
related	   targets	  among	   the	  predictions	  made	  by	   the	  nine	  algorithms	   for	   the	  17	  miRNA.	  
The	   combination	   of	   the	   2,220	   unique	   genes	   showed	   enrichment	   again	   across	   the	   five	  
groups	  of	  miRNA	  and	  algorithms,	  but	  not	  to	  as	  great	  an	  extent	  as	  the	  array	  data	  alone.	  
These	   data	   combined	   suggest	   that	   there	   is	   no	   common	   or	   useful	   enrichment	   of	   LTP-­‐
related	  targets	  across	  the	  algorithms.	  	  
	  
4.4.2 Co-­‐Regulated	  Clusters	  are	  not	  Regulated	  by	  miR-­‐34a-­‐5p	  or	  miR-­‐132-­‐3p	  
No	  algorithm	  was	  enriched	  for	  predicting	  LTP-­‐related	  target,	  nor	  able	  to	  predict	  
the	  majority	  of	  validated	  miRNA-­‐target	  interactions	  by	  themselves.	  As	  suggested	  in	  the	  
above	   analyses,	   each	   of	   the	   algorithms	   appears	   to	   be	   interrogating	   slightly	   different	  
parts	   of	   the	   whole	   miRNA-­‐target	   interactome.	   While	   taking	   the	   intersection	   of	   these	  
algorithms	   results	   in	   a	   concise	   list,	   only	   an	   extremely	   small	   portion	   of	   the	   total	  
interactome	  is	  being	  identified.	  Therefore,	  the	  only	  method	  to	  ensure	  maximal	  coverage	  
of	  the	  miRNA-­‐target	  interactome	  is	  to	  use	  the	  union	  of	  the	  targets	  predicted	  by	  the	  nine	  
algorithms.	  	  
Using	  this	  union	  of	  targets	  predicted	  by	  the	  nine	  algorithms	  for	  the	  two	  miRNA	  of	  
interest	   in	   this	   study,	   miR-­‐34a-­‐5p	   and	   miR-­‐132-­‐3p,	   determining	   whether	   they	   could	  
centrally	  regulate	  the	  majority	  of	  the	  genes	  in	  the	  co-­‐expression	  gene	  clusters	  previously	  
presented	  in	  Chapter	  3	  was	  carried	  out.	  Comparing	  each	  cluster	  of	  genes	  to	  the	  targets	  
predicted	   by	   all	   nine	   algorithms,	   the	   majority	   of	   genes	   in	   four	   and	   six	   clusters	   were	  
predicted	  to	  be	  regulated	  by	  miR-­‐34a-­‐	  5p	  and	  miR-­‐132-­‐3p	  respectively,	  with	  ‘Lime	  (6)’	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and	  ‘Purple	  (16)’	  predicted	  to	  be	  regulated	  by	  both	  miRNA	  (Table	  4.6).	  However,	  four	  of	  
the	   clusters	   contained	   fewer	   genes	   than	   the	   geometric	   average	   of	   34	   genes,	  which	   as	  
previously	   described	   increases	   their	   likelihood	   of	   meeting	   the	   50%	   threshold.	   These	  
four	   clusters	   were	   those	   predicted	   to	   be	   targeted	   by	   miR-­‐34a-­‐5p,	   two	   of	   which	   also	  
predicted	  to	  be	  targeted	  by	  miR-­‐132-­‐3p.	  	  
A	   DAVID	   analysis	   was	   carried	   out	   for	   functional	   enrichment	   on	   the	   four	  
remaining	   clusters	   that	   contained	   a	   sufficient	   number	   of	   genes.	   However,	   only	   one	  
cluster,	   ‘Turquoise	   (249)’,	   showed	   functional	  enrichment:	   for	   lung	   (2.71;	  6	  genes)	  and	  
limb	  (2.15;	  5	  genes)	  development,	  but	   these	  processes	  are	  not	  directly	   related	   to	  LTP.	  
The	   other	   three	   clusters	   showed	   no	   functional	   enrichment.	   Therefore,	   these	   co-­‐
regulated	  clusters	  that	  have	  the	  majority	  of	  their	  genes	  predicted	  to	  be	  targeted	  by	  miR-­‐
34a-­‐5-­‐	  and	  miR-­‐132-­‐3p	  are	  not	  enriched	  for	  LTP-­‐related	  targets.	  
	  
4.4.3 Filtering	  the	  Union	  of	  the	  Algorithms	  Identifies	  Biologically	  Relevant	  Targets	  
Using	  the	  union	  of	  the	  algorithms	  is	  likely	  to	  encompass	  all	  the	  targets	  within	  the	  
interactome,	   but	   this	   results	   in	   a	   large	   number	   of	   targets	   that	   is	   difficult	   to	   process.	  
Therefore,	   determining	   a	   method	   to	   identify	   targets	   for	   further	   study	   within	   the	  
combined	   list	  of	  all	   targets	  predicted	  by	   the	  nine	  algorithms	   is	  required.	  One	  potential	  
method	   to	   make	   it	   manageable	   is	   to	   use	   the	   annotations	   and	   previous	   literature	   to	  
identify	  LTP-­‐related	  genes	  in	  a	  non-­‐biased	  manner.	  	  
Using	   the	   KEGG	   pathways,	   GO	   processes,	   and	   array	   data	   collected	   for	   the	  
enrichment	  analysis	  above,	  genes	  related	  to	  LTP	  will	  be	  identified	  to	  different	  levels	  of	  
Table	  4.6:	  Clusters	  of	   co-­‐regulated	  genes	  post-­‐LTP	   that	   are	   common	   targets	  of	  miR-­‐34a-­‐5p	  and	  miR-­‐
132-­‐3p	   according	   to	   the	   union	   of	   targets	   predicted	   by	   the	   nine	   algorithms.	   n:	   number	   of	   genes;	   %	  
percentage	  of	  genes	  in	  the	  cluster	  targeted	  by	  that	  miRNA.	  
Cluster	  
miR-­‐34a	   miR-­‐132	  
n	   %	   n	   %	  
Brown	  (99)	   	   	   51	   51.52	  
Lime	  (24)	   13	   54.17	   	   	  
Lime	  (6)	   4	   66.67	   5	   83.33	  
Magenta	  (8)	   5	   62.50	   	   	  
Pink	  (45)	   	   	   25	   55.56	  
Purple	  (16)	   8	   50.00	   9	   56.25	  
Red	  (47)	   	   	   24	   51.06	  
Turquoise	  (249)	   	   	   144	   57.83	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confidence.	   Of	   lowest	   confidence	   will	   be	   those	   genes	   identified	   by	   the	   array	   data,	   as	  
although	   they	   are	   known	   to	   be	   regulated	   post-­‐LTP,	  whether	   they	   are	   involved	   in	   the	  
genetic	   response	   that	   contributes	   to	   the	   persistence	   of	   LTP	   is	   unknown.	   Increased	  
confidence	  can	  be	  assigned	  to	  those	  identified	  by	  KEGG	  pathways	  and	  GO	  processes,	  the	  
former	   more	   so	   due	   to	   the	   manual	   curation	   of	   terms	   and	   genes,	   providing	   robust	  
annotations,	   compared	   to	   the	   autonomic	   computationally-­‐assigned	   annotations	   of	   the	  
latter.	  	  
The	   unions	   of	   the	   nine	   algorithms	   for	   the	   17	   miRNA	   were	   compared	   to	   the	  
annotation	  and	  array	  lists.	  As	  above,	  results	  for	  miR-­‐34a-­‐5p	  and	  miR-­‐132-­‐3p,	  which	  are	  
known	  to	  be	  regulated	  post-­‐LTP	  are	  shown	  in	  Table	  4.7,	  with	  the	  remaining	  15	  miRNA	  
shown	   in	  Appendix	  C.	  7,273	  and	  6,903	  genes	  were	  predicted	   in	   total	   to	  be	   targets	   for	  
miR-­‐34a-­‐5p	   and	  miR-­‐132-­‐3p	   respectively	   by	   the	  nine	   algorithms.	   Filtering	   this	   by	   the	  
combination	   of	   the	   KEGG	   pathways,	   GO	   processes,	   and	   LTP	   array	   data,	   this	   list	   was	  
reduced	  by	  90%.	  Filtering	  the	  union	   individually	  with	  each	  set	  of	  annotations	  reduced	  
this	   further,	  with	   the	  LTP	  KEGG	  pathway	   reducing	   the	  number	  of	  predicted	   targets	  of	  
miR-­‐34a-­‐5p	   and	   miR-­‐132-­‐3p	   to	   35	   and	   34	   targets	   respectively.	   Interestingly,	   the	  
annotation	  and	  array	  data	  have	  very	  little	  overlap.	  Only	  94	  targets	  for	  miR-­‐34a-­‐5p	  and	  
81	  targets	  for	  miR-­‐132-­‐3p	  were	  co-­‐annotated	  by	  either	  the	  KEGG	  or	  GO	  annotations	  and	  
present	  within	  the	  array	  data.	  This	  suggests	  that	  the	  array	  data	  may	  contain	  a	  number	  of	  
LTP-­‐regulated	  genes	  not	  yet	  annotated	  to	  being	  involved	  in	  synaptic	  plasticity.	  	  
	  
4.4.4 LTP-­‐Related	  Genes	  are	  Targets	  for	  miR-­‐34a-­‐5p	  and	  miR-­‐132-­‐3p	  	  
Using	  these	  combined	  lists	  of	  annotations	  and	  array	  data,	  potential	  roles	  for	  miR-­‐
34-­‐5p	   were	   identified	   using	   DAVID	   analysis.	   With	   the	   data	   entered	   as	   human	   genes,	  
analysis	  set	  to	  the	  highest	  classification	  strategy,	  and	  only	  enrichment	  considered	  with	  
scores	  above	  2.0,	  equivalent	  to	  p<0.01,	  50	  clusters	  were	  identified	  as	  being	  significantly	  
enriched.	   As	   the	   KEGG	   pathway	   and	   GO	   process	   annotations	   were	   used,	   these	   were	  
found	   throughout	   these	   clusters,	   but	   they	   were	   not	   present	   in	   the	   top	   five	   clusters,	  
Table	   4.7:	  Number	   of	   LTP-­‐related	   targets	   predicted	   by	   the	   nine	   algorithms	   following	   filtering	   with	  
annotations	  and/or	  array	  data.	  
	   Total	  
Predicted	   LTP	  KEGG	   KEGG	   GO	   Array	   Combined	  
miR-­‐34a-­‐5p	   7,273	   35	   431	   140	   464	   844	  
miR-­‐132-­‐3p	   6,903	   34	   372	   105	   451	   769	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which	  included	  proteins	  binding	  to	  nucleotides	  or	  regulating	  their	  synthesis,	  regulation	  
of	   cyclic	   adenosine	   monophosphate,	   secretion	   of	   semaphorins,	   and	   integrin	   alpha	  
transmembrane	   proteins.	   MiR-­‐132-­‐3p	   had	   38	   clusters	   of	   target	   genes	   that	   were	  
significantly	  enriched.	  The	  top	  five	  clusters	  not	  only	  included	  axonogenesis	  and	  nucleic	  
acid	  transport,	  two	  of	  the	  terms	  included	  within	  the	  KEGG	  pathways,	  but	  also	  negative	  
regulation	   of	   cell	   death.	   Semaphorins	   and	   protein	   binding	   to	   nucleotides	   were	   also	  
present.	  While	  these	  data	  suggest	  the	  processes	  these	  miRNA	  may	  be	  regulators	  of,	  the	  
inherent	   bias	   introduced	   by	   functionally	   clustering	   genes	   based	   on	   their	   annotations	  
Figure	   4.12:	   Targets	   for	   miR-­‐34a-­‐5p	   and	  miR-­‐132-­‐3p	  within	   the	   LTP	   KEGG	   pathway.	   (A)	   A	   summary	  
diagram	  of	  the	  LTP	  KEGG	  pathway	  describing	  the	  groupings	  of	  genes	  within	  each	  box.	  (B)	  A	  detailed	  view	  
of	  the	  genes	  within	  the	  LTP	  KEGG	  pathway	  and	  which	  genes	  are	  targeted	  by	  miR-­‐34a-­‐5p	  (red),	  miR-­‐132-­‐
3p	   (blue),	   	   both	   (green),	   or	   none	   (black).	  All	  data	   is	   for	   human	  miRNA	  and	  mRNA	   transcripts.	  Adapted	  
from	  the	  KEGG	  database.	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from	   a	   list	   where	   some	   genes	   were	   selected	   based	   on	   their	   annotations	   makes	   the	  
conclusions	  based	  on	  such	  analysis	  minimal.	  	  
However,	   predicted	   target	   genes	   regulated	   post-­‐LTP	   on	   the	   arrays	   were	   not	  
biased	  in	  this	  way.	  Using	  DAVID	  to	  interrogate	  for	  common	  functions,	  the	  gene	  target	  list	  
for	   miR-­‐34a-­‐5p	   showed	   only	   one	   cluster	   with	   significant	   enrichment.	   This	   cluster	  
contained	  genes	  with	  ankyrin	  folds,	  important	  protein	  to	  protein	  interactions	  that	  have	  
been	  linked	  to	  transcription	  and	  the	  cytoskeleton.	  For	  miR-­‐132-­‐3p,	  seven	  clusters	  were	  
enriched,	   with	   clusters	   involved	   in	   glucose	   metabolism,	   zinc	   fingers,	   nuclear	   protein	  
import,	   and	   cell	   death	   regulation.	   Nevertheless,	   as	  mentioned	   before,	   these	   genes	   are	  
shown	  to	  be	  regulated	  post-­‐LTP	  but	  their	  involvement	  in	  LTP-­‐related	  processes	  are	  yet	  
to	  be	  determined.	  	  
Therefore,	   using	   the	   lists	   generated	   by	   the	   union	   of	   the	   nine	   algorithms	   and	  
filtered	   using	   the	   LTP	   KEGG	   pathway,	   potential	   directly	   related	   LTP	   targets	   were	  
identified.	   For	   both	  miR-­‐34a-­‐5p	   and	  miR-­‐132-­‐3p,	   multiple	   genes	   involved	   in	   the	   LTP	  
pathway	  are	  targeted	  by	  these	  two	  miRNA	  (Figure	  4.12).	  35	  and	  34	  genes	  within	  the	  70	  
gene	   pathway	   are	   predicted	   to	   be	   targeted	   by	   miR-­‐34a-­‐5p	   and	   miR-­‐132-­‐3p,	   with	   19	  
genes	   identified	   by	   the	   LTP	   KEGG	   pathway	   overlapping,	   implicating	   a	   potential	  
coordinated	  regulation	  of	   these	  genes	  by	   these	  miRNA	  and	  possibly	  other	  miRNA.	  The	  
functions	  of	  these	  genes	  are	  varied,	  from	  glutamate	  receptor	  subunits,	  calcium	  signalling	  
molecules,	   transcriptional	   regulators,	   to	   phosphotases.	   Seven	   for	   each	   miRNA	   were	  
predicted	   by	  more	   than	   four	   algorithms.	   As	   shown	   above	   in	   the	   enrichment	   analysis,	  
PITA	  and	  TargetScan	  were	  responsible	  for	  predicting	  the	  majority	  of	  these	  interactions,	  
and	   while	   significant	   enrichment	   was	   seen	   for	   miR-­‐132-­‐3p,	   miR-­‐34a-­‐5p	   showed	   no	  
enrichment	  across	  any	  algorithm.	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4.5 Discussion	  
This	   work	   has	   demonstrated	   that	   there	   is	   little	   overlap	   between	   the	   miRNA	  
targeting	   algorithms	   for	   the	   17	  miRNA	   investigated	   and	   that	   a	   consensus	   approach	   is	  
poor	  at	  predicting	  previously	  validated	   interactions.	  Therefore,	   taking	  the	  union	  of	   the	  
targets	  predicted	  by	  the	  various	  algorithms	  and	  filtering	  the	  list	  using	  annotations	  and	  
array	  data	  identified	  a	  list	  of	  LTP-­‐related	  targets	  that	  can	  be	  further	  investigated.	  
	  
4.5.1 Target	  Prediction	  Algorithms	  are	  Diverse	  
The	  current	  miRNA-­‐target	  prediction	  algorithms	  can	  predict	  real	  interactions,	  as	  
demonstrated	  with	  the	  comparison	  between	  validated	  and	  predicted	  targets.	  Further,	  it	  
is	  clear	   from	  comparing	  the	  nine	  algorithms	  with	  each	  other	  that	  the	  target	  prediction	  
algorithms	   are	   diverse,	   and	   that	   they	   are	   investigating	   different	   parts	   of	   the	   whole	  
miRNA-­‐target	   interactome,	   despite	   their	   common	   goal.	   As	   demonstrated	   through	   the	  
comparison	   of	   TargetScanS	   and	   the	   other	   algorithms	   with	   and	   without	   conservation	  
consideration,	  this	  variation	  is	  the	  result	  of	  their	  consideration	  of	  the	  characteristics	  of	  
miRNA-­‐target	  interactions	  and	  can	  be	  both	  a	  hindrance	  and	  constructive.	  
These	  differences	  lead	  to	  a	  lack	  of	  an	  intersection	  between	  algorithms,	  restricting	  
identification	  of	  potential	  targets	  using	  this	  method,	  and	  is	  clearly	  demonstrated	  by	  the	  
failure	   of	   a	   consensus	   approach	   in	   predicting	   validated	   targets.	   Furthermore,	   any	  
attempt	  to	  bring	  the	  algorithms	  closer	  together	  is	  hindered	  by	  a	  lack	  of	  standardisation.	  
While	   the	   algorithms	   all	   consider	   the	   seed	   site	   similarly,	   other	   features	   such	   as	   the	  
thermodynamics	  of	  the	  reaction,	  the	  conservation	  of	  the	  MRE	  site,	  and	  even	  the	  location	  
of	   the	  MRE	  on	   the	   target	   transcript	   can	  be	   considered	  differently	   between	   algorithms	  
and	   described	   with	   different	   scoring	   methods.	   Some	   algorithms	   make	   it	   difficult	   to	  
narrow	   their	   lists	   down	   in	   a	   biologically	   meaningful	   way,	   such	   as	   miTarget2	   which	  
underlies	  the	  miRDB	  website.	  As	  such,	  any	  attempt	  to	  align	  the	  algorithms	  requires	  an	  
in-­‐depth	  computational	  background	  to	  manipulate	  and	  run	  the	  underlying	  algorithms.	  
However,	  the	  diversity	  between	  the	  algorithms	  also	  allows	  for	  different	  types	  of	  
miRNA-­‐target	  interactions	  to	  be	  discovered.	  It	  is	  clear	  that	  the	  use	  of	  one	  algorithm	  will	  
not	  cover	  all	  potential	  targets	  because	  of	  the	  limitations	  in	  that	  algorithm.	  Using	  multiple	  
algorithms	   allows	   for	   the	   entire	   interactome	   to	   be	   interrogated.	   For	   instance,	  
TargetScanS	   and	   PicTar2	   both	   use	   the	   sequence	   database	  RefSeq,	  while	  miRanda	   and	  
DIANA-­‐microT	   use	   Ensembl.	   In	   2005,	   roughly	   10-­‐20%	   of	   each	   database	   was	   unique	  
(Larsson	   et	   al.,	   2005),	   meaning	   certain	   transcript	   sites	   may	   only	   be	   available	   in	   one	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database.	  The	  use	  of	  multiple	  algorithms	  may	  reduce	   the	   impact	   this	  may	  have	  on	   the	  
target	   identification.	   Furthermore,	   differences	   in	   the	   consideration	   of	   some	  
characteristics,	   such	   as	   conservation	   or	   thermodynamics,	   may	   negatively	   affect	   the	  
performance	  of	  the	  algorithm,	  which	  could	  also	  be	  compensated	  for	  through	  additional	  
use	  of	  other	  algorithms	  that	  do.	  However,	  as	  shown	  above,	  this	  present	  other	  problems.	  
As	   such,	   a	   balance	   needs	   to	   be	   reached	   between	   these	   benefits	   and	   costs	   in	   using	  
multiple	  algorithms.	  	  
Further,	   it	  may	  be	   that	   certain	   algorithms	   are	  better	   for	  predicting	   targets	   in	   a	  
particular	   biology.	  While	   in	   this	   study	   none	   of	   the	   nine	   algorithms	  were	   found	   to	   be	  
enriched	   for	   LTP-­‐related	   genes,	   if	   such	   a	   study	   was	   conducted	   for	   cancer	   or	   cardiac	  
function,	  a	  different	  answer	  may	  be	  found.	  Therefore,	  it	  is	  crucial	  that	  if	  these	  algorithms	  
are	  used,	  they	  are	  used	  in	  a	  manner	  that	  is	  suitable	  for	  the	  biology	  being	  undertaken	  and	  
are	  carefully	  considered,	  as	  one	  method	  would	  not	  necessary	  fit	  all.	  However,	  with	  the	  
increasing	   availability	   of	   screening	   data	   of	   interactions	   from	   experiments	   like	   HITS-­‐
CLIP,	  new	  target	  prediction	  algorithms	  based	  on	  this	  data	  are	  likely	  to	  be	  generated	  and	  
could	   allow	   for	  more	   dynamic	   prediction	  models	   that	   are	  more	   sensitive	   in	   detecting	  
novel	  interactions.	  	  
	  
4.5.2 Complexity	  in	  Identifying	  Biologically	  Relevant	  Targets	  
While	  using	  the	  union	  of	  the	  predictions	  made	  by	  the	  algorithms	  is	  less	  than	  ideal,	  
filtering	  it	  down	  using	  the	  literature	  to	  isolate	  biologically	  relevant	  targets	  is	  the	  optimal	  
solution	   beyond	   developing	   a	   new	   targeting	   algorithm.	   However,	   identifying	   targets	  
within	   the	  union	  of	   the	  nine	  algorithms	  requires	  multiple	  considerations.	  Determining	  
the	  lists	  to	  be	  used	  for	  comparison	  is	  crucial.	  For	  example,	  while	  the	  LTP	  KEGG	  pathways	  
are	  highly	  specific,	   they	  are	  not	  comprehensive.	   Indeed,	   in	   the	  above	   figure	  of	   the	  LTP	  
KEGG	  pathway,	  genes	  that	  are	  part	  of	  the	  transcriptional	  response	  and	  are	  important	  for	  
the	   consolidation	   and	   persistence	   of	   LTP	   are	   not	   included,	   such	   as	   Arc	   and	   Pkmζ.	   In	  
contrast,	  the	  GO	  processes	  are	  the	  opposite,	  containing	  thousands	  of	  genes	  that	  may	  or	  
may	   not	   be	   directly	   involved	   in	   LTP.	   Therefore,	   the	   reliance	   on	   the	   judgement	   of	   the	  
processes	   in	   annotating	   these	   genes	   being	   correct	   is	   significant,	   as	   is	   selecting	  which	  
terms	  should	  be	  used.	   In	  this	  study,	  a	  conservative	  approach	  in	  determining	  the	  terms	  
used	  was	  undertaken,	  which	  may	  have	  resulted	  in	  how	  these	  miRNA	  may	  be	  involved	  in	  
LTP	   not	   being	   fully	   understood.	   Conversely,	   the	   genes	   that	   are	   identified	   as	   potential	  
targets	  can	  be	  clearly	  established	  as	  being	  involved	  in	  LTP.	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The	  small	  overlap	  between	   the	   five	  sets	  of	  genes	  used	   to	   filter	   the	  union	  of	   the	  
targets	   of	   the	   nine	   algorithms	   reflects	   this	   varied	   nature	   of	   their	   sources.	   While	   the	  
KEGG	  pathways	  are	  manually	  curated	  annotations,	  the	  array	  data	  are	  a	  group	  of	  genes	  
that	  were	  regulated	  by	  but	  not	   functionally	   linked	   to	  LTP.	  The	  combined	   list	  gives	   the	  
widest	  possible	  list	  of	  genes	  that	  may	  be	  related	  to	  LTP	  as	  established	  through	  the	  array	  
or	  by	   annotation,	  which	  may	  make	   it	   suitable	   for	   giving	   a	  broad	  overview	  of	   how	   the	  
miRNA	  may	  be	  involved	  in	  LTP	  through	  its	  targets.	  On	  the	  other	  hand,	  the	  LTP	  KEGG	  list	  
has	   the	   highest	   specificity	   for	   genes	   involved	   in	   LTP	   and	  would	   be	  more	   suitable	   for	  
selecting	   targets	   to	   investigate	   further,	   such	   as	   with	   luciferase	   assays.	   Furthermore,	  
considering	  the	  small	  number	  of	  targets	  that	  have	  been	  validated	  for	  some	  miRNA,	  this	  
may	  provide	  a	  large	  number	  of	  novel	  targets	  to	  investigate.	  As	  such,	  the	  use	  of	  different	  
lists	   may	   suit	   different	   purposes.	   While	   the	   screen	   presents	   its	   own	   problems	   with	  
selective	   reinforcement,	   the	   use	   of	   the	   LTP	   KEGG	   pathway	   does	   limit	   the	   number	   of	  
targets,	  which	  may	  be	   further	   limited	  with	   a	   lack	   of	   homology	   in	   other	   species	   of	   the	  
MRE.	  
Lastly,	  the	  use	  of	  array	  or	  sequencing	  data	  comes	  with	  its	  own	  caveats.	  Array	  or	  
sequencing	   data	   can	   be	   useful	   for	   filtering	   the	   union	   down	   to	   genes	   that	   are	   only	  
expressed	  in	  the	  cell	  type	  or	  compartment	  of	  interest,	  as	  was	  used	  in	  recent	  work	  from	  
our	  lab	  (Joilin	  et	  al.,	  2014),	  or	  that	  are	  known	  to	  be	  regulated	  in	  the	  biology	  of	  interest,	  
such	   as	   those	   shown	   on	   the	   array	   post-­‐LTP	   (Ryan	   et	   al.,	   2011;	   Ryan	   et	   al.,	   2012).	  
However,	  as	  mentioned	  above,	  regulation	  does	  not	  infer	  causation	  between	  a	  gene	  and	  a	  
biology.	  While	  this	  may	  help	  to	  narrow	  down	  the	  list,	  whether	  these	  genes	  are	  involved	  
directly	   or	   indirectly	   cannot	   be	   known	   immediately	   and	   requires	  more	   consideration	  
about	   how	   they	   may	   be	   involved.	   Indeed,	   as	   shown	   with	   the	   cluster	   analysis,	   the	  
majority	  of	  the	  genes	  in	  the	   ‘Turquoise	  (249)’	  cluster	  was	  shown	  to	  be	  predicted	  to	  be	  
targeted	  by	  miR-­‐132-­‐3p,	  but	  the	  processes	  these	  genes	  are	  involved	  in	  are	  unrelated	  to	  
LTP.	   However,	   genes	   involved	   in	   LTP	   could	   still	   be	   elucidated	   from	   these	   clusters	  
through	   alternate	   methods,	   such	   as	   comparisons	   with	   the	   LTP	   KEGG	   pathway,	   for	  
example,	  though	  the	  advantage	  of	  doing	  this	  would	  be	  no	  greater	  than	  the	  comparison	  
with	  array	  data	  when	  the	  genes	  are	  not	  clustered	  together	  according	  to	  their	  expression	  
across	  time.	  
	  
Identification	  of	  miRNA	  Targets	   	   116	  
4.5.3 Conclusions	  
This	   work	   has	   shown	   that	   the	   algorithms	   predicting	   the	   targets	   of	   miRNA	   are	  
varied	  in	  their	  approach	  and	  their	  results.	  While	  there	  is	  a	  lack	  of	  overlap	  between	  the	  
algorithms	   or	   one	   algorithm	   outperforming	   the	   others,	   the	   algorithms	   are	   capable	   of	  
predicting	  validated	  interactions.	  Therefore,	  adapting	  new	  approaches	  to	  use	  the	  union	  
of	   targets	   predicted	   by	   pre-­‐existing	   algorithms	   and	   using	   the	   literature	   to	   isolate	  
biologically	   relevant	   targets	   for	   further	   investigation	   appears	   to	   be	   the	   appropriate	  
approach.	   Using	   this	   approach,	   a	   number	   of	   LTP-­‐related	   genes	   were	   identified	   as	  
potential	   targets	   of	   miR-­‐34a-­‐5p	   and	   miR-­‐132-­‐3p.	   	   However,	   further	   experimental	  
validation	  will	  be	  required	  to	  understand	  the	  biological	  relevance	  of	  the	  novel	  targets	  of	  
miR-­‐132-­‐3p	  in	  LTP.	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5.1 Introduction	  
In	  Chapter	  2,	  two	  miRNA,	  miR-­‐34a-­‐5p	  and	  miR-­‐132-­‐3p,	  were	  shown	  to	  be	  down-­‐
regulated	   following	  LTP	   induction.	  To	  understand	   the	   impact	  of	   this	   regulation	  on	   the	  
gene	  expression	  underlying	  LTP,	  target	  genes	  of	  these	  miRNA	  were	  predicted	  using	  the	  
methods	   developed	   in	   Chapter	   4.	   Using	   the	   union	   of	   nine	   algorithms,	   the	   predicted	  
targets	   of	   these	   miRNA	   were	   filtered	   using	   annotations	   and/or	   LTP	   array	   data	   to	  
identify	   LTP-­‐related	   genes.	   Using	   this	   approach,	   out	   of	   a	   total	   pool	   of	   6,903	   potential	  
targets	   predicted	   for	   miR-­‐132-­‐3p,	   34	   genes	   were	   identified	   to	   be	   present	   in	   the	   LTP	  
KEGG	  pathway.	  While	  an	  increase	  in	  the	  expression	  of	  the	  proteins	  of	  the	  target	  mRNA	  
post-­‐LTP	   might	   be	   observed	   concurrent	   with	   a	   decrease	   in	   miRNA	   expression,	   this	  
relationship	  would	  only	  be	  correlative.	  Therefore,	  luciferase	  assays	  were	  undertaken	  to	  
investigate	   if	  a	  causative	  relationship	  exists.	  The	  34	  predicated	  targets	   for	  miR-­‐132-­‐3p	  
were	   further	   filtered	   by	   those	   predicted	   by	   at	   least	   four	   algorithms	   to	   generate	   a	   list	  
suitable	  for	  testing	  by	  luciferase	  assays.	  
Using	   this	   approach,	   five	   targets	   were	   identified:	   E1A	   binding	   protein	   p300	  
(Ep300),	  glutamate	  receptor,	  ionotropic,	  AMPA	  2	  (Gria2),	  V-­‐Ki-­‐ras2	  Kirsten	  rat	  sarcoma	  
viral	  oncogene	  homolog	   (Kras),	   and	  mitogen-­‐activated	  protein	  kinase	  1	  and	  3	   (Mapk1,	  
Mapk3).	  As	  the	  predictions	  were	  made	  using	  human	  transcript	  sequences,	  determining	  
MRE	   homology	  within	   the	   sequences	   of	   rat	   transcripts	   was	   carried	   out.	   Of	   these	   five	  
targets,	  homologous	  sites	  in	  the	  rat	  sequences	  of	  Ep300,	  Gria2,	  and	  Mapk1 were	  found.	  
As	  a	  validated	   interaction	  between	  miR-­‐132-­‐3p	  and	  Ep300	  has	  been	  previously	  shown	  
(Lagos	  et	  al.,	  2010),	  supporting	  our	  approach,	  Gria2 and	  Mapk1 were	  selected	  for	  further	  
study	  as	  potential	  novel	   targets	   for	  miR-­‐132-­‐3p	  in	  the	  rat	  (Figure	  5.1).	  The	  aim	  of	  this	  
Figure	   5.1:	   Summary	   of	   the	   selection	   of	   LTP-­‐related	   targets	   of	  miR-­‐132-­‐3p	   for	   study	  with	   luciferase	  
assays.	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chapter	   was	   to	   first	   determine	   if	   the	   miRNA	   and	   the	   target	   transcript	   interact	   using	  
luciferase	  assays	  and	  then	  determine	  if	  there	  was	  differential	  expression	  following	  LTP	  
induction	  of	  these	  targets	  using	  RT-­‐qPCR	  and	  Western	  blots.	  
	  
5.1.1 Glutamate	  Receptor,	  Ionotropic,	  AMPA	  2	  (Gria2)	  
Present	   in	   the	   post-­‐synaptic	   density	   as	   one	   of	   the	   signal	   transducers	   following	  
synaptic	  transmission,	  AMPARs	  play	  an	  important	  role	  in	  the	  induction	  and	  persistence	  
of	   LTP.	   AMPARs	   are	   tetramers,	   comprising	   of	   dimers	   of	   the	   subunits	   GluA1,	   GluA2,	  
GluA3,	  and/or	  GluA4.	   In	  neurons,	   the	  AMPAR	  is	  generally	  heterogeneous,	  composed	  of	  
GluA1	  and	  GluA2	  subunit	  dimers	  (Isaac	  et	  al.,	  2007;	  Wenthold	  et	  al.,	  1996).	  Interestingly,	  
99%	  of	  all	  the	  GluA2	  subunits	  expressed	  differ	  from	  what	  is	  coded	  in	  the	  Gria2	  gene,	  as	  a	  
result	  of	  adenine	  to	  inosine	  (A	  to	  I)	  RNA	  editing	  of	  the	  mRNA	  transcript	  (Kawahara	  et	  al.,	  
2003;	   Sommer	   et	   al.,	   1991).	   This	   edit	   during	   translation	   is	   read	   as	   a	   G	   nucleotide,	  
resulting	   in	   a	   glutamine	   to	   arginine	   amino	   acid	   change	   at	   position	  607.	  As	   this	   amino	  
acid	  lies	  within	  the	  second	  transmembrane	  domain,	  this	  single	  modification	  changes	  the	  
internal	   structure	   of	   the	   channel	   and	   prevents	   divalent	   cations	   such	   as	   calcium	   from	  
passing	  through	  (Kuner	  et	  al.,	  2001).	  As	  a	  result,	  AMPAR	  channels	  containing	  the	  GluA2	  
subunit	  are	  impermeable	  to	  calcium.	  Deficits	  in	  GluA2	  being	  edited	  have	  been	  linked	  to	  
ischemia,	   neuronal	   death,	   and	   amyotrophic	   lateral	   sclerosis	   (ALS).	   In	   ALS,	   without	  
functional	   GluA2	   subunits,	   AMPAR	   mediate	   calcium	   influxes,	   creating	   excitotoxic	  
conditions.	  This	  has	  been	  hypothesised	  to	  occur	  within	  motor	  neurons,	  resulting	  in	  their	  
death	  and	  leading	  to	  the	  muscle	  weakness	  and	  atrophy	  that	  occurs	  in	  ALS	  (Hideyama	  &	  
Kwak,	  2011).	  	  
The	   GluA2	   subunit	   appears	   to	   affect	   the	   role	   AMPARs	   play	   following	   the	  
induction	  of	  LTP.	  In	  the	  early	  stages	  of	  LTP,	  GluA1-­‐containing	  AMPAR	  have	  been	  found	  
to	  be	  inserted	  extrasynaptically,	  before	  being	  moved	  to	  the	  synapse	  (Chen	  et	  al.,	  2000;	  
Hayashi	   et	   al.,	   2000;	   Passafaro	   et	   al.,	   2001).	   However,	   this	   early	   insertion	   of	   AMPAR	  
following	  LTP	  is	  not	  dependent	  on	  the	  presence	  of	  GluA1,	  as	  GluA2-­‐containing	  AMPAR	  
can	  compensate	  if	  the	  GluA1	  subunit	  is	  knocked	  out	  (Granger	  et	  al.,	  2013).	  Indeed,	  this	  
initial	   expression	   of	   GluA1-­‐containing	   receptors	   has	   been	   shown	   to	   be	   supplanted	   by	  
GluA2-­‐containing	   receptors,	   delivered	   initially	   exclusively	   to	   extrasynaptic	   sites	   in	   a	  
protein	  synthesis-­‐dependent	  manner,	  but	  can	  later	  be	  placed	  in	  the	  synapse	  (Plant	  et	  al.,	  
2006;	   Williams	   et	   al.,	   2007).	   This	   change	   in	   the	   subunit	   composition	   of	   the	   AMPAR	  
suggests	  that	  the	  initial	  receptors	  permeable	  to	  calcium	  may	  facilitate	  the	  initial	  influx	  of	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calcium	   following	   LTP	   induction	   and	   initiate	   associated	  molecular	   cascades.	  However,	  
this	  facilitation	  is	  not	  required	  long-­‐term	  as	  GluA2-­‐containing	  receptors	  are	  moved	  out	  
of	  the	  synapse	  by	  48	  h.	  While	  there	  is	  an	  increase	  in	  expression	  of	  GluA2	  globally	  in	  the	  
dentate	   gyrus,	   this	   increase	   was	   not	   detected	   at	   the	   synapse,	   suggesting	   that	   this	  
increase	   at	   the	   synapse	  may	  be	   transient,	   and	   an	   effect	   of	   short-­‐term	   synaptic	   scaling	  
(Kennard	  et	  al.,	  2009,	  2014;	  Williams	  et	  al.,	  2007).	  	  
Interestingly,	   the	   inclusion	   of	   the	   GluA2	   subunit	   may	   help	   to	   maintain	   the	  
expression	  of	  the	  AMPAR	  at	  the	  synapse.	  The	  C-­‐terminus	  of	  the	  GluA2	  subunit	  is	  able	  to	  
bind	   to	   the	   ATPase	   N-­‐ethylmaleimide-­‐sensitive	   factor	   (Nsf),	   facilitating	   insertion	   of	  
GluA2-­‐containing	   AMPAR	   into	   the	   synapse	   (Araki	   et	   al.,	   2010).	   With	   this	   interaction	  
stabilised	  by	  PKMζ,	   internalisation	   of	   the	  GluA2-­‐containing	  AMPAR	  may	  be	  prevented	  
(Migues	  et	  al.,	  2010;	  Yao	  et	  al.,	  2008),	   though	   this	  effect	   is	  not	  persistent.	  Further,	   the	  
insertion	  of	  GluA2-­‐containing	   receptors	   into	   the	  membrane	   is	   further	   facilitated	  when	  
the	   GluA2	   subunit	   is	   not	   edited	   (Araki	   et	   al.,	   2010),	   suggesting	   potential	   preferential	  
loading	  of	  AMPAR	  containing	  these	  subunits	  into	  the	  membrane.	  However,	  considering	  
the	   low	  percentage	   of	   unedited	  GluA2	   subunits	   present	   in	   neurons,	   this	   is	   unlikely	   to	  
mediate	  a	  significant	  effect.	  
Investigating	  the	  expression	  of	  the	  Gria2	  transcript	  following	  LTP	  induction	  in	  the	  
previously	   conducted	  microarrays	   in	   our	   lab,	   no	   significant	   change	   in	   expression	  was	  
detected	   (Ryan	   et	   al.,	   2011;	   Ryan	   et	   al.,	   2012).	   This	   suggests	   that	   if	  miR-­‐132-­‐3p	   does	  
target	  Gria2 and	  actively	  regulate	  it,	  this	  may	  be	  through	  a	  miRNA	  mediated	  translation	  
inhibitory	   mechanism,	   changing	   the	   expression	   of	   the	   protein	   without	   affecting	  
expression	  of	  its	  transcript.	  Alternatively,	  the	  microarrays	  may	  not	  be	  sensitive	  enough	  
to	  detect	  a	  change.	  
	  
5.1.2 Mitogen-­‐Activated	  Protein	  Kinase	  1	  (Mapk1)	  
The	  MAPK	   pathway	   is	   an	   important	   signalling	   cascade	   that	   allows	   an	   external	  
stimulus	   to	   initiate	   changes	   in	   gene	   expression	   in	   the	   nucleus	   of	   a	   cell.	   This	   pathway	  
contains	  multiple	  MAPKs,	  which	  are	  phosphorylated	  by	   their	  upstream	  regulators	  and	  
phosphorylate	  their	  immediate	  downstream	  targets.	  Further,	  other	  kinases,	  such	  as	  PKC,	  
PKA,	   and	   a	   number	   of	   CaMK,	   which	   are	   activated	   following	   LTP,	   can	   phosphorylate	  
members	   of	   this	   pathway,	   triggering	   its	   downstream	   effects	   (Bozon	   et	   al.,	   2003).	   The	  
final	  MAPK,	  of	  which	   there	  are	  multiple	   isoforms	   including	  p42-­‐MAPK	  and	  p44-­‐MAPK,	  
coded	   for	   by	   the	  Mapk1	   and	  Mapk3	  gene	   respectively,	   has	   been	   shown	   to	   translocate	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into	  the	  nucleus	  following	  phosphorylation,	  including	  in	  the	  dentate	  gyrus	  (Davis	  et	  al.,	  
2000).	  This	  subsequent	  activation	  of	  the	  targets	  of	  MAPK	  plays	  an	  important	  role	  in	  LTP,	  
as	   among	   the	   targets	   it	   can	   phosphorylate	   is	   the	   transcription	   factor	   CREB.	   The	  
activation	  of	  the	  constitutively	  expressed	  CREB	  can	  induce	  the	  transcription	  of	  multiple	  
important	  LTP-­‐related	  genes,	  including	  other	  LTP-­‐related	  transcription	  factors	  like	  Egr1,	  
and	  plasticity-­‐related	  genes	   such	  as	  Arc.	   Through	   these	  genes,	   the	  MAPK	  pathway	  has	  
been	   shown	   to	   be	   important	   for	   the	   changes	   in	   gene	   expression	   critical	   to	   the	  
persistence	  of	  LTP	  at	  synapses.	  	  
As	  with	  Gria2,	   no	   significant	   change	   in	  Mapk1	   expression	  was	   detected	   by	   our	  
microarray	   data	   following	   the	   induction	   of	   LTP	   (Ryan	   et	   al.,	   2011;	   Ryan	   et	   al.,	   2012).	  
Interestingly,	   previous	   studies	   have	   linked	   miR-­‐132-­‐3p	   and	   Mapk1,	   with	   evidence	  
suggesting	  Mapk1 regulates	  miR-­‐132-­‐3p	  (Kawashima	  et	  al.,	  2010;	  Remenyi	  et	  al.,	  2010).	  
Following	   inhibition	   of	   the	   MAPK	   pathway,	   a	   suppression	   of	   BDNF	   occurs,	   and	   an	  
associated	   increase	   in	   miR-­‐132-­‐3p	   normally	   observed	   did	   not	   occur,	   consistent	   with	  
other	  work	  demonstrating	  transcription	  of	  the	  pri-­‐miR-­‐132/212	  was	  dependent	  on	  the	  
MAPK	   pathway.	   Furthermore,	   Mapk1	   has	   been	   shown	   to	   phosphorylate	   the	  
transactivation	   responsive	   RNA	   binding	   protein	   (TRBP)	   a	   Dicer	   accessory	   protein	  
(Paroo	  et	  al.,	  2009).	  Changes	  in	  Mapk1	  expression	  may	  affect	  the	  stability	  of	  the	  miRISC	  
complex	   (Chendrimada	   et	   al.,	   2005),	   thus	   affecting	   the	   production	   of	   miRNA	   and	   the	  
regulation	  of	   their	   targets.	  Therefore,	   the	   targeting	  of	  miR-­‐132-­‐3p	   to	  Mapk1	  may	  have	  
broader	   consequences	  beyond	   changing	   its	   expression,	   and	   this	   relationship	  may	  play	  
an	  important	  role	  in	  the	  changes	  in	  gene	  expression	  post-­‐LTP.	  
	  
5.1.3 Luciferase	  Assays	  
Luciferase	   assays	   allow	   for	   the	   interrogation	   of	   a	   single	   interaction	   between	   a	  
miRNA	  and	  its	  target,	  and	  determine	  if	  there	  is	  a	  causative	  relationship,	  while	  providing	  
a	  easily	  readable	  endpoint	  (Kuhn	  et	  al.,	  2008).	  While	  the	  expression	  of	  a	  potential	  target	  
gene	   can	  be	  measured	   through	  microarrays,	  RT-­‐qPCR,	   or	  Western	  blots,	   this	   can	  only	  
suggest	  a	  correlative	  relationship	  of	  a	  binding	  relationship	  between	  the	  miRNA	  and	  its	  
target.	  However,	  with	  luciferase	  assays,	  the	  MRE	  from	  the	  target	  transcript	  is	  cloned	  into	  
a	   site	   located	   within	   the	   3’	   UTR	   of	   a	   luciferase	   enzyme	   gene	   in	   a	   reporter	   plasmid	  
(Figure	  5.2).	  These	  plasmids	  are	  then	  transfected	   into	  a	  population	  of	  cells,	  along	  with	  
the	  miRNA	  of	  interest.	  If	  an	  interaction	  between	  the	  miRNA	  and	  the	  inserted	  MRE	  on	  the	  
3’	  UTR	  of	  the	  luciferase	  gene	  occurs,	  there	  will	  be	  down-­‐regulation	  of	  the	  luciferase	  gene,	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resulting	   in	   decreased	   luciferase	   protein	   and	   activity	   and	   reduced	   luminescence	  
compared	   to	   the	   controls.	   These	   controls	   include	   plasmids	   that	   do	   not	   have	   the	  MRE	  
inserted,	  and	  co-­‐transfection	  of	  miRNA	  that	  should	  not	  bind	  to	  the	  MRE,	  or	  any	  feature	  
of	  the	  plasmid.	  Further	  validation	  of	  the	  interaction	  can	  also	  be	  undertaken	  through	  the	  
application	   of	   a	   target	   protector,	  which	  will	   bind	   to	   the	   target	   site	   on	   the	  mRNA	   and	  
prevents	   the	   miRNA	   from	   interacting	   with	   it	   without	   affecting	   the	   translation	   of	   the	  
luciferase	  activity	  and	  subsequent	  activity	  (Wynendaele	  et	  al.,	  2010).	  	  
	  
5.1.4 Current	  Study	  
In	   this	   chapter,	   the	   first	   aim	   of	   this	   work	   was	   to	   use	   luciferase	   assays	   to	  
investigate	  the	  predicted	  novel	  interactions	  between	  miR-­‐132-­‐3p	  and	  Gria2 and	  Mapk1	  
in	   the	   rat	   and	   determine	   the	   importance	   of	   the	   seed	   sites	   for	   these	   interactions.	   The	  
second	  aim	  of	  this	  work	  was	  to	  investigate	  the	  expression	  of	  validated	  targets	  post-­‐LTP	  
at	  both	  a	  transcript	  and	  protein	  level	  using	  RT-­‐qPCR	  and	  Western	  blots.	  Together,	  these	  
analyses	  brought	  an	  understanding	  of	  how	  miR-­‐132-­‐3p	  can	  affect	   the	  gene	  expression	  
underlying	  the	  persistence	  of	  LTP.	  	  
	  
	   	  
Figure	  5.2:	  Summary	  diagram	  of	  luciferase	  assays.	  The	  binding	  site	  of	  interest	  is	  cloned	  downstream	  of	  a	  
luciferase	  gene	  in	  a	  plasmid.	  Following	  transfection	  of	  the	  miRNA	  of	  interest,	  if	  binding	  occurs,	  reduced	  or	  
no	  luciferase	  expression	  will	  be	  seen.	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5.2 Methods	  and	  Materials	  
All	   work	   was	   done	   under	   aseptic	   techniques	   with	   the	   use	   of	   autoclaved	  
equipment	  and/or	  70%	  ethanol	  to	  decontaminate.	  The	  development	  and	  undertaking	  of	  
the	   luciferase	   assays	  were	   carried	   out	   in	   collaboration	  with	   the	   Claudianos	   lab	   in	   the	  
Queensland	   Brain	   Institute	   at	   the	   University	   of	   Queensland	   St	   Lucia,	   Brisbane,	  
Queensland,	  Australia	  (Cristino	  et	  al.,	  2014).	  	  
	  
5.2.1 Target	  Selection	  
Targets	  were	  selected	  based	  on	  the	  method	  developed	  in	  Chapter	  4.	  In	  short,	  lists	  
of	   predicted	   targets	   for	   the	   miRNA	   of	   interest	   in	   human	   were	   retrieved	   from	   nine	  
different	   miRNA	   targeting	   algorithms.	   These	   lists	   were	   then	   collated	   and	   filtered	  
through	  the	  LTP	  KEGG	  pathway	  and	  the	  resultant	   list	  of	  genes	  probed	  for	  whether	  the	  
target	   site	  existed	   in	   the	   rat.	  The	   list	  was	  narrowed	  down	   to	   those	  predicted	  by	  more	  
than	  four	  of	  the	  algorithms,	  and	  novel	  targets	  were	  selected	  for	  further	  study.	  
	  
5.2.2 Plasmids	  and	  Oligonucleotides	  
ψCheck-­‐2	   Plasmid.	   The	   plasmid	   used	   for	   these	   experiments	   is	   the	   ψCheck-­‐2	  
plasmid	  (Promega),	  which	  is	  6,273	  bp.	  These	  plasmids	  contain	  a	  Renilla	  luciferase	  gene	  
as	  the	  reporter	  gene	  for	  any	  RNA	  interference	  followed	  by	  a	  multiple	  cloning	  site	  (MCS)	  
in	   the	   3’	   UTR,	   a	   firefly	   luciferase	   gene	   that	   acts	   as	   an	   internal	   normaliser,	   and	   an	  
ampicillin	   resistance	   gene	   to	   aid	   selection	   for	   transformed	   colonies.	   With	   the	   MCS	  
downstream	   from	   Renilla	   luciferase	   gene,	   any	   insert	   placed	   in	   it	   can	   regulate	   the	  
translation	  of	  this	  gene.	  With	  the	  firefly	  luciferase	  gene	  independently	  regulated	  and	  not	  
affected	  by	  the	  MCS,	  it	  was	  used	  to	  normalise	  for	  cell	  number	  and	  transfection	  efficiency.	  
The	  genetic	  features	  of	  the	  ψCheck-­‐2	  plasmid	  are	  shown	  in	  Figure	  5.3.	  
Target	  Sequences.	  The	  inserts	  of	  the	  target	  sequences	  were	  designed	  based	  on	  the	  
target	  site	  of	  the	  interaction	  predicted	  by	  the	  bioinformatics	  analysis	  and	  use	  the	  mRNA	  
sequences	   from	   NCBI	   and/or	   the	   latest	   assembly	   of	   the	   rat	   genome	   on	   Ensembl	  
(Rnor_5.0).	  The	  wildtype	  insert	  encompasses	  the	  full	  MRE	  for	  the	  whole	  miRNA,	  and	  not	  
just	   the	   5’	   seed	   site.	   In	  mutant	   sequences,	   C	   and	  G	   nucleotides	   in	   the	   seed	   site	   of	   the	  
target	   transcript	   were	   replaced	   with	   A	   and	   T	   nucleotides.	   Flanking	   regions	   of	   the	  
transcript,	   followed	  by	   the	   restriction	   enzyme	   sites	  were	   engineered	  on	   either	   side	  of	  
the	   target	   site.	  The	  wildtype	   and	  mutant	   insert	   sequences	  of	   the	   genes	  of	   interest	   are	  
shown	  in	  Figure	  5.3.	  Oligonucleotides	  were	  synthesised	  for	  both	  the	  sense	  and	  antisense	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sequences	   of	   the	   insert	   (Geneworks).	   The	   location	   of	   the	   inserts	   can	   be	   found	   in	  
Appendix	  D.	  
Oligonucleotides.	   Synthetic	   miRIDIAN	   oligonucleotides	   (GE	   Healthcare	  
Dharmacon)	   were	   pre-­‐designed	   for	   exogenous	   rno-­‐miR-­‐132-­‐3p	   mimic	   and	   for	   the	  
negative	  control	  (miRIDIAN	  microRNA	  mimic	  negative	  control	  #2).	  The	  negative	  control	  
is	  based	  upon	  the	  sequence	  of	  cel-­‐miR-­‐239b	  which	  shares	  no	  homology	  with	  any	  miRNA	  
in	  the	  rat.	  Synthetic	  miRCURY	  locked	  nucleic	  acid	  (LNA)	  oligonucleotides	  (Exiqon)	  were	  
used	   to	   inhibit	   rno-­‐miR-­‐132-­‐3p	   sequences.	  All	   synthetic	  miRNA	  oligonucleotides	  were	  
pre-­‐desalted	   and	   were	   re-­‐suspended	   from	   a	   dry	   pellet	   to	   100	   μM.	   Sequences	   for	   the	  
mimic,	  inhibitor,	  and	  negative	  control	  sequences	  can	  be	  found	  in	  Table	  5.1.	  
	  
Figure	  5.3:	  Genetic	  features	  of	  the	  ψCheck-­‐2	  plasmid	  and	  placement	  and	  sequences	  of	  the	  wildtype	  and	  
mutant	   inserts	   of	   the	   genes	   of	   interest.	   The	   plasmid	   contains	   two	   luciferase	   genes,	   the	   Renilla	   for	  
quantification	   of	   RNAi,	   and	   firefly	   for	   internal	   normalisation.	   A	   cloning	   site	   exists	   downstream	   of	   the	  
Renilla	   luciferase	   gene	  with	  multiple	   restriction	   enzymes	   sites,	  with	  XhoI	   and	  NotI-­‐HF	   the	   enzymes	  of	  
choice.	   An	   ampicillin	   resistance	   gene	   allows	   for	   transformed	   colony	   selection.	   The	   total	   size	   of	   the	  
plasmid	  is	  normally	  6,273	  bp,	  and	  with	  the	  inserts	  varied	  between	  6,277	  and	  6,284	  bp.	  Inserts	  from	  the	  
genes	   of	   interest	   are	   in	   blue,	   the	   restriction	   enzyme	   sequences	   in	   red.	   Sequences	   are	   in	   the	   forward	  
direction	  from	  5’	  to	  3’.	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5.2.3 Quality	  Control	  and	  Quantification	  	  
Nanodrop.	  The	  Nanodrop	  was	  used	  as	  described	  above	  in	  section	  2.2.3.	  
	  	  
5.2.4 Insert	  and	  Vector	  Preparation	  
Annealing.	   Pairs	   of	   oligonucleotides	   designed	   to	   create	   the	   inserts	   that	   contain	  
the	  target	  site	  were	  annealed	  with	  each	  other	  to	  create	  double	  stranded	  DNA	  (dsDNA)	  
inserts.	   Using	   an	   adapted	   version	   of	   a	   recipe	   for	   a	   10x	   annealing	   buffer	   from	   Life	  
Technologies,	   a	   20x	   annealing	   buffer	   was	   created	  with	   5	  mmol	   Tris-­‐HCl	   (pH	   7.5),	   50	  
mmol	  NaCl,	  and	  0.5	  mmol	  EDTA.	  Two	  volumes	  of	  the	  20x	  annealing	  buffer	  were	  added	  to	  
one	  volume	  each	  of	  the	  pair	  of	  oligonucleotides	  for	  the	  insert.	  This	  was	  then	  placed	  in	  a	  
thermocycler	  at	  90°C	  for	  40	  min,	  followed	  by	  25°C	  for	  50	  min.	  The	  product	  was	  stored	  at	  
-­‐20°C	  if	  it	  was	  not	  purified	  immediately.	  
Gel	   and	   Column	   Purification.	   DsDNA	   inserts	   were	   depleted	   by	   size	   selection	  
through	   a	   1	  %	   TAE	   agarose	   gel	   containing	   SYBR	   Safe	   Dye	   (Life	   Technologies).	   Wells	  
were	  loaded	  with	  unpurified	  dsDNA	  and	  loading	  buffer,	  and	  run	  for	  20	  min	  at	  120	  V,	  or	  
until	   the	   bands	  were	   sufficiently	   run	   along	   the	   gel.	   The	   region	   containing	   the	   dsDNA	  
band	   was	   visualised	   and	   cut	   out	   under	   transillumination	   and	   purified	   using	   the	  
QIAquick	  gel	  extraction	  kit	  (Qiagen).	  
Each	  sample	  was	  weighed,	  and	  three	  volumes	  of	  the	  sample	  weight	  of	  Buffer	  QG	  
was	   added,	   and	   incubated	   at	   50°C	   for	   10	  min,	   vortexing	   every	   two	   to	   three	  minutes,	  
resulting	  in	  a	  yellow	  liquid	  mixture.	  One	  volume	  of	  100%	  isopropanol	  was	  then	  added	  to	  
the	  sample	   to	   increase	   the	  yield	  of	  DNA	  fragments	  smaller	   than	  500	  bp.	  The	  DNA	  was	  
bound	   to	   the	  QIAquick	   column	  by	   sequential	   application	  of	  800	  µL	  of	   the	   sample,	   and	  
centrifuged	  at	  13,000	  g	  for	  one	  minute,	  with	  the	  flow-­‐through	  discarded.	  To	  remove	  any	  
remaining	   traces	   of	   the	   agarose,	   500	   µL	   of	   Buffer	   QG	   was	   added	   to	   the	   column	   and	  
centrifuged	   at	   13,000	   g	   for	   one	  minute.	   Following	   removal	   of	   the	   flow-­‐through	   and	   a	  
Table	  5.1:	  Sequences	  of	  synthetic	  oligonucleotides	  used	  to	  modulate	  luciferase	  expression.	  
	   Modification	   Sequence	  (5’-­‐3’)	  
rno-­‐miR-­‐132-­‐3p	  
mimic	  








N/A	   UUGUACUACACAAAAGUACUG	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consequent	  dry	   spin,	  30	  µL	  of	  DNAse/RNAse-­‐free	  water	  was	  used	   to	  elute	   the	   sample	  
before	  the	  dsDNA	  concentration	  was	  measured	  using	  the	  Nanodrop.	  
Restriction	  Endonuclease	  Digestion.	  Two	  restriction	  enzymes	  were	  used	  to	  digest	  
the	   insert	   dsDNA	   fragments	   and	   the	   ψCheck-­‐2	   plasmid	   (Promega),	   previously	   cloned	  
and	   isolated	   using	   the	   QIAprep	   Spin	   Miniprep	   kit	   (Qiagen).	   Two	   restriction	   enzymes	  
which	   produce	   overhanding	   nucleotides	   were	   used	   to	   ensure	   directionality	   of	   the	  
cloning.	  XhoI	  recognises	  double	  stranded	  5’-­‐CTCGAG-­‐3’	  and	  cleaves	  after	  C1,	  while	  NotI-­‐
HF	  recognises	  double	  stranded	  5’-­‐GCGGCCGC-­‐3’	  and	  cleaves	  after	  C1.	  Both	  enzymes	  have	  
a	  100%	  efficiency	  in	  CutSmart	  Buffer	  (New	  England	  Biolabs).	  For	  2	  µg	  of	  plasmid	  or	  3	  µg	  
of	   insert,	   3	   µL	   of	   CutSmart	   Buffer,	   50	   units	   of	   the	   XhoI	   and	   30	   units	   of	   the	   NotI-­‐HF	  
restriction	   enzymes,	   and	   2	   µL	   bovine	   serum	   albumin	   (BSA)	   were	   added,	   with	  
DNAse/RNAse-­‐free	  water	  added	  to	  bring	  the	  volume	  to	  30	  µL.	  This	  was	  incubated	  in	  a	  
thermocycler	  at	  37°C	  for	  3	  h,	  followed	  by	  65°C	  for	  20	  min	  to	  inactivate	  the	  enzymes.	  
Dephosphorylation.	  To	  prevent	  the	  ψCheck-­‐2	  from	  religating,	  the	  double	  digested	  
plasmid	  was	  dephosphorylated.	  Following	  a	  5	  min	   incubation	  on	   ice	   for	  each	  30	  µL	  of	  
the	   double	   digested	   plasmid,	   30	   units	   of	   bovine	   alkaline	   phosphatase	   (New	   England	  
Biolabs),	  6	  µL	  of	  CutSmart	  buffer,	   and	  21	  µL	  of	  DNAse/RNAse-­‐free	  water	  were	  added.	  
This	  solution	  was	  incubated	  in	  a	  thermocycler	  at	  37°C	  for	  2	  h,	  followed	  by	  75°C	  for	  15	  
min	  for	  enzyme	  restriction.	  Following	  this,	  both	  the	  dephosphorylated	  double	  digested	  
ψCheck-­‐2	  plasmid	  and	  the	  double	  digested	  inserts	  were	  re-­‐purified	  by	  gel	  and	  column,	  
as	  described	  above.	  
Ligation.	  Using	  a	  molar	  ratio	  of	  1:20	  between	  plasmid	  and	  insert,	  the	  insert	  was	  
ligated	  into	  the	  ψCheck-­‐2	  plasmid.	  Plasmid	  (50	  ng)	  and	  insert	  (10	  ng)	  were	  incubated	  at	  
70°C	  for	  5	  min,	  followed	  on	  ice	  for	  5	  min.	  To	  ligate	  the	  plasmid	  and	  inserts	  together,	  60	  
units	  of	  the	  T4	  ligase	  (New	  England	  Biolabs)	  and	  1.5	  µL	  of	  the	  T4	  DNA	  ligase	  buffer	  were	  
added	  to	  each	  reaction	  and	  incubated	  at	  25°C	  for	  3	  min	  followed	  by	  4°C	  overnight.	  
	  
5.2.5 Plasmid	  Amplification	  and	  Isolation	  
Cell	   Transformation.	   The	   recombinant	   plasmids	   were	   cloned	   into	   TOP10	  
Escherichia	  coli	  chemically	  competent	  bacterial	  cells	  (Life	  Technologies).	  Frozen	  TOP10	  
cells	  (50	  µL)	  were	  thawed	  on	  ice	  and	  1	  µL	  of	  the	  ligation	  mix	  was	  added	  and	  mixed	  by	  
tapping	   gently,	   to	   prevent	   cell	   damage	   via	   pipetting	   and	   vortexing.	   Following	   an	  
incubation	  on	  ice	  for	  30	  min,	  the	  cells	  were	  heat	  shocked	  at	  42°C	  for	  30	  s	  before	  placed	  
back	  on	   ice.	  Pre-­‐warmed	  SOC	  medium	  (250	  µL)	  was	  added	   to	  each	   tube	   to	  encourage	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growth	  of	  the	  cells	  and	  tubes	  were	  shaken	  at	  37°C	  for	  one	  hour	  at	  225	  rpm.	  Using	  cooled	  
Luria	  broth	  (LB)	  agar	  media	  plates	  containing	  0.1%	  antibiotic	  ampicillin,	  150	  µL	  of	  the	  
transformation	  ligation	  mix	  with	  the	  TOP10	  cells	  were	  spread	  on	  the	  plates	  and	  inverted	  
and	  incubated	  at	  37°C	  overnight.	  
Subsequently,	  ampicillin-­‐resistant	  colonies	  were	  grown	  in	  liquid	  culture	  made	  of	  
10	  mL	  of	  LB	  with	  0.1%	  ampicillin	  mixed	  in	  a	  50	  mL	  falcon	  tube.	  A	  pipette	  tip	  was	  used	  to	  
touch	  the	  colony	  to	  transfer	  it	  into	  the	  falcon	  tube.	  This	  was	  incubated	  at	  37°C	  for	  12	  to	  
16	  h	  at	  200	  rpm.	  This	  could	  be	  stored	  at	  room	  temperature	  for	  two	  days	  or	  at	  4°C	  for	  a	  
week.	  For	  long-­‐term	  storage,	  glycerol	  stocks	  were	  prepared	  by	  mixing	  1	  mL	  of	  the	  liquid	  
culture	  with	  225	  µL	  of	  80%	  glycerol	  and	  225	  µL	  LB	  without	  ampicillin	  and	  stored	  at	   -­‐
80°C.	  
Plasmid	  Isolation.	  The	  QIAprep	  Spin	  Miniprep	  kit	  (Qiagen)	  was	  used	  to	  isolate	  and	  
purify	  the	  plasmids	  from	  the	  bacterial	  cultures.	  Cells	  were	  collected	  by	  centrifugation	  for	  
3	  min	  at	  8,000	  g	  from	  5	  mL	  of	  overnight	  liquid	  culture.	  The	  liquid	  was	  removed	  and	  the	  
pelleted	  bacterial	  cells	  resuspended	  in	  250	  µL	  Buffer	  P1,	  followed	  by	  250	  µL	  of	  Buffer	  P2	  
and	  mixed	  by	   inverting	   to	  become	   clear.	  Within	  5	  min	  of	   adding	  Buffer	  P2,	   350	  µL	  of	  
Buffer	  N3	  was	  added	  and	   inverted	  to	  mix	  thoroughly	   immediately	  to	  prevent	   localised	  
precipitation.	   The	   solution	  was	   centrifuged	   for	   10	  min	   at	   13,000	   g	   to	   form	  a	   compact	  
white	   pellet.	   The	   supernatant	   was	   removed	   and	   applied	   to	   a	   spin	   column,	   and	  
centrifuged	   for	   a	   minute	   at	   13,000	   g.	   Discarding	   the	   flow-­‐through	   and	   washing	   the	  
column	   with	   750	   µL	   of	   Puffer	   PE,	   the	   column	   was	   spun	   for	   an	   additional	   minute	   at	  
13,000	  rpm.	  The	  wash	  solution	  was	  discarded	  and	  the	  column	  spun	  dry	  for	  a	  minute	  at	  
13,000	  rpm.	  The	  plasmids	  were	  eluted	   in	  50	  µL	  of	  DNAse/RNAse-­‐free	  water,	   standing	  
for	   a	   minute	   before	   centrifuging	   again	   for	   a	   minute	   at	   13,000	   g.	   The	   dsDNA	  
concentration	  was	  measured	  using	  the	  Nanodrop	  as	  above	  and	  stored	  at	  -­‐20°C.	  
Sequencing	  of	  Plasmid.	  To	  ensure	  the	  inserts	  were	  present	  in	  the	  plasmid,	  Sanger	  
sequencing	   of	   the	   plasmid	   was	   carried	   out.	   Isolated	   plasmid	   was	   sent	   to	   Australian	  
Genomic	  Research	  Facility	  Limited	   in	  Brisbane,	  Queensland,	  Australia	   to	  be	  sequenced	  
according	   to	   their	   specifications,	   and	  with	   the	   primers	   designed	   to	   flank	   the	  multiple	  
cloning	  site	  (Table	  5.2).	  	  
	  
5.2.6 COS-­‐7	  Cell	  Culture	  
COS-­‐7	   cells,	   used	   in	   the	   luciferase	   assays,	   are	   an	   African	   green	  monkey	   kidney	  
fibroblast-­‐like	  cell	  line	  derived	  from	  the	  CV-­‐1	  cell	  line	  by	  transformation	  with	  an	  origin	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defective	  mutant	  of	  SV40	  which	  codes	  for	  wild	  type	  T	  antigen.	  While	  these	  cells	  are	  not	  
neuronal	   by	   nature,	   these	   cells	   are	   well	   suited	   for	   luciferase	   assays	   as	   they	   are	   fast	  
growing,	   provide	   minimal	   background	   signal	   and	   can	   be	   easily	   transfected	   with	  
oligonucleotides	   and	  plasmids.	  COS-­‐7	   cells	  were	  grown	   in	  Dulbecco's	  modified	  Eagle's	  
medium	  (DMEM)	  with	  10%	  fetal	  bovine	  serum	  (FBS).	  These	  cells	  were	  grown	  in	  a	  25	  mL	  
flask	  with	  an	  estimated	  5	  x	  105	  cells	  after	  48	  h	  growth	  in	  an	  incubator	  at	  37°C	  with	  5%	  
CO2.	  Cell	  counts	  were	  determined	  through	  the	  standard	  use	  of	  a	  haemocytometer.	  	  
	  
5.2.7 Cell	  Transfection	  for	  Luciferase	  Assays	  
	  To	  prepare	  the	  cells	  for	  transfection,	  COS-­‐7	  cells	  were	  removed	  from	  the	  bottom	  
of	  the	  flask	  with	  trypsin,	   the	  cells	  spun	  down	  for	  3	  min	  at	  100	  g,	  with	  the	  supernatant	  
discarded	   to	  remove	  cell	  debris.	  After	   the	  addition	  of	  5	  mL	  of	  DMEM	  media	  with	  10%	  
FBS	  and	  a	  cell	  count,	  50,000	  COS-­‐7	  cells	  were	  added	  to	  each	  well	  of	  a	  24	  well	  plate.	   In	  
addition	  to	  this,	  500	  µL	  of	  DMEM	  media	  with	  10%	  FBS	  was	  added	  to	  each	  well.	  The	  plate	  
was	   incubated	  for	  37°C	  with	  5%	  CO2	  for	  3	  to	  4	  h,	  or	  until	   the	  cells	  became	  about	  70%	  
confluent.	  
For	  each	  24-­‐well	  plate,	  there	  were	  six	  conditions	  or	  transfection	  mixes	  with	  four	  
replicates	  each.	  The	  six	  conditions	  were	  the	  plasmid	  by	   itself,	  plasmid	  with	   the	  mimic,	  
plasmid	  with	  the	   inhibitor,	  plasmid	  with	  the	  negative	  control,	  plasmid	  with	  mimic	  and	  
inhibitor,	   and	   plasmid	   with	   negative	   control	   and	   inhibitor	   (Figure	   5.4).	   For	   four	  
replicates	  for	  each	  transfection	  mix,	  400	  ng	  of	  the	  insert-­‐containing	  ψCheck-­‐2	  plasmid,	  
240	  pmol	  of	  each	  oligonucleotide	  being	  used,	  8	  µL	  of	  Lipofectamine	  LTX	  and	  2	  µL	  of	  the	  
PLUS	   reagent	   (Life	   Technologies)	   were	   combined	   with	   Opti-­‐MEM	   media	   (Life	  
Technologies)	   for	   a	   total	   volume	  of	   400	  µL.	  The	   transfection	  mixes	  were	   incubated	   at	  
room	  temperature	  for	  30	  min	  to	  allow	  the	  lipofectamine	  to	  bind	  to	  the	  DNA.	  Following	  
replacement	  of	  the	  media	  with	  100	  µL	  of	   fresh	  DMEM	  media	  with	  10%	  FBS,	  100	  µL	  of	  
the	  prepared	  transfection	  mix	  was	  added	  to	  each	  well.	  The	  plate	  was	  gently	  rocked	  for	  2	  
min	   at	   75	   g	   to	   mix	   the	   transfection	   mix	   into	   the	   cells,	   before	   being	   placed	   into	   the	  
incubator	  at	  37°C	  with	  5%	  CO2	  for	  no	  more	  than	  18	  h.	  	  
Table	  5.2:	  Sequences	  of	  primers	  to	  amplify	  the	  multiple	  cloning	  site	  in	  ψCheck-­‐2	  plasmid.	  
	   Sequence	  (5’-­‐3’)	  
ψCheck-­‐2	  Forward	   AGGACGCTCCAGATGAAATG	  
ψCheck-­‐2	  Reverse	   CAAACCCTAACCACCGCTTA	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  Following	  incubation,	  the	  DMEM	  media	  was	  removed	  from	  each	  well	  and	  washed	  
briefly	   with	   500	   µL	   of	   PBS,	   leaving	   the	   wells	   empty.	   To	   each	   well,	   200	   µL	   of	   the	   1x	  
passive	  lysis	  buffer	  (PLB;	  Promega)	  was	  added,	  and	  mixed	  by	  pipette	  to	  re-­‐suspend	  the	  
cells,	  followed	  by	  shaking	  the	  plate	  for	  20	  min	  at	  200	  g.	  The	  lysate	  was	  transferred	  to	  a	  
96-­‐well	  PCR	  plate	  for	  storage.	  Dilutions	  of	  1:1,	  1:2,	  1:5,	  1:10,	  1:20,	  and	  1:50	  were	  made	  
in	   1x	   PLB	   to	   determine	   the	   optimal	   range	   for	   measurement	   of	   the	   luminescence	   to	  
prevent	   signal	   saturation.	   All	   lysates	   for	   the	   same	   plasmid	   were	   diluted	   similarly	  
dilution	   for	   measuring,	   with	   20	   µL	   of	   the	   lysate	   placed	   in	   opaque	   96-­‐well	   plates	   for	  
measurement	  	  
	  
5.2.8 Measurement	  of	  Luciferase	  Activity	  and	  Analysis	  
Using	   the	  Dual-­‐Luciferase	   Reporter	   Assay	   System	   (Promega),	   3	  mL	   each	   of	   the	  
Luciferase	  Assay	  Reagent	  II	  (LARII)	  and	  Stop	  and	  Glo	  (S+G)	  was	  used	  per	  24-­‐well	  plate.	  
LARII	  activates	  and	  allows	  for	  the	  quantification	  of	  the	  firefly	  luciferase	  signal,	  while	  S+G	  
stops	   this	   reaction,	   and	   concurrently	   activates	   and	  allows	  quantification	  of	   the	  Renilla	  
luciferase	   signal.	   LARII	   came	   pre-­‐prepared	  while	   60	   µL	   of	   the	   50x	   S+G	   substrate	  was	  
added	  to	  3	  mL	  of	  S+G	  buffer	  prior	  to	  use.	  With	  the	  plate	  in	  the	  reader,	  100	  µL	  of	  LARII	  
was	  added	  to	   the	   lysate	  and	  mixed	   for	  2	  s,	  with	   the	   luminescence	  measured	   for	   firefly	  
Figure	  5.4:	  Layout	  of	  24-­‐well	  plate	   for	   luciferase	  assay.	  Within	  each	  well	  are	  50,000	  COS-­‐7	  cells,	  along	  
with	   the	   respective	   transfection	   mixes.	   Each	   well	   is	   a	   biological	   replicate	   due	   to	   the	   distinct	   cell	  
populations.	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luciferase	  activity.	  After	  12	  s,	  100	  µ	  of	   the	  S+G	  was	  added	  and	  mixed	   for	  2	  s,	  with	   the	  
following	  12	  s	  measured	  for	  the	  Renilla	  luciferase	  activity.	  
The	   average	   firefly	   luciferase	  measurement	  was	   taken	   from	  5	   to	   10	   s	   after	   the	  
beginning	  of	  the	  read,	  while	  the	  average	  Renilla	  luciferase	  measurement	  was	  taken	  from	  
15	  to	  20	  s.	  A	  ratio	  to	  normalise	  the	  Renilla	  measurement	  to	  the	  firefly	  measurement	  was	  
calculated	   and	   averaged	   across	   each	   condition	   or	   transfection	  mix.	   The	   ratios	   for	   the	  
plasmid	  with	  the	  mimic,	  plasmid	  with	  the	   inhibitor,	  plasmid	  with	  the	  negative	  control,	  
plasmid	  with	  mimic	  and	  inhibitor,	  and	  plasmid	  with	  negative	  control	  and	  inhibitor,	  were	  
normalised	  to	  the	  plasmid	  only.	  A	  two-­‐tailed	  t-­‐test	  was	  used	  to	  determine	  where	  there	  
was	   a	   statistical	   difference	   between	   any	   two	   conditions,	   with	   significance	   defined	   as	  
p<0.05.	  
	  
5.2.9 SYBR	  Green	  RT-­‐qPCR	  
RNA	  Samples.	  The	  samples	  used	   for	   these	  experiments	  are	   the	  same	  as	   isolated	  
above	  in	  section	  2.2.1	  and	  extracted	  in	  section	  2.2.2.	  
Primer	   Design.	   Two	   sets	   of	   primers	   for	   Mapk1 were	   developed	   by	   using	   the	  
following	   freely	   available	   tools.	   The	   first	   set	   of	   primers	   were	   designed	   to	   the	   coding	  
region	  of	   the	  Mapk1	  mRNA	  (NM_053842.1),	  while	  primers	   for	   the	  Mapk1 3’	  UTR	  were	  
designed	  to	  the	  3’	  UTR	  from	  the	  predicted	  X1	  variant	  (XM_006248658.2)	  that	  contains	  
the	  binding	  site	  for	  miR-­‐132-­‐3p	  used	  in	  the	  luciferase	  assays.	  The	  latest	  versions	  of	  these	  
rat	  mRNA	  transcripts	  of	  the	  Mapk1 gene	  were	  obtained	  from	  NCBI	  Nucleotide	  GenBank	  
(http://www.ncbi.nlm.nih.gov/nuccore).	   A	   BLAST	   search	   of	   the	   sequence	   was	  
undertaken	   to	   ensure	   that	   the	   reference	   sequence	   was	   specific	   to	   only	   this	   gene	   of	  
interest	   in	   the	  rat.	  A	  note	  was	  made	  of	  any	  other	  genes	   that	  received	  a	  100%	  score	   in	  
query	   coverage	   as	   targets	   for	   potential	   non-­‐specific	   amplification.	   Primers	   were	  
generated	   using	   Primer-­‐BLAST,	   with	   the	   parameters	   that	   it	   spanned	   an	   exon-­‐exon	  
junction	   for	   the	   Mapk1-­‐CDS	   primer	   set	   and	   was	   specific	   for	   the	   rat.	   Following	   the	  
generation	  of	  this	  list,	  primers	  were	  selected	  on	  a	  number	  of	  criteria:	  there	  was	  specific	  
amplification	  of	   the	   gene	  of	   interest,	   the	  Tm	  of	   each	  primer	  were	  within	  2.5°C	  of	   each	  
other,	   and	   the	   percentage	   of	   the	   primer	   made	   of	   guanine	   (G)	   or	   cytosine	   (C)	   was	  
between	  40%	  and	  60%.	  	  
These	   primers	   were	   then	   run	   through	   NetPrimer	   (Premier	   Biosoft;	  
http://www.premierbiosoft.com/netprimer/),	  where	  scores	  were	  generated	  about	  each	  
primer,	   where	   above	   80%	   was	   considered	   acceptable.	   This	   score	   considers	   primer	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dimers	   (binding	  with	   itself),	   repeats	   (nucleotide	   sequences	   repeating),	   runs	   (the	   same	  
nucleotide	   in	   a	   row),	   palindromes	   (a	   sequence	   that	   is	   the	   same	   when	   inverted),	   and	  
hairpins	   (distal	   parts	   of	   the	   primer	   bind	   to	   each	   other),	   features	   of	   the	   primer	  which	  
may	  affect	  its	  efficiency	  in	  the	  RT-­‐qPCR	  reaction.	  Cross	  dimers,	  or	  binding	  between	  the	  
primers	   in	   a	   set,	   are	   not	   considered	   in	   this	   score	   but	   are	   shown.	   The	   primer	   set	  
containing	  highly	  scored	  primers	  that	  met	   the	  criteria	  were	  ordered	  at	  25	  nmole	   from	  
Integrated	  DNA	  Technologies.	  For	  each	  gene	  of	   interest,	  the	  two	  best	  primer	  sets	  from	  
Primer-­‐BLAST	  were	  ordered.	  	  
cDNA	  Synthesis,	  qPCR	  Amplification	  and	  Data	  Acquisition,	  Primer	  Standard	  Curves,	  
and	  Sample	  Reactions	  and	  Data	  Analysis.	  The	  methods	  used	  are	   the	  same	  as	  presented	  
above	  in	  section	  2.2.7,	  and	  the	  primers	  used	  are	  in	  Table	  5.3.	  	  
Sequencing	  of	  Amplified	  Transcripts.	  For	  each	  10	  µL	  RT-­‐qPCR	  reaction,	  1	  µl	  SAP	  
and	  0.25	  µl	  EXO	  was	  added	  and	  mixed	   to	   remove	  excess	  dNTP	  and	  digest	   excess	  PCR	  
primers	  respectively.	  Each	  sample	  was	  heated	  to	  37°C	  for	  30	  min,	  followed	  by	  80°C	  for	  
15	  min.	  These	  samples	  were	  sent	  to	  the	  Otago	  Genetic	  Analysis	  Service	  at	  the	  University	  
of	  Otago	  according	  to	  their	  specifications,	  and	  with	  the	  primers	  used.	  	  
	  
5.2.10 Western	  Blots	  
Protein	   Samples.	   The	   samples	   used	   for	   these	   experiments	   were	   prepared	   by	  
Madeleine	  Kyrke-­‐Smith	  (Williams	  Lab,	  Department	  of	  Anatomy,	  University	  of	  Otago)	  (20	  
min:	   n=5;	   5	   h:	   n=5;	   24	   h:	   n=5).	   LTP	   was	   induced	   in	   awake	   freely	   moving	   rats	   as	  
described	  above	  in	  2.2.1.	  The	  hippocampus	  was	  rapidly	  dissected	  on	  ice	  to	  reduce	  RNA	  
degradation	   and	   the	   dentate	   gyrus	   was	   further	   subdissected	   into	   dorsal	   and	   ventral	  
sections	  from	  each	  hemisphere	  and	  snap	  frozen	  in	  liquid	  nitrogen.	  
Protein	  Extraction.	  Whole	  cell	  protein	  extracts	  were	  previously	  prepared	  from	  the	  
dorsal	   dentate	   gyrus	   of	   HFS-­‐stimulated	   rats	   using	   Cell	   Lysis	   Buffer	   (Biovision),	  
quantified	  using	  a	  Bradford	  assay,	  and	  aliquoted	  into	  5	  µg	  amounts	  by	  Madeleine	  Kryke-­‐
Table	  5.3:	  Sequences	  of	  primers	  to	  amplify	  Mapk1	  transcripts.	  
	   Sequence	  (5’-­‐3’)	  
Mapk1-­‐CDS	  Forward	   TACAGATCTTAAATTGGTCAGGACA	  
Mapk1-­‐CDS	  Reverse	   CGGCTCAAAGGAGTCAAGAGT	  
Mapk1-­‐3UTR	  Forward	   CACTGTGTGCTGTGGAGTTG	  
Mapk1-­‐3UTR	  Reverse	   ACCAAAGGATGTGACACTTGGA	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Smith.	  In	  brief,	  dissected	  tissue	  was	  immediately	  frozen	  in	  liquid	  nitrogen,	  ground	  into	  a	  
fine	   powder	   using	   a	   plastic	   pestle,	   and	   weighed.	   One	   tablet	   of	   the	   protease	   inhibitor	  
cocktail,	  Complete	  EDTA-­‐free	  (Roche),	  was	  added	  to	  25	  mL	  of	  the	  Cell	  Lysis	  Buffer.	  Per	  5	  
mg	  of	  tissue,	  300	  µL	  was	  added	  of	  this	  solution,	  and	  incubated	  for	  an	  hour	  on	  a	  rocking	  
platform	  at	  4°C.	  Lysate	  was	  passed	  through	  a	  25	  g	  needle	  and	  centrifuged	  at	  10,000	  g	  for	  
5	   min	   at	   4°C.	   The	   supernatant	   was	   transferred	   and	   kept	   on	   ice	   to	   estimate	   protein	  
concentration	  
Bradford	  Assay.	  Using	  BSA	  (Sigma),	  a	  standard	  curve	  was	  created	  comprising	  of	  
five	  serial	  dilutions	  of	  protein	  (12	  mg,	  8	  mg,	  4	  mg,	  2	  mg,	  0	  mg)	  measured	  in	  triplicate.	  
Using	   clear	   flat	   bottomed	  Microtest	   96-­‐well	   ELISA	  plates	   (BD	   Falcon),	   2	   µL	   of	   sample	  
was	  added	  to	  the	  plate.	  A	  1:4	  ratio	  of	   the	  BioRad	  protein	  assay	  reagent	  was	  made	  and	  
200	  µL	  was	  added	  to	  each	  well	  and	  left	  to	  develop	  for	  5	  min.	  Absorbance	  at	  595	  nm	  was	  
determined	  using	  a	  microplate	  reader	  (Biorad)	  and	  the	  microplate	  manager	  software.	  	  
9%	  SDS-­‐PAGE	  Gel.	  SDS-­‐PAGE	  gels	  were	  run	  and	  cast	  using	  cassettes	  for	  the	  Novex	  
system	   (Life	   Technologies).	   A	   9%	   SDS-­‐PAGE	   resolving	   gel	   was	   used,	   containing	   9%	  
acrylamide,	  0.5	  mM	  sodium	  dodecyl	  sulfate	  (SDS)	   in	  Tris(hydroxymethyl)methylamine	  
(Tris)	   at	   pH	   8.8,	   0.05%	   ammonium	   persulfate	   (APS)	   and	   0.05%	  
tetramethylethylenediamine	  (TEMED).	  The	  solution	  was	  pipetted	  three-­‐quarters	  of	  the	  
way	   up	   the	   cassette,	   sealed	   with	   water,	   and	   allowed	   to	   set.	   Once	   set,	   the	   water	   was	  
removed	  and	  a	  stacking	  gel	  of	  5%	  acrylamide,	  0.5	  mM	  SDS	  in	  Tris	  at	  pH	  6.8,	  0.05%	  APS,	  
and	  0.1%	  TEMED	  was	  pipetted	  on	  top	  with	  a	  15-­‐well	  comb	  inserted.	  Once	  set,	  the	  combs	  
were	  removed,	  the	  wells	  rinsed	  with	  1x	  running	  buffer,	  the	  white	  tape	  removed	  and	  the	  
cassette	   loaded	   into	   the	  Novex	  electrophoresis	   chamber	   (Invitrogen),	  which	  was	   filled	  
with	  running	  buffer	  of	  25	  mM	  Tris,	  192	  mM	  glycine,	  and	  0.1%	  SDS.	  
Sample	  Preparation.	  Samples	  were	  prepared	  with	  a	   total	  volume	  of	  12	  µL	  and	  a	  
2:1	  ratio	  between	  the	  sample	  and	  the	  sample	  buffer	  of	  10%	  SDS	  and	  0.625	  M	  Tris	  at	  pH	  
6.8.	  Water	   was	   added	   to	   the	   sample	   to	   increase	   the	   volume	   to	   the	   required	   amount.	  
Samples	  and	  the	  Rainbow	  marker	  (GE	  Healthcare	  Life	  Sciences)	  were	  heated	  to	  99°C	  for	  
10	  min	  and	  spun	  down.	  Samples	  were	  loaded	  into	  the	  top	  of	  each	  well	  with	  the	  Rainbow	  
marker	   pipetted	   into	   the	   first	   well	   so	   the	   molecular	   weight	   of	   the	   bands	   could	   be	  
determined.	  Samples	  were	  loaded	  in	  their	  pairs,	  with	  empty	  wells	  filled	  with	  additional	  
but	   unrelated	   sample	   of	   the	   same	   concentration	   to	   prevent	   the	   protein	   bands	   from	  
expanding	  into	  adjacent	  well	  lanes.	  The	  gel	  was	  run	  at	  a	  constant	  125	  V	  for	  2	  h.	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Transfer.	  The	  gel	  was	  removed	  from	  the	  cassette	  and	  one	  piece	  of	  filter	  paper	  was	  
placed	  on	   top	  of	   the	  gel,	  with	  any	  air	  bubbles	   rolled	  out.	  The	  nitrocellulose	  paper	   (GE	  
Healthcare	  Life	  Sciences),	  which	  had	  been	  soaking	   for	  at	   least	  an	  hour	   in	  cold	  transfer	  
buffer,	  with	   the	   date	   and	   initials	  written	   on	   the	   top	   left	   corner,	  was	   placed	   facedown	  
onto	  the	  gel	  and	  air	  bubbles	  removed	  before	  being	  repeated	  with	  another	   filter	  paper.	  
Using	  a	  Novex	   transfer	  module	   (Invitrogen),	   three	   sponges	  also	   soaked	   for	  an	  hour	   in	  
cold	  transfer	  buffer	  were	  placed	  at	  the	  bottom	  of	  the	  tray.	  The	  gel	  stack	  was	  placed	  on	  
top,	  with	  the	  nitrocellulose	  closest	  to	  the	  top	  (Figure	  5.5).	  Two	  additional	  wet	  and	  cold	  
sponges	  were	  placed	  on	   top,	  and	   the	  air	  bubbles	   removed.	  The	   lid	  of	   the	   transfer	  blot	  
module	  was	  placed	  on	  top	  and	  lifted	  into	  the	  Novex	  electrophoresis	  chamber.	  Transfer	  
buffer	  of	  12	  mM	  Tris	  and	  96	  mM	  glycine	  was	  poured	  into	  the	  transfer	  module	  and	  into	  
the	  chamber	  and	  was	  run	  at	  a	  constant	  100	  mA	  for	  2	  h.	  	  
Antibody	  Detection.	  When	  the	  transfer	  was	  finished,	  the	  membrane	  was	  rinsed	  in	  
PBS	  only,	   handling	  with	   forceps	   to	  prevent	  background	   staining	   and	  was	   cut	  down	   to	  
contain	  the	  bands	  of	  interest.	  To	  block	  non-­‐specific	  binding,	  the	  blots	  were	  incubated	  at	  
room	  temperature	  for	  1	  h	  in	  25	  mL	  of	  Odyssey	  blocking	  buffer	  (Licor).	  Membranes	  were	  
probed	   with	   anti-­‐mouse	   and	   anti-­‐rabbit	   antibodies	   recognising	   p42-­‐MAPK and	   p44-­‐
MAPK	   (New	   England	   Biolabs)	   and	   tubulin	   (Abcam)	   respectively.	   The	   p42-­‐MAPK and	  
p44-­‐MAPK	   and	   tubulin	   antibodies	   were	   diluted	   1:2,000	   and	   1:10,000	   respectively	   in	  
PBS/Tween,	  and	  added	  to	  a	  4	  mL	  solution	  with	  0.1%	  BSA	  and	  0.1%	  normal	  goat	  serum	  
(NGS).	  The	  membrane	  was	  placed	  face	  down	  into	  the	  solution	  in	  a	  tight-­‐fitting	  parafilm	  
boat	  and	  incubated	  at	  4°C	  overnight	  with	  gentle	  rocking.	  	  
Membranes	  were	  washed	  four	  times	  for	  5	  min	  each	  with	  PBS/Tween	  with	  gentle	  
mixing	  the	  next	  morning.	  The	  membrane	  was	  incubated	  face	  down	  with	  anti-­‐mouse	  and	  
Figure	  5.5:	  Transfer	  stack	  for	  a	  single	  gel.	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anti-­‐rabbit	  (Licor)	  antibodies	  that	  fluoresce	  at	  680	  and	  800	  nm	  at	  a	  dilution	  of	  1:10,000,	  
detecting	  tubulin	  and	  p42-­‐MAPK and	  p44-­‐MAPK	  respectively.	  Membranes	  were	  washed	  
again	  four	  times	  for	  5	  min	  each	  with	  PBS/Tween	  with	  gentle	  mixing,	  additonally	  washed	  
one	   last	   time	   in	   PBS	   to	   remove	   excess	   Tween.	   The	   blots	   were	   kept	   in	   the	   dark	   until	  
scanning	  to	  prevent	  bleaching	  of	  the	  signal.	  
Scanning	   and	   Data	   Analysis.	   Blots	   were	   scanned	   using	   the	   Odyssey	   (Licor)	  
machine	  using	  the	  accompanying	  ImageStudio	  software.	  The	  membrane	  was	  placed	  face	  
down	  on	  the	  scanner,	  and	  the	  software	  set	  up	   to	  acquire	  the	   image	  under	   ‘Membrane’	  
pre-­‐settings.	  The	  resolution	  was	  set	  at	  169	  µm,	  the	  scanning	  quality	  set	  to	  medium	  and	  
both	  700	  and	  800	  nm	  wavelengths	  measured.	  Once	  scanned,	  the	  file	  was	  saved,	  and	  the	  
blot	  placed	  between	  filter	  paper	  and	  wrapped	  in	  foil.	  
	  Within	  the	  software,	   the	  same	  sized	  measurement	  box	  was	  placed	  around	  each	  
protein	   band	   to	   determine	   their	   signal	   values,	   with	   the	   local	   background	   signal	  
determined	  by	  three	  pixels	  above	  and	  below	  the	  box.	  For	  each	  sample,	  the	  signal	  values	  
for	   p42-­‐MAPK and	  p44-­‐MAPK	  was	  normalised	   to	   tubulin,	   and	   fold	   changes	   calculated	  
between	  matched	  control	  and	  stimulated	  dentate	  gyri.	  Outliers	  were	  determined	  using	  
the	   Grubb's	   test	   (GraphPad;	   http://www.graphpad.com/quickcalcs/Grubbs1.cfm)	  
where	   α	   =	   0.05.	   To	   determine	   whether	   samples	   were	   differentially	   expressed,	   a	   one	  
sample	   Student's	   t-­‐test	   (Excel;	   Microsoft)	   was	   used	   with	   significance	   criterion	   set	   at	  
p<0.05.	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5.3 Validation	  of	  Target	  Interactions	  Using	  Luciferase	  Assays	  
To	  test	  whether	  miR-­‐132-­‐3p	  can	  bind	  to	  the	  predicted	  MRE	  sequences	  within	  the	  
3’	  UTR	  of	  the	  Gria2 and	  Mapk1	  mRNA	  in	  the	  rat,	  luciferase	  assays	  were	  carried	  out.	  
	  
5.3.1 Test	  Sequences	  were	  Successfully	  Inserted	  into	  the	  ψCheck-­‐2	  Plasmid	  
To	   ensure	   that	   the	   inserts	   have	   been	   successfully	   cloned	   within	   the	   ψCheck-­‐2	  
plasmid,	  Sanger	  sequencing	  was	  carried	  out	  using	  primers	  designed	  to	  flank	  either	  side	  
of	  the	  multiple	  cloning	  site.	  For	  each	  insert,	  at	  least	  two	  colonies	  that	  had	  grown	  on	  the	  
ampicillin	   agar	   plates	   were	   grown	   in	   liquid	   culture	   and	   plasmid	   isolated.	   Isolated	  
plasmid	   from	   both	   colonies	   were	   sequenced	   twice,	   once	   in	   each	   direction	   to	   ensure	  
confidence	  of	  a	  successful	  insertion.	  Based	  on	  the	  100%	  match	  of	  the	  sequence	  reads	  to	  
the	  reference	  sequences	  of	  the	  inserts	  and	  plasmids,	  the	  inserts	  were	  determined	  to	  be	  
successfully	  inserted.	  Further,	  the	  sequences	  of	  approximately	  one	  third	  of	  the	  plasmid	  
was	  found	  not	  to	  be	  altered	  in	  any	  way	  (Figure	  5.6).	  
	   	  
Figure	   5.6	   (on	   following	   page):	   Sequencing	   of	   ψCheck-­‐2	   plasmids	   with	   inserts	   of	   interest.	  
Chromatograms	  showing	  the	  expression	  of	  each	  nucleotide	  (green:	  A;	  red:	  T;	  black:	  G;	  blue:	  C)	  is	  shown	  
above	  the	  final	  sequences	  in	  blue	  text.	  Below	  the	  sequence	  text	  is	  displayed	  a	  line	  diagram	  representing	  
the	  sequenced	  fragment	  and	  the	  features	  within	  that	  fragment,	  green	  representing	  the	  Renilla	  luciferase	  
gene,	  the	  blue	  the	  insert,	  and	  the	  purple	  the	  accessory	  regions	  of	  the	  plasmid.	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5.3.2 miR-­‐132-­‐3p	  Mimic	  and	  Inhibitor	  Regulate	  the	  Perfect	  Match	  Control	  
To	   test	   that	   the	   assay	   was	   working	   with	   the	   reagents	   and	   oligonucleotides,	   a	  
positive	  control	  utilising	  a	  ψCheck-­‐2	  plasmid	  with	  a	  completely	  complementary	  insert	  to	  
the	   miR-­‐132-­‐3p	   mimic	   was	   undertaken.	   Complete	   complementarity	   of	   the	   target	  
sequence	   to	   the	  mimic	   should	   result	   in	   a	   dramatic	   decrease	   in	   activity	   of	   the	  Renilla	  
luciferase	   and	   associated	   luminescence.	   The	   RNAhybird	   algorithm	   indicated	   a	   strong	  
interaction	  occurred	  between	   the	   two	   sequences,	  with	   a	  negative	   large	  minimum	   free	  
energy	   of	   -­‐45.3	   kcal/mol	   (MFE;	   Figure	   5.7A).	   An	   expected	   normal	   luminescence	   trace	  
was	   observed,	   with	   an	   initial	   high	   luminescence,	   followed	   by	   a	   lower	   and	   decreasing	  
luminescence	   trace	   following	   the	   application	   of	   the	   S+G	   reagent	   (Figure	   5.8B).	   To	  
control	  for	  any	  cellular	  effects	  mediated	  by	  the	  ψCheck-­‐2	  plasmid,	  data	  were	  normalised	  
to	  the	  average	  ratio	  of	  the	  miR-­‐132-­‐3p	  perfect	  match	  plasmid	  (p132PM)	  only.	  Further,	  
data	   were	   compared	   to	   the	   p132PM	   transfected	   with	   the	   negative	   control	   as	   the	  
baseline,	   as	   this	   experienced	   the	   same	   double	   transfection	   conditions	   as	   the	  
experimental	  condition,	  but	  the	  oligonucleotide	  does	  not	  bind	  to	  the	  ψCheck-­‐2	  plasmid	  
and	   affect	   its	   luminescence.	   As	   a	   result,	   a	   highly	   significant	   decrease	   in	   the	   Renilla	  
luminescence	  of	   the	  p132PM	  transfected	  with	   the	  mimic	  was	  observed	   indicating	   that	  
the	  miR-­‐132-­‐3p	  mimic	  bound	  to	  the	  insert	  site	  within	  the	  3’	  UTR	  of	  the	  Renilla	  luciferase	  
transcript	  (p<0.001,	  n=4;	  Figure	  5.7B).	  
Figure	  5.7:	  Luciferase	  assay	   for	  miR-­‐132-­‐
3p	  perfect	  match	  sequence	  with	  mimic.	  A.	  
Details	   of	   the	   binding	   between	   the	   insert	  
sequence	   (blue)	   and	   the	   miR-­‐132-­‐3p	  
mimic	   (red).	  The	  minimum	   free	  energy	  of	  
the	   binding	   is	   -­‐45.3	   kcal/mol.	   B.	  
Luminescence	   of	   the	   miR-­‐132-­‐3p	   perfect	  
match	   plasmid	   (p132PM)	   with	   the	   miR-­‐
132-­‐3p	   mimic	   and	   negative	   control.	   A	  
significant	   decrease	   in	   Renilla	   luciferase	  
activity	   indicates	   a	   binding	   of	   the	   miR-­‐
132-­‐3p	  mimic	  to	  the	  insert	  site.	  Expression	  
values:	   average	   ratio	   ±	   SD;	   normalised	   to	  
ratio	   of	   plasmid	   only;	   ***	   Students’	   two	  
tailed	   t-­‐test	   p<0.001;	   n=4.	   Adapted	   from	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However,	   the	   addition	   of	   the	   inhibitor,	   which	   should	   bind	   to	   any	   endogenous	  
miR-­‐132-­‐3p	   within	   the	   COS-­‐7	   cells	   and/or	   miR-­‐132-­‐3p	   mimic,	   induced	   a	   lower	  
expression	  of	  the	  firefly	  luciferase	  than	  that	  of	  the	  Renilla	  luciferase	  (Figure	  5.8B).	  As	  the	  
luciferase	   assays	   are	   designed	   so	   that	   the	   firefly	   luciferase	   produces	   a	   higher	  
luminescence	   than	   that	   of	   the	   Renilla	   luciferase,	   a	   possible	   interaction	   between	   the	  
firefly	   and	   inhibitor	  may	   be	   occurring,	   resulting	   in	   reduced	   expression	   (Figure	   5.8A).	  
While	  the	  inhibitor	  was	  spiked	  with	  LNA	  backbone	  structures	  to	  increase	  specificity	  to	  
the	  exact	  miRNA	  sequence,	  the	  addition	  of	  the	  cholesterol	  conjugation	  which	  aids	  in	  its	  
transfection	  efficiency	  may	  alter	  its	  ability	  to	  bind	  to	  target	  sequences.	  Therefore,	  based	  
Figure	  5.8:	  Luciferase	  assay	  for	  miR-­‐132-­‐3p	  perfect	  match	  sequence	  with	  all	  oligonucleotides.	  A.	  Details	  
of	  the	  binding	  between	  the	  firefly	  luciferase	  gene	  (blue)	  and	  the	  miR-­‐132-­‐3p	  inhibitor	  (red).	  The	  minimum	  
free	   energy	   of	   the	   binding	   is	   –24.1	   kcal/mol.	   B-­‐C.	   Average	   luminescence	   traces	   across	   each	   condition	  
above	  bar	  representing	  their	  average	  ratio	  for	  miR-­‐132-­‐3p	  perfect	  match	  plasmid	  (p132PM)	  with	  the	  miR-­‐
132-­‐3p	  mimic,	   negative	   control,	   inhibitor,	   and	  various	   combinations.	   All	   traces	  with	   the	   inhibitor	   show	  
lower	   firefly	   luciferase	   activity	   than	   the	   Renilla	   luciferase	   activity,	   indicating	   that	   possible	   interaction	  
between	   the	   firefly	   luciferase	   gene	   and	   the	   miR-­‐132-­‐3p	   inhibitor	   may	   be	   occurring.	   The	   dotted	   line	  
represents	   the	   ratio	   where	   expression	   and	   activity	   of	   both	   luciferases	   are	   equal.	   Expression	   values:	  
average	   ratio	   ±	   SD;	   normalised	   to	   ratio	   of	   plasmid	   only;	   ***	   Students’	   two	   tailed	   t-­‐test	   p<0.001;	   n=4.	  
Adapted	  from	  Joilin	  et	  al.	  (2014).	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on	  these	  observations,	  those	  results	  that	  include	  the	  inhibitor	  presented	  in	  Figure	  5.8C	  
are	  not	  interpretable	  (Appendix	  D).	  Nevertheless,	  the	  luminescence	  traces	  with	  the	  use	  
of	  the	  mimic	  and	  the	  comparisons	  to	  the	  negative	  control	  show	  that	  the	  assay	  is	  valid.	  	  
	  	  
5.3.3 Gria2	  is	  Not	  Regulated	  by	  miR-­‐132-­‐3p	  
Gria2	   was	   tested	   for	   its	   predicted	   interaction	  with	  miR-­‐132-­‐3p.	   Evaluating	   the	  
sites	  predicted	  by	  the	  algorithms	  through	  their	  seed	  size,	  location	  in	  the	  3’UTR,	  and	  their	  
MFE	  through	  RNAhybrid,	  the	  MRE	  chosen	  for	  further	  analysis	  was	  26	  bp	  from	  the	  stop	  
codon	  in	  the	  3’UTR	  of	  the	  Gria2 mRNA	  (Figure	  5.9A-­‐B).	  The	  target	  MRE	  was	  a	  7mer-­‐m8	  
seed	   site	  with	  an	  MFE	  of	   -­‐22.7	  kcal/mol.	  With	  a	  normal	   luminescence	   trace	  observed,	  
and	   normalising	   to	   the	   ratio	   of	   the	   Gria2 wildtype	   plasmid	   (pGria2 WT)	   only,	   no	  
significant	   decrease	   occurred	   in	   the	  Renilla	   luminescence	   of	   the	  wildtype	   pGria2	  with	  
the	   mimic	   compared	   to	   the	   p132PM	   with	   the	   negative	   control	   (p=0.19,	   n=4;	   Figure	  
5.9C).	   These	   data	   suggest	   that	   miR-­‐132-­‐3p	   does	   not	   have	   a	   significant	   effect	   on	   the	  
regulation	  of	   the	   transcript	   through	   this	   target	   site.	  Additional	   experiments	   to	   further	  
characterise	   this	   possible	   interaction	   by	   mutating	   the	   seed	   site	   on	   the	   MRE	   were	  
Figure	   5.9:	   Details	   of	   the	   Gria2 wildtype	  
MRE	   sequences	   and	   luciferase	   assay.	   A.	  
Details	  of	   the	  Gria2 mRNA,	  with	   the	   coding	  
region	   in	   green.	   There	   are	   two	   major	  
variants	  of	  the	  transcript,	  but	  both	  share	  the	  
same	  sequence	  for	  the	  MRE,	  whose	  location	  
is	   marked	  with	   an	   arrow.	  B.	   Details	   of	   the	  
binding	   between	   the	   MRE	   insert	   sequence	  
(blue)	  and	  the	  miR-­‐132-­‐3p	  mimic	  (red).	  The	  
minimum	  free	  energy	  of	  the	  binding	  is	  -­‐22.7	  
kcal/mol.	   C.	   Luminescence	   of	   the	   Gria2 
wildtype	   plasmid	   (pGria2 WT)	   with	   the	  
miR-­‐132-­‐3p	  mimic	  and	  negative	  control.	  No	  
significant	   decrease	   in	   Renilla	   luciferase	  
activity	  indicates	  no	  binding	  of	  the	  miR-­‐132-­‐
3p	   mimic	   to	   the	   insert	   site.	   Expression	  
values:	   average	   ratio	   ±	   SD;	   normalised	   to	  
ratio	   of	   plasmid	   only;	   ns	   Students’	   two	  
tailed	   t-­‐test	   p>0.05;	   n=4).	   Adapted	   from	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concurrently	   conducted	   with	   these	   experiments,	   but	   are	   not	   presented	   as	   this	  
interaction	  between	  miR-­‐132-­‐3p	  and	  Gria2	  was	  not	  shown	  (Appendix	  D).	  
	  
5.3.4 Mapk1	  is	  Regulated	  by	  miR-­‐132-­‐3p	  Through	  an	  8mer	  Seed	  
The	  sites	  on	   the	  Mapk1	   transcript	  predicted	   to	  be	  bound	  by	  miR-­‐132-­‐3p	  by	   the	  
algorithms	  were	   evaluated	   by	   the	   same	  method	   as	  Gria2.	  The	   target	  MRE	   chosen	   for	  
further	   analysis	  was	   1,265	   bp	   from	   the	   stop	   codon	   in	   the	   3’	   UTR	   of	   the	   predicted	   X1	  
variant	  of	  the	  Mapk1 mRNA.	  The	  target	  MRE	  was	  an	  8mer	  seed	  site	  with	  an	  MFE	  of	  -­‐21.4	  
kcal/mol	  (Figure	  5.10A-­‐B).	  With	  a	  normal	  luminescence	  trace	  observed,	  and	  normalising	  
to	   the	   ratio	   of	   the	  Mapk1 wildtype	   plasmid	   (pMapk1 WT)	   only,	   a	   significant	   decrease	  
was	   detected	   in	   the	   Renilla	   luminescence	   of	   the	   wildtype	   pMapk1	   with	   the	   mimic	  
compared	  to	  the	  p132PM	  with	  the	  negative	  control	  (p<0.001,	  n=4;	  Figure	  5.10C).	  These	  
data	   suggest	   that	   miR-­‐132-­‐3p	   does	   bind	   to	   this	   target	   site,	   and	   could	   affect	   the	  
regulation	  of	  the	  Mapk1 transcript.	  	  
To	  investigate	  the	  importance	  of	  the	  8mer	  seed	  of	  the	  miRNA	  to	  the	  interaction	  
occurring,	   the	   seed	   site	   was	   mutated.	   As	   guanine	   and	   cytosine	   nucleotides	   create	   a	  
Figure	  5.10:	  Details	  of	   the	  Mapk1	  wildtype	  
MRE	   sequences	   and	   luciferase	   assay.	   A.	  
Details	  of	  the	  Mapk1	  mRNA,	  with	  the	  coding	  
region	   in	  green.	  The	   location	   of	   the	  MRE	   is	  
marked	   with	   an	   arrow.	   B.	   Details	   of	   the	  
binding	   between	   the	   MRE	   insert	   sequence	  
(blue)	  and	  the	  miR-­‐132-­‐3p	  mimic	  (red).	  The	  
minimum	  free	  energy	  of	  the	  binding	  is	  -­‐21.4	  
kcal/mol.	   C.	   Luminescence	   of	   the	   Mapk1	  
wildtype	   plasmid	   (pMapk1WT)	   with	   the	  
miR-­‐132-­‐3p	   mimic	   and	   negative	   control.	   A	  
significant	   decrease	   in	   Renilla	   luciferase	  
activity	   indicates	  a	  binding	  of	   the	  miR-­‐132-­‐
3p	   mimic	   to	   the	   insert	   site.	   Expression	  
values:	   average	   ratio	   ±	   SD;	   normalised	   to	  
ratio	   of	   plasmid	   only;	   ***	   Students’	   two	  
tailed	   t-­‐test	   p<0.001;	   n=4.	   Adapted	   from	  
Joilin	  et	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stronger	   bond	   to	   each	   other	   than	   adenosine	   and	   thymine	   nucleotides,	   all	   the	   former	  
nucleotides	  were	  changed	  to	  the	  latter,	  disrupting	  the	  MRE	  within	  the	  Mapk1	  transcript	  
(Figure	  5.11A).	  Carrying	  out	  the	  luciferase	  assay	  on	  the	  Mapk1 mutant	  plasmid	  (pMapk1 
MUT),	   following	   normalisation	   to	   the	  mutant	   pMapk1 only,	   no	   significant	   decrease	   in	  
Renilla	   luminescence	   with	   the	   mimic	   was	   observed	   when	   compared	   to	   the	   negative	  
control	  (p=0.07,	  n=4;	  Figure	  5.11B).	  While	  this	  suggests	  that	  the	  seed	  site	  is	  likely	  to	  be	  
important	   for	   this	   interaction,	   a	   decreasing	   trend	   can	   be	   observed,	   indicating	   that	  
compensatory	   binding	   at	   the	   3’	   end	   of	   the	   miRNA	   to	   the	   target	   transcript	   may	   be	  
occurring	  and	  may	  be	  sufficient	  for	  regulation.	  Therefore,	  it	  appears	  that	  the	  transcript	  










	   	  
Figure	   5.11:	   Details	   of	   the	   Mapk1	   mutant	  
MRE	   sequences	   and	   luciferase	   assay.	   A.	  
Details	   of	   the	   binding	   between	   the	   MRE	  
insert	   sequence	   (blue)	   and	   the	  miR-­‐132-­‐3p	  
mimic	   (red).	   The	   minimum	   free	   energy	   of	  
the	   binding	   is	   -­‐11.2	   kcal/mol.	   B.	  
Luminescence	  of	  the	  Mapk1	  mutant	  plasmid	  
(pMapk1MUT)	  with	   the	  miR-­‐132-­‐3p	  mimic	  
and	   negative	   control.	   No	   significant	  
decrease	   in	   Renilla	   luciferase	   activity	  
indicates	   no	   binding	   of	   the	   miR-­‐132-­‐3p	  
mimic	   to	   the	   insert	   site.	   Expression	  values:	  
average	   ratio	   ±	   SD;	   normalised	   to	   ratio	   of	  
plasmid	   only;	   ns	   Students’	   two	   tailed	   t-­‐test	  
p>0.01;	   n=4.	   Adapted	   from	   Joilin	   et	   al.	  
(2014).	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5.4 Expression	  of	  Mapk1 following	  LTP	  
With	  miR-­‐132-­‐3p	  shown	  to	  interact	  with	  Mapk1,	  and	  with	  miR-­‐132-­‐3p	  regulated	  
post-­‐LTP,	   a	   key	   question	  was	  whether	   it	  was	   concurrently	   regulated	   at	   the	  mRNA	   or	  
protein	   level.	   RT-­‐qPCR	   and	  Western	   blots	  were	   used	   to	   profile	   the	  Mapk1	  mRNA	   and	  
p42-­‐MAPK	  protein.	  
	  
5.4.1 Differential	  Expression	  of	  Mapk1	  mRNA	  following	  LTP	  	  
The	  mRNA	   transcript	  of	  Mapk1	  was	   found	   to	  not	  be	  differentially	  expressed	  on	  
the	  microarrays	  20	  min,	  5	  h,	   and	  24	  h	  post-­‐LTP	   (Ryan	  et	  al.,	   2011;	  Ryan	  et	  al.,	   2012).	  
However,	  these	  microarrays	  contained	  multiple	  probes	  sets	  against	  differing	  portions	  of	  
the	   Mapk1	   transcript,	   which	   may	   not	   all	   have	   the	   same	   efficacy	   in	   detecting	   its	  
differential	   expression.	   Further,	   it	   was	   found	   that	   the	   probes	   profiling	   Mapk1	   could	  
potentially	  measure	   different	   forms	   of	   the	   transcripts,	  with	   some	  probes	   selective	   for	  
certain	   transcripts,	   including	   these	   two	   transcripts	   profiled	   by	   RT-­‐qPCR.	   However,	  
attempts	  to	  see	  the	  expression	  of	  each	  probe	  to	  determine	  if	  the	  differential	  expression	  
of	  Mapk1	  was	  obscured	  by	   the	   averaging	  of	  multiple	  probes	  were	  unsuccessful.	  Using	  
the	  Affy	  package	  in	  R,	  the	  values	  of	  individual	  probes	  could	  be	  extracted	  before,	  but	  not	  
after	  normalisation	  of	  the	  data,	  which	  is	  necessary	  for	  any	  analysis	  of	  array	  data.	  
Therefore,	   to	   investigate	  whether	  Mapk1	  was	  differentially	  expressed	  post-­‐LTP,	  
the	  more	  sensitive	  technique	  of	  RT-­‐qPCR	  was	  used.	  Two	  set	  of	  primers	  were	  designed:	  
the	  first	  set	  of	  primers	  were	  designed	  to	  the	  coding	  region	  of	   the	  mRNA	  (Mapk1-­‐CDS),	  
while	   the	   second	   set	   were	   designed	   for	   the	   3’	   UTR	   from	   the	   predicted	   X1	   variant	  
Figure	   5.12:	   Long-­‐term	   potentiation	   regulates	   Mapk1	   transcripts.	   Primers	   that	   amplified	   the	   CDS	  
showed	  significant	  down-­‐regulation	  at	  20	  min	  and	  up-­‐regulation	  at	  5	  h.	   In	  contrast,	  primers	  amplifying	  
the	   3’	   UTR	   containing	   the	  miR-­‐132-­‐3p	   MRE	   showed	   significant	   down-­‐regulation	   at	   20	  min	   and	   24	   h.	  
Neither	  were	  regulated	  at	  20	  min	  with	  CPP.	  Expression	  values:	  Average	  fold	  change	  ±	  SEM;	  normalised	  to	  
Hprt;	  one	  sample	  two-­‐tailed	  t-­‐test	  *	  p	  <	  0.05	  ***	  p	  <	  0.001;	  n=3-­‐9.	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containing	  the	  MRE	  for	  miR-­‐132-­‐3p	  used	  in	  the	  luciferase	  assays	  (Mapk1-­‐3UTR).	  
Looking	   at	   the	   expression	   of	   Mapk1	   transcript	   amplified	   by	   the	   Mapk1-­‐CDS	  
primer	  set	  across	  time	  post-­‐LTP,	  it	  was	  found	  that	  there	  was	  significant	  down-­‐regulation	  
at	   20	   min	   (0.55±0.14,	   p<0.01,	   n=9;	   Figure	   5.12),	   significant	   up-­‐regulation	   at	   5	   h	  
(1.9±0.36	   p=0.03,	   n=9;	   Figure	   5.12),	   and	   no	   significant	   change	   at	   24	   h	   (0.44±0.30,	  
p=0.16,	  n=4;	  Figure	  5.12).	  In	  contrast,	  the	  expression	  of	  the	  X1	  variant	  that	  contains	  the	  
investigated	  MRE	  for	  miR-­‐132-­‐3p	  amplified	  by	  the	  Mapk1-­‐3UTR	  set	  of	  primers	  showed	  a	  
significant	   down-­‐regulation	   at	   20	   min	   (0.41±0.09,	   p<0.01,	   n=9;	   Figure	   5.12),	   no	  
significant	  change	  at	  5	  h	  (1.47±0.24,	  p=0.08,	  n=10;	  Figure	  5.12),	  and	  a	  significant	  down-­‐
regulation	  at	  24	  h	  (0.48±015,	  p=0.04,	  n=4;	  Figure	  5.12).	  The	  down-­‐regulation	  detected	  
by	  both	  sets	  of	  primers	  at	  20	  min	  was	  blocked	  with	  the	  application	  of	  CPP	  (Mapk1-­‐CDS:	  
1.05±0.31,	  p=0.88,	  n=3;	  Mapk1-­‐3UTR:	  1.52±0.77,	  p=0.57,	  n=3;	  Figure	  5.12).	  To	  ensure	  
that	  Mapk1	  was	  being	  amplified	  by	  these	  sets	  of	  primers,	  the	  products	  from	  the	  RT-­‐qPCR	  
reaction	   were	   sequenced	   and	   compared	   to	   the	   reference	   sequence.	   Combined	   with	  
single	   peaks	   present	   in	   the	  melting	   curve	   analysis,	   the	   sequencing	   confirmed	   that	   the	  
transcripts	   amplified	   were	   Mapk1,	   and	   no	   non-­‐specific	   amplification	   had	   occurred	  
(Figure	  5.13).	  Therefore,	  the	  RT-­‐qPCR	  results	  show	  an	  NMDAR-­‐dependent	  regulation	  of	  
Mapk1	   transcripts,	  with	  differential	   expression	  between	   those	   containing	   the	  CDS	  and	  
those	  containing	  the	  MRE	  of	  miR-­‐132-­‐3p.	  
	  
Figure	  5.13:	  Sequencing	  of	  RT-­‐qPCR	  products	  amplified	  by	   the	  Mapk1-­‐CDS	  and	   the	  Mapk1-­‐3UTR	  set	  of	  
primers.	  Chromatograms	  showing	  the	  expression	  of	   each	  nucleotide	   (green:	  A;	  red:	  T;	  black:	  G;	  blue:	  C)	  
are	  shown	  above	  and	  below	  the	  amplified	  sequences.	  The	  red	  line	  represents	  the	  total	  sequence	  that	  can	  
be	  mapped	  to	  the	  Mapk1	  transcripts.	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5.4.2 HFS	  Induced	  LTP	  	  
LTP	   was	   induced	   using	   protocols	   known	   to	   induce	   long	   lasting	   plasticity	  
dependent	   on	   gene	   expression	   (Abraham	   et	   al.,	   2002;	   Bowden	   et	   al.,	   2012).	   For	   each	  
group	   of	   adult	   male	   rats,	   DBS	   was	   administered	   while	   the	   animals	   were	   awake	   to	  
perforant	  path	  synapses	  in	  the	  dentate	  gyrus	  following	  a	  stable	  baseline	  for	  30	  min.	  All	  
LTP	   experimental	   groups	   of	   rats	   (20	   min,	   5	   h,	   and	   24	   h	   post-­‐LTP)	   met	   the	   minimal	  
criteria	   for	   LTP	   induction	   (fEPSP:	   15%	   increase)(Figure	   5.14).	   Amplification	   in	   both	  
fEPSP	  and	  PS	  persisted	  for	  the	  20	  min	  prior	  to	  their	  sacrifice	  for	  all	  three	  groups.	  
	  
5.4.3 p42-­‐MAPK	  is	  Differentially	  Expressed	  post-­‐LTP	  	  
Western	   blots	   were	   carried	   out	   to	   measure	   the	   expression	   of	   p42-­‐MAPK,	   the	  
protein	  that	  results	  from	  the	  Mapk1	  mRNA	  transcript,	  post-­‐LTP	  induction.	  Using	  dorsal	  
dentate	   gyrus	   tissue,	   it	  was	   found	   that	   there	  was	   significant	   down-­‐regulation	   of	   p42-­‐
MAPK	   at	   20	  min	   (0.86±0.01,	   p<0.01,	   n=4;	   Figure	   5.15),	   no	   change	   at	   5	   h	   (1.05±0.06,	  
p=0.51,	   n=5;	   Figure	   5.15),	   and	   a	   significant	   increase	   at	   24	   h	   (1.14±0.04,	   p=0.04,	   n=4;	  
Figure	  5.15).	  Further,	  the	  antibody	  against	  p42-­‐MAPK	  also	  recognises	  one	  other	  protein	  
ban	  for	  the	  protein	  p44-­‐MAPK,	  the	  resultant	  protein	  from	  the	  Mapk3	  transcript,	  and	  this	  
Figure	   5.14:	   Induction	   of	   long-­‐term	   potentiation	   following	   administration	   of	   delta-­‐burst	   stimulation	  20	  
min	  (A),	  5	  h	  (B),	  and	  24	  h	  (C)	  post-­‐LTP.	  The	  average	  field	  evoked	  postsynaptic	  potential	  is	  plotted.	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showed	  a	  down-­‐regulation	  only	  at	  20	  min	  post-­‐LTP	  (20	  min:	  0.81±0.02,	  p<0.01,	  n=4;	  5	  
h:	  0.94±0.06,	  p=0.35,	  n=5;	  24	  h:	  0.99±0.11,	  p=0.92,	  n=5;	  Figure	  5.15).	  This	  experiment	  
demonstrates	   that	  p42-­‐MAPK	  shows	  differential	   expression	   following	   the	   induction	  of	  
LTP.	   Furthermore,	  while	  both	   the	  mRNA	  and	   the	  protein	   show	  down-­‐regulation	  at	  20	  
min,	  the	  expression	  of	  the	  transcript	  and	  the	  protein	  differ	  at	  5	  h	  and	  24	  h,	  suggesting	  
that	   there	   are	   complex	   mechanisms	   underlying	   their	   regulation	   not	   immediately	  
apparent	  from	  their	  expression.	  
	  
	   	  
Figure	  5.15:	  Long-­‐term	  potentiation	   regulates	  p42-­‐MAPK	  and	  p44-­‐MAPK.	  Expression	  of	  p42-­‐MAPK,	  the	  
protein	  from	  the	  Mapk1	  transcript,	  was	  differentially	  expressed	  post-­‐LTP,	  with	  a	  decrease	  at	  20	  min	  and	  
an	   increase	   at	   24	  h.	  p44-­‐MAPK,	   the	   protein	   from	   the	  Mapk3	   transcript,	  was	  only	  down-­‐regulated	   at	   20	  
min.	  Expression	  values:	  Average	  fold	  change	  ±	  SEM;	  normalised	  to	  tubulin;	  one	  sample	  two-­‐tailed	  t-­‐test	  *	  
p	  <	  0.05	  **	  p	  <	  0.01;	  n=4-­‐5.	  Adapted	  from	  Joilin	  et	  al.	  (2014).	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5.5 Discussion	  
This	  work	  has	  demonstrated	  that	  the	  investigated	  target	  site	  for	  Gria2 is	  unlikely	  
to	  be	  a	  binding	  site	  for	  miR-­‐132-­‐3p,	  though	  this	  is	  not	  to	  say	  that	  Gria2	  is	  not	  targeted	  by	  
miR-­‐132-­‐3p,	   as	   there	   are	   additional	   target	   sites	  within	   the	   transcript	  which	   could	   be	  
functional.	  In	  contrast,	  the	  investigated	  target	  site	  for	  Mapk1 appears	  to	  be	  regulated	  by	  
miR-­‐132-­‐3p,	   with	   indications	   that	   binding	   at	   the	   5’	   seed	   site	   is	   important	   for	   this.	  
Furthermore,	   the	   Mapk1	   transcript	   and	   its	   associated	   protein	   p42-­‐MAPK	   showed	  
differential	  expression	  post-­‐LTP	  and	  to	  each	  other.	  
	  
5.5.1 Biological	  Significance	  of	  miR-­‐132-­‐3p-­‐Mapk1 Interaction	  in	  LTP	  
Through	  the	  use	  of	  luciferase	  assays,	  it	  has	  been	  shown	  that	  Mapk1	  is	  likely	  to	  be	  
regulated	  by	  miR-­‐132-­‐3p.	  Furthermore,	  it	  appears	  that	  binding	  between	  the	  5’	  seed	  site	  
and	   the	   MRE	   is	   crucial	   for	   this	   regulation,	   as	   mutations	   in	   this	   region	   disrupted	   the	  
interaction.	  However,	  while	  not	  significant,	  a	  trend	  for	  regulation	  of	  the	  mutant	  insert	  by	  
miR-­‐132-­‐3p	   can	   still	   be	   observed,	   suggesting	   that	   there	   may	   be	   sufficient	  
complementary	  binding	  of	  the	  3’	  end	  of	  the	  miRNA	  to	  the	  MRE	  on	  the	  Mapk1	  transcript.	  
Such	   a	   finding	   is	   not	   uncommon,	   with	   numerous	   interactions	   demonstrated	   to	   not	  
involve	   the	  binding	  of	   the	  miRNA	   through	   the	  5’	   seed	   site	   (Bartel,	   2009;	  Martin	  et	   al.,	  
2014),	  and	  other	  targets	  of	  miR-­‐132-­‐3p	  investigated	  using	  this	  protocol	  suggested	  such	  
an	  effect	  (Joilin	  et	  al.,	  2014).	  This	  suggests	  that	  miR-­‐132-­‐3p	  is	  likely	  to	  be	  involved	  in	  the	  
expression	   of	   the	   Mapk1	   transcript	   and	   protein,	   and	   this	   might	   be	   through	   non-­‐
canonical	  binding,	  though	  this	  requires	  further	  investigation.	  
This	   is	   supported	   by	   the	   expression	   data	   observed	   at	   both	   the	   transcript	   and	  
protein	  level	  across	  time	  post-­‐LTP.	  An	  up-­‐regulation	  in	  the	  Mapk1	  transcript	  at	  5	  h	  was	  
observed,	  consequently	  leading	  to	  an	  increase	  in	  total	  p42-­‐MAPK	  protein	  occurring	  24	  h	  
post-­‐LTP.	  Even	  though	  there	  is	  no	  down-­‐regulation	  of	  the	  miR-­‐132-­‐3p	  at	  the	  same	  time	  
points	  where	  an	  increase	  in	  Mapk1	  mRNA	  and	  protein	  occurs,	  the	  increase	  in	  the	  protein	  
at	  24	  h	  post-­‐LTP	  could	  still	  be	  mediated	  by	  the	  decrease	  in	  miR-­‐132-­‐3p	  expression	  at	  20	  
min,	   the	   delay	   resultant	   from	   the	   time	   required	   for	   the	   synthesis	   of	   the	   mRNA	   and	  
protein.	  Further,	  the	  up-­‐regulation	  of	  the	  Mapk1	  mRNA	  transcript	  at	  5	  h	  would	  suggest	  
that	   miR-­‐132-­‐3p	   regulates	   it	   through	   RNA	   degradation.	   The	   release	   of	   the	   inhibitory	  
regulation	  at	  20	  min	  could	  allow	  an	  accumulation	  of	  the	  Mapk1	  transcript	  as	  detected	  at	  
5	  h,	  which	  then	  is	  translated	  into	  the	  protein	  by	  24	  h.	  However,	  with	  basal	  expression	  of	  
miR-­‐132-­‐3p	  returned	  by	  5	  h,	  degradation	  of	  the	  Mapk1	  transcript	  resumes,	  resulting	  in	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its	  down-­‐regulation	  by	  24	  h.	  This	  suggests	  that	  the	  role	  of	  miR-­‐132-­‐3p	  regulating	  Mapk1	  
may	   be	   as	   a	   homeostatic	   mechanism	   to	   return	   Mapk1	   back	   to	   baseline	   levels	   and	  
preventing	   continued	   activation	   of	   the	   MAPK	   pathway	   in	   the	   long-­‐term	   post-­‐LTP.	  
However,	  as	   the	   total	  protein	  expression	  of	  Mapk1	   is	  unknown	  beyond	  24	  h	  post-­‐LTP,	  
further	  studies	  are	  required	  to	  investigate	  whether	  this	  is	  true.	  Further,	  as	  Mapk1	  is	  only	  
active	  when	   it	   is	  phosphorylated,	  how	  the	  changing	   levels	   in	  abundance	  of	   the	  protein	  
affects	   its	  overall	  activity	  post-­‐LTP	   is	  unknown	  across	   time.	  As	   it	  has	  been	  shown	  that	  
phosphorylation	   of	   p42-­‐MAPK	   can	   be	   independent	   of	   its	   total	   amount	   (Davis	   et	   al.,	  
2000),	  future	  studies	  should	  investigate	  its	  activity	  using	  phosphorylation	  state	  specific	  
antibodies	  and	  activity	  assays	  across	  these	  three	  time	  points	  and	  how	  this	  is	  influenced	  
by	  miR-­‐132-­‐3p.	  	  
Interestingly,	   the	  Mapk1	   transcript	   that	  did	  contain	  the	  site	  within	   its	  reference	  
3’UTR	  sequence	  did	  not	  show	  a	  significant	   increase	  in	  expression	  at	  5	  h.	  The	  observed	  
increase	  in	  the	  Mapk1	  mRNA	  at	  5	  h	  post-­‐LTP,	  that	  would	  precede	  this	  protein	  increase,	  
was	  for	  the	  Mapk1	  transcript	  that	  does	  not	  contain	  the	  binding	  site	  within	  the	  3’	  UTR	  on	  
the	   reference	   sequence	   (Figure	   5.16).	   However,	   it	   is	   possible	   that	   miR-­‐132-­‐3p	   could	  
bind	   to	   alternate	   sites	   outside	   of	   the	   3’	   UTR	   such	   as	   in	   the	   CDS.	   Indeed,	   RNAhybrid	  
predicts	  at	  least	  four	  MRE	  sites	  that	  show	  higher	  MFE	  than	  the	  site	  investigated	  within	  
the	   3’	   UTR	   –	   though	   through	   non-­‐canonical	   binding.	   Alternatively,	   this	   could	   indicate	  
that	   there	   may	   be	   multiple	   mechanisms	   regulating	   the	   expression	   of	   the	   p42-­‐MAPK	  
protein,	  through	  multiple	  variants	  of	  the	  transcripts.	  It	  may	  be	  that	  there	  are	  pathway-­‐
specific	   variants	   regulated	   separately	   by	   discrete	   molecular	   events,	   altering	   their	  
abundance.	   Indeed,	   the	   abundance	   of	   these	   transcripts	   and	   the	   proportions	   of	   these	  
transcripts	   are	   unknown,	   through	   the	   Cq	   values	   for	   both	   transcripts	   were	   similar.	  
Further,	   multiple	   other	   miRNA	   are	   predicted	   to	   regulate	   the	   expression	   of	   Mapk1,	  
including	  miR-­‐129-­‐5p	  and	  miR-­‐181c-­‐5p,	  both	  of	  which	  were	   found	   to	  be	   regulated	  20	  
Figure	  5.16:	  Summary	  diagram	  of	  the	  transcripts,	  location	  of	  the	  amplicon	  amplified	  by	  the	  primers	  used,	  
and	   the	   binding	   site	   investigated.	   (A)	   The	   transcript	   used	   to	   design	   primers	   for	   the	   Mapk1-­‐CDS	   set	   of	  
primers	  that	  showed	  an	  increase	  in	  expression	  at	  5	  h.	  The	  arrows	  denote	  potential	  MRE	  for	  miR-­‐132-­‐3p	  
that	   showed	   greater	  MFE	   than	   the	   site	   investigated.	   (B)	   The	   transcript	   used	   to	   design	   primers	   for	   the	  
Mapk1-­‐3UTR	   set	   of	   primers	   that	   showed	   no	   regulation	   at	   5	   h.	   The	   arrow	   denotes	   the	   location	   of	   the	  
investigated	  MRE.	  Coding	  region:	  green;	  amplicon:	  red.	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min	  post-­‐LTP	  on	  the	  array,	  though	  the	  down-­‐regulation	  of	  miR-­‐181c-­‐5p	  was	  previously	  
not	  validated	  with	  RT-­‐qPCR	  (Joilin	  et	  al.,	  2014).	  	  
Combined	  with	  the	  fact	  that	  the	  MAPK	  pathway,	  of	  which	  the	  Mapk1	  gene	  and	  its	  
resultant	  protein	  p42-­‐MAPK	  is	  a	  crucial	  endpoint	  for,	  has	  multiple	  points	  where	  it	  can	  be	  
regulated,	   regulation	  of	   the	   transcript	  and	  the	  protein	   independently	  of	  miR-­‐132-­‐3p	   is	  
highly	  likely.	  Therefore,	  based	  on	  the	  RT-­‐qCPR	  and	  Western	  blot	  data,	  only	  a	  correlative	  
relationship	  can	  be	  established	  between	   the	  expression	  of	  miR-­‐132-­‐3p	  and	   the	  Mapk1	  
transcript	  and	  p42-­‐MAPK	  protein,	  suggesting	  miR-­‐132-­‐3p	  may	  regulate	  the	  expression	  
of	   the	   gene	   following	   LTP.	  While	   miR-­‐132-­‐3p	   might	   be	   the	   main	   regulator	   of	  Mapk1	  
expression	  in	  another	  biology,	  the	  abundance	  of	  other	  regulators	  such	  as	  kinases	  known	  
to	  be	  regulated	  post-­‐LTP	   limit	   the	  conclusions	  drawn	   from	  these	  data.	  Further	  studies	  
manipulating	   the	   expression	   of	   miR-­‐132-­‐3p	   or	   the	   interaction	   between	   the	   two	  
transcripts	  will	  help	  to	  elucidate	  this	  relationship	  and	  the	  influence	  miR-­‐132-­‐3p	  has	  on	  
the	  expression	  of	  Mapk1	  at	  a	  transcript	  and	  protein	  level	  to	  demonstrate	  causation.	  
It	   should	   also	   be	   noted	   that	   these	   results	   are	   in	   contrast	   with	   array	   data	  
published	   by	   our	   own	   lab	   that	   demonstrated	   no	   significant	   change	   in	   expression	   for	  
Mapk1 (Ryan	   et	   al.,	   2011;	   Ryan	   et	   al.,	   2012),	   though	   this	   could	   be	   due	   to	   decreased	  
sensitivity	  or	  a	  lack	  of	  power	  due	  to	  small	  sample	  size.	  Further,	  this	  protein	  data	  differs	  
from	   the	   increases	   observed	   in	   total	   p42-­‐MAPK	   protein	   20	  min	   and	   4	   h	   post-­‐LTP	   in	  
hippocampal	  CA1	  slices	  observed	  by	  other	   labs	  (Alzoubi	  &	  Alkadhi,	  2014;	  Wang	  et	  al.,	  
2001),	   but	   differences	   in	   the	   hippocampal	   region	   and	   the	   stimulation	   paradigm	   could	  
underlie	  these	  diverging	  results.	  The	  decrease	  of	  the	  transcript	  and	  protein	  at	  20	  min	  is	  
interesting,	  but	  is	  an	  effect	  unlikely	  to	  be	  mediated	  by	  miR-­‐132-­‐3p,	  and	  the	  concurrent	  
down-­‐regulation	   of	   p44-­‐MAPK	   suggests	   that	   it	   may	   be	   against	   MAPK	   isoforms	   in	  
general.	   Again,	   how	   this	   affects	   the	   overall	   activity	   of	  MAPK	   is	   unknown	   though,	   and	  
investigation	   into	   the	   levels	   of	   phosphorylated	   protein	   should	   be	   carried	   out	   in	   the	  
future.	  
Further,	   Mapk1	   has	   been	   previously	   shown	   to	   affect	   miR-­‐132-­‐3p	   expression	  
through	  regulating	  its	  primary	  transcript	  (Kawashima	  et	  al.,	  2010;	  Remenyi	  et	  al.,	  2010).	  
Indeed,	  this	  would	  create	  a	  feedback	  loop,	  potentially	  as	  a	  homeostatic	  mechanism,	  a	  not	  
uncommon	  pattern	  in	  miRNA	  function	  (Tsang	  et	  al.,	  2007).	  This	  potential	  regulation	  of	  
Mapk1	  by	  miR-­‐132-­‐2p	  would	  fit	  well	  with	  the	  hypothesis	  proposed	  earlier	  that	  miR-­‐132-­‐
3p	   underlies	   a	   homeostatic	   mechanism	   ensuring	   only	   strongly	   stimulated	   synapses	  
result	   in	  persistent	  LTP.	  With	   the	  removal	  of	  miR-­‐132-­‐3p	   inhibiting	  Mapk1	  expression	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post-­‐LTP,	  the	  MAPK	  pathway	  would	  be	  activated.	  Downstream	  effects	  of	  this	  include	  the	  
activation	   of	   transcription	   factors,	   leading	   to	   changes	   in	   gene	   expression,	   a	   process	  
shown	   to	   be	   important	   for	   the	   persistence	   of	   LTP.	   This	   would	   also	   regulate	   the	  
production	  of	  pri-­‐miR-­‐132/212,	  which	  may	   return	  miR-­‐132-­‐3p	   to	   its	  basal	   expression	  
and	  its	  inhibition	  of	  Mapk1,	  thus	  returning	  both	  transcripts	  to	  their	  baseline	  levels.	  	  
	  
5.5.2 Limitations	  of	  Luciferase	  Assays	  
In	   this	   study,	   luciferase	   assays	   were	   undertaken	   to	   show	   that	   miR-­‐132-­‐3p	  
interacts	  with	  the	  MRE	  sequences	  on	  the	  target	  transcripts.	  However,	   luciferase	  assays	  
are	  not	  without	  their	  caveats.	  For	  example,	  the	  luciferase	  assays	  are	  an	  artificial	  system	  
involving	  the	  use	  of	  plasmids,	  oligonucleotides,	  and	  cell	  lines.	  Firstly,	  the	  sequence	  that	  
is	  inserted	  into	  the	  plasmid	  of	  choice	  should	  be	  considered.	  In	  this	  study,	  only	  the	  direct	  
MRE	  site	  with	  flanking	  regions	  of	  sequence	  was	  used	  in	  lieu	  of	  the	  full	  3’	  UTR.	  While	  the	  
use	  of	  the	  full	  3’	  UTR	  may	  allow	  for	  multiple	  sites	  to	  be	  interrogated,	  the	  strength	  of	  the	  
binding	  may	  be	  obscured	  through	  secondary	  structures	  formed	  while	  in	  the	  plasmid	  that	  
may	  not	  occur	  naturally	  (Cristino	  et	  al.,	  2014).	  Furthermore,	  often,	  hyper-­‐physiological	  
concentrations	   of	  miRNA	  mimic	  will	   be	   applied,	  which	  may	   cause	   a	   non-­‐physiological	  
interaction	  to	  take	  place,	  simply	  because	  of	  an	  increased	  probability	  that	  the	  miRNA	  will	  
bind	   to	   a	   sequence	   its	   shares	   low	   complementary	   and	   have	   an	   effect.	   Additionally,	  
luciferase	  assays	  are	  undertaken	  investigating	  one	  target	  and	  one	  miRNA,	  and	  therefore	  
do	  not	  allow	  consideration	  of	  preferential	  binding	  between	  the	  miRNA	  and	  other	  targets	  
or	  other	  miRNA	  and	  the	  target.	  These	  problems	  may	  therefore	  give	  the	  impression	  that	  
an	  interaction	  occurs	  when	  physiologically	  it	  does	  not	  because	  of	  a	  lack	  of	  competition.	  	  
Also,	  any	  data	  produced	  may	  be	  only	  relevant	  to	  the	  cell	  line	  used.	  As	  described	  
above,	   there	  are	  cell	   type-­‐specific	  mechanisms	  underlying	  miRNA	  function,	  which	  may	  
affect	  whether	  an	   interaction	  occurs	  or	  not.	  For	  example,	   the	   tumour	  suppressor	  gene	  
Fbw7	  was	  confirmed	  as	  a	  target	  of	  miR-­‐27a-­‐3p	  in	  the	  cancer	  cell	  lines	  MCF7	  and	  U2OS,	  
but	   not	   the	   embryonic	   cell	   line	   HEK293,	   suggesting	   this	   interaction	  may	   be	   a	   cancer	  
specific	   interaction	   (Lerner	   et	   al.,	   2011).	   Therefore,	   it	   is	   possible	   that	   the	   interactions	  
demonstrated	  above	  may	  occur	  only	   in	  COS-­‐7	  cells,	  and	  further	  work	  using	  a	  neuronal	  
cell	  culture	  may	  be	  necessary.	  However,	  both	  the	  miRNA	  and	  the	  target	  transcripts	  are	  
known	  to	  be	  expressed	  in	  neuronal	  cells,	  ruling	  out	  the	  possibility	  of	  the	  interaction	  not	  
occurring	  because	  of	  tissue-­‐specific	  gene	  expression.	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Other	   techniques	   could	   be	   used	   including	   biotin-­‐labelled	   pull-­‐downs,	   but	   these	  
techniques	   come	  with	   their	   own	   limitations,	   including	   time	  and	   cost.	   Therefore,	  while	  
luciferase	   assays	   are	   not	   an	   efficient	   technique	   to	   validate	   a	   large	   number	   of	   targets,	  
they	  are	  still	  a	  simple	  way	  to	  investigate	  an	  interaction	  between	  a	  miRNA	  and	  its	  target	  
and	  give	  a	  reliable	  indication	  of	  physiological	  interactions.	  
	  
5.5.3 Conclusions	  
This	  work	  has	  established	  that	  miR-­‐132-­‐3p	  has	  the	  ability	  to	  bind	  to	  a	  sequence	  
present	   on	   certain	   Mapk1	   transcripts,	   but	   not	   on	   Gria2.	   Furthermore,	   dynamic	  
regulation	  of	   the	  Mapk1	   transcript	   and	   its	  protein	  p42-­‐MAPK	   following	  LTP	   induction	  
across	   time	   was	   observed.	   While	   this	   differential	   expression	   may	   be	   due	   to	   other	  
regulatory	  elements,	  together	  it	  suggests	  that	  a	  novel	  functional	  relationship	  exists	  from	  
miR-­‐132-­‐3p	  and	  Mapk1,	  and	  that	  this	  may	  form	  part	  of	  a	  feedback	  loop	  between	  the	  two	  
that	  may	  contribute	  to	  the	  gene	  response	  underlying	  the	  persistence	  of	  LTP.	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6.1 Conclusions	  
Bioinformatic	  analysis	  of	  genes	  differentially	  expressed	  following	  the	  induction	  of	  
LTP	  suggested	  that	  miRNA	  may	  play	  a	  role	  in	  regulating	  the	  gene	  networks	  underlying	  
its	   persistence.	   With	   RT-­‐qPCR	   confirming	   these	   predictions	   at	   5	   h,	   and	   a	   microarray	  
study	   showing	   changes	   in	  miRNA	   expression	   at	   20	  min,	   the	   goal	   of	   this	   study	  was	   to	  
further	  investigate	  the	  role	  miRNA	  play	  in	  the	  regulation	  of	  LTP-­‐related	  gene	  expression,	  
with	   the	   hypothesis	   that	  miRNA	  differentially	   expressed	   following	   LTP	   induction	  may	  
play	  a	  role	  in	  regulating	  the	  gene	  networks	  underlying	  its	  persistence.	  
In	   Chapter	   2,	   five	   miRNA	   differentially	   expressed	   20	   min	   post-­‐LTP	   on	   the	  
microarray	  were	  selected	  to	  be	  validated	  using	  RT-­‐qPCR.	  Of	  these,	  two	  miRNA,	  miR-­‐34a-­‐
5p	  and	  miR-­‐132-­‐3p,	  were	   confirmed	   to	  be	  differentially	   expressed	  post-­‐LTP,	  with	   this	  
regulation	  mediated	   through	   the	  NMDAR.	  While	  miR-­‐34a-­‐5p	  showed	  continued	  down-­‐
regulation	   at	   5	   h	   before	   returning	   to	   baseline,	   miR-­‐132-­‐3p	   showed	   no	   continued	  
regulation	   at	   any	   further	   time	   point.	   Further	   investigations	   observed	   that	   primary	  
transcript	   for	   miR-­‐34a-­‐5p	   was	   not	   regulated	   following	   LTP	   induction,	   while	   pri-­‐miR-­‐
132/212	   showed	   a	   dramatic	   up-­‐regulation	   at	   20	   min,	   attenuated	   by	   5	   h,	   and	   down-­‐
regulated	  at	  24	  h.	  This	   regulation	  of	   this	  primary	   transcript	  appeared	   to	  contribute	   to	  
the	  expression	  of	  miR-­‐132-­‐3p,	  as	  the	  expression	  of	  the	  other	  mature	  miRNA	  present	  on	  
the	   pri-­‐miRNA,	   miR-­‐212-­‐3p,	   showed	   no	   regulation	   following	   LTP	   induction.	   These	  
results	   indicated	   that	   there	   were	   multiple	   regulatory	   mechanisms	   underlying	   the	  
expression	   of	   these	   miRNA	   transcripts.	   Indeed,	   while	   miR-­‐132-­‐3p	   appears	   to	   have	   a	  
homeostatic	  mechanism	  utilising	  its	  primary	  transcript	  to	  return	  its	  mature	  expression	  
back	   to	   baseline,	   this	   differs	   from	  miR-­‐34a-­‐5p,	  whose	   regulatory	  mechanism	   remains	  
unknown.	  	  
Previously	   validated	   targets	   of	   miR-­‐34a-­‐5p	   suggested	   it	   was	   involved	   in	   the	  
regulation	  of	  genes	  involved	  in	  the	  presynaptic	  release	  of	  neurotransmitter	  while	  miR-­‐
132-­‐3p	  appeared	  to	  be	  involved	  in	  the	  regulation	  of	  glutamate	  receptors,	  transcription,	  
and	  dendritic	  spine	  morphology.	  However,	  with	  the	  paucity	  of	  validated	  targets	  for	  these	  
miRNA,	   bioinformatic	   approaches	   were	   undertaken	   to	   identify	   novel	   targets	   and	  
elucidate	  a	  greater	  understanding	  of	  their	  role	  in	  the	  persistence	  of	  LTP.	  In	  Chapter	  3,	  an	  
investigation	  of	  genes	  co-­‐expressed	  following	  the	  induction	  of	  LTP	  found	  that	  although	  
genes	  were	   commonly	   regulated	  across	   time,	   they	  did	  not	   show	  common	   targeting	  by	  
one	  or	  a	  group	  of	  miRNA,	  including	  miR-­‐34a-­‐5p	  and	  miR-­‐132-­‐3p.	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Therefore,	   in	   Chapter	   4,	   an	   evaluation	   of	   using	   nine	   different	   algorithms	   that	  
predict	   targets	   for	   miRNA,	   and	   developing	   methods	   to	   identifying	   potential	   targets	  
within	   an	   LTP	   context	   for	   further	   experimental	   validation	   was	   carried	   out.	   Using	   17	  
miRNA,	   it	   was	   determined	   that	   no	   one	   algorithm,	   or	   their	   intersection,	   sufficiently	  
predicted	   previously	   validated	   targets.	   Indeed,	   the	   intersection	   of	   the	   algorithms	  
resulted	  in	  few	  targets	  being	  predicted,	  and	  suggested	  that	  each	  algorithm	  interrogated	  
a	  different	  part	  of	  the	  miRNA-­‐target	  interactome.	  Therefore,	  using	  the	  union	  of	  the	  nine	  
algorithms	   would	   allow	   the	   majority	   of	   the	   interactome	   to	   be	   covered.	   Filtering	   this	  
union	  for	  target	  genes	  annotated	  to	  be	  involved	  in	  LTP-­‐related	  processes,	  this	  identified	  
several	   target	   genes	   for	   miR-­‐34a-­‐5p	   and	  miR-­‐132-­‐3p	   known	   to	   be	   important	   for	   the	  
persistence	   of	   LTP.	   Thus,	   through	   the	   careful	   consideration	   of	   how	   to	   utilise	   the	  
predictions	  generated	  by	  the	  targeting	  algorithms,	  potential	  gene	  targets	  of	  these	  miRNA	  
can	  be	  identified	  for	  further	  experimental	  investigation	  to	  validate	  these	  interactions.	  
From	   this	   analysis,	   two	   predicted	   targets	   of	   miR-­‐132-­‐3p,	   the	   AMPAR	   subunit	  
gene	  Gria2,	   and	   the	   important	   signalling	  molecule	   gene	  Mapk1	   predicted	   as	   targets	   of	  
miR-­‐132-­‐3p,	   were	   focused	   on	   in	   Chapter	   5.	   In	   vitro	   luciferase	   assays	   were	   used	   to	  
determine	  if	  their	  predicted	  MRE	  interacted	  with	  the	  miRNA.	  The	  investigated	  MRE	  for	  
Gria2	  did	  not	  show	  any	  interaction	  with	  miR-­‐132-­‐3p.	  In	  contrast,	  an	  interaction	  between	  
miR-­‐132-­‐3p	   and	   Mapk1	   was	   found	   through	   an	   8mer	   seed	   site	   on	   the	   3’	   UTR,	   with	  
mutation	  of	  the	  seed	  site	  on	  the	  MRE	  affecting	  the	  interaction.	  Investigation	  of	  the	  mRNA	  
transcripts	   and	   its	   resultant	   protein,	   p42-­‐MAPK,	   found	   that	   there	   was	   differential	  
expression	  post-­‐LTP.	  With	  a	  decrease	   in	  miR-­‐132-­‐3p	  at	  20	  min,	   increase	   in	   the	  mRNA	  
transcript	   at	   5	   h,	   and	   increase	   in	   the	   protein	   by	   24	   h,	   while	   these	   results	   do	   not	  
conclusively	   show	   that	   miR-­‐132-­‐3p	   regulates	   Mapk1,	   the	   temporal	   relationship	   is	  
supportive	   of	   this	   regulation	   post-­‐LTP.	   Further	   work	   though	   is	   needed	   to	   show	   the	  
validated	  interaction	  occurs	  post-­‐LTP	  in	  vivo	  and	  to	  understand	  the	  role	  that	  these	  and	  
other	  miRNA	  play	  in	  the	  persistence	  of	  LTP.	  
	  
6.1.1 Future	  Directions	  
In	  order	  to	  fully	  understand	  the	  role	  of	  miR-­‐34a-­‐5p	  and	  miR-­‐132-­‐3p	  in	  regulating	  
the	  gene	  expression	  underlying	  LTP	  and	  through	  extension	  memory,	  there	  are	  a	  number	  
of	   studies	   that	  need	   to	  be	   carried	  out.	   Firstly,	  manipulation	  of	   the	  expression	  of	   these	  
two	  miRNA	  and	  the	  effect	   that	   this	  has	  on	  the	  potentiation	  and	  the	  persistence	  of	  LTP	  
will	   need	   to	   be	   investigated.	   With	   the	   administration	   of	   mimics	   or	   inhibitors	   of	   the	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miRNA,	  either	   through	  the	  use	  of	   in	  vitro	  or	   in	  vivo	  models	  of	  LTP,	   if	   these	  miRNA	  are	  
involved,	  there	  would	  be	  alterations	  to	  the	  persistence	  of	  LTP.	  For	  example,	  application	  
of	  miR-­‐34a-­‐5p	  mimic	  may	  result	  in	  reduced	  release	  of	  neurotransmitter	  post-­‐LTP,	  while	  
miR-­‐132-­‐3p	   mimic	   may	   result	   in	   a	   decreased	   transcriptional	   response,	   that	   may	   be	  
mediated	  through	  its	  interaction	  with	  Mapk1.	  If	  such	  changes	  were	  detected,	  this	  would	  
demonstrate	   that	   these	  miRNA	  play	   an	   important	   role	  not	   only	   in	  LTP,	   but	   in	   general	  
regulating	  these	  particular	  processes.	  	  
Further,	   observing	   the	   effect	   of	   applying	   sub-­‐threshold	   stimulation	   in	   the	  
presence	  of	  the	  mimic	  and/or	  inhibitor	  could	  provide	  further	  clues	  to	  their	  importance	  
to	  LTP.	   It	  could	  be	  hypothesised	  that	  application	  of	   inhibitors	  to	  miR-­‐34a-­‐5p	  and	  miR-­‐
132-­‐3p	  would	  result	  in	  LTP	  occurring	  with	  this	  stimulation	  intensity	  where	  it	  would	  not	  
normally	  induce	  LTP.	  Following	  such	  studies,	  measurement	  of	  potential	  target	  genes	  at	  
both	  the	  mRNA	  and	  protein	  levels	  would	  begin	  to	  elucidate	  any	  regulatory	  mechanisms	  
mediated	  by	  the	  miRNA.	  Furthermore,	  as	  miRNA	  are	  able	  to	  affect	  the	  expression	  of	  the	  
protein	   without	   affecting	   the	   expression	   of	   its	   respective	   mRNA,	   undertaking	  
quantitative	  proteomics	  to	  measure	  the	  expression	  of	  proteins	  regulated	  following	  LTP	  
induction	  with	  and	  without	  these	  miRNA	  manipulators	  would	  provide	  opportunities	  to	  
identify	   novel	   miRNA-­‐target	   relationships.	   Supplemented	   with	   mRNA	   screens,	   and	  
bioinformatic	  analysis,	  potential	   relationships	  between	  any	  of	   the	  regulated	  genes	  and	  
the	  miRNA	  could	  be	  identified	  and	  validated	  using	  luciferase	  assays.	  
Additionally,	  investigation	  of	  the	  potential	  role	  that	  the	  interaction	  between	  miR-­‐
132-­‐3p	  and	  Mapk1	  plays	   in	   the	  persistence	  of	  LTP	  needs	   to	  be	   investigated.	  While	   the	  
above	   approaches	   with	   mimics	   and	   inhibitors	   could	   result	   in	   changes	   in	  Mapk1,	   the	  
endpoint	  nature	  that	  this	  gene	  plays	  in	  the	  MAPK	  pathway	  may	  mean	  that	  these	  results	  
may	   still	   result	   in	   a	   correlative	   relationship.	   However,	   there	   are	   target	   site	   inhibitors	  
that	   allow	   the	   target	   site	   on	   the	  Mapk1	   transcript	   to	   be	   blocked	   to	   any	   regulation	   by	  
miR-­‐132-­‐3p.	   These	   target	   site	   inhibitors	   work	   by	   overlapping	   and	   competing	   more	  
effectively	   than	   a	   miRISC	   to	   bind	   to	   the	   site	   on	   the	   transcript,	   while	   not	   causing	  
degradation	  of	  the	  transcript	  (Wynendaele	  et	  al.,	  2010).	  By	  using	  this	  approach,	  the	  role	  
this	   interaction	   plays	   in	   the	   persistence	   of	   LTP	   would	   be	   able	   to	   be	   selectively	  
investigated	  in	  LTP	  models	  in	  vitro	  or	  in	  vivo.	  
To	   strengthen	   the	   identification	   of	  miRNA	   important	   in	   the	   persistence	   of	   LTP,	  
additional	  screens	  of	  molecular	  changes	  across	  time	  following	  its	  induction	  are	  crucial.	  
Firstly,	   measuring	   miRNA	   expression	   through	   microarrays,	   sequencing	   or	   high-­‐
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throughput	   techniques	   tools	   at	   5	   h	   and	   24	   h	  would	   not	   only	   help	   identify	   commonly	  
regulated	  miRNA	  across	  time,	  but	  may	  allow	  an	  exploration	  of	  how	  they	  are	  regulated	  
across	   time.	   Undertaking	   high-­‐throughput	   quantitative	   proteomics	   such	   as	   mass	  
spectrometry	   to	   measure	   the	   protein	   expression	   following	   LTP	   would	   allow	   for	  
powerful	   analyses	   to	   be	   undertaken	   on	   the	   expression	   of	  miRNA,	  mRNA,	   and	   protein	  
during	  LTP,	  to	  elucidate	  novel	  relationships	  and	  processes.	  
Lastly,	  if	  pri-­‐	  and	  pre-­‐miRNA	  are	  included	  in	  the	  arrays	  above,	  this	  would	  provide	  
some	   insight	   into	   how	   these	  miRNA	  may	   be	   regulated	   post-­‐LTP	   at	   a	   biogenesis	   level,	  
though	  how	  the	  stability	  of	  the	  mature	  miRNA	  is	  regulated	  will	  require	  additional	  work.	  
Further,	  work	  into	  the	  signals	  regulating	  the	  expression	  of	  the	  miRNA	  is	  needed.	  While	  it	  
was	   shown	   that	   NMDAR	   played	   an	   important	   role	   in	   their	   regulation,	   the	   role	   of	  
additional	   pathways	   such	   as	   mGluR	   is	   required	   to	   determine	   if	   the	   differential	  
expression	  observed	  is	  the	  sum	  of	  these	  pathways	  through	  the	  application	  of	  inhibitors	  
as	   demonstrated	   in	  Wibrand	   et	   al.	   (2010).	  Whether	   these	   findings	   of	  miR-­‐34a-­‐5p	   and	  
mIR-­‐132-­‐3p	   regulation	   can	   be	   generalised	   to	   other	   synapses	   undergoing	   LTP	   is	  
unknown.	  Whether	   the	   findings	   that	  miR-­‐34a-­‐5p	   and	  miR-­‐132-­‐3p	   can	   be	   regulated	   at	  
perforant	   path	   synapses	   are	   generalisable	   to	   other	   synapses	   showing	   NMDAR-­‐
dependent	  LTP	   in	  different	   regions	  of	   the	  brain	   is	  also	  unknown,	  and	  so	   further	  work	  
would	  be	  required	  here	  as	  well.	  
	  
6.1.2 Significance	  of	  the	  Work	  
This	  work	  has	  demonstrated	  the	  potential	  role	  that	  miRNA	  play	  in	  the	  regulation	  
of	  the	  gene	  expression	  underlying	  LTP.	  The	  changing	  expression	  and	  the	  number	  of	  LTP-­‐
related	  genes	  known	  and	  predicted	  to	  be	  targeted	  by	  miRNA	  shows	  yet	  another	  level	  of	  
regulation	  underlying	  the	  gene	  expression	  following	  the	  induction	  of	  LTP.	  This	  is	  a	  clear	  
demonstration	   of	   how	   complex	   the	   process	   of	   memory	   formation	   is,	   beyond	   just	   the	  
circuitry	   of	   the	   brain.	   Further,	   considering	   the	   high	   conservation	   of	   miR-­‐34a-­‐5p	   and	  
miR-­‐132-­‐3p	  across	  species,	  this	  could	  suggest	  that	  these	  miRNA	  are	  crucial	  for	  memory	  
formation.	  Therefore,	  understanding	  the	  function	  of	  these	  miRNA	  in	  a	  normal	  biological	  
setting	  in	  species	  such	  as	  rat	  is	  crucial	  as	  recent	  studies	  have	  suggested	  use	  of	  miRNA	  as	  
potential	  therapeutic	  agents	  for	  diseases	  in	  human.	  	  
Indeed,	   one	   previous	   report	   suggested	   that	   the	   use	   of	   the	  miRNA,	  miR-­‐34c-­‐5p,	  
which	  is	   functionally	  similar	  to	  miR-­‐34a-­‐5p	  through	  common	  seed	  sites,	  could	  be	  used	  
as	  a	  treatment	  for	  dementia	  (Zovoilis	  et	  al.,	  2011).	  This	  conclusion	  was	  based	  upon	  the	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evidence	  that	  miR-­‐34c-­‐5p	  was	  elevated	  in	  patients	  with	  Alzheimer’s	  disease	  and	  use	  of	  
the	   miR-­‐34c-­‐5p	   inhibitors	   improved	   the	   performance	   of	   mouse	   models	   previously	  
demonstrating	   memory	   deficits.	   While	   the	   authors	   acknowledge	   technical	   challenges,	  
considerations	   of	   off-­‐target	   effects	   in	   advance	   of	   development	   as	   a	   therapy	   cannot	   be	  
considered	  without	  there	  being	  basic	  research	  to	  understand	  its	  role.	  With	  miRNA	  likely	  
to	   be	   involved	   in	   multiple	   processes	   in	   multiple	   tissues,	   the	   net	   effects	   of	   such	   a	  
treatment	  could	  be	  detrimental.	  	  
Therefore,	  this	  study	  investigating	  the	  involvement	  of	  miRNA	  in	  LTP	  allows	  for	  an	  
understanding	  of	  the	  normal	  functional	  role	  of	  these	  miRNA,	  and	  the	  genes	  in	  which	  it	  
regulates.	   Further,	   the	   evaluation	   of	   the	   bioinformatic	   tools	   to	   predict	   targets	   was	  
important	   in	  order	  to	  be	  able	  to	  confidently	  use	  these	  algorithms,	  as	   if	   their	  use	   is	  not	  
properly	   considered,	   poor	   conclusions	  may	   be	   reached.	   Indeed,	   the	   development	   of	   a	  
method	   to	   use	   them	   effectively	   identified	   two	   genes	   to	   investigate	   for	   potential	  
interaction	   and	   one	  was	   validated.	   Further	   use	   could	   provide	   further	   insight	   into	   the	  
function	  of	  these	  miRNA.	  As	  such,	  this	  work	  will	  contribute	  to	  a	  greater	  understanding	  of	  
miRNA	  function	  and	  refine	  the	  undertaking	  of	  research	  in	  this	  area.	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A.1 Pri-­‐miR-­‐132	  and	  pre-­‐miR-­‐123	  Primer	  and	  Transcript	  Sequences	  
	  
A.1.1 pre-­‐miR-­‐132	  Hairpin	  Sequence	  
Section	  highlighted	   in	  bold	   and	  underlined	   is	   the	  pre-­‐miR-­‐132	  hairpin	  within	  a	  
section	  of	  the	  the	  pri-­‐miRNA	  transcript.	  
	  














A.1.2 Primers	  for	  the	  First	  Attempt	  at	  Profiling	  pre-­‐miR-­‐132	  
The	  location	  of	  these	  primers	  to	  the	  sequence	  of	  the	  pre-­‐miR-­‐132	  were	  designed	  
according	   to	   the	   parameters	   described	   in	   section	   2.2.6,	   and	   are	   based	   on	   method	  
described	  in	  Schmittgen	  et	  al	  (2004).	  This	  approach	  used	  a	  common	  primer	  within	  the	  
hairpin.	  
	  
Table	  A.1:	  The	  first	  set	  of	  primers	  used	  for	  the	  first	  attempt	  at	  profiling	  pre-­‐miR-­‐132.	  
	   	   Sequence	  (5’-­‐3’)	   	  
pri-­‐miR-­‐132	  Forward	  1	   CAGACACTAGCGCTACCCCC	  
pri-­‐miR-­‐132	  Forward	  2	   TAGCCCCGCAGACACTAGC	  
pri-­‐miR-­‐132	  Forward	  3	   GCTAGCCCCGCAGACACTA	  
pre-­‐miR-­‐132	  Forward	   ACCGTGGCTTTCGATTGTTACT	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Table	  A.2:	  The	  second	  set	  of	  primers	  used	  for	  the	  first	  attempt	  at	  profiling	  pre-­‐miR-­‐132.	  
	   	   Sequence	  (5’-­‐3’)	   	  
pri-­‐miR-­‐132	  Reverse	  1	   GAGCACATCTCTTGCCACCT	  
pri-­‐miR-­‐132	  Reverse	  2	   TGAGCACATCTCTTGCCACC	  
pre-­‐miR-­‐132	  Reverse	   ACCGTGGCTTTCGATTGTTACT	  
pri-­‐/pre-­‐miR-­‐132	  Forward	   CGACCATGGCTGTAGACTGTTAC	  
	  
A.1.3 Primers	  for	  the	  Second	  Attempt	  at	  Profiling	  pre-­‐miR-­‐132	  
The	   location	   of	   these	   primers	   to	   the	   sequence	   of	   the	   pri-­‐miR-­‐132	  was	   located	  
adjacent	   to	   the	   hairpin	   similar	   to	   the	   methods	   used	   by	   TaqMan	   for	   their	   pri-­‐miRNA	  
probes.	  Further,	  primers	  for	  the	  hairpin	  from	  Qiagen	  were	  used,	  but	  the	  exact	  details	  of	  
the	  primer	  sequence	  were	  not	  avaliable.	  
	  
Table	  A.3:	  Primers	  used	  for	  the	  second	  attempt	  at	  profiling	  pre-­‐miR-­‐132.	  
	   	   Sequence	  (5’-­‐3’)	   	  
pri-­‐miR-­‐132	  Forward	   CGGAGGTGGCAAGAGATGTG	  
pri-­‐miR-­‐132	  Reverse	  	   GATCGTCAGACACTCCGTGG	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B.1 Script	  Used	  for	  WGCNA	  Analysis	  
The	  following	  script	  was	  used	  with	  the	  WGCNA	  v1.20	  package	  and	  run	  in	  R	  64	  bit	  
v2.14	  with	  all	  the	  prerequisite	  packages	  and	  required	  settings,	  and	  is	  based	  upon	  work	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B.2 List	  of	  Genes	  Present	  in	  Each	  Cluster	  
Table	  B.1:	  List	  of	  genes	  found	  within	  the	  clusters	  of	  genes	  co-­‐expressed	  across	  time	  post-­‐LTP	  
	  
Cluster	   List	  of	  Genes	  
Black	  (60)	   Agmat,	  Aoc3/G6pc/Psme3,	  Apba1,	  Arc,	  Arl10,	  Atf3,	  Bace2,	  Bcl9,	  Btg2,	  
Casc3,	  Ccdc155,	  Csrnp1,	  Cxcr3,	  Dhh,	  Dlk1,	  Dnajb5,	  Dusp2,	  Egr1,	  Egr2,	  
Egr4,	   Fgf2,	   Gadd45g,	   Gjb5,	   Gpr19,	   Hist1h2aa,	   Ier2,	   Junb,	   Klrb1b,	  
Krt36,	   Lect2,	   LOC100362769/Mt1a/Ttr,	   Lrrc15,	   Mcl1,	   Mdga1,	  
Micall2,	   Nab2,	   Nos1,	   Nr4a1,	   Nr4a3,	   Plac8,	   Ppp1r15a,	   Rassf5,	   Rnf39,	  
RT1-­‐Db1,	   Sdc1,	   Sertad1,	   Siah2,	   Slc10a7,	   Slc51a,	   Slc7a5,	   Spry2,	  
Srcrb4d,	  Srf,	  Tor1b,	  Trib1,	  Ubr4,	  Wnt10a,	  Zfp36	  
Black	  (5)	   Adam2,	  Afmid,	  Cyp26a1,	  Fndc1	  
Blue	  (57)	   Adra1b,	  Ak4,	  Aldh1l2,	  Arg1,	  Bcl2a1,	  Camta2,	  Cdk20,	  Colec11,	  Coro1c,	  
Ctrc,	  Dapk1,	  Dmwd,	  Dock11,	  Dsn1,	  Edn2,	  Evc,	  Fam101a,	  Fat4,	  Fbxl6,	  
Fbxo23,	   Fmo4,	   Foxp4,	   Fxn,	   Git2,	   Igsf8,	   Irs3,	   Kcnj2,	   Kdm6a,	  
LOC100361661/LOC100363391/LOC100364645/Rpl39,	  
LOC100910745,	   Lrp2,	   Mapk13,	   Mmp23,	   Mrm1,	   Nup133,	   Phc1,	   Ppl,	  
Pygo2,	   Rnf113a2,	   S1pr2,	   siat7D,	   Smarca4,	   Syk,	   Syp,	   Tacc3,	   Tdh,	  
Tdrd12,	  Thoc2,	  Wbp7,	  Wbp7,	  Wdr4,	  Whamm,	  Zc3h7b,	  Zmat5	  
Blue	  (122)	   Adamtsl4,	   Adap2,	   Adora1,	   Agps,	   Akirin2,	   App,	   Arhgap1,	  
Arhgef9/LOC100912165,	   Atp11a,	   Blcap,	   Bre,	   Camk1g,	   Camk2d,	  
Camk2n1,	   Cars,	   Ccnd1,	   Cdc23,	   Cdyl2,	   Chd1,	   Chrm1,	   Chrm5,	   Cinp,	  
Clcn4,	   Clcnka,	   Cry2,	   Cttn,	   Cyp3a23/3a1/Sptlc1,	  Dbc1,	  Dhx36,	  Dhx36,	  
Dlgap1,	   Dmtn,	   Dtnb,	   Dzip3,	   Eif3c,	   Eprs,	   Eps15,	   Esf1,	   Etv1,	   Ezh1,	  
Fam49a,	   Fam63b,	   Fermt2,	   Fgfr2,	   Foxo1,	   Foxp1,	   Gls,	   Golt1b,	   Grm3,	  
Hars,	  Hdac1,	  Hectd1,	  Hira/LOC100911837,	  Hk1,	  Homer1,	  Hs3st2,	  Id4,	  
Itsn2,	  Itsn2,	  Kcnip3,	  Klc1,	  Lasp1,	  Lmo4,	  LOC100910033,	  Lrpprc,	  Luc7l,	  
Man1a1,	  Mbnl2,	  Mbp,	  Mobp,	  Mospd2,	  Ncor1,	  Orc3,	  Osbpl1a,	  Otud7a,	  
Pds5b,	   Peli2,	   Pex5l,	   Pi4k2a,	   Pik3r3,	   Pknox1,	   Plekhb2,	   Ppp1r12a,	  
Ppp2r1a,	   Prkca,	   Rab10,	   Rap2a,	   Rasal2,	   Rbbp6,	   Rgs4,	   Rnf4,	   Runx1t1,	  
Scn2b,	   Secisbp2l,	   Sertad2,	   Slc10a1,	   Slc16a6,	   Slc6a7,	   Slc6a9,	   Snapc5,	  
Spag9,	   Spats2,	   Thsd7a,	   Tjp1,	   Tram1,	   Ube2g2,	   Ubn2,	   Usp11,	   Utp6,	  
Vamp1,	  Vezf1,	  Vsnl1,	  Xrn2,	  Zc3h13,	  Zc3h13,	  Zc3h15,	  Zfp91,	  Zmynd11,	  
Zrsr2	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Brown	  (41)	   Adamts19,	   Arhgap27,	   Asph,	   Atxn7l4,	   Btnl3,	   Cldn12,	   Elmod3,	   Gata2,	  
Gfra4,	   Homer3,	   Icos,	   Ikbkb,	   Inpp4b,	   Kank3,	   Kcnj14,	   Klf11,	   Krt4,	  
LOC100909485/Spin2a,	  Mapkapk3,	  Megf11,	  Oma1,	  Oraov1,	  Pcdhb12,	  
Pdzd4,	  Polm,	  Prap1,	  Rasgrf2,	  Ripk1,	  Sall2,	  Sf3a1,	  Sftpd,	  Shc2,	  Slc24a1,	  
Slc35b2,	  Slc7a10,	  Sntg2,	  Tlk2,	  Tmem194b,	  Trim39,	  Txlnb,	  Zfp775	  	  
Brown	  (99)	   Abca4,	   Abhd5,	   Ace,	   Akap8l,	   Ank2,	   Ankib1,	  
Apitd1/Cort/Kif1b/LOC100360180,	   Arl6ip5,	   Arnt,	   Arnt2,	   Atp2b4,	  
C1qtnf3,	   Ccdc113,	   Cdkn1c,	   Cldn2,	   Cox8b,	   Cpne8,	   Cspg5,	   Dab2,	   Dcc,	  
Efnb1,	   Egfr,	   Eml2,	   Enc1,	   Exoc8,	   Faf2,	   Fam134c,	   Fam179b,	   Fam46a,	  
Fam81a,	   Fgf14,	   Fndc3b,	   Folr1,	   Gabre,	   Gas6,	   Gatad2b,	   Homer1,	   Igf2,	  
Igfbpl1,	   Ing3,	   Kcnd3,	   Kcne2,	   Kcnj3,	   Klhl24,	   Krt18,	   Llgl2,	  
LOC100910520/LOC680562/LOC690779/Mob1a,	   LOC498369/Nbr1,	  
LOC685590/Pik3ca,	   Lppr4,	  Man2a1,	  Map1b,	  Mre11a,	  Nedd4,	  Negr1,	  
Pcmtd2,	   Pdia3,	   Phlda3,	   Pla2g5,	   Pnn,	   Prkaa2,	   Prlr,	   Psap,	   Rab22a,	  
Rad23a,	   Rai14,	   Raly,	   Rbpj,	   Rfc1,	   Rtn4,	   Scgb1c1,	   Sgcb,	   Slc16a13,	  
Slc2a13,	   Slc6a6,	   Sox6,	   St18,	   Steap1,	   Sv2b,	   Syt4,	   Taok1,	   Tbl1x,	  
Tmem27,	  Tnpo1,	  Tnrc6b,	  Tnrc6b,	  Top3a,	  Trps1,	  Trpv4,	  Ttyh1,	  Usp42,	  
Utrn,	  Vasn	  
Green	  (28)	   Alpk2,	  Ankrd16,	  Anks1b,	  Aox1,	  Blvra,	  Cabp1,	  Chtf18,	  Cutc,	  Egfl8,	  Ext1,	  
Grpr,	  Grtp1,	  Heatr6,	  Hpse,	  Il1a,	  LOC100910161/Mycbp2,	  Nasp,	  Parp4,	  
Per3,	  Scyl3,	  Sirt4,	  Stap2,	  Terf2,	  Tnfaip2,	  Zfp213,	  Zfp346	  
Green	  (42)	   Abp10,	   Ago1,	   Atp11a,	   Bmp3,	   C1qtnf1,	   Col8a1,	   Crb3,	   Dnmt3a,	   Dpp8,	  
Dyrk2,	   F5,	   Foxo1,	   Glb1l,	   Hic2,	   Hspa4,	   Kdm5a,	   Kif1a,	  
LOC100911492/Otx2,	   LOC100912698/Tmcc1,	   Lpgat1,	   Ly6h,	   Nfe2l1,	  
Nubp1,	   Pbx2,	   Pde4d,	   Pip5k1a,	   Plk2,	   Ppp1r37,	   Prlr,	   Rab5c,	   Rbm47,	  
Rnf152,	  RT1-­‐EC2,	  Samd14,	  Shank1,	  Slc5a5,	  Slco1a5,	  Sostdc1,	  St6gal1,	  
Synj2,	  Zfyve9	  
Lime	  (6)	   Arid1a,	  Mrvi1,	  Pla2g4a,	  Rif1,	  Ska3,	  Snrnp48	  
Lime	  (24)	   Adam23,	  Arhgap10,	  Cnnm1,	  Crybb3,	  Cst7,	  Epha2,	  Fam69b,	  Fgf21,	  Fgg,	  
Grm6,	   Irs2,	   Kcnk3,	   Klf2,	   Mex3b,	   Ncf4,	   Oprd1,	   Pkn3,	   Ptbp1,	   Rnf207,	  
Sema6c,	  Slc25a25	  
Magenta	  (8)	   Cdca7,	  Chrdl1,	  Fas,	  Ggct,	  LOC100911617/Prmt6,	  Pacs1,	  Pctp,	  Zfp105	  
Magenta	  (47)	   Acta2/Actc1,	   Aqp3,	   Arl4d,	   Chd4,	   Crem,	   Cspp1,	   Cxcl13,	   Ddit3,	   Dusp1,	  
Egr3,	   Erf,	   Fcgr3a,	   Fosl2,	   Foxn3,	   Foxo3,	   Gadd45b,	   Gc,	   Irf2bpl,	   Jun,	  
Klhl31,	   Krt19,	   Mbl1,	   Mid2,	   Myo5c,	   Nlrp6,	   Nmu,	   Nr1h2,	   Nr4a2,	  
Ppp1r3b,	   Psd4,	   Ptgs2,	   Rasl11b,	   Rbfox1,	   Slc38a4,	   Slc9a4,	   Spp1,	  
Tbc1d10a,	  Tcf20,	  Tiparp,	  Tnni2,	  Tob1,	  Vhl,	  Vom1r102,	  Vom2r31	  
Pink	  (18)	   Abcg8,	  Adora2a,	  Bank1,	  Bcl2l14,	  Cdk5r2,	  Dnase1l2,	  Eva1a,	  Fam135a,	  
Got2,	  Kprp,	  Naaladl1,	  Phf7,	  Rilpl1,	  Slc22a5,	  Slc7a7,	  Tyrp1	  
Pink	  (45)	   Ace,	   Add3,	   Arhgap32,	   B3gnt2,	   Ccne2,	   Cdc27,	   Cdh3,	   Cep350,	   Crb3,	  
Cyp19a1,	   Dusp5,	   Dusp6,	   Dync1li1,	   Fam120b,	   Glycam1,	   Hrasls,	   Ier5,	  
Kcna3,	   Kdm6b,	   Lama2,	   Lrrc51,	   Lyn,	   Map1b,	   Map7,	   Mfap3,	   Nr4a3,	  
Pdlim2,	  Pfkfb2,	  Polg,	   Ppp3ca,	  Ptk7,	  Reps1,	   Setd5,	   Sfrp1,	   Snx18,	  Tal1,	  
Tas2r13,	  Thbs2,	  Ttpal,	  Vash2,	  Zbtb11,	  Zfyve9	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Purple	  (29)	   Abcc9,	   Adra2b,	   Afp,	   Apoc3,	   Atp4b,	   Birc7,	  
Btnl5/Btnl7/Btnl8/LOC100911938/LOC100911983/LOC100912021,	  
Capn8,	  Clec1b,	  Defa-­‐rs1,	  Fetub,	  Gfra3,	  Hmgb1,	  Hrg/LOC681544,	  Il17b,	  
Il5,	   Per1,	   Prf1,	   Rasgrp4,	   Sbk1,	   Sik1,	   Slc25a41,	   Sphk1,	   Srebf2,	   Tgif1,	  
Tmprss11d,	  Tnfaip8l2,	  Wwtr1,	  Zc4h2	  
Purple	  (16)	   Adora2b,	   Arhgap24,	   Clspn/LOC100912530,	   Dctn6,	   Fkbp11,	   Gmnn,	  
Il1rap,	   Kctd1,	   Kpna1,	   Lrba,	   Mir384,	   Ntmt1,	   Pex10,	   Pmel,	   Stx3,	  
Tmem117	  
Red	  (20)	   Aldh1a2,	   Alkbh1,	   Arl4c,	   Ctla2a,	   Gmip,	   Gpihbp1,	   Klrc1,	   Lims2,	   Lmo7,	  
LOC100910021,	  Lpin2,	  Ngfr,	  Nkx3-­‐1,	  Pola2,	  Rassf1,	  Rnase12,	  Slco2a1,	  
Tef,	  Zscan20	  
Red	  (47)	   Alg13,	   Ankrd34b,	   Arx,	   Azi2,	   Cacng4,	   Cebpg,	   Etv5,	   Fdft1,	   Fermt2,	  
Fkbp5,	   Gap43,	   Gna14,	   Gnb4,	   Gucy1a3,	   Homer1,	   Htr1d,	   Ints6,	   Kcns3,	  
Kctd15,	   LOC100909758/Vkorc1l1,	   Lphn2,	   Mtmr1,	   Nde1,	   Nfix,	   Nog,	  
Numbl,	  Pcgf3,	  Pde8a,	  Plxna2,	  Psmc4,	  Qdpr,	  Ramp3,	  Rasd1,	  Rgs2,	  Rgs2,	  
Rhod,	  Rnft2,	  Slu7,	  Timp1,	  Tm4sf1,	  Tspan5,	  Tuba8	  
Turquoise	  (91)	   Acvr1,	  Adamtsl5,	  Agtr2,	  Aldh16a1,	  Ankrd13b,	  Anxa7,	  Atad3a,	  Atp2a1,	  
Bcas3,	   Btbd16,	   Car6,	   Caskin1,	   Ccdc115,	   Cenpv,	   Cpne9,	   Cyp2e1,	   Dgki,	  
Dnajc21,	  Dnal4/RGD1559781,	  Dnali1,	  Dnase1,	  Dsp,	  Ehhadh,	  Elmod3,	  
Ethe1,	   Fam13b,	   Fam13b,	   Fance,	   Fhl1,	   Galr2/LOC100910349,	   Gfod2,	  
Gmnn,	   Gpd2,	   Gpr107,	   Grwd1,	   Gstcd,	   Helq,	   Hrk,	   Htr3b,	   Invs,	   Kifap3,	  
Lrg1,	   Lrrc16a,	   Lrrc26,	   Mcm6,	   Mdk,	   Mitd1,	   Mmp23,	   Mylpf,	   Mypop,	  
Nfkbiz,	  Nle1,	  Npr2,	  Nr1d1,	   Orai3,	   PCOLCE2,	   Pdzd3,	   Pgp,	   Pklr,	   Plcd3,	  
Pqlc2,	   Prr12,	   Ptgr1,	   Ptpn21,	   Pzp,	   Rab11fip3,	   Rab22a,	   Rad51ap1,	  
Rad9b,	  Rock1,	   Samd4b,	   Scn11a,	   Senp3,	   Sfi1,	   Sgsm2,	   Slc37a4,	   Slc9a5,	  
Sp2,	   Taf9b,	   Thra,	   Tp53i11,	   Trerf1,	   Tut1,	  Urb2,	  Wdfy2,	  Wfdc6a,	   Xylb,	  
Zfhx4,	  Zfp428	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Turquoise	  (249)	   Aak1,	   Aff4,	   Ahcyl1,	   Akap13,	   Ank2,	   Ankhd1,	   Ap2b1/LOC100912146,	  
Appbp2,	   Aqp1,	   Ar,	   Arcn1,	   Arhgef12,	   Arl6ip5,	   Ash1l,	   Atad5,	   Atl3,	  
Atp1a1,	   Atp2a2,	   Atp2b1,	   Atpaf1,	   Atrx,	   Baz2b,	   Bcr,	   Bhlhb9,	   Bhlhb9,	  
Bhmt2,	   Bmpr1a,	   C7/Tubb4b,	   Cacng8,	   Cadm3,	   Cald1,	   Camk4,	  
Ccar1/LOC100911233,	   Ccnd2,	   Cd99l2/LOC100911604/LOC501437,	  
Cdc42bpa,	  Cdr2,	  Cep41,	  Cgnl1,	  Chrm3,	  Chtf8,	  Cisd2,	  Clcn3,	  Clic4,	  Cnr1,	  
Cpd,	  Cpne3,	  Csnk1d,	  Csnk2a2,	  Ctnnb1,	  Cyth1,	  Dcun1d4,	  Ddah1,	  Ddr2,	  
Dek,	   Dicer1,	   Dlg4,	   Dnajb5,	   Dnm3,	   Dpm1,	   Dpp8,	   Dyrk2,	   Eef1g,	   Ehd1,	  
Eif2s1,	   Eif4g1/LOC100910289/LOC100911431,	   Elavl1,	  
Elovl6/LOC100910695,	  Eml4,	  Enpp2,	  Epha4,	  Erlin2,	  Erp44,	  Fam126b,	  
Fam168a,	   Fam168b,	   Fgfr2,	   Fmod,	   Foxn3,	   Fry,	   Fyttd1,	   Fzd3,	  
Gabarapl1,	   Gabbr1,	   Gad2,	   Gas6,	   Gls,	   Gmfb,	   Got1,	   Grin2a,	   Grin3a,	  
Gsk3b,	   Gtf2f1,	   Hectd1,	   Hira/LOC100911837,	   Hk1,	  
Hnrnpa2b1/LOC100365752,	  Hnrnpa3,	  Hpcal4,	  Ifnar1,	  Igfbp2,	  Igfbp5,	  
Igsf1,	  Il6st,	  Itgb6,	  Jmjd1c,	  Kcne2,	  Kcnj4,	  Kcnq3,	  Kif5a,	  Kl,	  Kras,	  Lama5,	  
LOC100910882/Rbm39,	   Lsamp,	   Magt1,	   Map2,	   Mapk8ip1,	   Mbnl2,	  
Med1,	  Metrn,	  Mfrp,	  Mier1,	  Mmp14,	  Mpp5,	  Msi2,	  Msx1,	  Ncam2,	  Ndst1,	  
Nedd4,	   Neto2,	   Nfat5,	   Nkain3,	   Nolc1,	   Nrxn1,	   Nsf,	   Nt5dc2,	   Ntm,	   Ocln,	  
Optn,	   Pabpn1,	   Pafah1b1,	   Papola,	   Parvb,	   Pbrm1,	   Pcdha13,	   Pnisr,	  
Pnmal2,	   Pon1,	   Ppap2b,	   Ppp1r7,	   Ppp3r1,	   Prkacb,	   Prpf38b,	   Prrc2c,	  
Ptprd,	   Rab14,	   Rab8b,	   Rad23b,	   Rala,	   Ralgapa1,	   Rfx7,	  
RGD1561897/Uhmk1,	   Rgs17,	   Rhbdl3,	   Rngtt,	   Rnps1,	   Rock2,	   Rora,	  
Rprd1a,	  Rybp,	   Scap,	   Sec63,	   Sf3b1,	   Slc20a2,	   Slc30a9,	   Slc31a1,	   Slc4a2,	  
Smarce1,	  Snx27,	  Sort1,	  Sp1,	  Sppl2a,	  Sspn,	  St8sia3,	  Stmn4,	  Syn2,	  Syt1,	  
Tanc2,	   Tbl1xr1,	   Thoc2,	   Tm9sf3,	   Tm9sf4,	   Tmed9,	   Tmem86a,	   Tmx4,	  
Tnr,	  Tollip,	  Tpr,	  Tra2a,	  Trim2,	  Trove2,	  Tsc22d2,	  Ube2s,	  Ube3a,	  Ube4a,	  
Ubp1,	  Uggt1,	  Usp29,	  Usp8,	   Vapb,	   Vcpip1,	   Vgf,	  Wtap,	   Xpnpep3,	   Xpo7,	  
Ythdf2,	   Zbtb20,	   Zfp292,	   Zfp462,	   Zfp536,	   Zfp655,	   Zfp91,	   Zfyve20,	  
Zranb2,	  Zrsr1	  
Yellow	  (27)	   Abca8,	   Arhgef15,	   Baz2b,	   Bhlhe22,	   Clec10a,	   Csf3r,	   Dbh,	   Jak3,	  
LOC100912131,	  Lpxn,	  Lrp3,	  Lypd3,	  Nav2,	  Phf20,	  Ppif,	  Prokr1,	  Riok1,	  
Spdya,	   Tacr2,	   Tsga10,	   UST4r/Ust5r,	   Vash1,	   Vps13c,	   Zfp598,	   Zfpm2,	  
Zhx3	  
Yellow	  (56)	   Aamp,	  Agtpbp1,	  Akr7a3,	  Amn1,	  Ap2a2,	  Armcx3,	  Arpc5l,	  Chn2,	  Cmklr1,	  
Cog2,	   Col9a3,	   Ctr9,	   Dhrs4,	   Dhx36,	   Dnaja4,	   Enpp1,	   Ermn,	   Fam115a,	  
Frs2,	   Grasp,	   Grik1,	   Gulp1,	   Hes1,	   Hfe,	   Khsrp,	   Klf10,	   Lin7a,	   Lingo1,	  
Lingo1,	   LOC100125362,	   Lynx1,	  Man1a1,	  Mapk8ip3,	  Mdm4,	  Mpped1,	  
Nxph1,	  Nxph1,	  Osbpl2,	  Pcyt1b,	  Pet112l,	  Phf17,	  Plaur,	  Pmepa1,	  Pmm2,	  
Rif1,	  Sbk1,	  Sbno1,	  Sgtb,	  Sorcs3,	  Strn4,	  Treh,	  Whsc1l1,	  Zdhhc20	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C.1 List	  of	  Gene	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These	  annotations	  were	  downloaded	  and	  current	  on	  1	  March	  2014.	  
	  





of	  Genes	   List	  of	  Genes	  
LTP	  KEGG	   70	   Adcy1,	  Adcy8,	  Araf,	  Atf4,	  Braf,	  Cacna1c,	  Calm1,	  Calm2,	  Calm3,	  
Calml3,	   Calml5,	   Calml6,	   Camk2a,	   Camk2b,	   Camk2d,	   Camk2g,	  
Camk4,	  Chp1,	  Chp2,	  Crebbp,	  Ep300,	  Gnaq,	  Gria1,	  Gria2,	  Grin1,	  
Grin2a,	  Grin2b,	  Grin2c,	  Grin2d,	  Grm1,	  Grm5,	  Hras,	  Itpr1,	  Itpr2,	  
Itpr3,	   Kras,	   Map2k1,	   Map2k2,	   Mapk1,	   Mapk3,	   Nras,	   Plcb1,	  
Plcb2,	   Plcb3,	   Plcb4,	   Ppp1ca,	   Ppp1cb,	   Ppp1cc,	   Ppp1r12a,	  
Ppp1r1a,	   Ppp3ca,	   Ppp3cb,	   Ppp3cc,	   Ppp3r1,	   Ppp3r2,	   Prkaca,	  
Prkacb,	  Prkacg,	  Prkca,	  Prkcb,	  Prkcg,	  Prkx,	  Raf1,	  Rap1a,	  Rap1b,	  
Rapgef3,	  Rps6ka1,	  Rps6ka2,	  Rps6ka3,	  Rps6ka6	  
KEGG	   896	   Abi2,	  Abl1,	  Ablim1,	  Ablim2,	  Ablim3,	  Acin1,	  Actb,	  Actg1,	  Actn1,	  
Actn2,	  Actn3,	  Actn4,	  Adcy1,	  Adcy2,	  Adcy3,	  Adcy4,	  Adcy7,	  Adcy8,	  
Adcy9,	   Adora2a,	   Adora2b,	   Adra1a,	   Adra1b,	   Adra1d,	   Adrb1,	  
Adrb2,	   Adrb3,	   Agtr1,	   Akt1,	   Akt2,	   Akt3,	   Alyref,	   Apaf1,	   Apbb1,	  
Apc,	   Apc2,	   Apoe,	   App,	   Araf,	   Arhgap35,	   Arhgef1,	   Arhgef12,	  
Arhgef4,	   Arhgef6,	   Arhgef7,	   Arpc1a,	   Arpc1b,	   Arpc2,	   Arpc3,	  
Arpc4,	   Arpc5,	   Arpc5l,	   Arrb1,	   Arrb2,	   Atf2,	   Atf4,	   Atf6,	   Atp2a1,	  
Atp2a2,	   Atp2a3,	   Atp2b1,	   Atp2b2,	   Atp2b3,	   Atp2b4,	   Avpr1a,	  
Avpr1b,	   Bad,	   Baiap2,	   Bcar1,	   Bdkrb1,	   Bdkrb2,	   Bdnf,	   Bid,	   Braf,	  
Brk1,	   Bst1,	   Btg1,	   Btg2,	   Btg3,	   Btg4,	   Cacna1a,	   Cacna1b,	  
Cacna1c,	   Cacna1d,	   Cacna1e,	   Cacna1f,	   Cacna1g,	   Cacna1h,	  
Cacna1i,	  Cacna1s,	  Cacna2d1,	  Cacna2d2,	  Cacna2d3,	  Cacna2d4,	  
Cacnb1,	   Cacnb2,	   Cacnb3,	   Cacnb4,	   Cacng1,	   Cacng2,	   Cacng3,	  
Cacng4,	   Cacng5,	   Cacng6,	   Cacng7,	   Cacng8,	   Calm1,	   Calm2,	  
Calm3,	   Calml3,	   Calml5,	   Calml6,	   Camk2a,	   Camk2b,	   Camk2d,	  
Camk2g,	   Camk4,	   Capn1,	   Capn2,	   Casc3,	   Casp3,	   Casp8,	   Casp9,	  
Cckar,	   Cckbr,	   Cd14,	   Cd38,	   Cdc25b,	   Cdc42,	   Cdk5,	   Cdk5r1,	   Cfl1,	  
Cfl2,	   Chp1,	   Chp2,	   Chrm1,	   Chrm2,	   Chrm3,	   Chrm4,	   Chrm5,	  
Chrna7,	   Chuk,	   Cnot1,	   Cnot10,	   Cnot2,	   Cnot3,	   Cnot4,	   Cnot6,	  
Cnot6l,	  Cnot7,	  Cnot8,	  Crebbp,	  Crh,	  Crhr1,	  Crk,	  Crkl,	  Csk,	  Cxcl12,	  
Cxcr4,	   Cycs,	   Cyfip1,	   Cyfip2,	   Cysltr1,	   Cysltr2,	  Daxx,	  Dcc,	  Dcp1a,	  
Dcp1b,	   Dcp2,	   Ddit3,	   Ddx20,	   Ddx39b,	   Ddx6,	   Dhx36,	   Diaph1,	  
Diaph2,	   Diaph3,	   Dis3,	   Dock1,	   Dpysl2,	   Drd1,	   Drd5,	   Dusp1,	  
Dusp10,	   Dusp14,	   Dusp16,	   Dusp2,	   Dusp22,	   Dusp3,	   Dusp4,	  
Dusp5,	  Dusp6,	  Dusp7,	  Dusp8,	  Dusp9,	  Ecsit,	  Edc3,	  Edc4,	  Ednra,	  
Ednrb,	   Eef1a1,	   Eef1a2,	   Efna1,	   Efna2,	   Efna3,	   Efna4,	   Efna5,	  
Efnb1,	   Efnb2,	   Efnb3,	   Egf,	   Egfr,	   Eif1,	   Eif1ax,	   Eif1ay,	   Eif1b,	  
Eif2ak3,	   Eif2b1,	   Eif2b2,	   Eif2b3,	   Eif2b4,	   Eif2b5,	   Eif2s1,	   Eif2s2,	  
Eif2s3,	  Eif3a,	  Eif3b,	  Eif3c,	  Eif3d,	  Eif3e,	  Eif3f,	  Eif3g,	  Eif3h,	  Eif3i,	  
Eif3j,	   Eif4a1,	   Eif4a2,	   Eif4a3,	   Eif4b,	   Eif4e,	   Eif4e1b,	   Eif4e2,	  
Eif4g1,	   Eif4g2,	   Eif4g3,	   Eif5,	   Elk1,	   Elk4,	   Enah,	   Ep300,	   Epha1,	  
Epha2,	   Epha3,	   Epha4,	   Epha5,	   Epha6,	   Epha7,	   Epha8,	   Ephb1,	  
Ephb2,	   Ephb3,	   Ephb4,	   Ephb6,	   Erbb2,	   Erbb3,	   Erbb4,	   Ern1,	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Exosc1,	   Exosc10,	   Exosc2,	   Exosc3,	   Exosc4,	   Exosc5,	   Exosc6,	  
Exosc7,	   Exosc8,	   Exosc9,	   Ezr,	   F2r,	   Fadd,	   Fas,	   Faslg,	   Fes,	   Fgd1,	  
Fgd3,	   Fgf1,	   Fgf10,	   Fgf11,	   Fgf12,	   Fgf13,	   Fgf14,	   Fgf16,	   Fgf17,	  
Fgf18,	  Fgf19,	  Fgf2,	  Fgf20,	  Fgf21,	  Fgf22,	  Fgf23,	  Fgf3,	  Fgf4,	  Fgf5,	  
Fgf6,	   Fgf7,	   Fgf8,	   Fgf9,	   Fgfr1,	   Fgfr2,	   Fgfr3,	   Fgfr4,	   Flna,	   Flnb,	  
Flnc,	   Fos,	   Fyn,	   Gadd45a,	   Gadd45b,	   Gadd45g,	   Gapdh,	   Gemin2,	  
Gemin4,	   Gemin5,	   Gemin6,	   Gemin7,	   Gemin8,	   Git1,	   Gna11,	  
Gna12,	   Gna13,	   Gna14,	   Gna15,	   Gnai1,	   Gnai2,	   Gnai3,	   Gnal,	  
Gnao1,	   Gnaq,	   Gnas,	   Gnaz,	   Gng12,	   Grb2,	   Gria1,	   Gria2,	   Gria3,	  
Grin1,	   Grin2a,	   Grin2b,	   Grin2c,	   Grin2d,	   Grm1,	   Grm5,	   Grpr,	  
Gsk3b,	   Gsn,	   Gucy1a2,	   Gucy1a3,	   Gucy1b3,	   Hras,	   Hrh1,	   Hrh2,	  
Hspa1a,	  Hspa1b,	  Hspa1l,	  Hspa2,	  Hspa6,	  Hspa8,	  Hspb1,	  Htr2a,	  
Htr2b,	  Htr2c,	  Htr4,	  Htr5a,	  Htr6,	  Htr7,	  Igf1,	  Igf1r,	  Ikbkb,	  Ikbkg,	  
Il1a,	   Il1b,	   Il1r1,	   Il1r2,	   Insrr,	   Iqgap1,	   Iqgap2,	   Iqgap3,	   Itga1,	  
Itga10,	   Itga11,	   Itga2,	   Itga2b,	   Itga3,	   Itga4,	   Itga5,	   Itga6,	   Itga7,	  
Itga8,	   Itga9,	   Itgad,	   Itgae,	   Itgal,	   Itgam,	   Itgav,	   Itgax,	   Itgb1,	  
Itgb2,	   Itgb3,	   Itgb4,	   Itgb5,	   Itgb6,	   Itgb7,	   Itgb8,	   Itpka,	   Itpkb,	  
Itpr1,	   Itpr2,	   Itpr3,	   Jmjd7-­‐Pla2g4b,	   Jun,	   Jund,	   Kpnb1,	   Kras,	  
L1cam,	  Lamtor3,	  Lhcgr,	  Limk1,	  Limk2,	  Lpl,	  Lrp1,	  Lrrc4c,	  Lsm1,	  
Lsm2,	   Lsm3,	   Lsm4,	   Lsm5,	   Lsm6,	   Lsm7,	   Ltb4r2,	   Lyn,	   Magoh,	  
Magohb,	   Map2k1,	   Map2k2,	   Map2k3,	   Map2k4,	   Map2k5,	  
Map2k6,	   Map2k7,	   Map3k1,	   Map3k11,	   Map3k12,	   Map3k13,	  
Map3k14,	   Map3k2,	   Map3k3,	   Map3k4,	   Map3k5,	   Map3k6,	  
Map3k7,	  Map3k8,	  Map4k1,	  Map4k2,	  Map4k3,	  Map4k4,	  Mapk1,	  
Mapk10,	  Mapk11,	  Mapk12,	  Mapk13,	  Mapk14,	  Mapk3,	  Mapk7,	  
Mapk8,	   Mapk8ip1,	   Mapk8ip2,	   Mapk8ip3,	   Mapk9,	   Mapkapk2,	  
Mapkapk3,	   Mapkapk5,	   Mapt,	   Max,	   Mecom,	   Mef2c,	   Mknk1,	  
Mknk2,	   Mos,	   Mras,	   Msn,	   Myc,	   Myh10,	   Myh14,	   Myh9,	   Myl10,	  
Myl12a,	  Myl12b,	  Myl2,	  Myl5,	  Myl7,	  Myl9,	  Mylk,	  Mylk2,	  Mylk3,	  
Mylpf,	   Naa38,	   Nae1,	   Ncbp1,	   Ncbp2,	   Nck1,	   Nck2,	   Nckap1,	  
Nckap1l,	   Nf1,	   Nfat5,	   Nfatc1,	   Nfatc2,	   Nfatc3,	   Nfatc4,	   Nfkb1,	  
Nfkb2,	   Ngef,	   Ngf,	   Nlk,	   Nmd3,	   Nos1,	   Nos2,	   Nos3,	   Nr4a1,	   Nras,	  
Nrp1,	   Ntf3,	   Ntf4,	   Ntn1,	   Ntng1,	   Ntrk1,	   Ntrk2,	   Ntsr1,	   Nup107,	  
Nup133,	  Nup153,	  Nup155,	  Nup160,	  Nup188,	  Nup205,	  Nup214,	  
Nup35,	  Nup37,	  Nup43,	  Nup54,	  Nup62,	  Nup85,	  Nup88,	  Nup93,	  
Nup98,	  Nupl1,	  Nupl2,	  Nxf1,	  Nxf2,	  Nxf2b,	  Nxf3,	  Nxf5,	  Nxt1,	  Nxt2,	  
Oxtr,	  P2rx1,	  P2rx2,	  P2rx3,	  P2rx4,	  P2rx5,	  P2rx6,	  P2rx7,	  Pabpc1,	  
Pabpc1l,	   Pabpc1l2a,	   Pabpc1l2b,	   Pabpc3,	   Pabpc4,	   Pabpc4l,	  
Pabpc5,	   Paip1,	   Pak1,	   Pak2,	   Pak3,	   Pak4,	   Pak6,	   Pak7,	   Pan2,	  
Pan3,	  Papd7,	  Parn,	   Patl1,	   Pde1a,	  Pde1b,	  Pde1c,	   Pdgfa,	   Pdgfb,	  
Pdgfra,	   Pdgfrb,	   Pfn1,	   Pfn2,	   Pfn3,	   Pfn4,	   Phax,	   Phka1,	   Phka2,	  
Phkb,	   Phkg1,	   Phkg2,	   Pik3ca,	   Pik3cb,	   Pik3cd,	   Pik3cg,	   Pik3r1,	  
Pik3r2,	   Pik3r3,	   Pik3r5,	   Pikfyve,	   Pip4k2a,	   Pip4k2b,	   Pip4k2c,	  
Pip5k1a,	   Pip5k1b,	   Pip5k1c,	   Pla2g10,	   Pla2g12a,	   Pla2g12b,	  
Pla2g1b,	  Pla2g2a,	  Pla2g2c,	  Pla2g2d,	  Pla2g2e,	  Pla2g2f,	  Pla2g3,	  
Pla2g4a,	   Pla2g4b,	   Pla2g4e,	   Pla2g5,	   Pla2g6,	   Plcb1,	   Plcb2,	  
Plcb3,	  Plcb4,	  Plcd1,	  Plcd3,	  Plcd4,	  Plce1,	  Plcg1,	  Plcg2,	  Plcz1,	  Pln,	  
Plxna1,	   Plxna2,	   Plxna3,	   Plxnb1,	   Plxnb2,	   Plxnb3,	   Plxnc1,	   Pnn,	  
Ppid,	   Ppm1a,	   Ppm1b,	   Ppp1ca,	   Ppp1cb,	   Ppp1cc,	   Ppp1r12a,	  
Ppp1r17,	   Ppp1r1a,	   Ppp2ca,	   Ppp2cb,	   Ppp2r1a,	   Ppp2r1b,	  
Ppp3ca,	   Ppp3cb,	   Ppp3cc,	   Ppp3r1,	   Ppp3r2,	   Ppp5c,	   Prkaca,	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Prkacb,	  Prkacg,	  Prkca,	  Prkcb,	  Prkcg,	  Prkg1,	  Prkg2,	  Prkx,	  Psen1,	  
Psen2,	  Ptafr,	  Ptger1,	  Ptger3,	  Ptgfr,	  Ptk2,	  Ptk2b,	  Ptpn5,	  Ptpn7,	  
Ptprr,	   Pxn,	   Rac1,	   Rac2,	   Rac3,	   Rae1,	   Raf1,	   Ran,	   Ranbp2,	  
Rangap1,	   Rap1a,	   Rap1b,	   Rapgef2,	   Rapgef3,	   Rasa1,	   Rasa2,	  
Rasgrf1,	  Rasgrf2,	  Rasgrp1,	  Rasgrp2,	  Rasgrp3,	  Rasgrp4,	  Rbm8a,	  
Rdx,	  Rela,	  Relb,	  Rgs3,	  Rhoa,	  Rhod,	  Rnd1,	  Rnps1,	  Robo1,	  Robo2,	  
Robo3,	   Rock1,	   Rock2,	   Rps6ka1,	   Rps6ka2,	   Rps6ka3,	   Rps6ka4,	  
Rps6ka5,	   Rps6ka6,	   Rqcd1,	   Rras,	   Rras2,	   Ryr1,	   Ryr2,	   Ryr3,	  
Sap18,	   Scin,	   Sec13,	   Seh1l,	   Sema3a,	  Sema3b,	  Sema3c,	   Sema3d,	  
Sema3e,	  Sema3f,	  Sema3g,	  Sema4a,	  Sema4b,	  Sema4c,	  Sema4d,	  
Sema4f,	   Sema4g,	   Sema7a,	   Senp2,	   Skiv2l,	   Skiv2l2,	   Slc25a31,	  
Slc25a4,	  Slc25a5,	  Slc25a6,	  Slc8a1,	  Slc8a2,	  Slc8a3,	  Slc9a1,	  Slit1,	  
Slit2,	   Smn1,	   Smn2,	   Snupn,	   Sos1,	   Sos2,	   Srf,	   Srgap1,	   Srgap2,	  
Srgap3,	   Ssh1,	   Ssh2,	   Ssh3,	   Stk3,	   Stk4,	   Stmn1,	   Strap,	   Sumo1,	  
Sumo2,	   Sumo3,	   Sumo4,	   Tab1,	   Tab2,	   Tacr1,	   Tacr2,	   Tacr3,	  
Tbxa2r,	   Tgfb1,	   Tgfb2,	   Tgfb3,	   Tgfbr1,	   Tgfbr2,	   Thoc1,	   Thoc2,	  
Thoc5,	   Thoc6,	   Thoc7,	   Tiam1,	   Tiam2,	   Tmsb4x,	   Tmsb4xp8,	  
Tmsb4y,	  Tnf,	  Tnfrsf1a,	  Tnnc1,	  Tnnc2,	  Tob1,	  Tob2,	  Tp53,	  Traf2,	  
Traf6,	  Trhr,	  Trpc1,	  Ttc37,	  Ube2i,	  Unc5a,	  Unc5b,	  Unc5c,	  Unc5d,	  
Upf1,	  Upf2,	  Upf3a,	  Upf3b,	  Vav1,	  Vav2,	  Vav3,	  Vcl,	  Vdac1,	  Vdac2,	  
Vdac3,	   Was,	   Wasf1,	   Wasf2,	   Wasl,	   Wdr61,	   Wibg,	   Xpo1,	   Xpo5,	  
Xpot,	  Zak,	  Zcchc7	  
GO	   513	   2mit,	  5-­‐Ht1a,	  5htt,	  Abca7,	  Abhd6,	  Accn2,	  Adcy1,	  Adcy8,	  Add-­‐1,	  
Adf1,	   Adnp,	   Adora1,	   Adora2a,	   Adrb1,	   Agt,	   Akt1,	   Amn,	   Ampa	  
Glur3	  Flop,	  Anapc2,	  Anapl_00085,	  Anapl_01052,	  Anapl_01115,	  
Anapl_01731,	   Anapl_02219,	   Anapl_04684,	   Anapl_04813,	  
Anapl_05342,	   Anapl_05823,	   Anapl_06149,	   Anapl_07005,	  
Anapl_09579,	   Anapl_11460,	   Anapl_13664,	   Anapl_13944,	  
Anapl_14149,	  Anapl_14731,	  Anapl_15045,	  Anapl_17920,	  Ank2,	  
Anon1a3,	   Apkc,	   Apoe,	   Appl,	   Arc,	   Arf1,	   Arm,	   Armi,	   Arr,	   Aru,	  
Asic1,	   Atad1,	   Atp1a3,	   Atp2b2,	   Atp2b3,	   Atp2b4,	   Baiap2,	   Bcan,	  
Bdnf,	  Bdnf	  1-­‐5,	  Bdnf	  2-­‐5,	  Be,	  Bhlhb3,	  Bhlhe40,	  Bmk,	  Braf,	  Brp,	  
Bs,	   Btbd9,	   Cabp1,	   Cacna1d,	   Calb1,	   Camk2,	   Camk2a,	   Camk2b,	  
Camk2b-­‐2,	   Camk2g,	   Camk2n2,	   Camk4,	   Camkii,	   Cana1,	   Cask,	  
Casp1,	   Cb1_000340040,	   Cb1_001033005,	   Cb1_001033007,	  
Cb1_061758001,	   Cd38,	   Cdc20,	   Cdk5,	   Cer,	   Cg1910,	   Chat,	  
Chrfam7a,	  Chrna7,	  Chrnb2,	  Chst10,	  Cnr1,	  Cntn2,	  Cntn4,	  Comt,	  
Cpeb1,	   Cpeb3,	   Cpg1,	   Cplx2,	   Creb1,	   Crebb,	   Crh,	   Crhr1,	   Crhr2,	  
Crmp,	   Crtc1,	   Ctnnd2,	   Ctns,	   Cux2,	   Cyp7b1,	   D1a,	   D1ar,	   D1r,	  
D623_10010876,	   D623_10011523,	   D623_10034181,	   Dbdr,	  
Dbh,	   Dbn1,	   Dbr,	   Ddc,	   Dgk-­‐3,	   Dikar,	   Dkfzp459p1345,	  
Dkfzp586o1422,	   Dkfzp666e058,	   Dlg4,	   Dnc,	   Dome,	   Dop1r1,	  
Dopamine	  D4	   Receptor,	   Drd1,	   Drd1a,	   Drd2,	   Drd4,	   Drd5,	   Drk,	  
Drl,	   Dys,	   Dysb,	   Eas,	   Ecr,	   Egk_06754,	   Egk_07579,	   Egk_08492,	  
Egk_10885,	   Egk_13715,	   Egk_17301,	   Egk_17782,	   Egk_20490,	  
Egk_21097,	   Egm_08947,	   Egm_18769,	   Egr1,	   Egr2,	   Egr2a,	  
Egr2b,	  Ephb2,	  Fabp,	  Fas2,	  Fen1,	  Fgf13,	  Fmr1,	  For,	  G9a,	  Gclm,	  
Gfap,	   Gip,	   Gipc1,	   Gld2,	   Glp1r,	   Glr-­‐1,	   Glud1,	   Glur1/A,	   Glur6,	  
Gria1,	   Grid2ip,	   Grik1,	   Grik2,	   Grin1,	   Grin2a,	   Grin2b,	   Grm5,	  
Grm7,	   Gry,	   Gsk3b,	   Gsteng00003068001,	   Gsteng00012033001,	  
Gsteng00015539001,	   Gsteng00023512001,	   Gw7_20097,	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Gw7_20553,	  H-­‐Ras,	  Hd,	  Hdac4,	  Hdh,	  Hn,	  Hop,	  Hras,	  Hrh1,	  Hrh2,	  
Hrh3,	   Htr2a,	   Htr6,	   Htr7,	   Htt,	   Huntingtin,	   I79_004266,	  
I79_012252,	   I79_017386,	   Igf1,	   Igf2,	   Il-­‐1ra3,	   Il1b,	   Il1rn,	   Inx6,	  
Inx7,	  Ip3ka,	  Itga3,	  Itga5,	  Itga8,	  Itpka,	  Itpr3,	  Jph3,	  Jph4,	  K-­‐Ras,	  
Kcnj10,	   Kcnn2,	   Kdr,	   Kir1.2,	   Kit,	   Klg,	   Klk8,	   Kra,	   Kras,	   Laps18,	  
Llp,	   Lnpep,	   Loc100027128,	   Loc100051785,	   Loc100074355,	  
Loc100078807,	   Loc100085430,	   Loc100087588,	  
Loc100424539,	   Loc100429201,	   Loc100429880,	  
Loc100462513,	   Loc100464004,	   Loc100469483,	  
Loc100471067,	   Loc100471742,	   Loc100473900,	  
Loc100478979,	   Loc100479130,	   Loc100480755,	  
Loc100481007,	   Loc100518193,	   Loc100543989,	  
Loc100553975,	   Loc100558419,	   Loc100563575,	  
Loc100566637,	   Loc100621117,	   Loc100621119,	  
Loc100621290,	   Loc100690409,	   Loc100693221,	  
Loc100700952,	   Loc100707058,	   Loc100737780,	  
Loc100856162,	   Loc100857281,	   Loc100858799,	  
Loc100859203,	   Loc100930913,	   Loc101063188,	  
Loc101070904,	   Loc101072537,	   Loc101078298,	  
Loc101167749,	   Loc101168118,	   Loc101749001,	   Loc430487,	  
Loc706977,	   Loc715570,	   Loc737111,	   Lrrn4,	   Lrrtm1,	   Lrrtm2,	  
Lzts1,	   M91_06294,	   M91_09841,	   Magi-­‐1,	   Map1b,	   Mblk-­‐1,	  
Mda_Glean10025350,	   Mdk,	   Mecp2,	   Mef2c,	   Mgll,	   Mld,	   Mmp9,	  
Mob2,	  Mol,	   Mura,	   Musk,	   Mylk2,	   Myo6,	   N,	   N-­‐Ras,	   Nacp,	   Ncdn,	  
Nelf,	   Nemy,	   Neto1,	   Neto1	   (2	   Of	   2),	   Neto1l,	   Neur,	   Neurl1,	  
Neurod2,	  Nf1,	  Nfatc4,	  Ngf,	  Nicb2,	  Nmda2c,	  Nmdar1,	  Nmdar2,	  
Nptn,	   Nptx2b,	   Nqo2,	   Nr1,	   Nr2a,	   Nr2e1,	   Nr3c1,	   Nras,	   Nsmf,	  
Nsun2,	  Nt1,	  Ntan1,	  Ntf4,	  Ntf5,	  Ntrk2,	  Orb2,	  Os,	  Osk,	  Oxt,	  Oxtr,	  
P21	   Ras,	   P2rx3,	   P2x3,	   P2x3r,	   P70s6k/P85s6k	   Gene,	   Paip2,	  
Pak6,	   Pak7,	   Pal_Glean10001454,	   Pal_Glean10017165,	  
Panda_002316,	   Panda_002531,	   Panda_003288,	  
Panda_004718,	   Panda_006022,	   Panda_006106,	  
Panda_006277,	   Panda_006399,	   Panda_007686,	  
Panda_007846,	   Panda_008389,	   Panda_008470,	  
Panda_009139,	   Panda_009214,	   Panda_009520,	  
Panda_009907,	   Panda_010155,	   Panda_010687,	  
Panda_011743,	   Panda_012625,	   Panda_012816,	  
Panda_012985,	   Panda_013201,	   Panda_018915,	  
Panda_019361,	  Panda_019720,	  Panda_020790,	  Pcdh8,	  Pde4d,	  
Pde5a,	   Pdzgef1,	   Per,	   Phm,	   Pi3k92e,	   Pick1,	   Pja2,	   Pka-­‐C1,	  
Pkc98e,	   Pla2g6,	   Plat,	   Plcb1,	   Plk2,	   Plk3,	   Pmca,	   Pmca2,	   Pmch,	  
Pn-­‐1,	   Ppfia3,	   Ppp3cb,	   Ppt1,	   Prkcz,	   Psen1,	   Psen2,	   Pst,	   Pten,	  
Ptgs1,	  Ptgs2,	  Ptk2b,	  Ptp10d,	  Pum,	  Pxb,	  Rab11a,	  Rab5a,	  Rab8a,	  
Rad,	   Rapgef2,	   Rara,	   Rasgrf1,	   Rcan1,	   Rcan2,	   Reln,	   Rg,	   Rgs14,	  
Rheb,	   Rim,	   Rims1,	   Rin1,	   Rnf39,	   Rps6kb1,	   Rut,	   S100b,	   S100p,	  
Sap47,	  Scamp,	  Scb,	   Serpine2,	   Serpinf1,	   Sgk1,	   Shank1,	  Shank2,	  
Shank3,	  Shi,	  Shisa8,	  Shisa9,	  Shisa9a,	  Shisa9b,	  Sipa1l1,	  Slc17a7,	  
Slc24a2,	  Slc6a4,	  Snap25,	  Snap47,	  Snca,	  Socs36e,	  Sorcs3,	  Spoon,	  
Spz5,	   Sra,	   Src64b,	   Srf,	   Ss,	   Star,	   Stat92e,	   Stau,	   Stx3,	   Stxbp1,	  
Su(H),	   Svr,	   Syn,	   Syngap1,	   Syngr1,	   Syp,	   Sypa,	   Sypb,	   Syph,	   Syt4,	  
Tac1,	   Tacr1,	   Tbh,	   Tequila,	   Th,	   Tip60,	   Tnr,	   Tomosyn,	   Tpa,	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Trees_T100006419,	   Trpm7,	   Tyrosine	   Hydroxylase,	   Ube3a,	  
Unc13a,	   Unc13b,	   Uy3_07175,	   Vamp2,	   Vgf,	   Vldlr,	   Vsg,	  W,	  Wg,	  
Ywhag,	  Ywhah	  
Array	   1,026	   Aak1,	  Aamp,	  Abca4,	  Abca8,	  Abcc9,	  Abcg8,	  Abhd5,	  Abp10,	  Ace,	  
Acta2/Actc1,	   Acvr1,	   Adam2,	   Adam23,	   Adamts19,	   Adamtsl4,	  
Adamtsl5,	  Adap2,	  Add3,	  Adora1,	  ADORA2A,	  ADORA2B,	  Adra1b,	  
Adra2b,	  Aff4,	  Afmid,	  Afp,	  Agmat,	  Ago1,	  Agps,	  Agtpbp1,	  Agtr2,	  
Ahcyl1,	   Ak4,	   Akap13,	   Akap8l,	   Akirin2,	   Akr7a3,	   Aldh16a1,	  
Aldh1a2,	  Aldh1l2,	  Alg13,	  Alkbh1,	  Alpk2,	  Amn1,	  Ank2,	  Ankhd1,	  
Ankib1,	   Ankrd13b,	   Ankrd16,	   Ankrd34b,	   Anks1b,	   Anxa7,	  
Aoc3/G6pc/Psme3,	   Aox1,	   Ap2a2,	   Ap2b1/LOC100912146,	  
Apba1,	   Apitd1/Cort/Kif1b/LOC100360180,	   Apoc3,	   App,	  
Appbp2,	  Aqp1,	  Aqp3,	  Ar,	  Arc,	  Arcn1,	  Arg1,	  Arhgap1,	  Arhgap10,	  
Arhgap24,	   Arhgap27,	   Arhgap32,	   ARHGEF12,	   Arhgef15,	  
Arhgef9/LOC100912165,	   Arid1a,	   Arl10,	   Arl4c,	   Arl4d,	   Arl6ip5,	  
Armcx3,	  Arnt,	  Arnt2,	  ARPC5L,	  Arx,	  Ash1l,	  Asph,	  Atad3a,	  Atad5,	  
Atf3,	   Atl3,	   Atp11a,	   Atp1a1,	   ATP2A1,	   ATP2A2,	   ATP2B1,	  
ATP2B4,	   Atp4b,	   Atpaf1,	   Atrx,	   Atxn7l4,	   Azi2,	   B3gnt2,	   Bace2,	  
Bank1,	   Baz2b,	   Bcas3,	   Bcl2a1,	   Bcl2l14,	   Bcl9,	   Bcr,	   Bhlhb9,	  
Bhlhe22,	   Bhmt2,	   Birc7,	   Blcap,	   Blvra,	   Bmp3,	   Bmpr1a,	   Bre,	  
Btbd16,	   Btg2,	   Btnl3,	  
Btnl5/Btnl7/Btnl8/LOC100911938/LOC100911983/LOC1009
12021,	  C1qtnf1,	  C1qtnf3,	  C7/Tubb4b,	  Cabp1,	  Cacng4,	  Cacng8,	  
Cadm3,	  Cald1,	  Camk1g,	  CAMK2D,	  Camk2n1,	  CAMK4,	  Camta2,	  
Capn8,	   Car6,	   Cars,	   Casc3,	   Caskin1,	   Ccar1/LOC100911233,	  
Ccdc113,	   Ccdc115,	   Ccdc155,	   Ccnd1,	   Ccnd2,	   Ccne2,	  
Cd99l2/LOC100911604/LOC501437,	  Cdc23,	  Cdc27,	  Cdc42bpa,	  
Cdca7,	   Cdh3,	   Cdk20,	   Cdk5r2,	   Cdkn1c,	   Cdr2,	   Cdyl2,	   Cebpg,	  
Cenpv,	   Cep350,	   Cep41,	   Cgnl1,	   Chd1,	   Chd4,	   Chn2,	   Chrdl1,	  
CHRM1,	   CHRM3,	   CHRM5,	   Chtf18,	   Chtf8,	   Cinp,	   Cisd2,	   Clcn3,	  
Clcn4,	   Clcnka,	   Cldn12,	   Cldn2,	   Clec10a,	   Clec1b,	   Clic4,	  
Clspn/LOC100912530,	   Cmklr1,	   Cnnm1,	   CNR1,	   Cog2,	   Col8a1,	  
Col9a3,	   Colec11,	   Coro1c,	   Cox8b,	   Cpd,	   Cpne3,	   Cpne8,	   Cpne9,	  
Crb3,	   Crem,	   Cry2,	   Crybb3,	   Csf3r,	   Csnk1d,	   Csnk2a2,	   Cspg5,	  
Cspp1,	   Csrnp1,	   Cst7,	   Ctla2a,	   Ctnnb1,	   Ctr9,	   Ctrc,	   Cttn,	   Cutc,	  
Cxcl13,	   Cxcr3,	   Cyp19a1,	   Cyp26a1,	   Cyp2e1,	  
Cyp3a23/3a1/Sptlc1,	   Cyth1,	   Dab2,	   Dapk1,	   Dbc1,	   DBH,	   DCC,	  
Dctn6,	  Dcun1d4,	  Ddah1,	  Ddit3,	  Ddr2,	  Defa-­‐Rs1,	  Dek,	  Dgki,	  Dhh,	  
Dhrs4,	   DHX36,	   Dicer1,	   Dlg4,	   Dlgap1,	   Dlk1,	   Dmtn,	   Dmwd,	  
Dnaja4,	   Dnajb5,	   Dnajc21,	   Dnal4/RGD1559781,	   Dnali1,	  
Dnase1,	  Dnase1l2,	  Dnm3,	  Dnmt3a,	  Dock11,	  Dpm1,	  Dpp8,	  Dsn1,	  
Dsp,	   Dtnb,	   Dusp1,	   Dusp2,	   DUSP5,	   Dusp6,	   Dync1li1,	   Dyrk2,	  
Dzip3,	   Edn2,	   Eef1g,	   EFNB1,	   Egfl8,	   EGFR,	   Egr1,	   Egr2,	   Egr3,	  
Egr4,	   Ehd1,	   Ehhadh,	   EIF2S1,	   EIF3C,	  
Eif4g1/LOC100910289/LOC100911431,	   Elavl1,	   Elmod3,	  
Elovl6/LOC100910695,	   Eml2,	   Eml4,	   Enc1,	   Enpp1,	   Enpp2,	  
EPHA2,	   EPHA4,	   Eprs,	   Eps15,	   Erf,	   Erlin2,	   Ermn,	   Erp44,	   Esf1,	  
Ethe1,	   Etv1,	   Etv5,	   Eva1a,	   Evc,	   Exoc8,	   Ext1,	   Ezh1,	   F5,	   Faf2,	  
Fam101a,	  Fam115a,	  Fam120b,	  Fam126b,	  Fam134c,	  Fam135a,	  
Fam13b,	   Fam168a,	   Fam168b,	   Fam179b,	   Fam46a,	   Fam49a,	  
Fam63b,	   Fam69b,	   Fam81a,	   Fance,	   FAS,	   Fat4,	   Fbxl6,	   Fbxo23,	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Fcgr3a,	  Fdft1,	  Fermt2,	  Fetub,	  FGF14,	  FGF2,	  FGF21,	  Fgfr2,	  Fgg,	  
Fhl1,	  Fkbp11,	  Fkbp5,	  Fmo4,	  Fmod,	  Fndc1,	  Fndc3b,	  Folr1,	  Fosl2,	  
Foxn3,	   Foxo1,	   Foxo3,	   Foxp1,	   Foxp4,	   Frs2,	   Fry,	   Fxn,	   Fyttd1,	  
Fzd3,	   Gabarapl1,	   Gabbr1,	   Gabre,	   Gad2,	   Gadd45b,	   GADD45G,	  
Galr2/LOC100910349,	   Gap43,	   Gas6,	   Gata2,	   Gatad2b,	   Gc,	  
Gfod2,	  Gfra3,	  Gfra4,	  Ggct,	  Git2,	  Gjb5,	  Glb1l,	  Gls,	  Glycam1,	  Gmfb,	  
Gmip,	  Gmnn,	  GNA14,	  Gnb4,	  Golt1b,	  Got1,	  Got2,	  Gpd2,	  Gpihbp1,	  
Gpr107,	   Gpr19,	   Grasp,	   Grik1,	   GRIN2A,	   Grin3a,	   Grm3,	   Grm6,	  
GRPR,	   Grtp1,	   Grwd1,	   Gsk3b,	   Gstcd,	   Gtf2f1,	   GUCY1A3,	   Gulp1,	  
Hars,	   Hdac1,	   Heatr6,	   Hectd1,	   Helq,	   Hes1,	   Hfe,	   Hic2,	  
Hira/LOC100911837,	   Hist1h2aa,	   Hk1,	   Hmgb1,	  
Hnrnpa2b1/LOC100365752,	   Hnrnpa3,	   Homer1,	   Homer3,	  
Hpcal4,	   Hpse,	   Hrasls,	   Hrg/LOC681544,	   Hrk,	   Hs3st2,	   Hspa4,	  
Htr1d,	  Htr3b,	   Icos,	   Id4,	   Ier2,	   Ier5,	   Ifnar1,	   Igf2,	   Igfbp2,	   Igfbp5,	  
Igfbpl1,	   Igsf1,	   Igsf8,	   IKBKB,	   Il17b,	   Il1a,	   Il1rap,	   Il5,	   Il6st,	   Ing3,	  
Inpp4b,	   Ints6,	   Invs,	   Irf2bpl,	   Irs2,	   Irs3,	   ITGB6,	   Itsn2,	   Jak3,	  
Jmjd1c,	  Jun,	  Junb,	  Kank3,	  Kcna3,	  Kcnd3,	  Kcne2,	  Kcnip3,	  Kcnj14,	  
Kcnj2,	   Kcnj3,	   Kcnj4,	   Kcnk3,	   Kcnq3,	   Kcns3,	   Kctd1,	   Kctd15,	  
Kdm5a,	   Kdm6a,	   Kdm6b,	   Khsrp,	   Kif1a,	   Kif5a,	   Kifap3,	   Kl,	   Klc1,	  
Klf10,	   Klf11,	   Klf2,	   Klhl24,	   Klhl31,	   Klrb1b,	   Klrc1,	   Kpna1,	   Kprp,	  
Kras,	  Krt18,	  Krt19,	  Krt36,	  Krt4,	   Lama2,	  Lama5,	  Lasp1,	  Lect2,	  
Lims2,	   Lin7a,	   Lingo1,	   Llgl2,	   Lmo4,	   Lmo7,	   LOC100125362,	  
LOC100361661/LOC100363391/LOC100364645/Rpl39,	  
LOC100362769/Mt1a/Ttr,	   LOC100909485/Spin2a,	  
LOC100909758/Vkorc1l1,	   LOC100910021,	   LOC100910033,	  
LOC100910161/Mycbp2,	  
LOC100910520/LOC680562/LOC690779/Mob1a,	  
LOC100910745,	   LOC100910882/Rbm39,	  
LOC100911492/Otx2,	   LOC100911617/Prmt6,	   LOC100912131,	  
LOC100912698/Tmcc1,	   LOC498369/Nbr1,	  
LOC685590/Pik3ca,	   Lpgat1,	   Lphn2,	   Lpin2,	   Lppr4,	   Lpxn,	   Lrba,	  
Lrg1,	   Lrp2,	   Lrp3,	   Lrpprc,	   Lrrc15,	   Lrrc16a,	   Lrrc26,	   Lrrc51,	  
Lsamp,	   Luc7l,	   Ly6h,	   Lyn,	   Lynx1,	   Lypd3,	   Magt1,	   Man1a1,	  
Man2a1,	   Map1b,	   Map2,	   Map7,	   Mapk13,	   MAPK8IP1,	  
MAPK8IP3,	   MAPKAPK3,	   Mbl1,	   Mbnl2,	   Mbp,	   Mcl1,	   Mcm6,	  
Mdga1,	   MDK,	   Mdm4,	   Med1,	   Megf11,	   Metrn,	   Mex3b,	   Mfap3,	  
Mfrp,	   Micall2,	   Mid2,	   Mier1,	   Mir384,	   Mitd1,	   Mmp14,	   Mmp23,	  
Mobp,	   Mospd2,	   Mpp5,	   Mpped1,	   Mre11a,	   Mrm1,	   Mrvi1,	   Msi2,	  
Msx1,	   Mtmr1,	   MYLPF,	   Myo5c,	   Mypop,	   Naaladl1,	   Nab2,	   Nasp,	  
Nav2,	  Ncam2,	  Ncf4,	  Ncor1,	  Nde1,	  Ndst1,	  Nedd4,	  Negr1,	  Neto2,	  
NFAT5,	  Nfe2l1,	  Nfix,	  Nfkbiz,	  Ngfr,	  Nkain3,	  Nkx3-­‐1,	  Nle1,	  Nlrp6,	  
Nmu,	   Nog,	   Nolc1,	   NOS1,	   Npr2,	   Nr1d1,	   Nr1h2,	   Nr4a1,	   Nr4a2,	  
Nr4a3,	   Nrxn1,	   Nsf,	   Nt5dc2,	   Ntm,	   Ntmt1,	   Nubp1,	   Numbl,	  
NUP133,	  Nxph1,	  Ocln,	  Oma1,	  Oprd1,	  Optn,	  Orai3,	  Oraov1,	  Orc3,	  
Osbpl1a,	   Osbpl2,	   Otud7a,	   Pabpn1,	   Pacs1,	   Pafah1b1,	   Papola,	  
Parp4,	  Parvb,	  Pbrm1,	  Pbx2,	  Pcdha13,	  Pcdhb12,	  Pcgf3,	  Pcmtd2,	  
PCOLCE2,	   Pctp,	   Pcyt1b,	   Pde4d,	   Pde8a,	   Pdia3,	   Pdlim2,	   Pds5b,	  
Pdzd3,	  Pdzd4,	  Peli2,	  Per1,	  Per3,	  Pet112l,	  Pex10,	  Pex5l,	  Pfkfb2,	  
Pgp,	   Phc1,	   Phf17,	   Phf20,	   Phf7,	   Phlda3,	   Pi4k2a,	   PIK3R3,	  
PIP5K1A,	  Pklr,	  Pkn3,	  Pknox1,	  PLA2G4A,	  PLA2G5,	  Plac8,	  Plaur,	  
Plcd3,	   Plekhb2,	   PLK2,	   PLXNA2,	   Pmel,	   Pmepa1,	   Pmm2,	   Pnisr,	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Pnmal2,	   PNN,	   Pola2,	   Polg,	   Polm,	   Pon1,	   Ppap2b,	   Ppif,	   Ppl,	  
PPP1R12A,	   Ppp1r15a,	   Ppp1r37,	   Ppp1r3b,	   Ppp1r7,	   PPP2R1A,	  
Ppp3ca,	  PPP3R1,	  Pqlc2,	  Prap1,	  Prf1,	  Prkaa2,	  PRKACB,	  PRKCA,	  
Prlr,	  Prokr1,	  Prpf38b,	  Prr12,	  Prrc2c,	  Psap,	  Psd4,	  Psmc4,	  Ptbp1,	  
Ptgr1,	   PTGS2,	   Ptk7,	   Ptpn21,	   Ptprd,	   Pygo2,	   Pzp,	   Qdpr,	   Rab10,	  
Rab11fip3,	   Rab14,	   Rab22a,	   Rab5c,	   Rab8b,	   Rad23a,	   Rad23b,	  
Rad51ap1,	  Rad9b,	  Rai14,	  Rala,	  Ralgapa1,	  Raly,	  Ramp3,	  Rap2a,	  
Rasal2,	   Rasd1,	   Rasgrf2,	   RASGRP4,	   Rasl11b,	   Rassf1,	   Rassf5,	  
Rbbp6,	   Rbfox1,	   Rbm47,	   Rbpj,	   Reps1,	   Rfc1,	   Rfx7,	  
RGD1561897/Uhmk1,	   Rgs17,	   Rgs2,	   Rgs4,	   Rhbdl3,	   Rhod,	   Rif1,	  
Rilpl1,	   Riok1,	   Ripk1,	   Rnase12,	   Rnf113a2,	   Rnf152,	   Rnf207,	  
Rnf39,	  Rnf4,	  Rnft2,	  Rngtt,	  RNPS1,	  Rock1,	  ROCK2,	  Rora,	  Rprd1a,	  
RT1-­‐Db1,	  RT1-­‐EC2,	  Rtn4,	  Runx1t1,	  Rybp,	  S1pr2,	  Sall2,	  Samd14,	  
Samd4b,	   Sbk1,	   Sbno1,	   Scap,	   Scgb1c1,	   Scn11a,	   Scn2b,	   Scyl3,	  
Sdc1,	  Sec63,	  Secisbp2l,	  Sema6c,	  Senp3,	  Sertad1,	  Sertad2,	  Setd5,	  
Sf3a1,	   Sf3b1,	   Sfi1,	   Sfrp1,	   Sftpd,	   Sgcb,	   Sgsm2,	   Sgtb,	   Shank1,	  
Shc2,	   Siah2,	   Siat7d,	   Sik1,	   Sirt4,	   Ska3,	   Slc10a1,	   Slc10a7,	  
Slc16a13,	   Slc16a6,	   Slc20a2,	   Slc22a5,	   Slc24a1,	   Slc25a25,	  
Slc25a41,	   Slc2a13,	   Slc30a9,	   Slc31a1,	   Slc35b2,	   Slc37a4,	  
Slc38a4,	   Slc4a2,	   Slc51a,	   Slc5a5,	   Slc6a6,	   Slc6a7,	   Slc6a9,	  
Slc7a10,	  Slc7a5,	  Slc7a7,	  Slc9a4,	  Slc9a5,	  Slco1a5,	  Slco2a1,	  Slu7,	  
Smarca4,	   Smarce1,	   Snapc5,	   Snrnp48,	   Sntg2,	   Snx18,	   Snx27,	  
Sorcs3,	   Sort1,	   Sostdc1,	   Sox6,	   Sp1,	   Sp2,	   Spag9,	   Spats2,	   Spdya,	  
Sphk1,	   Spp1,	   Sppl2a,	   Spry2,	   Srcrb4d,	   Srebf2,	   Srf,	   Sspn,	   St18,	  
St6gal1,	  St8sia3,	  Stap2,	  Steap1,	  Stmn4,	  Strn4,	  Stx3,	  Sv2b,	  Syk,	  
Syn2,	  Synj2,	  Syp,	  Syt1,	  Syt4,	  Tacc3,	  TACR2,	  Taf9b,	  Tal1,	  Tanc2,	  
Taok1,	  Tas2r13,	  Tbc1d10a,	  Tbl1x,	  Tbl1xr1,	  Tcf20,	  Tdh,	  Tdrd12,	  
Tef,	  Terf2,	  Tgif1,	  Thbs2,	  THOC2,	  Thra,	  Thsd7a,	  Timp1,	  Tiparp,	  
Tjp1,	   Tlk2,	   Tm4sf1,	   Tm9sf3,	   Tm9sf4,	   Tmed9,	   Tmem117,	  
Tmem194b,	   Tmem27,	   Tmem86a,	   Tmprss11d,	   Tmx4,	   Tnfaip2,	  
Tnfaip8l2,	   Tnni2,	   Tnpo1,	   TNR,	   Tnrc6b,	   Tob1,	   Tollip,	   Top3a,	  
Tor1b,	  Tp53i11,	  Tpr,	  Tra2a,	  Tram1,	  Treh,	  Trerf1,	  Trib1,	  Trim2,	  
Trim39,	  Trove2,	  Trps1,	  Trpv4,	  Tsc22d2,	  Tsga10,	  Tspan5,	  Ttpal,	  
Ttyh1,	   Tuba8,	   Tut1,	   Txlnb,	   Tyrp1,	   Ube2g2,	   Ube2s,	   Ube3a,	  
Ube4a,	  Ubn2,	  Ubp1,	  Ubr4,	  Uggt1,	  Urb2,	  Usp11,	  Usp29,	  Usp42,	  
Usp8,	   UST4r/Ust5r,	   Utp6,	   Utrn,	   Vamp1,	   Vapb,	   Vash1,	   Vash2,	  
Vasn,	   Vcpip1,	   Vezf1,	   Vgf,	   Vhl,	   Vom1r102,	   Vom2r31,	   Vps13c,	  
Vsnl1,	   Wbp7,	   Wdfy2,	   Wdr4,	   Wfdc6a,	   Whamm,	   Whsc1l1,	  
Wnt10a,	   Wtap,	   Wwtr1,	   Xpnpep3,	   Xpo7,	   Xrn2,	   Xylb,	   Ythdf2,	  
Zbtb11,	   Zbtb20,	   Zc3h13,	   Zc3h15,	   Zc3h7b,	   Zc4h2,	   Zdhhc20,	  
Zfhx4,	  Zfp105,	  Zfp213,	  Zfp292,	  Zfp346,	  Zfp36,	  Zfp428,	  Zfp462,	  
Zfp536,	  Zfp598,	  Zfp655,	  Zfp775,	  Zfp91,	  Zfpm2,	  Zfyve20,	  Zfyve9,	  
Zhx3,	  Zmat5,	  Zmynd11,	  Zranb2,	  Zrsr1,	  Zrsr2,	  Zscan20	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C.2 Script	  Used	  to	  Test	  for	  Algorithm	  Enrichment	  
The	   script	   was	   run	   in	   R	   64	   bit	   v2.14	   and	   is	   based	   upon	   work	   by	   Associate	  
Professor	  Cris	  Print	  (University	  of	  Auckland).	  
	  
C.2.1 Script	  
print("Have	  you	  changed	  the	  working	  directory	  yet	  (y/n)?")	  
confirm<-­‐as.character(readLines(con=stdin(),n=1,ok=TRUE))	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if(PS=="5")	  





	  	  	  	  	  





	  	  	  	  	  
b	  <-­‐	  read.delim(individfilename,	  skip=0,	  sep="\t",	  as.is=TRUE)	  
algorithm.permutation.gene.numbers<-­‐b[1,]	  






	  	  	  	  	  
fileOut<-­‐paste(loopfiles,"	  ",KEGG.pathway.name,"	  All	  Single	  Permutation.txt",sep="")	  
fileOut2<-­‐paste(KEGG.pathway.name,"	  All	  Single	  Permutation.txt",sep="")	  
	  	  	  	  	  
new.path=file.path(KEGG.pathway.name)	  
	  	  	  	  	  
dir.create(new.path)	  




#NEW	  ALGORITHM	  LOOP	  
values<-­‐c("1","2","3","4","5","6","7","8","9")	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#optionally	  adjust	  p	  for	  multiple	  testing	  
	  	  	  





	  	  	  	  	  
#LIST	  COMBINATION	  AND	  PRINTING-­‐	  
combinedlist<-­‐list(list2,list9,list6,list4,list3,list1,list7,list8,list5)	  
	  	  	  
lapply(X=combinedlist,FUN=function(x){write(x,append=T,file=mypath1,ncolumns=len
gth(x),sep="\t")})	  
	  	  	  	  	  
lapply(X=combinedlist,FUN=function(x){write(x,append=T,file=mypath2,ncolumns=len
gth(x),sep="\t")})	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C.3 Enrichment	  Analysis	  for	  the	  15	  microRNA	  
	  
Table	  C.2:	  Enrichment	  analysis	  of	  LTP-­‐related	  targets	  predicted	  by	  targeting	  algorithms	  for	  15	  miRNA.	  
	   LTP	  KEGG	   KEGG	   GO	   Array	   Combined	  







DIANA-­‐microT	   4	   0.50	   65	   1.00	   18	   0.88	   71	   0.00	   126	   0.01	  
miRanda	   12	   0.49	   174	   1.00	   50	   1.00	   224	   0.00	   361	   0.51	  
miRWalk	   5	   0.95	   116	   1.00	   32	   1.00	   154	   0.00	   245	   1.00	  
MiTarget2	   2	   0.52	   19	   1.00	   8	   0.95	   36	   0.00	   54	   0.65	  
PicTar2	   6	   0.24	   72	   1.00	   27	   0.59	   101	   0.00	   164	   0.00	  
PITA	   14	   0.77	   238	   1.00	   70	   1.00	   295	   0.00	   496	   0.65	  
RNA22	   4	   0.23	   34	   1.00	   8	   0.97	   38	   0.00	   70	   0.11	  
RNAhybrid	   2	   0.88	   47	   1.00	   19	   0.96	   80	   0.00	   123	   0.38	  







DIANA-­‐microT	   4	   0.04	   25	   1.00	   8	   0.70	   28	   0.00	   48	   0.09	  
miRanda	   18	   0.21	   198	   1.00	   63	   1.00	   277	   0.00	   443	   0.86	  
miRWalk	   17	   0.01	   111	   1.00	   34	   1.00	   115	   0.00	   203	   0.99	  
MiTarget2	   3	   0.67	   54	   1.00	   15	   1.00	   80	   0.00	   131	   0.13	  
PicTar2	   6	   0.05	   42	   1.00	   13	   0.85	   60	   0.00	   94	   0.01	  
PITA	   27	   0.03	   243	   1.00	   81	   1.00	   319	   0.00	   511	   0.49	  
RNA22	   4	   0.07	   33	   1.00	   8	   0.80	   31	   0.00	   56	   0.04	  
RNAhybrid	   1	   0.61	   13	   1.00	   5	   0.91	   21	   0.01	   29	   0.88	  







DIANA-­‐microT	   0	   1.00	   16	   1.00	   2	   0.98	   14	   0.05	   26	   0.57	  
miRanda	   12	   0.23	   142	   1.00	   31	   1.00	   139	   0.00	   255	   0.73	  
miRWalk	   12	   0.55	   167	   1.00	   48	   1.00	   158	   0.00	   286	   1.00	  
MiTarget2	   2	   0.34	   17	   1.00	   5	   0.86	   18	   0.02	   30	   0.65	  
PicTar2	   3	   0.32	   37	   1.00	   10	   0.78	   38	   0.00	   63	   0.08	  
PITA	   19	   0.33	   233	   1.00	   63	   1.00	   273	   0.00	   458	   0.67	  
RNA22	   18	   0.00	   147	   1.00	   36	   0.89	   116	   0.00	   247	   0.00	  
RNAhybrid	   30	   0.21	   350	   1.00	   107	   1.00	   403	   0.00	   688	   0.79	  
TargetScanS	   18	   0.31	   226	   1.00	   61	   1.00	   277	   0.00	   451	   0.82	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   LTP	  KEGG	   KEGG	   GO	   Array	   Combined	  







DIANA-­‐microT	   0	   1.00	   2	   1.00	   2	   0.35	   5	   0.03	   7	   0.28	  
miRanda	   12	   0.08	   122	   1.00	   28	   1.00	   127	   0.00	   218	   0.74	  
miRWalk	   12	   0.32	   151	   1.00	   45	   1.00	   145	   0.00	   273	   0.97	  
MiTarget2	   3	   0.04	   15	   1.00	   5	   0.56	   15	   0.01	   26	   0.18	  
PicTar2	   1	   0.20	   4	   0.96	   0	   1.00	   4	   0.05	   8	   0.05	  
PITA	   22	   0.06	   210	   1.00	   67	   1.00	   255	   0.00	   420	   0.27	  
RNA22	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	  
RNAhybrid	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	  







DIANA-­‐microT	   2	   0.80	   54	   1.00	   15	   0.78	   68	   0.00	   108	   0.00	  
miRanda	   11	   0.23	   114	   1.00	   33	   1.00	   146	   0.00	   241	   0.92	  
miRWalk	   7	   0.71	   112	   1.00	   30	   1.00	   128	   0.00	   213	   0.95	  
MiTarget2	   1	   0.72	   10	   1.00	   8	   0.70	   19	   0.07	   33	   0.89	  
PicTar2	   3	   0.64	   60	   1.00	   19	   0.74	   79	   0.00	   124	   0.00	  
PITA	   18	   0.19	   210	   1.00	   64	   1.00	   249	   0.00	   426	   0.05	  
RNA22	   10	   0.00	   61	   1.00	   18	   0.64	   50	   0.00	   107	   0.00	  
RNAhybrid	   2	   0.20	   13	   1.00	   5	   0.75	   16	   0.02	   28	   0.44	  







DIANA-­‐microT	   7	   0.01	   42	   1.00	   19	   0.29	   61	   0.00	   90	   0.01	  
miRanda	   20	   0.02	   172	   1.00	   51	   1.00	   224	   0.00	   365	   0.16	  
miRWalk	   2	   0.94	   65	   1.00	   18	   1.00	   76	   0.00	   132	   0.69	  
MiTarget2	   3	   0.26	   27	   1.00	   11	   0.80	   41	   0.00	   60	   0.45	  
PicTar2	   5	   0.13	   45	   1.00	   20	   0.32	   76	   0.00	   104	   0.00	  
PITA	   27	   0.02	   245	   1.00	   71	   1.00	   292	   0.00	   493	   0.17	  
RNA22	   5	   0.08	   43	   1.00	   15	   0.39	   44	   0.00	   88	   0.00	  
RNAhybrid	   2	   0.36	   20	   1.00	   7	   0.72	   20	   0.02	   35	   0.59	  








DIANA-­‐microT	   5	   0.17	   48	   1.00	   16	   0.58	   59	   0.00	   100	   0.00	  
miRanda	   10	   0.50	   145	   1.00	   46	   1.00	   194	   0.00	   319	   0.36	  
miRWalk	   16	   0.34	   187	   1.00	   54	   1.00	   207	   0.00	   372	   0.88	  
MiTarget2	   5	   0.03	   31	   1.00	   12	   0.40	   42	   0.00	   64	   0.01	  
PicTar2	   6	   0.02	   47	   1.00	   16	   0.28	   74	   0.00	   98	   0.00	  
PITA	   31	   0.02	   295	   1.00	   82	   1.00	   327	   0.00	   549	   0.27	  
RNA22	   15	   0.00	   119	   1.00	   30	   0.67	   95	   0.00	   190	   0.00	  
RNAhybrid	   8	   0.08	   61	   1.00	   22	   0.93	   73	   0.00	   128	   0.48	  
TargetScanS	   18	   0.13	   195	   1.00	   55	   1.00	   257	   0.00	   407	   0.02	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   LTP	  KEGG	   KEGG	   GO	   Array	   Combined	  







DIANA-­‐microT	   1	   0.28	   8	   1.00	   1	   0.89	   2	   0.82	   11	   0.35	  
miRanda	   9	   0.10	   83	   1.00	   25	   0.99	   95	   0.00	   171	   0.25	  
miRWalk	   11	   0.12	   97	   1.00	   26	   1.00	   106	   0.00	   181	   0.80	  
MiTarget2	   2	   0.19	   12	   1.00	   5	   0.63	   17	   0.00	   32	   0.04	  
PicTar2	   5	   0.01	   32	   1.00	   13	   0.17	   45	   0.00	   77	   0.00	  
PITA	   22	   0.07	   238	   1.00	   75	   0.99	   275	   0.00	   473	   0.01	  
RNA22	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	  
RNAhybrid	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	  







DIANA-­‐microT	   0	   1.00	   4	   1.00	   3	   0.21	   4	   0.18	   7	   0.52	  
miRanda	   24	   0.04	   240	   1.00	   74	   1.00	   279	   0.00	   493	   0.23	  
miRWalk	   10	   0.27	   103	   1.00	   38	   0.99	   109	   0.00	   196	   1.00	  
MiTarget2	   12	   0.00	   65	   1.00	   22	   0.89	   89	   0.00	   146	   0.01	  
PicTar2	   7	   0.00	   42	   1.00	   19	   0.04	   61	   0.00	   97	   0.00	  
PITA	   38	   0.01	   340	   1.00	   104	   1.00	   394	   0.00	   689	   0.06	  
RNA22	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	  
RNAhybrid	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	  







DIANA-­‐microT	   1	   0.75	   31	   1.00	   12	   0.17	   32	   0.00	   59	   0.00	  
miRanda	   17	   0.13	   184	   1.00	   59	   1.00	   243	   0.00	   408	   0.41	  
miRWalk	   5	   0.77	   90	   1.00	   28	   1.00	   105	   0.00	   185	   0.93	  
MiTarget2	   2	   0.67	   36	   1.00	   12	   0.94	   50	   0.00	   88	   0.10	  
PicTar2	   3	   0.24	   29	   1.00	   19	   0.12	   61	   0.00	   85	   0.00	  
PITA	   25	   0.04	   232	   1.00	   78	   1.00	   291	   0.00	   495	   0.36	  
RNA22	   7	   0.04	   48	   1.00	   17	   0.51	   32	   0.05	   85	   0.07	  
RNAhybrid	   5	   0.00	   21	   1.00	   6	   0.68	   21	   0.00	   34	   0.21	  







DIANA-­‐microT	   0	   1.00	   1	   0.68	   0	   1.00	   0	   1.00	   1	   0.45	  
miRanda	   8	   0.22	   82	   1.00	   26	   1.00	   109	   0.00	   187	   0.39	  
miRWalk	   1	   0.94	   38	   1.00	   13	   0.95	   36	   0.06	   72	   0.93	  
MiTarget2	   1	   0.44	   9	   1.00	   0	   1.00	   13	   0.01	   18	   0.70	  
PicTar2	   1	   0.42	   14	   0.99	   5	   0.20	   13	   0.00	   22	   0.01	  
PITA	   13	   0.09	   111	   1.00	   38	   0.99	   162	   0.00	   257	   0.08	  
RNA22	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	  
RNAhybrid	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	  
TargetScanS	   9	   0.13	   82	   1.00	   26	   1.00	   117	   0.00	   185	   0.39	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   LTP	  KEGG	   KEGG	   GO	   Array	   Combined	  








DIANA-­‐microT	   9	   0.00	   56	   1.00	   20	   0.35	   65	   0.00	   111	   0.00	  
miRanda	   24	   0.03	   203	   1.00	   57	   1.00	   253	   0.00	   422	   0.81	  
miRWalk	   11	   0.20	   110	   1.00	   35	   1.00	   110	   0.00	   197	   1.00	  
MiTarget2	   9	   0.02	   55	   1.00	   20	   0.95	   84	   0.00	   123	   0.42	  
PicTar2	   12	   0.00	   67	   1.00	   25	   0.30	   96	   0.00	   148	   0.00	  
PITA	   26	   0.04	   250	   1.00	   79	   1.00	   321	   0.00	   510	   0.21	  
RNA22	   1	   0.80	   29	   1.00	   12	   0.29	   25	   0.00	   54	   0.05	  
RNAhybrid	   2	   0.24	   15	   1.00	   2	   0.99	   14	   0.14	   27	   0.80	  







DIANA-­‐microT	   1	   0.67	   17	   1.00	   7	   0.33	   18	   0.00	   32	   0.07	  
miRanda	   10	   0.78	   165	   1.00	   46	   1.00	   192	   0.00	   335	   0.91	  
miRWalk	   23	   0.63	   330	   1.00	   100	   1.00	   362	   0.00	   638	   0.91	  
MiTarget2	   1	   0.79	   22	   1.00	   4	   0.99	   19	   0.15	   38	   0.88	  
PicTar2	   6	   0.01	   36	   1.00	   11	   0.74	   56	   0.00	   74	   0.01	  
PITA	   37	   0.02	   336	   1.00	   102	   1.00	   367	   0.00	   653	   0.26	  
RNA22	   14	   0.06	   141	   1.00	   41	   0.72	   129	   0.00	   255	   0.00	  
RNAhybrid	   5	   0.16	   44	   1.00	   11	   0.95	   48	   0.00	   81	   0.22	  








DIANA-­‐microT	   1	   0.07	   2	   0.94	   1	   0.41	   3	   0.04	   4	   0.18	  
miRanda	   8	   0.23	   78	   1.00	   26	   1.00	   100	   0.00	   162	   0.92	  
miRWalk	   5	   0.34	   56	   1.00	   13	   1.00	   59	   0.00	   110	   0.65	  
MiTarget2	   1	   0.47	   8	   1.00	   2	   0.95	   15	   0.00	   21	   0.50	  
PicTar2	   1	   0.26	   9	   0.99	   6	   0.02	   13	   0.00	   26	   0.00	  
PITA	   20	   0.06	   186	   1.00	   54	   1.00	   237	   0.00	   382	   0.44	  
RNA22	   2	   0.57	   34	   1.00	   15	   0.15	   41	   0.00	   72	   0.00	  
RNAhybrid	   0	   1.00	   1	   1.00	   0	   1.00	   2	   0.30	   3	   0.67	  







DIANA-­‐microT	   0	   1.00	   3	   1.00	   2	   0.38	   6	   0.01	   7	   0.33	  
miRanda	   11	   0.18	   121	   1.00	   31	   1.00	   124	   0.00	   219	   0.89	  
miRWalk	   10	   0.43	   140	   1.00	   42	   1.00	   134	   0.00	   248	   0.99	  
MiTarget2	   3	   0.03	   12	   1.00	   4	   0.68	   15	   0.00	   24	   0.20	  
PicTar2	   5	   0.00	   17	   1.00	   4	   0.62	   15	   0.00	   27	   0.03	  
PITA	   22	   0.06	   213	   1.00	   72	   0.99	   254	   0.00	   427	   0.24	  
RNA22	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	  
RNAhybrid	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	   0	   1.00	  
TargetScanS	   18	   0.01	   145	   1.00	   38	   1.00	   178	   0.00	   293	   0.31	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C.4 Total	  Number	  of	  LTP-­‐Related	  Targets	  Predicted	  
	  
Table	   C.3:	   Number	   of	   LTP-­‐related	   targets	   predicted	   by	   the	   nine	   algorithms	   following	   filtering	   with	  
annotations	  and/or	  array	  data	  for	  15	  miRNA.	  
	   Total	  
Predicted	   LTP	  KEGG	   KEGG	   GO	   Array	   Combined	  
miR-­‐9-­‐5p	   8,189	   26	   408	   125	   401	   874	  
miR-­‐23a-­‐3p	   7,618	   40	   397	   118	   481	   802	  
miR-­‐24-­‐3p	   9,768	   49	   532	   150	   598	   1,044	  
miR-­‐28-­‐5p	   6,424	   28	   345	   109	   402	   684	  
miR-­‐29a-­‐3p	   6,348	   37	   369	   109	   426	   740	  
miR-­‐101-­‐3p	   6,345	   34	   351	   102	   455	   745	  
miR-­‐103a-­‐3p	   8,942	   47	   499	   152	   577	   993	  
miR-­‐129-­‐3p	   5,558	   31	   324	   99	   377	   650	  
miR-­‐129-­‐5p	   8,772	   47	   444	   137	   531	   920	  
miR-­‐141-­‐3p	   7,026	   35	   364	   107	   435	   757	  
miR-­‐151-­‐3p	   3,604	   20	   178	   56	   240	   401	  
miR-­‐181c-­‐5p	   7,137	   37	   377	   106	   460	   773	  
miR-­‐214-­‐3p	   11,009	   51	   600	   175	   663	   1,184	  
miR-­‐365a-­‐3p	   4,937	   30	   267	   78	   332	   550	  
miR-­‐708-­‐5p	   6,436	   27	   344	   114	   524	   681	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D.1 Location	  of	  Insert	  Sites	  in	  Gria2	  and	  Mapk1	  Transcripts	  
The	  MRE	  identified	  as	  potential	  sites	  of	  regulation	  by	  miR-­‐132-­‐3p	  and	  cloned	  into	  
the	  ψCheck-­‐2	  plasmid	  are	  marked	  in	  bold	  and	  underlined.	  
	  
D.1.1 Gria2	  Transcript	  
>gi|139394532|ref|NM_017261.2|	  Rattus	  norvegicus	  glutamate	  receptor,	  ionotropic,	  








































































































D.1.2 Mapk1	  Transcript	  
>gi|672071642|ref|XM_006248658.2|	  PREDICTED:	  Rattus	  norvegicus	  mitogen	  activated	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D.2 Luciferase	  Results	  with	  pGria2	  MUT	  and	  Inhibitors	  
	  
D.2.1 Luciferase	  Assays	  for	  Mutated	  Gria2	  Insert	  
Carried	   out	   concurrently	  with	   the	   pGria2	  WT	   luciferase	   assay,	   the	   pGria2	  MUT	  
luciferase	   assay	   was	   carried	   out	   to	   determine	   if	   the	   seed	   site	   was	   crucial	   for	   its	  
persistence.	  However,	  as	  the	  pGria2	  WT	  did	  not	  show	  significant	  regulation	  by	  the	  miR-­‐
132-­‐3p	  mimic	  over	  the	  negative	  control,	  consideration	  of	  the	  importance	  of	  the	  seed	  site	  
was	  not	  required.	  	  
	  
D.2.2 Luciferase	  Assays	  for	  Gria2	  and	  Mapk1	  Inserts	  with	  Inhibitors	  
Carried	   out	   concurrently	  with	   every	   condition	  was	   the	   application	   of	   the	  miR-­‐
132-­‐3p	   inhibitor.	   This	   inhibitor	   should	   target	   the	   miR-­‐132-­‐3p	   mimic	   and/or	   any	  
endogenous	  miR-­‐132-­‐3p	  in	  the	  COS-­‐7	  cells.	  However,	  with	  the	  p132PM,	  the	  expression	  
of	  the	  firefly	  luciferase	  was	  lower	  than	  that	  of	  the	  Renilla,	  suggesting	  that	  an	  interaction	  
between	   the	   inhibitor	   and	   the	  plasmid	  occurred.	  As	   this	  plasmid	   is	   the	   same	  as	   those	  
used	   for	   interrogating	   Gria2	   and	   Mapk1	   except	   for	   the	   inserts,	   the	   chance	   of	   an	  
interaction	   would	   confound	   any	   potential	   results.	   Therefore,	   these	   results	   were	  
excluded	  from	  the	  main	  analysis	  and	  are	  presented	  here.	  
Figure	  D.1:	  Details	  of	  the	  Gria2	  mutant	  MRE	  
sequences	  and	  luciferase	  assay.	  A.	  Details	  of	  
the	   binding	   between	   the	   MRE	   insert	  
sequence	  (blue)	  and	  the	  miR-­‐132-­‐3p	  mimic	  
(red).	   The	   minimum	   free	   energy	   of	   the	  
binding	   is	   -­‐14.7	   kcal/mol.	  B.	   Luminesce	   of	  
the	  Gria2	  mutant	  plasmid	  (pGria2MUT)	  with	  
the	  miR-­‐132-­‐3p	  mimic	  and	  negative	  control.	  
No	   significant	  decrease	   in	  Renilla	   luciferase	  
activity	  indicates	  no	  binding	  of	  the	  miR-­‐132-­‐
3p	   mimic	   to	   the	   insert	   site.	   Expression	  
values:	   average	   ratio	   ±	   SD;	   normalised	   to	  
ratio	   of	   plasmid	   only;	   ns	   Students’	   two	  
tailed	  t-­‐test	  p>0.01;	  n=4.	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Figure	  D.2:	  The	  results	  of	  the	  luciferase	  assay	  with	  the	  miR-­‐132-­‐3p	  inhibitor.	  The	  results	  for	  pGria2	  WT	  
(A),	  pGria2	  MUT	  (B),	  pMapk1	  WT	  (C),	  and	  pMapk1	  MUT	  (D)	  are	  shown	  when	  the	   inhibitor	  was	  applied.	  
The	   application	   of	   the	   inhibitor	   in	   the	   p132PM	   condition	   affected	   the	   efficiency	   of	   the	   plasmid,	   which	  
could	  occur	  with	   these	   plasmids.	   Expression	  values:	   average	   ratio	   ±	   SD;	  normalised	   to	   ratio	  of	  plasmid	  
only.	  
